9593791	Estrogens	Redelmeier DA	The treatment of unrelated disorders in patients with chronic medical diseases.	The New England journal of medicine	1998	138
10591334	Estrogens	Visser M	Elevated C-reactive protein levels in overweight and obese adults.	JAMA	1999	351
15181027	Estrogens	Bray GA	Medical consequences of obesity.	The Journal of clinical endocrinology and metabolism	2004	228
17981890	Estrogens	Rose DP	Adiposity, the metabolic syndrome, and breast cancer in African-American and white American women.	Endocrine reviews	2007	71
18334610	Estrogens	Gao Q	Cross-talk between estrogen and leptin signaling in the hypothalamus.	American journal of physiology. Endocrinology and metabolism	2008	56
20031276	Estrogens	Rasgon NL	Insulin resistance and hippocampal volume in women at risk for Alzheimer's disease.	Neurobiology of aging	2011	48
20051526	Estrogens	Manolagas SC	From estrogen-centric to aging and oxidative stress: a revised perspective of the pathogenesis of osteoporosis.	Endocrine reviews	2010	176
21109497	Estrogens	Mauvais-Jarvis F	Estrogen and androgen receptors: regulators of fuel homeostasis and emerging targets for diabetes and obesity.	Trends in endocrinology and metabolism	2011	53
21281456	Estrogens	Meyer MR	Obesity, insulin resistance and diabetes: sex differences and role of oestrogen receptors.	Acta physiologica	2011	54
21689398	Estrogens	Patnaik JL	Cardiovascular disease competes with breast cancer as the leading cause of death for older females diagnosed with breast cancer: a retrospective cohort study.	Breast cancer research 	2011	87
21747171	Estrogens	Tiano JP	Estrogen receptor activation reduces lipid synthesis in pancreatic islets and prevents β cell failure in rodent models of type 2 diabetes.	The Journal of clinical investigation	2011	50
22936542	Estrogens	Rose DP	The cellular and molecular mechanisms by which insulin influences breast cancer risk and progression.	Endocrine-related cancer	2012	33
23676496	Estrogens	Gan Z	Nuclear receptor/microRNA circuitry links muscle fiber type to energy metabolism.	The Journal of clinical investigation	2013	52
24556859	Estrogens	Bernal-Mizrachi E	Human β-cell proliferation and intracellular signaling part 2: still driving in the dark without a road map.	Diabetes	2014	48
26919573	Estrogens	Klair JS	A longer duration of estrogen deficiency increases fibrosis risk among postmenopausal women with nonalcoholic fatty liver disease.	Hepatology	2016	12
27914795	Estrogens	Wintrob ZA	Insulin use, adipokine profiles and breast cancer prognosis.	Cytokine	2017	11
16141358	Aldosterone	Hunyady L	Pleiotropic AT1 receptor signaling pathways mediating physiological and pathogenic actions of angiotensin II.	Molecular endocrinology	2006	121
19487712	Aldosterone	Sowers JR	Narrative review: the emerging clinical implications of the role of aldosterone in the metabolic syndrome and resistant hypertension.	Annals of internal medicine	2009	65
21693741	Aldosterone	de Boer IH	Temporal trends in the prevalence of diabetic kidney disease in the United States.	JAMA	2011	180
23349535	Aldosterone	Bender SB	Mineralocorticoid receptor-mediated vascular insulin resistance: an early contributor to diabetes-related vascular disease?	Diabetes	2013	44
24026560	Aldosterone	Groop PH	Linagliptin lowers albuminuria on top of recommended standard treatment in patients with type 2 diabetes and renal dysfunction.	Diabetes care	2013	51
24130346	Aldosterone	Dart AB	Earlier onset of complications in youth with type 2 diabetes.	Diabetes care	2014	22
24866132	Aldosterone	Fernandes-Rosa FL	Genetic spectrum and clinical correlates of somatic mutations in aldosterone-producing adenoma.	Hypertension	2014	42
25400162	Aldosterone	Kandzari DE	Predictors of blood pressure response in the SYMPLICITY HTN-3 trial.	European heart journal	2015	48
25767285	Aldosterone	Hall JE	Obesity-induced hypertension: interaction of neurohumoral and renal mechanisms.	Circulation research	2015	66
25801871	Aldosterone	Pilz S	Effects of vitamin D on blood pressure and cardiovascular risk factors: a randomized controlled trial.	Hypertension	2015	24
26086328	Aldosterone	Srinivasa S	RAAS Activation Is Associated With Visceral Adiposity and Insulin Resistance Among HIV-infected Patients.	The Journal of clinical endocrinology and metabolism	2015	17
26678809	Aldosterone	Jia G	Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy.	Nature reviews. Endocrinology	2016	42
26705059	Aldosterone	Russo I	Diabetes-associated cardiac fibrosis: Cellular effectors, molecular mechanisms and therapeutic opportunities.	Journal of molecular and cellular cardiology	2016	22
26936907	Aldosterone	Lindhardt M	Proteomic prediction and Renin angiotensin aldosterone system Inhibition prevention Of early diabetic nephRopathy in TYpe 2 diabetic patients with normoalbuminuria (PRIORITY): essential study design and rationale of a randomised clinical multicentre trial.	BMJ open	2016	14
27470431	Aldosterone	Gnudi L	Diabetic Nephropathy: Perspective on Novel Molecular Mechanisms.	Trends in endocrinology and metabolism	2016	16
7587918	Blood Glucose	Ohkubo Y	Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study.	Diabetes research and clinical practice	1995	343
7622004	Blood Glucose	-	The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial.	Diabetes	1995	217
9042129	Blood Glucose	Anderson B	Parental involvement in diabetes management tasks: relationships to blood glucose monitoring adherence and metabolic control in young adolescents with insulin-dependent diabetes mellitus.	The Journal of pediatrics	1997	111
10318828	Blood Glucose	Jonas JC	Chronic hyperglycemia triggers loss of pancreatic beta cell differentiation in an animal model of diabetes.	The Journal of biological chemistry	1999	100
10731498	Blood Glucose	Meyer KA	Carbohydrates, dietary fiber, and incident type 2 diabetes in older women.	The American journal of clinical nutrition	2000	155
10860187	Blood Glucose	Shichiri M	Long-term results of the Kumamoto Study on optimal diabetes control in type 2 diabetic patients.	Diabetes care	2000	109
10868930	Blood Glucose	Soria B	Insulin-secreting cells derived from embryonic stem cells normalize glycemia in streptozotocin-induced diabetic mice.	Diabetes	2000	116
10911004	Blood Glucose	Shapiro AM	Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen.	The New England journal of medicine	2000	757
11794168	Blood Glucose	van den Berghe G	Intensive insulin therapy in critically ill patients.	The New England journal of medicine	2001	1200
11861436	Blood Glucose	Sacks DB	Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus.	Clinical chemistry	2002	123
12540621	Blood Glucose	Garvey WT	Effects of insulin resistance and type 2 diabetes on lipoprotein subclass particle size and concentration determined by nuclear magnetic resonance.	Diabetes	2003	100
12576937	Blood Glucose	Van den Berghe G	Outcome benefit of intensive insulin therapy in the critically ill: Insulin dose versus glycemic control.	Critical care medicine	2003	114
12854339	Blood Glucose	Gary TL	Meta-analysis of randomized educational and behavioral interventions in type 2 diabetes.	The Diabetes educator	2003	89
12869762	Blood Glucose	Grimsby J	Allosteric activators of glucokinase: potential role in diabetes therapy.	Science	2003	98
12941770	Blood Glucose	Butler AE	Increased beta-cell apoptosis prevents adaptive increase in beta-cell mass in mouse model of type 2 diabetes: evidence for role of islet amyloid formation rather than direct action of amyloid.	Diabetes	2003	104
15161755	Blood Glucose	Butler AE	Diabetes due to a progressive defect in beta-cell mass in rats transgenic for human islet amyloid polypeptide (HIP Rat): a new model for type 2 diabetes.	Diabetes	2004	73
15728645	Blood Glucose	Malmberg K	Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity.	European heart journal	2005	121
15767618	Blood Glucose	Boden G	Effect of a low-carbohydrate diet on appetite, blood glucose levels, and insulin resistance in obese patients with type 2 diabetes.	Annals of internal medicine	2005	74
15837923	Blood Glucose	Xu A	Angiopoietin-like protein 4 decreases blood glucose and improves glucose tolerance but induces hyperlipidemia and hepatic steatosis in mice.	Proceedings of the National Academy of Sciences of the United States of America	2005	74
15951574	Blood Glucose	Crowther CA	Effect of treatment of gestational diabetes mellitus on pregnancy outcomes.	The New England journal of medicine	2005	362
16230722	Blood Glucose	Heine RJ	Exenatide versus insulin glargine in patients with suboptimally controlled type 2 diabetes: a randomized trial.	Annals of internal medicine	2005	145
16352960	Blood Glucose	Kanji S	Reliability of point-of-care testing for glucose measurement in critically ill adults.	Critical care medicine	2005	88
17065355	Blood Glucose	Van den Berghe G	Intensive insulin therapy in mixed medical/surgical intensive care units: benefit versus harm.	Diabetes	2006	77
17088535	Blood Glucose	Lee RH	Multipotent stromal cells from human marrow home to and promote repair of pancreatic islets and renal glomeruli in diabetic NOD/scid mice.	Proceedings of the National Academy of Sciences of the United States of America	2006	186
17151862	Blood Glucose	Krabbe KS	Brain-derived neurotrophic factor (BDNF) and type 2 diabetes.	Diabetologia	2007	97
17244779	Blood Glucose	Golden SH	Endogenous sex hormones and glucose tolerance status in postmenopausal women.	The Journal of clinical endocrinology and metabolism	2007	58
17277040	Blood Glucose	Pittas AG	The effects of calcium and vitamin D supplementation on blood glucose and markers of inflammation in nondiabetic adults.	Diabetes care	2007	149
17591623	Blood Glucose	Farmer A	Impact of self monitoring of blood glucose in the management of patients with non-insulin treated diabetes: open parallel group randomised trial.	BMJ	2007	95
17924864	Blood Glucose	Russell-Jones D	Insulin-associated weight gain in diabetes--causes, effects and coping strategies.	Diabetes, obesity & metabolism	2007	71
17926232	Blood Glucose	Chen WW	Circulating FGF-21 levels in normal subjects and in newly diagnose patients with Type 2 diabetes mellitus.	Experimental and clinical endocrinology & diabetes 	2008	52
18374840	Blood Glucose	Bretzel RG	Once-daily basal insulin glargine versus thrice-daily prandial insulin lispro in people with type 2 diabetes on oral hypoglycaemic agents (APOLLO): an open randomised controlled trial.	Lancet	2008	72
18502299	Blood Glucose	Weng J	Effect of intensive insulin therapy on beta-cell function and glycaemic control in patients with newly diagnosed type 2 diabetes: a multicentre randomised parallel-group trial.	Lancet	2008	145
18664780	Blood Glucose	Egi M	Blood glucose concentration and outcome of critical illness: the impact of diabetes.	Critical care medicine	2008	84
18694998	Blood Glucose	Cohen RM	Red cell life span heterogeneity in hematologically normal people is sufficient to alter HbA1c.	Blood	2008	78
18715214	Blood Glucose	Hirsch IB	Sensor-augmented insulin pump therapy: results of the first randomized treat-to-target study.	Diabetes technology & therapeutics	2008	67
18984744	Blood Glucose	Martin B	Exendin-4 improves glycemic control, ameliorates brain and pancreatic pathologies, and extends survival in a mouse model of Huntington's disease.	Diabetes	2009	64
19037628	Blood Glucose	Højberg PV	Four weeks of near-normalisation of blood glucose improves the insulin response to glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide in patients with type 2 diabetes.	Diabetologia	2009	49
19196887	Blood Glucose	Bunck MC	One-year treatment with exenatide improves beta-cell function, compared with insulin glargine, in metformin-treated type 2 diabetic patients: a randomized, controlled trial.	Diabetes care	2009	105
19199892	Blood Glucose	Crawford TN	Diabetic retinopathy and angiogenesis.	Current diabetes reviews	2009	73
19373249	Blood Glucose	Matschinsky FM	Assessing the potential of glucokinase activators in diabetes therapy.	Nature reviews. Drug discovery	2009	95
19450229	Blood Glucose	Pound LD	Deletion of the mouse Slc30a8 gene encoding zinc transporter-8 results in impaired insulin secretion.	The Biochemical journal	2009	56
19623253	Blood Glucose	Muzumdar RH	Humanin: a novel central regulator of peripheral insulin action.	PloS one	2009	51
19858063	Blood Glucose	Rodbard HW	Statement by an American Association of Clinical Endocrinologists/American College of Endocrinology consensus panel on type 2 diabetes mellitus: an algorithm for glycemic control.	Endocrine practice 	2009	204
19883376	Blood Glucose	Wang F	Brd2 disruption in mice causes severe obesity without Type 2 diabetes.	The Biochemical journal	2009	46
20225132	Blood Glucose	Jitrapakdee S	Regulation of insulin secretion: role of mitochondrial signalling.	Diabetologia	2010	70
20424233	Blood Glucose	German JP	Leptin deficiency causes insulin resistance induced by uncontrolled diabetes.	Diabetes	2010	46
20609969	Blood Glucose	Diamant M	Once weekly exenatide compared with insulin glargine titrated to target in patients with type 2 diabetes (DURATION-3): an open-label randomised trial.	Lancet	2010	90
20638012	Blood Glucose	Ingerski LM	Blood glucose monitoring and glycemic control in adolescence: contribution of diabetes-specific responsibility and family conflict.	The Journal of adolescent health 	2010	42
20660625	Blood Glucose	Bindom SM	Angiotensin I-converting enzyme type 2 (ACE2) gene therapy improves glycemic control in diabetic mice.	Diabetes	2010	43
20975552	Blood Glucose	Egi M	The interaction of chronic and acute glycemia with mortality in critically ill patients with diabetes.	Critical care medicine	2011	37
21188353	Blood Glucose	Ramos E	Replication of genome-wide association studies (GWAS) loci for fasting plasma glucose in African-Americans.	Diabetologia	2011	37
21241070	Blood Glucose	Graham GG	Clinical pharmacokinetics of metformin.	Clinical pharmacokinetics	2011	127
21282364	Blood Glucose	Xiao F	Leucine deprivation increases hepatic insulin sensitivity via GCN2/mTOR/S6K1 and AMPK pathways.	Diabetes	2011	67
21377179	Blood Glucose	Jorge ML	The effects of aerobic, resistance, and combined exercise on metabolic control, inflammatory markers, adipocytokines, and muscle insulin signaling in patients with type 2 diabetes mellitus.	Metabolism	2011	47
21459328	Blood Glucose	Porat S	Control of pancreatic β cell regeneration by glucose metabolism.	Cell metabolism	2011	112
21531886	Blood Glucose	Bakris GL	Recognition, pathogenesis, and treatment of different stages of nephropathy in patients with type 2 diabetes mellitus.	Mayo Clinic proceedings	2011	35
21593290	Blood Glucose	Katula JA	One-year results of a community-based translation of the Diabetes Prevention Program: Healthy-Living Partnerships to Prevent Diabetes (HELP PD) Project.	Diabetes care	2011	64
21617108	Blood Glucose	Sacks DB	Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus.	Diabetes care	2011	73
21617152	Blood Glucose	Sacks DB	Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus.	Clinical chemistry	2011	58
21647189	Blood Glucose	Barrera JG	GLP-1 and energy balance: an integrated model of short-term and long-term control.	Nature reviews. Endocrinology	2011	58
21805476	Blood Glucose	Borena W	Metabolic risk factors and primary liver cancer in a prospective study of 578,700 adults.	International journal of cancer	2012	41
21824266	Blood Glucose	D'Alessio D	The role of dysregulated glucagon secretion in type 2 diabetes.	Diabetes, obesity & metabolism	2011	55
21868679	Blood Glucose	Little JP	Low-volume high-intensity interval training reduces hyperglycemia and increases muscle mitochondrial capacity in patients with type 2 diabetes.	Journal of applied physiology	2011	87
21984584	Blood Glucose	Christensen M	Glucose-dependent insulinotropic polypeptide: a bifunctional glucose-dependent regulator of glucagon and insulin secretion in humans.	Diabetes	2011	40
22011407	Blood Glucose	Gunderson EP	Lactation intensity and postpartum maternal glucose tolerance and insulin resistance in women with recent GDM: the SWIFT cohort.	Diabetes care	2012	31
22013105	Blood Glucose	Chaudhuri A	Exenatide exerts a potent antiinflammatory effect.	The Journal of clinical endocrinology and metabolism	2012	36
22035595	Blood Glucose	Mirza S	Type 2-diabetes is associated with elevated levels of TNF-alpha, IL-6 and adiponectin and low levels of leptin in a population of Mexican Americans: a cross-sectional study.	Cytokine	2012	38
22268455	Blood Glucose	Gillen JB	Acute high-intensity interval exercise reduces the postprandial glucose response and prevalence of hyperglycaemia in patients with type 2 diabetes.	Diabetes, obesity & metabolism	2012	37
22355316	Blood Glucose	Liang Y	Effect of canagliflozin on renal threshold for glucose, glycemia, and body weight in normal and diabetic animal models.	PloS one	2012	47
22499789	Blood Glucose	Kodama K	Expression-based genome-wide association study links the receptor CD44 in adipose tissue with type 2 diabetes.	Proceedings of the National Academy of Sciences of the United States of America	2012	45
22723582	Blood Glucose	Barton FB	Improvement in outcomes of clinical islet transplantation: 1999-2010.	Diabetes care	2012	145
22776039	Blood Glucose	Meloni AR	GLP-1 receptor activated insulin secretion from pancreatic β-cells: mechanism and glucose dependence.	Diabetes, obesity & metabolism	2013	28
22777524	Blood Glucose	Yeh HC	Comparative effectiveness and safety of methods of insulin delivery and glucose monitoring for diabetes mellitus: a systematic review and meta-analysis.	Annals of internal medicine	2012	54
22945360	Blood Glucose	Meier JJ	GLP-1 receptor agonists for individualized treatment of type 2 diabetes mellitus.	Nature reviews. Endocrinology	2012	122
23099275	Blood Glucose	Kwon KC	Oral delivery of human biopharmaceuticals, autoantigens and vaccine antigens bioencapsulated in plant cells.	Advanced drug delivery reviews	2013	37
23296071	Blood Glucose	Scheen AJ	Cardiovascular effects of gliptins.	Nature reviews. Cardiology	2013	28
23498294	Blood Glucose	Katula JA	The Healthy Living Partnerships to Prevent Diabetes study: 2-year outcomes of a randomized controlled trial.	American journal of preventive medicine	2013	29
23764390	Blood Glucose	Croze ML	Potential role and therapeutic interests of myo-inositol in metabolic diseases.	Biochimie	2013	36
23891854	Blood Glucose	Anguizola J	Review: Glycation of human serum albumin.	Clinica chimica acta; international journal of clinical chemistry	2013	31
24102912	Blood Glucose	Mitranun W	Continuous vs interval training on glycemic control and macro- and microvascular reactivity in type 2 diabetic patients.	Scandinavian journal of medicine & science in sports	2014	30
24153444	Blood Glucose	Kerti L	Higher glucose levels associated with lower memory and reduced hippocampal microstructure.	Neurology	2013	33
24226519	Blood Glucose	Rieg T	Increase in SGLT1-mediated transport explains renal glucose reabsorption during genetic and pharmacological SGLT2 inhibition in euglycemia.	American journal of physiology. Renal physiology	2014	32
24320621	Blood Glucose	Monami M	Efficacy and safety of sodium glucose co-transport-2 inhibitors in type 2 diabetes: a meta-analysis of randomized clinical trials.	Diabetes, obesity & metabolism	2014	28
24456991	Blood Glucose	Dutta D	Vitamin-D supplementation in prediabetes reduced progression to type 2 diabetes and was associated with decreased insulin resistance and systemic inflammation: an open label randomized prospective study from Eastern India.	Diabetes research and clinical practice	2014	22
24622715	Blood Glucose	Preiss D	Metformin for non-diabetic patients with coronary heart disease (the CAMERA study): a randomised controlled trial.	The lancet. Diabetes & endocrinology	2014	22
24746806	Blood Glucose	Wang Z	Pancreatic β cell dedifferentiation in diabetes and redifferentiation following insulin therapy.	Cell metabolism	2014	76
24847880	Blood Glucose	Madiraju AK	Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase.	Nature	2014	164
24855202	Blood Glucose	Ussher JR	Cardiovascular actions of incretin-based therapies.	Circulation research	2014	44
25341005	Blood Glucose	Vallon V	The mechanisms and therapeutic potential of SGLT2 inhibitors in diabetes mellitus.	Annual review of medicine	2015	25
25834231	Blood Glucose	Sandoval DA	Physiology of proglucagon peptides: role of glucagon and GLP-1 in health and disease.	Physiological reviews	2015	34
25908839	Blood Glucose	Russ HA	Controlled induction of human pancreatic progenitors produces functional beta-like cells in vitro.	The EMBO journal	2015	61
25943590	Blood Glucose	Huckvale K	Smartphone apps for calculating insulin dose: a systematic assessment.	BMC medicine	2015	19
26077345	Blood Glucose	Abu-Farha M	Higher plasma betatrophin/ANGPTL8 level in Type 2 Diabetes subjects does not correlate with blood glucose or insulin resistance.	Scientific reports	2015	22
26100900	Blood Glucose	Yu J	Microneedle-array patches loaded with hypoxia-sensitive vesicles provide fast glucose-responsive insulin delivery.	Proceedings of the National Academy of Sciences of the United States of America	2015	33
26167912	Blood Glucose	Balk EM	Combined Diet and Physical Activity Promotion Programs to Prevent Type 2 Diabetes Among Persons at Increased Risk: A Systematic Review for the Community Preventive Services Task Force.	Annals of internal medicine	2015	36
26207054	Blood Glucose	Hirsch IB	Glycemic Variability and Diabetes Complications: Does It Matter? Of Course It Does!	Diabetes care	2015	16
26502220	Blood Glucose	Sussman JB	Rates of Deintensification of Blood Pressure and Glycemic Medication Treatment Based on Levels of Control and Life Expectancy in Older Patients With Diabetes Mellitus.	JAMA internal medicine	2015	19
26621825	Blood Glucose	Zaccardi F	Pathophysiology of type 1 and type 2 diabetes mellitus: a 90-year perspective.	Postgraduate medical journal	2016	16
26784127	Blood Glucose	Rodbard D	Continuous Glucose Monitoring: A Review of Successes, Challenges, and Opportunities.	Diabetes technology & therapeutics	2016	27
26848630	Blood Glucose	Bailey TS	AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY 2016 OUTPATIENT GLUCOSE MONITORING CONSENSUS STATEMENT.	Endocrine practice 	2016	15
28053201	Blood Glucose	Noakes TD	Evidence that supports the prescription of low-carbohydrate high-fat diets: a narrative review.	British journal of sports medicine	2017	5
11889194	Glucagon	Nauck MA	Effects of glucagon-like peptide 1 on counterregulatory hormone responses, cognitive functions, and insulin secretion during hyperinsulinemic, stepped hypoglycemic clamp experiments in healthy volunteers.	The Journal of clinical endocrinology and metabolism	2002	83
11935150	Glucagon	Agersø H	The pharmacokinetics, pharmacodynamics, safety and tolerability of NN2211, a new long-acting GLP-1 derivative, in healthy men.	Diabetologia	2002	83
12540611	Glucagon	Kjems LL	The influence of GLP-1 on glucose-stimulated insulin secretion: effects on beta-cell sensitivity in type 2 and nondiabetic subjects.	Diabetes	2003	91
12554744	Glucagon	Drucker DJ	Glucagon-like peptides: regulators of cell proliferation, differentiation, and apoptosis.	Molecular endocrinology	2003	91
12960095	Glucagon	Farilla L	Glucagon-like peptide 1 inhibits cell apoptosis and improves glucose responsiveness of freshly isolated human islets.	Endocrinology	2003	117
15044356	Glucagon	Brubaker PL	Minireview: Glucagon-like peptides regulate cell proliferation and apoptosis in the pancreas, gut, and central nervous system.	Endocrinology	2004	104
15111485	Glucagon	Degn KB	One week's treatment with the long-acting glucagon-like peptide 1 derivative liraglutide (NN2211) markedly improves 24-h glycemia and alpha- and beta-cell function and reduces endogenous glucose release in patients with type 2 diabetes.	Diabetes	2004	71
15271645	Glucagon	Holst JJ	Role of incretin hormones in the regulation of insulin secretion in diabetic and nondiabetic humans.	American journal of physiology. Endocrinology and metabolism	2004	88
15331566	Glucagon	Baggio LL	A recombinant human glucagon-like peptide (GLP)-1-albumin protein (albugon) mimics peptidergic activation of GLP-1 receptor-dependent pathways coupled with satiety, gastrointestinal motility, and glucose homeostasis.	Diabetes	2004	74
15353407	Glucagon	Nyström T	Effects of glucagon-like peptide-1 on endothelial function in type 2 diabetes patients with stable coronary artery disease.	American journal of physiology. Endocrinology and metabolism	2004	144
16460677	Glucagon	Timper K	Human adipose tissue-derived mesenchymal stem cells differentiate into insulin, somatostatin, and glucagon expressing cells.	Biochemical and biophysical research communications	2006	74
17306374	Glucagon	Doyle ME	Mechanisms of action of glucagon-like peptide 1 in the pancreas.	Pharmacology & therapeutics	2007	129
17409288	Glucagon	Dunning BE	The role of alpha-cell dysregulation in fasting and postprandial hyperglycemia in type 2 diabetes and therapeutic implications.	Endocrine reviews	2007	84
18430778	Glucagon	Laferrère B	Effect of weight loss by gastric bypass surgery versus hypocaloric diet on glucose and incretin levels in patients with type 2 diabetes.	The Journal of clinical endocrinology and metabolism	2008	148
18786299	Glucagon	DeFronzo RA	Effects of exenatide versus sitagliptin on postprandial glucose, insulin and glucagon secretion, gastric emptying, and caloric intake: a randomized, cross-over study.	Current medical research and opinion	2008	85
19056578	Glucagon	Greenfield JR	Oral glutamine increases circulating glucagon-like peptide 1, glucagon, and insulin concentrations in lean, obese, and type 2 diabetic subjects.	The American journal of clinical nutrition	2009	49
20798346	Glucagon	Unger RH	Paracrinology of islets and the paracrinopathy of diabetes.	Proceedings of the National Academy of Sciences of the United States of America	2010	71
20971966	Glucagon	Rezania A	Production of functional glucagon-secreting α-cells from human embryonic stem cells.	Diabetes	2011	59
21868791	Glucagon	Salehi M	Gastric bypass surgery enhances glucagon-like peptide 1-stimulated postprandial insulin secretion in humans.	Diabetes	2011	76
22166985	Glucagon	Cryer PE	Minireview: Glucagon in the pathogenesis of hypoglycemia and hyperglycemia in diabetes.	Endocrinology	2012	42
22965295	Glucagon	Marchetti P	A local glucagon-like peptide 1 (GLP-1) system in human pancreatic islets.	Diabetologia	2012	39
23305646	Glucagon	Habegger KM	Fibroblast growth factor 21 mediates specific glucagon actions.	Diabetes	2013	31
23359039	Glucagon	Haidar A	Glucose-responsive insulin and glucagon delivery (dual-hormone artificial pancreas) in adults with type 1 diabetes: a randomized crossover controlled trial.	CMAJ 	2013	38
23649520	Glucagon	Jørgensen NB	Exaggerated glucagon-like peptide 1 response is important for improved β-cell function and glucose tolerance after Roux-en-Y gastric bypass in patients with type 2 diabetes.	Diabetes	2013	52
24204325	Glucagon	Courtney M	The inactivation of Arx in pancreatic α-cells triggers their neogenesis and conversion into functional β-like cells.	PLoS genetics	2013	47
24224750	Glucagon	van Bon AC	Feasibility of a portable bihormonal closed-loop system to control glucose excursions at home under free-living conditions for 48 hours.	Diabetes technology & therapeutics	2014	23
24233056	Glucagon	Marselli L	Are we overestimating the loss of beta cells in type 2 diabetes?	Diabetologia	2014	23
24315990	Glucagon	Salehi M	Blockade of glucagon-like peptide 1 receptor corrects postprandial hypoglycemia after gastric bypass.	Gastroenterology	2014	30
24393785	Glucagon	Pernicova I	Metformin--mode of action and clinical implications for diabetes and cancer.	Nature reviews. Endocrinology	2014	151
24467746	Glucagon	Pyke C	GLP-1 receptor localization in monkey and human tissue: novel distribution revealed with extensively validated monoclonal antibody.	Endocrinology	2014	68
24703698	Glucagon	Song WJ	Glucagon regulates hepatic kisspeptin to impair insulin secretion.	Cell metabolism	2014	35
25918235	Glucagon	Spijker HS	Loss of β-Cell Identity Occurs in Type 2 Diabetes and Is Associated With Islet Amyloid Deposits.	Diabetes	2015	21
26850709	Glucagon	Russell SJ	Day and night glycaemic control with a bionic pancreas versus conventional insulin pump therapy in preadolescent children with type 1 diabetes: a randomised crossover trial.	The lancet. Diabetes & endocrinology	2016	16
28215845	Glucagon	Chakravarthy H	Converting Adult Pancreatic Islet α Cells into β Cells by Targeting Both Dnmt1 and Arx.	Cell metabolism	2017	5
1778354	Insulin	Eriksson KF	Prevention of type 2 (non-insulin-dependent) diabetes mellitus by diet and physical exercise. The 6-year Malmö feasibility study.	Diabetologia	1991	138
1954451	Insulin	Hales CN	Fetal and infant growth and impaired glucose tolerance at age 64.	BMJ	1991	383
2403659	Insulin	Shulman GI	Quantitation of muscle glycogen synthesis in normal subjects and subjects with non-insulin-dependent diabetes by 13C nuclear magnetic resonance spectroscopy.	The New England journal of medicine	1990	200
3288530	Insulin	Ricordi C	Automated method for isolation of human pancreatic islets.	Diabetes	1988	215
3317417	Insulin	Cooper GJ	Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients.	Proceedings of the National Academy of Sciences of the United States of America	1987	182
6367724	Insulin	Klein R	The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years.	Archives of ophthalmology	1984	210
6367725	Insulin	Klein R	The Wisconsin epidemiologic study of diabetic retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years.	Archives of ophthalmology	1984	216
7555499	Insulin	Polonsky WH	Assessment of diabetes-related distress.	Diabetes care	1995	208
7738205	Insulin	Hotamisligil GS	Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance.	The Journal of clinical investigation	1995	501
8039601	Insulin	Kahn CR	Banting Lecture. Insulin action, diabetogenes, and the cause of type II diabetes.	Diabetes	1994	132
8040759	Insulin	-	Effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus: Diabetes Control and Complications Trial. Diabetes Control and Complications Trial Research Group.	The Journal of pediatrics	1994	230
8436255	Insulin	Barker DJ	Type 2 (non-insulin-dependent) diabetes mellitus, hypertension and hyperlipidaemia (syndrome X): relation to reduced fetal growth.	Diabetologia	1993	340
8447318	Insulin	Spielman RS	Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM).	American journal of human genetics	1993	725
8635647	Insulin	Haffner SM	Increased insulin resistance and insulin secretion in nondiabetic African-Americans and Hispanics compared with non-Hispanic whites. The Insulin Resistance Atherosclerosis Study.	Diabetes	1996	142
9054944	Insulin	Vafiadis P	Insulin expression in human thymus is modulated by INS VNTR alleles at the IDDM2 locus.	Nature genetics	1997	146
9054945	Insulin	Pugliese A	The insulin gene is transcribed in the human thymus and transcription levels correlated with allelic variation at the INS VNTR-IDDM2 susceptibility locus for type 1 diabetes.	Nature genetics	1997	173
9303923	Insulin	Ferrannini E	Insulin resistance and hypersecretion in obesity. European Group for the Study of Insulin Resistance (EGIR).	The Journal of clinical investigation	1997	122
9353126	Insulin	Ogg S	The Fork head transcription factor DAF-16 transduces insulin-like metabolic and longevity signals in C. elegans.	Nature	1997	593
9408743	Insulin	Dunaif A	Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis.	Endocrine reviews	1997	289
9449872	Insulin	Ravelli AC	Glucose tolerance in adults after prenatal exposure to famine.	Lancet	1998	221
9495343	Insulin	Withers DJ	Disruption of IRS-2 causes type 2 diabetes in mice.	Nature	1998	328
9525995	Insulin	Patti ME	Bidirectional modulation of insulin action by amino acids.	The Journal of clinical investigation	1998	104
9568680	Insulin	Spiegelman BM	PPAR-gamma: adipogenic regulator and thiazolidinedione receptor.	Diabetes	1998	245
9589228	Insulin	Fitzgerald JT	The reliability and validity of a brief diabetes knowledge test.	Diabetes care	1998	104
9609109	Insulin	White MF	The IRS-signalling system: a network of docking proteins that mediate insulin action.	Molecular and cellular biochemistry	1998	120
9710447	Insulin	Barber AJ	Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin.	The Journal of clinical investigation	1998	280
9793760	Insulin	Duckworth WC	Insulin degradation: progress and potential.	Endocrine reviews	1998	155
10064092	Insulin	Poulsen P	Heritability of type II (non-insulin-dependent) diabetes mellitus and abnormal glucose tolerance--a population-based twin study.	Diabetologia	1999	135
10194465	Insulin	Virkamäki A	Protein-protein interaction in insulin signaling and the molecular mechanisms of insulin resistance.	The Journal of clinical investigation	1999	112
10331418	Insulin	Jacob S	Association of increased intramyocellular lipid content with insulin resistance in lean nondiabetic offspring of type 2 diabetic subjects.	Diabetes	1999	109
10359389	Insulin	Turner RC	Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group.	JAMA	1999	352
10409121	Insulin	Winder WW	AMP-activated protein kinase, a metabolic master switch: possible roles in type 2 diabetes.	The American journal of physiology	1999	165
10581081	Insulin	Smith LE	Regulation of vascular endothelial growth factor-dependent retinal neovascularization by insulin-like growth factor-1 receptor.	Nature medicine	1999	105
10645822	Insulin	Hanson RL	Evaluation of simple indices of insulin sensitivity and insulin secretion for use in epidemiologic studies.	American journal of epidemiology	2000	101
10819232	Insulin	Ahrén B	Autonomic regulation of islet hormone secretion--implications for health and disease.	Diabetologia	2000	148
10845877	Insulin	Hotta K	Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients.	Arteriosclerosis, thrombosis, and vascular biology	2000	454
10866053	Insulin	Kurtzhals P	Correlations of receptor binding and metabolic and mitogenic potencies of insulin analogs designed for clinical use.	Diabetes	2000	106
10878750	Insulin	Moller DE	Potential role of TNF-alpha in the pathogenesis of insulin resistance and type 2 diabetes.	Trends in endocrinology and metabolism	2000	104
10884429	Insulin	Bonner-Weir S	In vitro cultivation of human islets from expanded ductal tissue.	Proceedings of the National Academy of Sciences of the United States of America	2000	175
10902785	Insulin	Katz A	Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans.	The Journal of clinical endocrinology and metabolism	2000	508
10903330	Insulin	Shulman GI	Cellular mechanisms of insulin resistance.	The Journal of clinical investigation	2000	468
10953022	Insulin	Kahn BB	Obesity and insulin resistance.	The Journal of clinical investigation	2000	484
11151758	Insulin	Weyer C	Enlarged subcutaneous abdominal adipocyte size, but not obesity itself, predicts type II diabetes independent of insulin resistance.	Diabetologia	2000	137
11160134	Insulin	Rui L	Insulin/IGF-1 and TNF-alpha stimulate phosphorylation of IRS-1 at inhibitory Ser307 via distinct pathways.	The Journal of clinical investigation	2001	135
11334417	Insulin	Hotta K	Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys.	Diabetes	2001	139
11376336	Insulin	Lee KH	Structure of a human insulin peptide-HLA-DQ8 complex and susceptibility to type 1 diabetes.	Nature immunology	2001	91
11443198	Insulin	Dandona P	Insulin inhibits intranuclear nuclear factor kappaB and stimulates IkappaB in mononuclear cells in obese subjects: evidence for an anti-inflammatory effect?	The Journal of clinical endocrinology and metabolism	2001	120
11445664	Insulin	Vozarova B	Circulating interleukin-6 in relation to adiposity, insulin action, and insulin secretion.	Obesity research	2001	88
11502781	Insulin	Facchini FS	Insulin resistance as a predictor of age-related diseases.	The Journal of clinical endocrinology and metabolism	2001	110
11551504	Insulin	Cederberg A	FOXC2 is a winged helix gene that counteracts obesity, hypertriglyceridemia, and diet-induced insulin resistance.	Cell	2001	165
11606564	Insulin	Aguirre V	Phosphorylation of Ser307 in insulin receptor substrate-1 blocks interactions with the insulin receptor and inhibits insulin action.	The Journal of biological chemistry	2002	218
11686294	Insulin	Lawlor MA	PKB/Akt: a key mediator of cell proliferation, survival and insulin responses?	Journal of cell science	2001	231
11694656	Insulin	Giovannucci E	Insulin, insulin-like growth factors and colon cancer: a review of the evidence.	The Journal of nutrition	2001	211
11739335	Insulin	Nakae J	Distinct and overlapping functions of insulin and IGF-I receptors.	Endocrine reviews	2001	121
11742410	Insulin	Bell GI	Diabetes mellitus and genetically programmed defects in beta-cell function.	Nature	2001	103
11742413	Insulin	Maechler P	Mitochondrial function in normal and diabetic beta-cells.	Nature	2001	119
11773152	Insulin	Goodwin PJ	Fasting insulin and outcome in early-stage breast cancer: results of a prospective cohort study.	Journal of clinical oncology 	2002	194
11826411	Insulin	Chitturi S	NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome.	Hepatology	2002	167
11864854	Insulin	Liu S	Relation between a diet with a high glycemic load and plasma concentrations of high-sensitivity C-reactive protein in middle-aged women.	The American journal of clinical nutrition	2002	96
11895820	Insulin	Whincup PH	Early evidence of ethnic differences in cardiovascular risk: cross sectional comparison of British South Asian and white children.	BMJ	2002	83
11914736	Insulin	Melloul D	Regulation of insulin gene transcription.	Diabetologia	2002	81
11916936	Insulin	Festa A	Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study.	Diabetes	2002	194
12011435	Insulin	Olbrot M	Identification of beta-cell-specific insulin gene transcription factor RIPE3b1 as mammalian MafA.	Proceedings of the National Academy of Sciences of the United States of America	2002	93
12037147	Insulin	Diabetes Prevention Trial--Type 1 Diabetes Study Group.	Effects of insulin in relatives of patients with type 1 diabetes mellitus.	The New England journal of medicine	2002	154
12087016	Insulin	Hanley AJ	Homeostasis model assessment of insulin resistance in relation to the incidence of cardiovascular disease: the San Antonio Heart Study.	Diabetes care	2002	101
12099954	Insulin	Wallace TM	The assessment of insulin resistance in man.	Diabetic medicine 	2002	86
12136128	Insulin	McClain DA	Altered glycan-dependent signaling induces insulin resistance and hyperleptinemia.	Proceedings of the National Academy of Sciences of the United States of America	2002	86
12169433	Insulin	White MF	IRS proteins and the common path to diabetes.	American journal of physiology. Endocrinology and metabolism	2002	216
12174319	Insulin	Korytkowski M	When oral agents fail: practical barriers to starting insulin.	International journal of obesity and related metabolic disorders 	2002	103
12364302	Insulin	DAFNE Study Group.	Training in flexible, intensive insulin management to enable dietary freedom in people with type 1 diabetes: dose adjustment for normal eating (DAFNE) randomised controlled trial.	BMJ	2002	134
12417588	Insulin	Lee YH	c-Jun N-terminal kinase (JNK) mediates feedback inhibition of the insulin signaling cascade.	The Journal of biological chemistry	2003	96
12453886	Insulin	Gale EA	The rise of childhood type 1 diabetes in the 20th century.	Diabetes	2002	88
12453891	Insulin	Senn JJ	Interleukin-6 induces cellular insulin resistance in hepatocytes.	Diabetes	2002	131
12512031	Insulin	Ruhl CE	Determinants of the association of overweight with elevated serum alanine aminotransferase activity in the United States.	Gastroenterology	2003	120
12540592	Insulin	Tschritter O	Plasma adiponectin concentrations predict insulin sensitivity of both glucose and lipid metabolism.	Diabetes	2003	97
12606503	Insulin	Daitoku H	Regulation of PGC-1 promoter activity by protein kinase B and the forkhead transcription factor FKHR.	Diabetes	2003	84
12634421	Insulin	Farris W	Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo.	Proceedings of the National Academy of Sciences of the United States of America	2003	329
12750520	Insulin	Petersen KF	Mitochondrial dysfunction in the elderly: possible role in insulin resistance.	Science	2003	471
12771873	Insulin	Furnary AP	Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting.	The Journal of thoracic and cardiovascular surgery	2003	128
12879249	Insulin	Rorsman P	Insulin granule dynamics in pancreatic beta cells.	Diabetologia	2003	159
12882902	Insulin	Short KR	Impact of aerobic exercise training on age-related changes in insulin sensitivity and muscle oxidative capacity.	Diabetes	2003	136
12959935	Insulin	Barthel A	Novel concepts in insulin regulation of hepatic gluconeogenesis.	American journal of physiology. Endocrinology and metabolism	2003	85
14657487	Insulin	White MF	Insulin signaling in health and disease.	Science	2003	143
14698276	Insulin	Dandona P	Inflammation: the link between insulin resistance, obesity and diabetes.	Trends in immunology	2004	349
14709204	Insulin	Boston RC	MINMOD Millennium: a computer program to calculate glucose effectiveness and insulin sensitivity from the frequently sampled intravenous glucose tolerance test.	Diabetes technology & therapeutics	2003	142
14767595	Insulin	Donath MY	Decreased beta-cell mass in diabetes: significance, mechanisms and therapeutic implications.	Diabetologia	2004	77
14980532	Insulin	Craft S	Insulin and neurodegenerative disease: shared and specific mechanisms.	The Lancet. Neurology	2004	176
14985484	Insulin	Bhargava SK	Relation of serial changes in childhood body-mass index to impaired glucose tolerance in young adulthood.	The New England journal of medicine	2004	192
14988838	Insulin	Shintani Y	Hepatitis C virus infection and diabetes: direct involvement of the virus in the development of insulin resistance.	Gastroenterology	2004	133
15023346	Insulin	Hanada M	Structure, regulation and function of PKB/AKT--a major therapeutic target.	Biochimica et biophysica acta	2004	163
15047607	Insulin	Morton NM	Novel adipose tissue-mediated resistance to diet-induced visceral obesity in 11 beta-hydroxysteroid dehydrogenase type 1-deficient mice.	Diabetes	2004	87
15094069	Insulin	Banks WA	The source of cerebral insulin.	European journal of pharmacology	2004	90
15094074	Insulin	Zhao WQ	Insulin and the insulin receptor in experimental models of learning and memory.	European journal of pharmacology	2004	86
15166380	Insulin	George S	A family with severe insulin resistance and diabetes due to a mutation in AKT2.	Science	2004	117
15201411	Insulin	Klein S	Absence of an effect of liposuction on insulin action and risk factors for coronary heart disease.	The New England journal of medicine	2004	117
15245384	Insulin	Rose DP	Obesity, adipocytokines, and insulin resistance in breast cancer.	Obesity reviews 	2004	105
15308380	Insulin	DeFronzo RA	Pathogenesis of type 2 diabetes mellitus.	The Medical clinics of North America	2004	180
15331542	Insulin	Chimienti F	Identification and cloning of a beta-cell-specific zinc transporter, ZnT-8, localized into insulin secretory granules.	Diabetes	2004	105
15480982	Insulin	Yang YX	Insulin therapy and colorectal cancer risk among type 2 diabetes mellitus patients.	Gastroenterology	2004	89
15546003	Insulin	Ling C	Multiple environmental and genetic factors influence skeletal muscle PGC-1alpha and PGC-1beta gene expression in twins.	The Journal of clinical investigation	2004	74
15564314	Insulin	Gershengorn MC	Epithelial-to-mesenchymal transition generates proliferative human islet precursor cells.	Science	2004	102
15604363	Insulin	Fukuhara A	Visfatin: a protein secreted by visceral fat that mimics the effects of insulin.	Science	2005	283
15616025	Insulin	Lyssenko V	Predictors of and longitudinal changes in insulin sensitivity and secretion preceding onset of type 2 diabetes.	Diabetes	2005	92
15655035	Insulin	Lihn AS	Adiponectin: action, regulation and association to insulin sensitivity.	Obesity reviews 	2005	95
15662003	Insulin	Rhodes CJ	Type 2 diabetes-a matter of beta-cell life and death?	Science	2005	202
15677487	Insulin	Goldstein BJ	Redox paradox: insulin action is facilitated by insulin-stimulated reactive oxygen species with multiple potential signaling targets.	Diabetes	2005	81
15750214	Insulin	de la Monte SM	Review of insulin and insulin-like growth factor expression, signaling, and malfunction in the central nervous system: relevance to Alzheimer's disease.	Journal of Alzheimer's disease 	2005	129
15768047	Insulin	Bordone L	Calorie restriction, SIRT1 and metabolism: understanding longevity.	Nature reviews. Molecular cell biology	2005	273
15889096	Insulin	Kent SC	Expanded T cells from pancreatic lymph nodes of type 1 diabetic subjects recognize an insulin epitope.	Nature	2005	113
15910627	Insulin	Donnelly LA	Frequency and predictors of hypoglycaemia in Type 1 and insulin-treated Type 2 diabetes: a population-based study.	Diabetic medicine 	2005	84
15924147	Insulin	Foti D	Lack of the architectural factor HMGA1 causes insulin resistance and diabetes in humans and mice.	Nature medicine	2005	69
15983313	Insulin	Pitteloud N	Relationship between testosterone levels, insulin sensitivity, and mitochondrial function in men.	Diabetes care	2005	70
15996257	Insulin	Froud T	Islet transplantation in type 1 diabetes mellitus using cultured islets and steroid-free immunosuppression: Miami experience.	American journal of transplantation 	2005	86
15998257	Insulin	Goldstein BJ	Role of insulin-induced reactive oxygen species in the insulin signaling pathway.	Antioxidants & redox signaling	2005	65
15998259	Insulin	Evans JL	The molecular basis for oxidative stress-induced insulin resistance.	Antioxidants & redox signaling	2005	87
16036612	Insulin	Karin M	From JNK to pay dirt: jun kinases, their biochemistry, physiology and clinical importance.	IUBMB life	2005	124
16046308	Insulin	Kitabchi AE	Role of insulin secretion and sensitivity in the evolution of type 2 diabetes in the diabetes prevention program: effects of lifestyle intervention and metformin.	Diabetes	2005	134
16054041	Insulin	Kahn BB	AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism.	Cell metabolism	2005	696
16061606	Insulin	Hannon TS	Childhood obesity and type 2 diabetes mellitus.	Pediatrics	2005	72
16123358	Insulin	Bach D	Expression of Mfn2, the Charcot-Marie-Tooth neuropathy type 2A gene, in human skeletal muscle: effects of type 2 diabetes, obesity, weight loss, and the regulatory role of tumor necrosis factor alpha and interleukin-6.	Diabetes	2005	71
16186296	Insulin	Polonsky WH	Psychological insulin resistance in patients with type 2 diabetes: the scope of the problem.	Diabetes care	2005	102
16186392	Insulin	Berndt J	Plasma visfatin concentrations and fat depot-specific mRNA expression in humans.	Diabetes	2005	93
16215165	Insulin	Thrailkill KM	Is insulin an anabolic agent in bone? Dissecting the diabetic bone for clues.	American journal of physiology. Endocrinology and metabolism	2005	71
16234302	Insulin	Chen MP	Elevated plasma level of visfatin/pre-B cell colony-enhancing factor in patients with type 2 diabetes mellitus.	The Journal of clinical endocrinology and metabolism	2006	82
16239255	Insulin	Frezza EE	Influence of obesity on the risk of developing colon cancer.	Gut	2006	63
16249538	Insulin	Peyrot M	Resistance to insulin therapy among patients and providers: results of the cross-national Diabetes Attitudes, Wishes, and Needs (DAWN) study.	Diabetes care	2005	158
16284649	Insulin	Morino K	Reduced mitochondrial density and increased IRS-1 serine phosphorylation in muscle of insulin-resistant offspring of type 2 diabetic parents.	The Journal of clinical investigation	2005	218
16306344	Insulin	Hotamisligil GS	Role of endoplasmic reticulum stress and c-Jun NH2-terminal kinase pathways in inflammation and origin of obesity and diabetes.	Diabetes	2005	90
16332653	Insulin	Albu JB	Independent association of insulin resistance with larger amounts of intermuscular adipose tissue and a greater acute insulin response to glucose in African American than in white nondiabetic women.	The American journal of clinical nutrition	2005	70
16339897	Insulin	Pinkse GG	Autoreactive CD8 T cells associated with beta cell destruction in type 1 diabetes.	Proceedings of the National Academy of Sciences of the United States of America	2005	87
16352795	Insulin	Stolzenberg-Solomon RZ	Insulin, glucose, insulin resistance, and pancreatic cancer in male smokers.	JAMA	2005	108
16388523	Insulin	Basaria S	Hyperglycemia and insulin resistance in men with prostate carcinoma who receive androgen-deprivation therapy.	Cancer	2006	66
16399206	Insulin	Qiu WQ	Insulin, insulin-degrading enzyme and amyloid-beta peptide in Alzheimer's disease: review and hypothesis.	Neurobiology of aging	2006	106
16434464	Insulin	Smith MR	Insulin sensitivity during combined androgen blockade for prostate cancer.	The Journal of clinical endocrinology and metabolism	2006	99
16443778	Insulin	Ostenson CG	Impaired gene and protein expression of exocytotic soluble N-ethylmaleimide attachment protein receptor complex proteins in pancreatic islets of type 2 diabetic patients.	Diabetes	2006	69
16445986	Insulin	Summers SA	Ceramides in insulin resistance and lipotoxicity.	Progress in lipid research	2006	209
16456680	Insulin	Yki-Järvinen H	Insulin glargine or NPH combined with metformin in type 2 diabetes: the LANMET study.	Diabetologia	2006	84
16506274	Insulin	Cersosimo E	Insulin resistance and endothelial dysfunction: the road map to cardiovascular diseases.	Diabetes/metabolism research and reviews	2006	64
16531507	Insulin	Yang RZ	Identification of omentin as a novel depot-specific adipokine in human adipose tissue: possible role in modulating insulin action.	American journal of physiology. Endocrinology and metabolism	2006	108
16627931	Insulin	Lester-Coll N	Intracerebral streptozotocin model of type 3 diabetes: relevance to sporadic Alzheimer's disease.	Journal of Alzheimer's disease 	2006	109
16644702	Insulin	Clerk LH	Obesity blunts insulin-mediated microvascular recruitment in human forearm muscle.	Diabetes	2006	85
16670091	Insulin	Armoni M	FOXO1 represses peroxisome proliferator-activated receptor-gamma1 and -gamma2 gene promoters in primary adipocytes. A novel paradigm to increase insulin sensitivity.	The Journal of biological chemistry	2006	60
16731817	Insulin	Cancello R	Increased infiltration of macrophages in omental adipose tissue is associated with marked hepatic lesions in morbid human obesity.	Diabetes	2006	112
16753575	Insulin	Um SH	Nutrient overload, insulin resistance, and ribosomal protein S6 kinase 1, S6K1.	Cell metabolism	2006	215
16855264	Insulin	Florez JC	TCF7L2 polymorphisms and progression to diabetes in the Diabetes Prevention Program.	The New England journal of medicine	2006	230
16873706	Insulin	Draznin B	Molecular mechanisms of insulin resistance: serine phosphorylation of insulin receptor substrate-1 and increased expression of p85alpha: the two sides of a coin.	Diabetes	2006	75
16885550	Insulin	Pearson ER	Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations.	The New England journal of medicine	2006	214
16894525	Insulin	Gurney JG	Metabolic syndrome and growth hormone deficiency in adult survivors of childhood acute lymphoblastic leukemia.	Cancer	2006	64
16936218	Insulin	Damcott CM	Polymorphisms in the transcription factor 7-like 2 (TCF7L2) gene are associated with type 2 diabetes in the Amish: replication and evidence for a role in both insulin secretion and insulin resistance.	Diabetes	2006	67
17068144	Insulin	Granata R	Acylated and unacylated ghrelin promote proliferation and inhibit apoptosis of pancreatic beta-cells and human islets: involvement of 3',5'-cyclic adenosine monophosphate/protein kinase A, extracellular signal-regulated kinase 1/2, and phosphatidyl inositol 3-Kinase/Akt signaling.	Endocrinology	2007	58
17116184	Insulin	Franklin VL	A randomized controlled trial of Sweet Talk, a text-messaging system to support young people with diabetes.	Diabetic medicine 	2006	141
17130197	Insulin	Charbonnel B	Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin added to ongoing metformin therapy in patients with type 2 diabetes inadequately controlled with metformin alone.	Diabetes care	2006	127
17132539	Insulin	Sugden MC	Mechanisms underlying regulation of the expression and activities of the mammalian pyruvate dehydrogenase kinases.	Archives of physiology and biochemistry	2006	65
17167487	Insulin	Hafner M	Inhibition of cytohesins by SecinH3 leads to hepatic insulin resistance.	Nature	2006	74
17192339	Insulin	Abdul-Ghani MA	Muscle and liver insulin resistance indexes derived from the oral glucose tolerance test.	Diabetes care	2007	86
17276175	Insulin	Han SH	Adiponectin and cardiovascular disease: response to therapeutic interventions.	Journal of the American College of Cardiology	2007	59
17341558	Insulin	Balagopal P	Reduction of elevated serum retinol binding protein in obese children by lifestyle intervention: association with subclinical inflammation.	The Journal of clinical endocrinology and metabolism	2007	63
17344645	Insulin	Ferré P	SREBP-1c transcription factor and lipid homeostasis: clinical perspective.	Hormone research	2007	59
17374708	Insulin	Anderson PD	Innate immunity modulates adipokines in humans.	The Journal of clinical endocrinology and metabolism	2007	57
17407387	Insulin	Pearson ER	Macrosomia and hyperinsulinaemic hypoglycaemia in patients with heterozygous mutations in the HNF4A gene.	PLoS medicine	2007	71
17416796	Insulin	Laferrère B	Incretin levels and effect are markedly enhanced 1 month after Roux-en-Y gastric bypass surgery in obese patients with type 2 diabetes.	Diabetes care	2007	123
17426693	Insulin	Jiang W	In vitro derivation of functional insulin-producing cells from human embryonic stem cells.	Cell research	2007	89
17430239	Insulin	Craft S	Insulin resistance and Alzheimer's disease pathogenesis: potential mechanisms and implications for treatment.	Current Alzheimer research	2007	138
17443605	Insulin	Horvath K	Long-acting insulin analogues versus NPH insulin (human isophane insulin) for type 2 diabetes mellitus.	The Cochrane database of systematic reviews	2007	70
17472435	Insulin	Parikh H	TXNIP regulates peripheral glucose metabolism in humans.	PLoS medicine	2007	130
17525361	Insulin	Muniyappa R	Cardiovascular actions of insulin.	Endocrine reviews	2007	186
17533210	Insulin	Wilson PW	Prediction of incident diabetes mellitus in middle-aged adults: the Framingham Offspring Study.	Archives of internal medicine	2007	236
17563060	Insulin	In't Veld P	Screening for insulitis in adult autoantibody-positive organ donors.	Diabetes	2007	59
17571924	Insulin	Liu M	Network-based analysis of affected biological processes in type 2 diabetes models.	PLoS genetics	2007	75
17586614	Insulin	Cooper SA	Renin-angiotensin-aldosterone system and oxidative stress in cardiovascular insulin resistance.	American journal of physiology. Heart and circulatory physiology	2007	67
17615265	Insulin	Karnieli O	Generation of insulin-producing cells from human bone marrow mesenchymal stem cells by genetic manipulation.	Stem cells	2007	73
17620421	Insulin	Kolak M	Adipose tissue inflammation and increased ceramide content characterize subjects with high liver fat content independent of obesity.	Diabetes	2007	79
17661009	Insulin	Schäfer SA	Impaired glucagon-like peptide-1-induced insulin secretion in carriers of transcription factor 7-like 2 (TCF7L2) gene polymorphisms.	Diabetologia	2007	83
17666486	Insulin	Bertram R	Metabolic and electrical oscillations: partners in controlling pulsatile insulin secretion.	American journal of physiology. Endocrinology and metabolism	2007	72
17681146	Insulin	Jing E	SIRT2 regulates adipocyte differentiation through FoxO1 acetylation/deacetylation.	Cell metabolism	2007	116
17681171	Insulin	Gastaldelli A	Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects.	Gastroenterology	2007	98
17715056	Insulin	Parthier C	Crystal structure of the incretin-bound extracellular domain of a G protein-coupled receptor.	Proceedings of the National Academy of Sciences of the United States of America	2007	85
17823366	Insulin	Gustafson B	Inflamed adipose tissue: a culprit underlying the metabolic syndrome and atherosclerosis.	Arteriosclerosis, thrombosis, and vascular biology	2007	81
17827400	Insulin	Grarup N	Studies of association of variants near the HHEX, CDKN2A/B, and IGF2BP2 genes with type 2 diabetes and impaired insulin release in 10,705 Danish subjects: validation and extension of genome-wide association studies.	Diabetes	2007	95
17982337	Insulin	Lain KY	Metabolic changes in pregnancy.	Clinical obstetrics and gynecology	2007	83
18008060	Insulin	Sparsø T	The GCKR rs780094 polymorphism is associated with elevated fasting serum triacylglycerol, reduced fasting and OGTT-related insulinaemia, and reduced risk of type 2 diabetes.	Diabetologia	2008	61
18094066	Insulin	Wei Y	Skeletal muscle insulin resistance: role of inflammatory cytokines and reactive oxygen species.	American journal of physiology. Regulatory, integrative and comparative physiology	2008	52
18162504	Insulin	Muscelli E	Separate impact of obesity and glucose tolerance on the incretin effect in normal subjects and type 2 diabetic patients.	Diabetes	2008	68
18171435	Insulin	Hawley JA	Exercise training-induced improvements in insulin action.	Acta physiologica	2008	73
18178393	Insulin	Zhang L	Insulin as an autoantigen in NOD/human diabetes.	Current opinion in immunology	2008	72
18192540	Insulin	Molven A	Mutations in the insulin gene can cause MODY and autoantibody-negative type 1 diabetes.	Diabetes	2008	50
18197261	Insulin	Chao KC	Islet-like clusters derived from mesenchymal stem cells in Wharton's Jelly of the human umbilical cord for transplantation to control type 1 diabetes.	PloS one	2008	70
18223156	Insulin	Chung J	HSP72 protects against obesity-induced insulin resistance.	Proceedings of the National Academy of Sciences of the United States of America	2008	122
18227495	Insulin	Shanik MH	Insulin resistance and hyperinsulinemia: is hyperinsulinemia the cart or the horse?	Diabetes care	2008	98
18265477	Insulin	Giovannucci E	Metabolic syndrome, hyperinsulinemia, and colon cancer: a review.	The American journal of clinical nutrition	2007	134
18265479	Insulin	Barb D	Adiponectin in relation to malignancies: a review of existing basic research and clinical evidence.	The American journal of clinical nutrition	2007	101
18269634	Insulin	Palomer X	Role of vitamin D in the pathogenesis of type 2 diabetes mellitus.	Diabetes, obesity & metabolism	2008	74
18270681	Insulin	Ling C	Epigenetic regulation of PPARGC1A in human type 2 diabetic islets and effect on insulin secretion.	Diabetologia	2008	105
18281274	Insulin	Zabolotny JM	Protein-tyrosine phosphatase 1B expression is induced by inflammation in vivo.	The Journal of biological chemistry	2008	91
18299316	Insulin	Hayashi T	Visceral adiposity, not abdominal subcutaneous fat area, is associated with an increase in future insulin resistance in Japanese Americans.	Diabetes	2008	53
18328671	Insulin	Suarez EC	Self-reported symptoms of sleep disturbance and inflammation, coagulation, insulin resistance and psychosocial distress: evidence for gender disparity.	Brain, behavior, and immunity	2008	68
18346983	Insulin	Freathy RM	Common variation in the FTO gene alters diabetes-related metabolic traits to the extent expected given its effect on BMI.	Diabetes	2008	106
18355813	Insulin	Korenblat KM	Liver, muscle, and adipose tissue insulin action is directly related to intrahepatic triglyceride content in obese subjects.	Gastroenterology	2008	117
18391968	Insulin	Burgering BM	A brief introduction to FOXOlogy.	Oncogene	2008	76
18401346	Insulin	Guilherme A	Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes.	Nature reviews. Molecular cell biology	2008	462
18408164	Insulin	Engel MF	Membrane damage by human islet amyloid polypeptide through fibril growth at the membrane.	Proceedings of the National Academy of Sciences of the United States of America	2008	114
18436705	Insulin	Scheuner D	The unfolded protein response: a pathway that links insulin demand with beta-cell failure and diabetes.	Endocrine reviews	2008	156
18451265	Insulin	Bouatia-Naji N	A polymorphism within the G6PC2 gene is associated with fasting plasma glucose levels.	Science	2008	101
18451997	Insulin	Colombo C	Seven mutations in the human insulin gene linked to permanent neonatal/infancy-onset diabetes mellitus.	The Journal of clinical investigation	2008	61
18463376	Insulin	Rowan JA	Metformin versus insulin for the treatment of gestational diabetes.	The New England journal of medicine	2008	121
18477703	Insulin	Sakamoto K	Emerging role for AS160/TBC1D4 and TBC1D1 in the regulation of GLUT4 traffic.	American journal of physiology. Endocrinology and metabolism	2008	116
18510434	Insulin	Swarbrick MM	Physiological, pharmacological, and nutritional regulation of circulating adiponectin concentrations in humans.	Metabolic syndrome and related disorders	2008	67
18591391	Insulin	Forouhi NG	Baseline serum 25-hydroxy vitamin d is predictive of future glycemic status and insulin resistance: the Medical Research Council Ely Prospective Study 1990-2000.	Diabetes	2008	140
18644063	Insulin	Pickup JC	Severe hypoglycaemia and glycaemic control in Type 1 diabetes: meta-analysis of multiple daily insulin injections compared with continuous subcutaneous insulin infusion.	Diabetic medicine 	2008	72
18682704	Insulin	Shaham O	Metabolic profiling of the human response to a glucose challenge reveals distinct axes of insulin sensitivity.	Molecular systems biology	2008	122
18769445	Insulin	Cohen E	The insulin paradox: aging, proteotoxicity and neurodegeneration.	Nature reviews. Neuroscience	2008	94
18769626	Insulin	Schenk S	Insulin sensitivity: modulation by nutrients and inflammation.	The Journal of clinical investigation	2008	331
18796548	Insulin	Cacho J	Validation of simple indexes to assess insulin sensitivity during pregnancy in Wistar and Sprague-Dawley rats.	American journal of physiology. Endocrinology and metabolism	2008	85
18814906	Insulin	Näntö-Salonen K	Nasal insulin to prevent type 1 diabetes in children with HLA genotypes and autoantibodies conferring increased risk of disease: a double-blind, randomised controlled trial.	Lancet	2008	82
18854399	Insulin	Fernández-Real JM	The relationship of serum osteocalcin concentration to insulin secretion, sensitivity, and disposal with hypocaloric diet and resistance training.	The Journal of clinical endocrinology and metabolism	2009	51
18929493	Insulin	Tilg H	Insulin resistance, inflammation, and non-alcoholic fatty liver disease.	Trends in endocrinology and metabolism	2008	85
19053021	Insulin	Haupt A	Variation in the FTO gene influences food intake but not energy expenditure.	Experimental and clinical endocrinology & diabetes 	2009	56
19073504	Insulin	Goodwin PJ	Insulin-lowering effects of metformin in women with early breast cancer.	Clinical breast cancer	2008	61
19106328	Insulin	Liu E	Plasma 25-hydroxyvitamin d is associated with markers of the insulin resistant phenotype in nondiabetic adults.	The Journal of nutrition	2009	74
19128359	Insulin	Willcox A	Analysis of islet inflammation in human type 1 diabetes.	Clinical and experimental immunology	2009	147
19141606	Insulin	Maratou E	Studies of insulin resistance in patients with clinical and subclinical hypothyroidism.	European journal of endocrinology	2009	56
19145584	Insulin	Weinstein D	Insulin analogues display IGF-I-like mitogenic and anti-apoptotic activities in cultured cancer cells.	Diabetes/metabolism research and reviews	2009	48
19149564	Insulin	Potenza MA	Endothelial dysfunction in diabetes: from mechanisms to therapeutic targets.	Current medicinal chemistry	2009	66
19153412	Insulin	Vetter ML	Narrative review: effect of bariatric surgery on type 2 diabetes mellitus.	Annals of internal medicine	2009	46
19168596	Insulin	da Silva Xavier G	TCF7L2 regulates late events in insulin secretion from pancreatic islet beta-cells.	Diabetes	2009	66
19188682	Insulin	Qatanani M	Macrophage-derived human resistin exacerbates adipose tissue inflammation and insulin resistance in mice.	The Journal of clinical investigation	2009	51
19208913	Insulin	Sutherland AP	Interleukin-21 is required for the development of type 1 diabetes in NOD mice.	Diabetes	2009	46
19349193	Insulin	Wheatcroft SB	IGF-dependent and IGF-independent actions of IGF-binding protein-1 and -2: implications for metabolic homeostasis.	Trends in endocrinology and metabolism	2009	53
19376193	Insulin	Confavreux CB	A paradigm of integrative physiology, the crosstalk between bone and energy metabolisms.	Molecular and cellular endocrinology	2009	51
19386626	Insulin	Shu L	Decreased TCF7L2 protein levels in type 2 diabetes mellitus correlate with downregulation of GIP- and GLP-1 receptors and impaired beta-cell function.	Human molecular genetics	2009	76
19394973	Insulin	Atlantis E	Inverse associations between muscle mass, strength, and the metabolic syndrome.	Metabolism	2009	49
19401422	Insulin	Capel F	Macrophages and adipocytes in human obesity: adipose tissue gene expression and insulin sensitivity during calorie restriction and weight stabilization.	Diabetes	2009	45
19460915	Insulin	Catalano PM	Fetuses of obese mothers develop insulin resistance in utero.	Diabetes care	2009	141
19470610	Insulin	Helmerhorst HJ	Objectively measured sedentary time may predict insulin resistance independent of moderate- and vigorous-intensity physical activity.	Diabetes	2009	69
19475663	Insulin	Wiltzius JJ	Atomic structures of IAPP (amylin) fusions suggest a mechanism for fibrillation and the role of insulin in the process.	Protein science 	2009	64
19490822	Insulin	Gross DN	The role of FOXO in the regulation of metabolism.	Current diabetes reports	2009	57
19515410	Insulin	Tabák AG	Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: an analysis from the Whitehall II study.	Lancet	2009	165
19565214	Insulin	Hemkens LG	Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: a cohort study.	Diabetologia	2009	146
19588120	Insulin	Jonasson JM	Insulin glargine use and short-term incidence of malignancies-a population-based follow-up study in Sweden.	Diabetologia	2009	100
19603149	Insulin	Colhoun HM	Use of insulin glargine and cancer incidence in Scotland: a study from the Scottish Diabetes Research Network Epidemiology Group.	Diabetologia	2009	98
19638921	Insulin	Peterli R	Improvement in glucose metabolism after bariatric surgery: comparison of laparoscopic Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy: a prospective randomized trial.	Annals of surgery	2009	95
19651814	Insulin	Kantartzis K	Dissociation between fatty liver and insulin resistance in humans carrying a variant of the patatin-like phospholipase 3 gene.	Diabetes	2009	72
19662657	Insulin	Raji CA	Brain structure and obesity.	Human brain mapping	2010	161
19742322	Insulin	Kuroda A	Insulin gene expression is regulated by DNA methylation.	PloS one	2009	69
19755625	Insulin	Ghanim H	Increase in plasma endotoxin concentrations and the expression of Toll-like receptors and suppressor of cytokine signaling-3 in mononuclear cells after a high-fat, high-carbohydrate meal: implications for insulin resistance.	Diabetes care	2009	106
19797280	Insulin	Landon MB	A multicenter, randomized trial of treatment for mild gestational diabetes.	The New England journal of medicine	2009	247
19864431	Insulin	Foster KG	Regulation of mTOR complex 1 (mTORC1) by raptor Ser863 and multisite phosphorylation.	The Journal of biological chemistry	2010	58
19877133	Insulin	Hwang YC	The uncarboxylated form of osteocalcin is associated with improved glucose tolerance and enhanced beta-cell function in middle-aged male subjects.	Diabetes/metabolism research and reviews	2009	47
19890090	Insulin	Kowluru A	Small G proteins in islet beta-cell function.	Endocrine reviews	2010	46
19906806	Insulin	Ziemke F	Adiponectin in insulin resistance: lessons from translational research.	The American journal of clinical nutrition	2010	87
19965390	Insulin	Rosengren AH	Overexpression of alpha2A-adrenergic receptors contributes to type 2 diabetes.	Science	2010	68
20018750	Insulin	Sugii S	PPARgamma activation in adipocytes is sufficient for systemic insulin sensitization.	Proceedings of the National Academy of Sciences of the United States of America	2009	79
20022465	Insulin	Das UN	Obesity: genes, brain, gut, and environment.	Nutrition	2010	49
20029383	Insulin	Kashyap SR	Acute effects of gastric bypass versus gastric restrictive surgery on beta-cell function and insulinotropic hormones in severely obese patients with type 2 diabetes.	International journal of obesity	2010	63
20053958	Insulin	Jewell JL	Exocytosis mechanisms underlying insulin release and glucose uptake: conserved roles for Munc18c and syntaxin 4.	American journal of physiology. Regulatory, integrative and comparative physiology	2010	43
20076942	Insulin	Tai ES	Insulin resistance is associated with a metabolic profile of altered protein metabolism in Chinese and Asian-Indian men.	Diabetologia	2010	110
20086256	Insulin	Karter AJ	Barriers to insulin initiation: the translating research into action for diabetes insulin starts project.	Diabetes care	2010	52
20091571	Insulin	Misso ML	Continuous subcutaneous insulin infusion (CSII) versus multiple insulin injections for type 1 diabetes mellitus.	The Cochrane database of systematic reviews	2010	51
20092585	Insulin	Vilsbøll T	Efficacy and safety of sitagliptin when added to insulin therapy in patients with type 2 diabetes.	Diabetes, obesity & metabolism	2010	70
20103556	Insulin	Peyrot M	Correlates of insulin injection omission.	Diabetes care	2010	86
20185812	Insulin	Yang X	Associations of hyperglycemia and insulin usage with the risk of cancer in type 2 diabetes: the Hong Kong diabetes registry.	Diabetes	2010	43
20212113	Insulin	Chagpar RB	Direct positive regulation of PTEN by the p85 subunit of phosphatidylinositol 3-kinase.	Proceedings of the National Academy of Sciences of the United States of America	2010	61
20216312	Insulin	Summers SA	Sphingolipids and insulin resistance: the five Ws.	Current opinion in lipidology	2010	51
20339361	Insulin	Preis SR	Abdominal subcutaneous and visceral adipose tissue and insulin resistance in the Framingham heart study.	Obesity	2010	85
20357365	Insulin	Sarruf DA	Fibroblast growth factor 21 action in the brain increases energy expenditure and insulin sensitivity in obese rats.	Diabetes	2010	68
20360006	Insulin	Boucher J	Insulin and insulin-like growth factor-1 receptors act as ligand-specific amplitude modulators of a common pathway regulating gene transcription.	The Journal of biological chemistry	2010	42
20410232	Insulin	Brøns C	Deoxyribonucleic acid methylation and gene expression of PPARGC1A in human muscle is influenced by high-fat overfeeding in a birth-weight-dependent manner.	The Journal of clinical endocrinology and metabolism	2010	43
20421924	Insulin	Whincup PH	Early emergence of ethnic differences in type 2 diabetes precursors in the UK: the Child Heart and Health Study in England (CHASE Study).	PLoS medicine	2010	46
20484465	Insulin	Fu Z	Genistein induces pancreatic beta-cell proliferation through activation of multiple signaling pathways and prevents insulin-deficient diabetes in mice.	Endocrinology	2010	42
20530744	Insulin	Gupta S	PERK (EIF2AK3) regulates proinsulin trafficking and quality control in the secretory pathway.	Diabetes	2010	44
20562852	Insulin	Marcheva B	Disruption of the clock components CLOCK and BMAL1 leads to hypoinsulinaemia and diabetes.	Nature	2010	345
20581420	Insulin	HEALTHY Study Group.	A school-based intervention for diabetes risk reduction.	The New England journal of medicine	2010	96
20592469	Insulin	Liew CW	The pseudokinase tribbles homolog 3 interacts with ATF4 to negatively regulate insulin exocytosis in human and mouse beta cells.	The Journal of clinical investigation	2010	49
20663687	Insulin	Gallagher EJ	The proliferating role of insulin and insulin-like growth factors in cancer.	Trends in endocrinology and metabolism	2010	66
20693352	Insulin	Nettleton JA	Interactions of dietary whole-grain intake with fasting glucose- and insulin-related genetic loci in individuals of European descent: a meta-analysis of 14 cohort studies.	Diabetes care	2010	51
20739649	Insulin	Matsuzaki T	Insulin resistance is associated with the pathology of Alzheimer disease: the Hisayama study.	Neurology	2010	89
20858492	Insulin	Williams CD	Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study.	Gastroenterology	2011	398
20889126	Insulin	Welsh GI	Insulin signaling to the glomerular podocyte is critical for normal kidney function.	Cell metabolism	2010	100
21051417	Insulin	Yu Q	Insulin says NO to cardiovascular disease.	Cardiovascular research	2011	39
21070248	Insulin	Belgardt BF	CNS leptin and insulin action in the control of energy homeostasis.	Annals of the New York Academy of Sciences	2010	69
21104225	Insulin	Yang BT	Insulin promoter DNA methylation correlates negatively with insulin gene expression and positively with HbA(1c) levels in human pancreatic islets.	Diabetologia	2011	50
21115952	Insulin	Schrijvers EM	Insulin metabolism and the risk of Alzheimer disease: the Rotterdam Study.	Neurology	2010	72
21181894	Insulin	Manning AK	Meta-analysis of gene-environment interaction: joint estimation of SNP and SNP × environment regression coefficients.	Genetic epidemiology	2011	55
21186369	Insulin	Holland WL	Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin.	Nature medicine	2011	232
21362568	Insulin	Smukler SR	The adult mouse and human pancreas contain rare multipotent stem cells that express insulin.	Cell stem cell	2011	62
21367930	Insulin	Steil GM	The effect of insulin feedback on closed loop glucose control.	The Journal of clinical endocrinology and metabolism	2011	49
21376236	Insulin	Zinzalla V	Activation of mTORC2 by association with the ribosome.	Cell	2011	210
21403394	Insulin	Rhee EP	Lipid profiling identifies a triacylglycerol signature of insulin resistance and improves diabetes prediction in humans.	The Journal of clinical investigation	2011	134
21471135	Insulin	Schramm TK	Mortality and cardiovascular risk associated with different insulin secretagogues compared with metformin in type 2 diabetes, with or without a previous myocardial infarction: a nationwide study.	European heart journal	2011	66
21540285	Insulin	Gallagher EJ	Minireview: IGF, Insulin, and Cancer.	Endocrinology	2011	90
21562325	Insulin	Steck AK	Age of islet autoantibody appearance and mean levels of insulin, but not GAD or IA-2 autoantibodies, predict age of diagnosis of type 1 diabetes: diabetes autoimmunity study in the young.	Diabetes care	2011	60
21593202	Insulin	Lamers D	Dipeptidyl peptidase 4 is a novel adipokine potentially linking obesity to the metabolic syndrome.	Diabetes	2011	104
21598254	Insulin	Liu Y	Deficient brain insulin signalling pathway in Alzheimer's disease and diabetes.	The Journal of pathology	2011	91
21632448	Insulin	La Vecchia C	Overweight, obesity, diabetes, and risk of breast cancer: interlocking pieces of the puzzle.	The oncologist	2011	41
21633180	Insulin	Seino S	Dynamics of insulin secretion and the clinical implications for obesity and diabetes.	The Journal of clinical investigation	2011	82
21636800	Insulin	Dabelea D	Etiological approach to characterization of diabetes type: the SEARCH for Diabetes in Youth Study.	Diabetes care	2011	53
21680720	Insulin	Giannoukakis N	Phase I (safety) study of autologous tolerogenic dendritic cells in type 1 diabetic patients.	Diabetes care	2011	100
21690251	Insulin	Daniel C	Prevention of type 1 diabetes in mice by tolerogenic vaccination with a strong agonist insulin mimetope.	The Journal of experimental medicine	2011	45
21705062	Insulin	Tahrani AA	Management of type 2 diabetes: new and future developments in treatment.	Lancet	2011	74
21829658	Insulin	Karolina DS	MicroRNA 144 impairs insulin signaling by inhibiting the expression of insulin receptor substrate 1 in type 2 diabetes mellitus.	PloS one	2011	88
21864752	Insulin	Dimitriadis G	Insulin effects in muscle and adipose tissue.	Diabetes research and clinical practice	2011	41
21873549	Insulin	Strawbridge RJ	Genome-wide association identifies nine common variants associated with fasting proinsulin levels and provides new insights into the pathophysiology of type 2 diabetes.	Diabetes	2011	102
21956710	Insulin	Ruiter R	Risk of cancer in patients on insulin glargine and other insulin analogues in comparison with those on human insulin: results from a large population-based follow-up study.	Diabetologia	2012	40
21986512	Insulin	Newbern D	Placental hormones and the control of maternal metabolism and fetal growth.	Current opinion in endocrinology, diabetes, and obesity	2011	57
22055501	Insulin	Bornfeldt KE	Insulin resistance, hyperglycemia, and atherosclerosis.	Cell metabolism	2011	116
22056147	Insulin	Kunisada Y	Small molecules induce efficient differentiation into insulin-producing cells from human induced pluripotent stem cells.	Stem cell research	2012	51
22074781	Insulin	Akirav EM	Detection of β cell death in diabetes using differentially methylated circulating DNA.	Proceedings of the National Academy of Sciences of the United States of America	2011	60
22167125	Insulin	Dai C	Islet-enriched gene expression and glucose-induced insulin secretion in human and mouse islets.	Diabetologia	2012	57
22167127	Insulin	Cooper AR	Sedentary time, breaks in sedentary time and metabolic variables in people with newly diagnosed type 2 diabetes.	Diabetologia	2012	42
22213807	Insulin	Coppieters KT	Demonstration of islet-autoreactive CD8 T cells in insulitic lesions from recent onset and long-term type 1 diabetes patients.	The Journal of experimental medicine	2012	145
22226086	Insulin	Devineni D	Canagliflozin improves glycaemic control over 28 days in subjects with type 2 diabetes not optimally controlled on insulin.	Diabetes, obesity & metabolism	2012	48
22241293	Insulin	Jeschke MG	Severe injury is associated with insulin resistance, endoplasmic reticulum stress response, and unfolded protein response.	Annals of surgery	2012	33
22271188	Insulin	Drew BG	The emerging role of HDL in glucose metabolism.	Nature reviews. Endocrinology	2012	35
22278418	Insulin	Chen G	Metformin inhibits growth of thyroid carcinoma cells, suppresses self-renewal of derived cancer stem cells, and potentiates the effect of chemotherapeutic agents.	The Journal of clinical endocrinology and metabolism	2012	37
22313123	Insulin	Peyrot M	Insulin adherence behaviours and barriers in the multinational Global Attitudes of Patients and Physicians in Insulin Therapy study.	Diabetic medicine 	2012	90
22315324	Insulin	Santulli G	Age-related impairment in insulin release: the essential role of β(2)-adrenergic receptor.	Diabetes	2012	35
22328150	Insulin	Kriegel MA	Pancreatic islet expression of chemokine CCL2 suppresses autoimmune diabetes via tolerogenic CD11c+ CD11b+ dendritic cells.	Proceedings of the National Academy of Sciences of the United States of America	2012	31
22330739	Insulin	Tiano JP	Importance of oestrogen receptors to preserve functional β-cell mass in diabetes.	Nature reviews. Endocrinology	2012	41
22337149	Insulin	Pollak M	The insulin and insulin-like growth factor receptor family in neoplasia: an update.	Nature reviews. Cancer	2012	276
22374636	Insulin	Dunstan DW	Breaking up prolonged sitting reduces postprandial glucose and insulin responses.	Diabetes care	2012	191
22385956	Insulin	Samuel VT	Mechanisms for insulin resistance: common threads and missing links.	Cell	2012	436
22411919	Insulin	Karagiannis T	Dipeptidyl peptidase-4 inhibitors for treatment of type 2 diabetes mellitus in the clinical setting: systematic review and meta-analysis.	BMJ	2012	79
22431523	Insulin	Norseen J	Retinol-binding protein 4 inhibits insulin signaling in adipocytes by inducing proinflammatory cytokines in macrophages through a c-Jun N-terminal kinase- and toll-like receptor 4-dependent and retinol-independent mechanism.	Molecular and cellular biology	2012	62
22476196	Insulin	Bomfim TR	An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer's disease- associated Aβ oligomers.	The Journal of clinical investigation	2012	123
22476197	Insulin	Talbot K	Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline.	The Journal of clinical investigation	2012	269
22492369	Insulin	Bjermo H	Effects of n-6 PUFAs compared with SFAs on liver fat, lipoproteins, and inflammation in abdominal obesity: a randomized controlled trial.	The American journal of clinical nutrition	2012	55
22492527	Insulin	Rosengren AH	Reduced insulin exocytosis in human pancreatic β-cells with gene variants linked to type 2 diabetes.	Diabetes	2012	70
22511205	Insulin	Würtz P	Metabolic signatures of insulin resistance in 7,098 young adults.	Diabetes	2012	69
22533577	Insulin	Pickup JC	Insulin-pump therapy for type 1 diabetes mellitus.	The New England journal of medicine	2012	33
22569073	Insulin	Ren G	Identification of RIFL, a novel adipocyte-enriched insulin target gene with a role in lipid metabolism.	American journal of physiology. Endocrinology and metabolism	2012	63
22593429	Insulin	Cohen DH	Obesity, type 2 diabetes, and cancer: the insulin and IGF connection.	Endocrine-related cancer	2012	55
22719752	Insulin	Hsieh MC	The influence of type 2 diabetes and glucose-lowering therapies on cancer risk in the Taiwanese.	Experimental diabetes research	2012	42
22740171	Insulin	Rezania A	Maturation of human embryonic stem cell-derived pancreatic progenitors into functional islets capable of treating pre-existing diabetes in mice.	Diabetes	2012	112
22766318	Insulin	Supale S	Mitochondrial dysfunction in pancreatic β cells.	Trends in endocrinology and metabolism	2012	48
22768844	Insulin	Taneera J	A systems genetics approach identifies genes and pathways for type 2 diabetes in human islets.	Cell metabolism	2012	84
22796579	Insulin	Sparks JD	Selective hepatic insulin resistance, VLDL overproduction, and hypertriglyceridemia.	Arteriosclerosis, thrombosis, and vascular biology	2012	31
22820012	Insulin	Banks WA	Insulin in the brain: there and back again.	Pharmacology & therapeutics	2012	71
22840388	Insulin	Fine EJ	Targeting insulin inhibition as a metabolic therapy in advanced cancer: a pilot safety and feasibility dietary trial in 10 patients.	Nutrition	2012	35
22885924	Insulin	Scott RA	Large-scale association analyses identify new loci influencing glycemic traits and provide insight into the underlying biological pathways.	Nature genetics	2012	237
23062212	Insulin	Gurka MJ	A confirmatory factor analysis of the metabolic syndrome in adolescents: an examination of sex and racial/ethnic differences.	Cardiovascular diabetology	2012	35
23069840	Insulin	Jastreboff AM	Neural correlates of stress- and food cue-induced food craving in obesity: association with insulin levels.	Diabetes care	2013	45
23070488	Insulin	Broussard JL	Impaired insulin signaling in human adipocytes after experimental sleep restriction: a randomized, crossover study.	Annals of internal medicine	2012	74
23169676	Insulin	Girgis CM	The roles of vitamin D in skeletal muscle: form, function, and metabolism.	Endocrine reviews	2013	62
23183535	Insulin	Thatava T	Intrapatient variations in type 1 diabetes-specific iPS cell differentiation into insulin-producing cells.	Molecular therapy 	2013	29
23187122	Insulin	Bradley D	Gastric bypass and banding equally improve insulin sensitivity and β cell function.	The Journal of clinical investigation	2012	55
23207292	Insulin	Djiogue S	Insulin resistance and cancer: the role of insulin and IGFs.	Endocrine-related cancer	2013	42
23209187	Insulin	El Hajj N	Metabolic programming of MEST DNA methylation by intrauterine exposure to gestational diabetes mellitus.	Diabetes	2013	39
23223406	Insulin	Pisprasert V	Limitations in the use of indices using glucose and insulin levels to predict insulin sensitivity: impact of race and gender and superiority of the indices derived from oral glucose tolerance test in African Americans.	Diabetes care	2013	33
23263489	Insulin	Huyghe JR	Exome array analysis identifies new loci and low-frequency variants influencing insulin processing and secretion.	Nature genetics	2013	109
23302862	Insulin	Menting JG	How insulin engages its primary binding site on the insulin receptor.	Nature	2013	67
23349537	Insulin	Costes S	β-Cell failure in type 2 diabetes: a case of asking too much of too few?	Diabetes	2013	31
23381014	Insulin	Singh S	Anti-diabetic medications and the risk of hepatocellular cancer: a systematic review and meta-analysis.	The American journal of gastroenterology	2013	51
23385611	Insulin	Lu J	Insulin resistance and the metabolism of branched-chain amino acids.	Frontiers of medicine	2013	26
23466711	Insulin	Duggan C	Association between markers of obesity and progression from Barrett's esophagus to esophageal adenocarcinoma.	Clinical gastroenterology and hepatology 	2013	39
23471659	Insulin	Ye J	Mechanisms of insulin resistance in obesity.	Frontiers of medicine	2013	47
23561637	Insulin	Breslavsky A	Effect of high doses of vitamin D on arterial properties, adiponectin, leptin and glucose homeostasis in type 2 diabetic patients.	Clinical nutrition	2013	28
23569174	Insulin	Spijker HS	Conversion of mature human β-cells into glucagon-producing α-cells.	Diabetes	2013	27
23619195	Insulin	Liu JJ	Lower circulating irisin is associated with type 2 diabetes mellitus.	Journal of diabetes and its complications	2013	65
23620761	Insulin	Sarfstein R	Metformin downregulates the insulin/IGF-I signaling pathway and inhibits different uterine serous carcinoma (USC) cells proliferation and migration in p53-dependent or -independent manners.	PloS one	2013	32
23652116	Insulin	Ahmadian M	PPARγ signaling and metabolism: the good, the bad and the future.	Nature medicine	2013	284
23690305	Insulin	Zhang C	Genetic variants and the risk of gestational diabetes mellitus: a systematic review.	Human reproduction update	2013	36
23694765	Insulin	Amisten S	An atlas and functional analysis of G-protein coupled receptors in human islets of Langerhans.	Pharmacology & therapeutics	2013	28
23720280	Insulin	Roberts CK	Metabolic syndrome and insulin resistance: underlying causes and modification by exercise training.	Comprehensive Physiology	2013	44
23737756	Insulin	Nogueira TC	GLIS3, a susceptibility gene for type 1 and type 2 diabetes, modulates pancreatic beta cell apoptosis via regulation of a splice variant of the BH3-only protein Bim.	PLoS genetics	2013	39
23780460	Insulin	Ziegler AG	Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children.	JAMA	2013	135
23796113	Insulin	Östenson CG	Self-reported non-severe hypoglycaemic events in Europe.	Diabetic medicine 	2014	29
23801714	Insulin	Rhodes CJ	Direct autocrine action of insulin on β-cells: does it make physiological sense?	Diabetes	2013	26
23847240	Insulin	Wolpin BM	Hyperglycemia, insulin resistance, impaired pancreatic β-cell function, and risk of pancreatic cancer.	Journal of the National Cancer Institute	2013	30
23916992	Insulin	Scharp DW	Encapsulated islets for diabetes therapy: history, current progress, and critical issues requiring solution.	Advanced drug delivery reviews	2014	36
23932846	Insulin	Aroor AR	Maladaptive immune and inflammatory pathways lead to cardiovascular insulin resistance.	Metabolism	2013	47
24003918	Insulin	Imai S	The importance of NAMPT/NAD/SIRT1 in the systemic regulation of metabolism and ageing.	Diabetes, obesity & metabolism	2013	38
24011069	Insulin	Gaich G	The effects of LY2405319, an FGF21 analog, in obese human subjects with type 2 diabetes.	Cell metabolism	2013	115
24041680	Insulin	Stahn A	Relationship between hypoglycemic episodes and ventricular arrhythmias in patients with type 2 diabetes and cardiovascular diseases: silent hypoglycemias and silent arrhythmias.	Diabetes care	2014	23
24042324	Insulin	Ashcroft FM	K(ATP) channels and islet hormone secretion: new insights and controversies.	Nature reviews. Endocrinology	2013	49
24051378	Insulin	Tamaki M	The diabetes-susceptible gene SLC30A8/ZnT8 regulates hepatic insulin clearance.	The Journal of clinical investigation	2013	51
24130353	Insulin	Sell H	Adipose dipeptidyl peptidase-4 and obesity: correlation with insulin resistance and depot-specific release from adipose tissue in vivo and in vitro.	Diabetes care	2013	29
24140094	Insulin	Lee YS	Anti-diabetic actions of glucagon-like peptide-1 on pancreatic beta-cells.	Metabolism	2014	29
24170695	Insulin	Hidalgo B	Epigenome-wide association study of fasting measures of glucose, insulin, and HOMA-IR in the Genetics of Lipid Lowering Drugs and Diet Network study.	Diabetes	2014	49
24174327	Insulin	Finan B	Unimolecular dual incretins maximize metabolic benefits in rodents, monkeys, and humans.	Science translational medicine	2013	27
24241533	Insulin	Bojsen-Møller KN	Early enhancements of hepatic and later of peripheral insulin sensitivity combined with increased postprandial insulin secretion contribute to improved glycemic control after Roux-en-Y gastric bypass.	Diabetes	2014	31
24252877	Insulin	Lee J	Expansion and conversion of human pancreatic ductal cells into insulin-secreting endocrine cells.	eLife	2013	41
24281010	Insulin	Guo S	Insulin signaling, resistance, and the metabolic syndrome: insights from mouse models into disease mechanisms.	The Journal of endocrinology	2014	83
24284436	Insulin	Ley SH	Associations between red meat intake and biomarkers of inflammation and glucose metabolism in women.	The American journal of clinical nutrition	2014	25
24296717	Insulin	Dimas AS	Impact of type 2 diabetes susceptibility variants on quantitative glycemic traits reveals mechanistic heterogeneity.	Diabetes	2014	80
24356592	Insulin	Nathan DM	The diabetes control and complications trial/epidemiology of diabetes interventions and complications study at 30 years: overview.	Diabetes care	2014	80
24380887	Insulin	de la Monte SM	Brain metabolic dysfunction at the core of Alzheimer's disease.	Biochemical pharmacology	2014	55
24458353	Insulin	Leproult R	Circadian misalignment augments markers of insulin resistance and inflammation, independently of sleep loss.	Diabetes	2014	79
24462370	Insulin	Holmes MV	Causal effects of body mass index on cardiometabolic traits and events: a Mendelian randomization analysis.	American journal of human genetics	2014	42
24478399	Insulin	Ortega FJ	Profiling of circulating microRNAs reveals common microRNAs linked to type 2 diabetes that change with insulin sensitization.	Diabetes care	2014	52
24519298	Insulin	Wang G	Preterm birth and random plasma insulin levels at birth and in early childhood.	JAMA	2014	30
24529663	Insulin	Werner H	Insulin and insulin-like growth factor receptors in the brain: physiological and pathological aspects.	European neuropsychopharmacology 	2014	24
24567379	Insulin	Cai W	Oral glycotoxins are a modifiable cause of dementia and the metabolic syndrome in mice and humans.	Proceedings of the National Academy of Sciences of the United States of America	2014	24
24603685	Insulin	Dayeh T	Genome-wide DNA methylation analysis of human pancreatic islets from type 2 diabetic and non-diabetic donors identifies candidate genes that influence insulin secretion.	PLoS genetics	2014	101
24613355	Insulin	Chen YJ	De novo formation of insulin-producing "neo-β cell islets" from intestinal crypts.	Cell reports	2014	33
24626293	Insulin	Mo R	Emerging micro- and nanotechnology based synthetic approaches for insulin delivery.	Chemical Society reviews	2014	27
24633305	Insulin	Ardestani A	MST1 is a key regulator of beta cell apoptosis and dysfunction in diabetes.	Nature medicine	2014	37
24725149	Insulin	Peyser T	The artificial pancreas: current status and future prospects in the management of diabetes.	Annals of the New York Academy of Sciences	2014	31
24751356	Insulin	Davidson HW	Zinc transporter 8 (ZnT8) and β cell function.	Trends in endocrinology and metabolism	2014	20
24757202	Insulin	Chow E	Risk of cardiac arrhythmias during hypoglycemia in patients with type 2 diabetes and cardiovascular risk.	Diabetes	2014	50
24931033	Insulin	De Felice FG	Inflammation, defective insulin signaling, and mitochondrial dysfunction as common molecular denominators connecting type 2 diabetes to Alzheimer disease.	Diabetes	2014	66
24931034	Insulin	Kleinridders A	Insulin action in brain regulates systemic metabolism and brain function.	Diabetes	2014	52
24931035	Insulin	Yarchoan M	Repurposing diabetes drugs for brain insulin resistance in Alzheimer disease.	Diabetes	2014	33
24943065	Insulin	Thabit H	Home use of closed-loop insulin delivery for overnight glucose control in adults with type 1 diabetes: a 4-week, multicentre, randomised crossover study.	The lancet. Diabetes & endocrinology	2014	37
24947355	Insulin	Tubbs E	Mitochondria-associated endoplasmic reticulum membrane (MAM) integrity is required for insulin signaling and is implicated in hepatic insulin resistance.	Diabetes	2014	36
24947364	Insulin	Scott RA	Common genetic variants highlight the role of insulin resistance and body fat distribution in type 2 diabetes, independent of obesity.	Diabetes	2014	32
24963110	Insulin	Leelarathna L	Day and night home closed-loop insulin delivery in adults with type 1 diabetes: three-center randomized crossover study.	Diabetes care	2014	35
25015099	Insulin	Zhou Y	TCF7L2 is a master regulator of insulin production and processing.	Human molecular genetics	2014	30
25028522	Insulin	Heni M	Central insulin administration improves whole-body insulin sensitivity via hypothalamus and parasympathetic outputs in men.	Diabetes	2014	26
25036708	Insulin	Rivera JF	Autophagy defends pancreatic β cells from human islet amyloid polypeptide-induced toxicity.	The Journal of clinical investigation	2014	49
25043022	Insulin	Moltke I	A common Greenlandic TBC1D4 variant confers muscle insulin resistance and type 2 diabetes.	Nature	2014	59
25062042	Insulin	Arnold N	Regulation of cardiac expression of the diabetic marker microRNA miR-29.	PloS one	2014	21
25101872	Insulin	Park S	A genetic strategy to measure circulating Drosophila insulin reveals genes regulating insulin production and secretion.	PLoS genetics	2014	28
25182023	Insulin	Ballak DB	IL-37 protects against obesity-induced inflammation and insulin resistance.	Nature communications	2014	27
25187364	Insulin	Albers PH	Human muscle fiber type-specific insulin signaling: impact of obesity and type 2 diabetes.	Diabetes	2015	16
25247581	Insulin	Jenwitheesuk A	Melatonin regulates aging and neurodegeneration through energy metabolism, epigenetics, autophagy and circadian rhythm pathways.	International journal of molecular sciences	2014	20
25287287	Insulin	Lynch CJ	Branched-chain amino acids in metabolic signalling and insulin resistance.	Nature reviews. Endocrinology	2014	93
25287289	Insulin	Frier BM	Hypoglycaemia in diabetes mellitus: epidemiology and clinical implications.	Nature reviews. Endocrinology	2014	35
25303535	Insulin	Pagliuca FW	Generation of functional human pancreatic β cells in vitro.	Cell	2014	241
25362253	Insulin	Hasnain SZ	Glycemic control in diabetes is restored by therapeutic manipulation of cytokines that regulate beta cell stress.	Nature medicine	2014	31
25375650	Insulin	Olsson AH	Genome-wide associations between genetic and epigenetic variation influence mRNA expression and insulin secretion in human pancreatic islets.	PLoS genetics	2014	33
25377875	Insulin	Lin Y	In vivo pancreatic β-cell-specific expression of antiaging gene Klotho: a novel approach for preserving β-cells in type 2 diabetes.	Diabetes	2015	19
25465273	Insulin	Cariou B	Frequency and predictors of confirmed hypoglycaemia in type 1 and insulin-treated type 2 diabetes mellitus patients in a real-life setting: results from the DIALOG study.	Diabetes & metabolism	2015	22
25468945	Insulin	Neal B	Efficacy and safety of canagliflozin, an inhibitor of sodium-glucose cotransporter 2, when used in conjunction with insulin therapy in patients with type 2 diabetes.	Diabetes care	2015	46
25502755	Insulin	Yuan W	An integrated epigenomic analysis for type 2 diabetes susceptibility loci in monozygotic twins.	Nature communications	2014	23
25596529	Insulin	Keembiyehetty C	Conditional knock-out reveals a requirement for O-linked N-Acetylglucosaminase (O-GlcNAcase) in metabolic homeostasis.	The Journal of biological chemistry	2015	20
25600304	Insulin	Del Favero S	Multicenter outpatient dinner/overnight reduction of hypoglycemia and increased time of glucose in target with a wearable artificial pancreas using modular model predictive control in adults with type 1 diabetes.	Diabetes, obesity & metabolism	2015	18
25625282	Insulin	Mahajan A	Identification and functional characterization of G6PC2 coding variants influencing glycemic traits define an effector transcript at the G6PC2-ABCB11 locus.	PLoS genetics	2015	33
25631608	Insulin	Wessel J	Low-frequency and rare exome chip variants associate with fasting glucose and type 2 diabetes susceptibility.	Nature communications	2015	44
25642774	Insulin	Herold KC	β cell death and dysfunction during type 1 diabetes development in at-risk individuals.	The Journal of clinical investigation	2015	36
25660258	Insulin	Krischer JP	The 6 year incidence of diabetes-associated autoantibodies in genetically at-risk children: the TEDDY study.	Diabetologia	2015	39
25673412	Insulin	Shungin D	New genetic loci link adipose and insulin biology to body fat distribution.	Nature	2015	208
25673413	Insulin	Locke AE	Genetic studies of body mass index yield new insights for obesity biology.	Nature	2015	564
25677912	Insulin	Færch K	GLP-1 Response to Oral Glucose Is Reduced in Prediabetes, Screen-Detected Type 2 Diabetes, and Obesity and Influenced by Sex: The ADDITION-PRO Study.	Diabetes	2015	20
25697093	Insulin	Rutter GA	Pancreatic β-cell identity, glucose sensing and the control of insulin secretion.	The Biochemical journal	2015	40
25713189	Insulin	Nolan CJ	Insulin resistance as a physiological defense against metabolic stress: implications for the management of subsets of type 2 diabetes.	Diabetes	2015	20
25733449	Insulin	Rahman SA	Molecular mechanisms of congenital hyperinsulinism.	Journal of molecular endocrinology	2015	17
25754552	Insulin	Cederberg H	Increased risk of diabetes with statin treatment is associated with impaired insulin sensitivity and insulin secretion: a 6 year follow-up study of the METSIM cohort.	Diabetologia	2015	40
25766618	Insulin	Kim B	Insulin resistance as a key link for the increased risk of cognitive impairment in the metabolic syndrome.	Experimental & molecular medicine	2015	28
25776943	Insulin	Guo K	Serum betatrophin concentrations are significantly increased in overweight but not in obese or type 2 diabetic individuals.	Obesity	2015	18
25795413	Insulin	Kullmann S	Selective insulin resistance in homeostatic and cognitive control brain areas in overweight and obese adults.	Diabetes care	2015	18
25831495	Insulin	Nakayama M	Regulatory vs. inflammatory cytokine T-cell responses to mutated insulin peptides in healthy and type 1 diabetic subjects.	Proceedings of the National Academy of Sciences of the United States of America	2015	17
25898052	Insulin	Bonifacio E	Effects of high-dose oral insulin on immune responses in children at high risk for type 1 diabetes: the Pre-POINT randomized clinical trial.	JAMA	2015	22
25944304	Insulin	Yabe D	β cell dysfunction versus insulin resistance in the pathogenesis of type 2 diabetes in East Asians.	Current diabetes reports	2015	26
25999530	Insulin	Stewart AF	Human β-cell proliferation and intracellular signaling: part 3.	Diabetes	2015	26
26009231	Insulin	Gilbert RE	Heart failure in diabetes: effects of anti-hyperglycaemic drug therapy.	Lancet	2015	37
26044465	Insulin	Simó R	Novel insights in SHBG regulation and clinical implications.	Trends in endocrinology and metabolism	2015	20
26063450	Insulin	Ferrannini E	Impact of glucose-lowering drugs on cardiovascular disease in type 2 diabetes.	European heart journal	2015	26
26076035	Insulin	van der Meulen T	Urocortin3 mediates somatostatin-dependent negative feedback control of insulin secretion.	Nature medicine	2015	29
26077431	Insulin	Rönn T	DNA methylation as a diagnostic and therapeutic target in the battle against Type 2 diabetes.	Epigenomics	2015	20
26153338	Insulin	Clements MA	Hemoglobin A1c (HbA1c) changes over time among adolescent and young adult participants in the T1D exchange clinic registry.	Pediatric diabetes	2016	15
26159692	Insulin	Dibble CC	Regulation of mTORC1 by PI3K signaling.	Trends in cell biology	2015	103
26211738	Insulin	Xu H	The circular RNA Cdr1as, via miR-7 and its targets, regulates insulin transcription and secretion in islet cells.	Scientific reports	2015	59
26257839	Insulin	Keane KN	Molecular Events Linking Oxidative Stress and Inflammation to Insulin Resistance and β-Cell Dysfunction.	Oxidative medicine and cellular longevity	2015	23
26268733	Insulin	Hua F	TRB3 links insulin/IGF to tumour promotion by interacting with p62 and impeding autophagic/proteasomal degradations.	Nature communications	2015	23
26304037	Insulin	Agulnick AD	Insulin-Producing Endocrine Cells Differentiated In Vitro From Human Embryonic Stem Cells Function in Macroencapsulation Devices In Vivo.	Stem cells translational medicine	2015	24
26389675	Insulin	Sharma RB	Insulin demand regulates β cell number via the unfolded protein response.	The Journal of clinical investigation	2015	35
26404065	Insulin	Abdulla H	Role of insulin in the regulation of human skeletal muscle protein synthesis and breakdown: a systematic review and meta-analysis.	Diabetologia	2016	13
26408801	Insulin	Khodabandehloo H	Molecular and cellular mechanisms linking inflammation to insulin resistance and β-cell dysfunction.	Translational research 	2016	32
26432775	Insulin	Kropff J	2 month evening and night closed-loop glucose control in patients with type 1 diabetes under free-living conditions: a randomised crossover trial.	The lancet. Diabetes & endocrinology	2015	38
26489970	Insulin	Nauck M	Incretin therapies: highlighting common features and differences in the modes of action of glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors.	Diabetes, obesity & metabolism	2016	23
26542580	Insulin	Perelis M	Pancreatic β cell enhancers regulate rhythmic transcription of genes controlling insulin secretion.	Science	2015	49
26576641	Insulin	Hasnain SZ	Oxidative and endoplasmic reticulum stress in β-cell dysfunction in diabetes.	Journal of molecular endocrinology	2016	17
26577716	Insulin	Ohn JH	10-year trajectory of β-cell function and insulin sensitivity in the development of type 2 diabetes: a community-based prospective cohort study.	The lancet. Diabetes & endocrinology	2016	23
26580236	Insulin	Wong PM	Social Jetlag, Chronotype, and Cardiometabolic Risk.	The Journal of clinical endocrinology and metabolism	2015	20
26581594	Insulin	Campbell-Thompson M	Insulitis and β-Cell Mass in the Natural History of Type 1 Diabetes.	Diabetes	2016	38
26607638	Insulin	Acosta JR	Increased fat cell size: a major phenotype of subcutaneous white adipose tissue in non-obese individuals with type 2 diabetes.	Diabetologia	2016	18
26696633	Insulin	Gommers LM	Hypomagnesemia in Type 2 Diabetes: A Vicious Circle?	Diabetes	2016	15
26808499	Insulin	Khamaisi M	PKCδ inhibition normalizes the wound-healing capacity of diabetic human fibroblasts.	The Journal of clinical investigation	2016	11
26858360	Insulin	Leete P	Differential Insulitic Profiles Determine the Extent of β-Cell Destruction and the Age at Onset of Type 1 Diabetes.	Diabetes	2016	15
26959184	Insulin	Talukdar S	A Long-Acting FGF21 Molecule, PF-05231023, Decreases Body Weight and Improves Lipid Profile in Non-human Primates and Type 2 Diabetic Subjects.	Cell metabolism	2016	25
26988411	Insulin	Zaykov AN	Pursuit of a perfect insulin.	Nature reviews. Drug discovery	2016	13
27029739	Insulin	Bacos K	Blood-based biomarkers of age-associated epigenetic changes in human islets associate with insulin secretion and diabetes.	Nature communications	2016	18
27061677	Insulin	NCD Risk Factor Collaboration (NCD-RisC).	Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants.	Lancet	2016	186
27376324	Insulin	Yoon MS	The Emerging Role of Branched-Chain Amino Acids in Insulin Resistance and Metabolism.	Nutrients	2016	16
27432942	Insulin	Stanley M	Changes in insulin and insulin signaling in Alzheimer's disease: cause or consequence?	The Journal of experimental medicine	2016	13
27434443	Insulin	Palmer SC	Comparison of Clinical Outcomes and Adverse Events Associated With Glucose-Lowering Drugs in Patients With Type 2 Diabetes: A Meta-analysis.	JAMA	2016	34
27489306	Insulin	Kullmann S	Brain Insulin Resistance at the Crossroads of Metabolic and Cognitive Disorders in Humans.	Physiological reviews	2016	18
27532830	Insulin	Stewart ZA	Closed-Loop Insulin Delivery during Pregnancy in Women with Type 1 Diabetes.	The New England journal of medicine	2016	10
27565734	Insulin	Sawada T	Effects of 6-month eicosapentaenoic acid treatment on postprandial hyperglycemia, hyperlipidemia, insulin secretion ability, and concomitant endothelial dysfunction among newly-diagnosed impaired glucose metabolism patients with coronary artery disease. An open label, single blinded, prospective randomized controlled trial.	Cardiovascular diabetology	2016	10
27594187	Insulin	Frid AH	New Insulin Delivery Recommendations.	Mayo Clinic proceedings	2016	11
27629148	Insulin	Bergenstal RM	Safety of a Hybrid Closed-Loop Insulin Delivery System in Patients With Type 1 Diabetes.	JAMA	2016	25
27814523	Insulin	Li P	Hematopoietic-Derived Galectin-3 Causes Cellular and Systemic Insulin Resistance.	Cell	2016	16
27916275	Insulin	Li J	Artemisinins Target GABAA Receptor Signaling and Impair α Cell Identity.	Cell	2017	22
28052999	Insulin	Templeman NM	A causal role for hyperinsulinemia in obesity.	The Journal of endocrinology	2017	10
28097367	Insulin	Pillinger T	Impaired Glucose Homeostasis in First-Episode Schizophrenia: A Systematic Review and Meta-analysis.	JAMA psychiatry	2017	13
28118453	Insulin	Beck RW	Effect of Continuous Glucose Monitoring on Glycemic Control in Adults With Type 1 Diabetes Using Insulin Injections: The DIAMOND Randomized Clinical Trial.	JAMA	2017	35
28118454	Insulin	Lind M	Continuous Glucose Monitoring vs Conventional Therapy for Glycemic Control in Adults With Type 1 Diabetes Treated With Multiple Daily Insulin Injections: The GOLD Randomized Clinical Trial.	JAMA	2017	21
28199805	Insulin	Schauer PR	Bariatric Surgery versus Intensive Medical Therapy for Diabetes - 5-Year Outcomes.	The New England journal of medicine	2017	40
28263308	Insulin	Kracht MJ	Autoimmunity against a defective ribosomal insulin gene product in type 1 diabetes.	Nature medicine	2017	14
12081851	Carbohydrates	Willett W	Glycemic index, glycemic load, and risk of type 2 diabetes.	The American journal of clinical nutrition	2002	83
12684358	Carbohydrates	Esposito K	Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial.	JAMA	2003	235
16238454	Carbohydrates	Housa D	Adipocytokines and cancer.	Physiological research	2006	62
16365106	Carbohydrates	Layman DK	Potential importance of leucine in treatment of obesity and the metabolic syndrome.	The Journal of nutrition	2006	73
16704347	Carbohydrates	King JC	Maternal obesity, metabolism, and pregnancy outcomes.	Annual review of nutrition	2006	67
17108241	Carbohydrates	Liang H	PGC-1alpha: a key regulator of energy metabolism.	Advances in physiology education	2006	175
18265476	Carbohydrates	Xue F	Diabetes, metabolic syndrome, and breast cancer: a review of the current evidence.	The American journal of clinical nutrition	2007	98
19246357	Carbohydrates	Sacks FM	Comparison of weight-loss diets with different compositions of fat, protein, and carbohydrates.	The New England journal of medicine	2009	330
19680540	Carbohydrates	Church C	A mouse model for the metabolic effects of the human fat mass and obesity associated FTO gene.	PLoS genetics	2009	102
21471513	Carbohydrates	Godfrey KM	Epigenetic gene promoter methylation at birth is associated with child's later adiposity.	Diabetes	2011	162
21527736	Carbohydrates	Wright EM	Biology of human sodium glucose transporters.	Physiological reviews	2011	183
21719444	Carbohydrates	Musselman LP	A high-sugar diet produces obesity and insulin resistance in wild-type Drosophila.	Disease models & mechanisms	2011	99
23627878	Carbohydrates	Eng DS	The promise and peril of mobile health applications for diabetes and endocrinology.	Pediatric diabetes	2013	33
23858092	Carbohydrates	Contreras AV	PPAR-α as a key nutritional and environmental sensor for metabolic adaptation.	Advances in nutrition	2013	32
24731669	Carbohydrates	Yki-Järvinen H	Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome.	The lancet. Diabetes & endocrinology	2014	83
25170079	Carbohydrates	Jiang S	Fibroblast growth factor 21 is regulated by the IRE1α-XBP1 branch of the unfolded protein response and counteracts endoplasmic reticulum stress-induced hepatic steatosis.	The Journal of biological chemistry	2014	32
25253086	Carbohydrates	Jia G	Overnutrition, mTOR signaling, and cardiovascular diseases.	American journal of physiology. Regulatory, integrative and comparative physiology	2014	31
25871295	Carbohydrates	Gammone MA	Anti-obesity activity of the marine carotenoid fucoxanthin.	Marine drugs	2015	20
11679420	Hormones	Goran MI	Longitudinal study on pubertal insulin resistance.	Diabetes	2001	120
11681807	Hormones	Trayhurn P	Physiological role of adipose tissue: white adipose tissue as an endocrine and secretory organ.	The Proceedings of the Nutrition Society	2001	152
14749280	Hormones	Havel PJ	Update on adipocyte hormones: regulation of energy balance and carbohydrate/lipid metabolism.	Diabetes	2004	107
16950139	Hormones	Batterham RL	Critical role for peptide YY in protein-mediated satiation and body-weight regulation.	Cell metabolism	2006	104
19079713	Hormones	Turyk ME	Hormone disruption by PBDEs in adult male sport fish consumers.	Environmental health perspectives	2008	64
22899902	Hormones	Suzuki K	Obesity and appetite control.	Experimental diabetes research	2012	35
24583766	Hormones	Hardie DG	AMPK: regulating energy balance at the cellular and whole body levels.	Physiology	2014	43
24606092	Hormones	Bartz S	Severe acute malnutrition in childhood: hormonal and metabolic status at presentation, response to treatment, and predictors of mortality.	The Journal of clinical endocrinology and metabolism	2014	22
25651184	Hormones	Alfa RW	Suppression of insulin production and secretion by a decretin hormone.	Cell metabolism	2015	22
11147798	Peptides	Bonny C	Cell-permeable peptide inhibitors of JNK: novel blockers of beta-cell death.	Diabetes	2001	117
14755342	Peptides	Arif S	Autoreactive T cell responses show proinflammatory polarization in diabetes but a regulatory phenotype in health.	The Journal of clinical investigation	2004	120
15567406	Peptides	Uhlik MT	Structural and evolutionary division of phosphotyrosine binding (PTB) domains.	Journal of molecular biology	2005	81
16715091	Peptides	Ochi H	Oral CD3-specific antibody suppresses autoimmune encephalomyelitis by inducing CD4+ CD25- LAP+ T cells.	Nature medicine	2006	82
17372018	Peptides	Scannell M	Annexin-1 and peptide derivatives are released by apoptotic cells and stimulate phagocytosis of apoptotic neutrophils by macrophages.	Journal of immunology	2007	58
17979302	Peptides	Luca S	Peptide conformation and supramolecular organization in amylin fibrils: constraints from solid-state NMR.	Biochemistry	2007	167
18216022	Peptides	Liu Z	Glucagon-like peptide-1 activation of TCF7L2-dependent Wnt signaling enhances pancreatic beta cell proliferation.	The Journal of biological chemistry	2008	71
18287102	Peptides	Runge S	Crystal structure of the ligand-bound glucagon-like peptide-1 receptor extracellular domain.	The Journal of biological chemistry	2008	104
18442979	Peptides	Apostolidou M	Structure of alpha-helical membrane-bound human islet amyloid polypeptide and its implications for membrane-mediated misfolding.	The Journal of biological chemistry	2008	69
19208933	Peptides	Abedini A	A role for helical intermediates in amyloid formation by natively unfolded polypeptides?	Physical biology	2009	60
20068138	Peptides	Arakawa M	Inhibition of monocyte adhesion to endothelial cells and attenuation of atherosclerotic lesion by a glucagon-like peptide-1 receptor agonist, exendin-4.	Diabetes	2010	102
20215461	Peptides	Buse JB	DURATION-1: exenatide once weekly produces sustained glycemic control and weight loss over 52 weeks.	Diabetes care	2010	56
20534508	Peptides	Lorieau JL	The complete influenza hemagglutinin fusion domain adopts a tight helical hairpin arrangement at the lipid:water interface.	Proceedings of the National Academy of Sciences of the United States of America	2010	67
20929995	Peptides	Best JH	Risk of cardiovascular disease events in patients with type 2 diabetes prescribed the glucagon-like peptide 1 (GLP-1) receptor agonist exenatide twice daily or other glucose-lowering therapies: a retrospective analysis of the LifeLink database.	Diabetes care	2011	57
21334333	Peptides	Elashoff M	Pancreatitis, pancreatic, and thyroid cancer with glucagon-like peptide-1-based therapies.	Gastroenterology	2011	136
22147710	Peptides	Koole C	Second extracellular loop of human glucagon-like peptide-1 receptor (GLP-1R) has a critical role in GLP-1 peptide binding and receptor activation.	The Journal of biological chemistry	2012	32
22471248	Peptides	Deacon CF	Glycaemic efficacy of glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors as add-on therapy to metformin in subjects with type 2 diabetes-a review and meta analysis.	Diabetes, obesity & metabolism	2012	34
22565812	Peptides	Müller TD	Restoration of leptin responsiveness in diet-induced obese mice using an optimized leptin analog in combination with exendin-4 or FGF21.	Journal of peptide science 	2012	33
22659620	Peptides	Cho YM	Targeting the glucagon receptor family for diabetes and obesity therapy.	Pharmacology & therapeutics	2012	31
22862847	Peptides	Niswender K	Weight change with liraglutide and comparator therapies: an analysis of seven phase 3 trials from the liraglutide diabetes development programme.	Diabetes, obesity & metabolism	2013	31
23141817	Peptides	Buse JB	Exenatide once weekly versus liraglutide once daily in patients with type 2 diabetes (DURATION-6): a randomised, open-label study.	Lancet	2013	88
23297075	Peptides	Wu Z	Development and evaluation of 18F-TTCO-Cys40-Exendin-4: a PET probe for imaging transplanted islets.	Journal of nuclear medicine 	2013	32
23440284	Peptides	Singh S	Glucagonlike peptide 1-based therapies and risk of hospitalization for acute pancreatitis in type 2 diabetes mellitus: a population-based matched case-control study.	JAMA internal medicine	2013	66
23479653	Peptides	Wootten D	Polar transmembrane interactions drive formation of ligand-specific and signal pathway-biased family B G protein-coupled receptor conformations.	Proceedings of the National Academy of Sciences of the United States of America	2013	38
23829656	Peptides	Monami M	Effects of glucagon-like peptide-1 receptor agonists on cardiovascular risk: a meta-analysis of randomized clinical trials.	Diabetes, obesity & metabolism	2014	26
24239002	Peptides	Gottlieb PA	Chromogranin A is a T cell antigen in human type 1 diabetes.	Journal of autoimmunity	2014	23
24263424	Peptides	Katout M	Effect of GLP-1 mimetics on blood pressure and relationship to weight loss and glycemia lowering: results of a systematic meta-analysis and meta-regression.	American journal of hypertension	2014	21
24488022	Peptides	Brom M	Non-invasive quantification of the beta cell mass by SPECT with ¹¹¹In-labelled exendin.	Diabetologia	2014	22
24655583	Peptides	Kim YG	Differences in the HbA1c-lowering efficacy of glucagon-like peptide-1 analogues between Asians and non-Asians: a systematic review and meta-analysis.	Diabetes, obesity & metabolism	2014	27
24731672	Peptides	Diamant M	Exenatide once weekly versus insulin glargine for type 2 diabetes (DURATION-3): 3-year results of an open-label randomised trial.	The lancet. Diabetes & endocrinology	2014	25
25071023	Peptides	van Bloemendaal L	GLP-1 receptor activation modulates appetite- and reward-related brain areas in humans.	Diabetes	2014	42
25433637	Peptides	Su P	A dopamine D2 receptor-DISC1 protein complex may contribute to antipsychotic-like effects.	Neuron	2014	23
25485909	Peptides	Finan B	A rationally designed monomeric peptide triagonist corrects obesity and diabetes in rodents.	Nature medicine	2015	30
25589610	Peptides	Schanstra JP	Diagnosis and Prediction of CKD Progression by Assessment of Urinary Peptides.	Journal of the American Society of Nephrology 	2015	30
25645567	Peptides	Blonde L	Association among weight change, glycemic control, and markers of cardiovascular risk with exenatide once weekly: a pooled analysis of patients with type 2 diabetes.	Cardiovascular diabetology	2015	17
25703647	Peptides	Grek CL	Topical administration of a connexin43-based peptide augments healing of chronic neuropathic diabetic foot ulcers: A multicenter, randomized trial.	Wound repair and regeneration 	2015	17
26995376	Peptides	Holman RR	Rationale and design of the EXenatide Study of Cardiovascular Event Lowering (EXSCEL) trial.	American heart journal	2016	10
27621419	Peptides	Tagawa T	Epstein-Barr viral miRNAs inhibit antiviral CD4+ T cell responses targeting IL-12 and peptide processing.	The Journal of experimental medicine	2016	16
1357346	Glucose	Martin BC	Role of glucose and insulin resistance in development of type 2 diabetes mellitus: results of a 25-year follow-up study.	Lancet	1992	147
1532777	Glucose	DeFronzo RA	Pathogenesis of NIDDM. A balanced overview.	Diabetes care	1992	218
3894418	Glucose	DeFronzo RA	Effects of insulin on peripheral and splanchnic glucose metabolism in noninsulin-dependent (type II) diabetes mellitus.	The Journal of clinical investigation	1985	184
7677463	Glucose	Pories WJ	Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus.	Annals of surgery	1995	266
8112322	Glucose	Mueckler M	Facilitative glucose transporters.	European journal of biochemistry	1994	135
8247074	Glucose	Lillioja S	Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. Prospective studies of Pima Indians.	The New England journal of medicine	1993	212
8857019	Glucose	Perseghin G	Increased glucose transport-phosphorylation and muscle glycogen synthesis after exercise training in insulin-resistant subjects.	The New England journal of medicine	1996	117
8945471	Glucose	Yamagata K	Mutations in the hepatocyte nuclear factor-4alpha gene in maturity-onset diabetes of the young (MODY1)	Nature	1996	216
9509261	Glucose	Goodyear LJ	Exercise, glucose transport, and insulin sensitivity.	Annual review of medicine	1998	157
9749880	Glucose	Csermely P	The 90-kDa molecular chaperone family: structure, function, and clinical applications. A comprehensive review.	Pharmacology & therapeutics	1998	183
9773724	Glucose	Williams GC	Supporting autonomy to motivate patients with diabetes for glucose control.	Diabetes care	1998	166
9867845	Glucose	Postic C	Dual roles for glucokinase in glucose homeostasis as determined by liver and pancreatic beta cell-specific gene knock-outs using Cre recombinase.	The Journal of biological chemistry	1999	389
10382692	Glucose	Carr A	Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort study.	Lancet	1999	175
10395191	Glucose	Hotamisligil GS	The role of TNFalpha and TNF receptors in obesity and insulin resistance.	Journal of internal medicine	1999	97
10413736	Glucose	Cline GW	Impaired glucose transport as a cause of decreased insulin-stimulated muscle glycogen synthesis in type 2 diabetes.	The New England journal of medicine	1999	106
10413738	Glucose	Shepherd PR	Glucose transporters and insulin action--implications for insulin resistance and diabetes mellitus.	The New England journal of medicine	1999	191
10491414	Glucose	Weyer C	The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus.	The Journal of clinical investigation	1999	293
10571771	Glucose	Gilbert RE	The tubulointerstitium in progressive diabetic kidney disease: more than an aftermath of glomerular injury?	Kidney international	1999	121
10675357	Glucose	Cusi K	Insulin resistance differentially affects the PI 3-kinase- and MAP kinase-mediated signaling in human muscle.	The Journal of clinical investigation	2000	169
10731493	Glucose	Goodpaster BH	Thigh adipose tissue distribution is associated with insulin resistance in obesity and in type 2 diabetes mellitus.	The American journal of clinical nutrition	2000	152
10857969	Glucose	Bonora E	Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity.	Diabetes care	2000	367
10946914	Glucose	Mohanty P	Glucose challenge stimulates reactive oxygen species (ROS) generation by leucocytes.	The Journal of clinical endocrinology and metabolism	2000	92
11067779	Glucose	Vionnet N	Genomewide search for type 2 diabetes-susceptibility genes in French whites: evidence for a novel susceptibility locus for early-onset diabetes on chromosome 3q27-qter and independent replication of a type 2-diabetes locus on chromosome 1q21-q24.	American journal of human genetics	2000	114
11118008	Glucose	Hundal RS	Mechanism by which metformin reduces glucose production in type 2 diabetes.	Diabetes	2000	181
11157411	Glucose	Geffken DF	Association between physical activity and markers of inflammation in a healthy elderly population.	American journal of epidemiology	2001	103
11287357	Glucose	Kern PA	Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance.	American journal of physiology. Endocrinology and metabolism	2001	300
11289482	Glucose	Mari A	A model-based method for assessing insulin sensitivity from the oral glucose tolerance test.	Diabetes care	2001	94
11315831	Glucose	Isomaa B	Cardiovascular morbidity and mortality associated with the metabolic syndrome.	Diabetes care	2001	599
11502817	Glucose	Yang WS	Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin.	The Journal of clinical endocrinology and metabolism	2001	130
11574423	Glucose	Barzilay JI	The relation of markers of inflammation to the development of glucose disorders in the elderly: the Cardiovascular Health Study.	Diabetes	2001	92
11584370	Glucose	Paradis V	High glucose and hyperinsulinemia stimulate connective tissue growth factor expression: a potential mechanism involved in progression to fibrosis in nonalcoholic steatohepatitis.	Hepatology	2001	92
11588148	Glucose	Weinstein LS	Endocrine manifestations of stimulatory G protein alpha-subunit mutations and the role of genomic imprinting.	Endocrine reviews	2001	99
11742415	Glucose	Moller DE	New drug targets for type 2 diabetes and the metabolic syndrome.	Nature	2001	114
11755481	Glucose	Kuzuya T	Report of the Committee on the classification and diagnostic criteria of diabetes mellitus.	Diabetes research and clinical practice	2002	102
11809615	Glucose	Hales CN	The thrifty phenotype hypothesis.	British medical bulletin	2001	401
11812755	Glucose	Vozarova B	High white blood cell count is associated with a worsening of insulin sensitivity and predicts the development of type 2 diabetes.	Diabetes	2002	90
11916953	Glucose	Peila R	Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: The Honolulu-Asia Aging Study.	Diabetes	2002	265
11978661	Glucose	Freeman DJ	C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study.	Diabetes	2002	127
11994345	Glucose	Bastard JP	Adipose tissue IL-6 content correlates with resistance to insulin activation of glucose uptake both in vivo and in vitro.	The Journal of clinical endocrinology and metabolism	2002	97
12021250	Glucose	Petersen KF	Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy.	The Journal of clinical investigation	2002	172
12086956	Glucose	Romeo G	Activation of nuclear factor-kappaB induced by diabetes and high glucose regulates a proapoptotic program in retinal pericytes.	Diabetes	2002	89
12145144	Glucose	Fernández-Real JM	Cross-talk between iron metabolism and diabetes.	Diabetes	2002	85
12235117	Glucose	Maedler K	Glucose-induced beta cell production of IL-1beta contributes to glucotoxicity in human pancreatic islets.	The Journal of clinical investigation	2002	251
12354786	Glucose	Vasseur F	Single-nucleotide polymorphism haplotypes in the both proximal promoter and exon 3 of the APM1 gene modulate adipocyte-secreted adiponectin hormone levels and contribute to the genetic risk for type 2 diabetes in French Caucasians.	Human molecular genetics	2002	93
12360255	Glucose	De Meyts P	Structural biology of insulin and IGF1 receptors: implications for drug design.	Nature reviews. Drug discovery	2002	135
12368292	Glucose	Kataoka K	MafA is a glucose-regulated and pancreatic beta-cell-specific transcriptional activator for the insulin gene.	The Journal of biological chemistry	2002	82
12551870	Glucose	Rutter MK	Impact of glucose intolerance and insulin resistance on cardiac structure and function: sex-related differences in the Framingham Heart Study.	Circulation	2003	100
12558712	Glucose	Haan MN	Prevalence of dementia in older latinos: the influence of type 2 diabetes mellitus, stroke and genetic factors.	Journal of the American Geriatrics Society	2003	107
12568659	Glucose	Wood IS	Glucose transporters (GLUT and SGLT): expanded families of sugar transport proteins.	The British journal of nutrition	2003	97
12626323	Glucose	Jiang G	Glucagon and regulation of glucose metabolism.	American journal of physiology. Endocrinology and metabolism	2003	128
12676647	Glucose	Sugden MC	Recent advances in mechanisms regulating glucose oxidation at the level of the pyruvate dehydrogenase complex by PDKs.	American journal of physiology. Endocrinology and metabolism	2003	108
12679416	Glucose	Goran MI	Obesity and risk of type 2 diabetes and cardiovascular disease in children and adolescents.	The Journal of clinical endocrinology and metabolism	2003	107
12716761	Glucose	Shanmugam N	High glucose-induced expression of proinflammatory cytokine and chemokine genes in monocytic cells.	Diabetes	2003	93
12766131	Glucose	Cryer PE	Hypoglycemia in diabetes.	Diabetes care	2003	198
12791994	Glucose	Du K	TRB3: a tribbles homolog that inhibits Akt/PKB activation by insulin in liver.	Science	2003	250
12808457	Glucose	Mootha VK	PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes.	Nature genetics	2003	1829
12815107	Glucose	Lieberman SM	Identification of the beta cell antigen targeted by a prevalent population of pathogenic CD8+ T cells in autoimmune diabetes.	Proceedings of the National Academy of Sciences of the United States of America	2003	112
12829641	Glucose	Basu R	Mechanisms of the age-associated deterioration in glucose tolerance: contribution of alterations in insulin secretion, action, and clearance.	Diabetes	2003	87
12829649	Glucose	Duncan BB	Low-grade systemic inflammation and the development of type 2 diabetes: the atherosclerosis risk in communities study.	Diabetes	2003	217
12874439	Glucose	Lee HB	Reactive oxygen species-regulated signaling pathways in diabetic nephropathy.	Journal of the American Society of Nephrology 	2003	89
12952969	Glucose	Rotter V	Interleukin-6 (IL-6) induces insulin resistance in 3T3-L1 adipocytes and is, like IL-8 and tumor necrosis factor-alpha, overexpressed in human fat cells from insulin-resistant subjects.	The Journal of biological chemistry	2003	170
14633821	Glucose	Ascaso JF	Diagnosing insulin resistance by simple quantitative methods in subjects with normal glucose metabolism.	Diabetes care	2003	89
14633846	Glucose	Russell AP	Endurance training in humans leads to fiber type-specific increases in levels of peroxisome proliferator-activated receptor-gamma coactivator-1 and peroxisome proliferator-activated receptor-alpha in skeletal muscle.	Diabetes	2003	108
14747278	Glucose	Holten MK	Strength training increases insulin-mediated glucose uptake, GLUT4 content, and insulin signaling in skeletal muscle in patients with type 2 diabetes.	Diabetes	2004	103
14976218	Glucose	Miao F	In vivo chromatin remodeling events leading to inflammatory gene transcription under diabetic conditions.	The Journal of biological chemistry	2004	82
15016359	Glucose	Kamata K	Structural basis for allosteric regulation of the monomeric allosteric enzyme human glucokinase.	Structure	2004	99
15057233	Glucose	Evans RM	PPARs and the complex journey to obesity.	Nature medicine	2004	373
15059920	Glucose	Schwartzenberg-Bar-Yoseph F	The tumor suppressor p53 down-regulates glucose transporters GLUT1 and GLUT4 gene expression.	Cancer research	2004	160
15094078	Glucose	Hoyer S	Glucose metabolism and insulin receptor signal transduction in Alzheimer disease.	European journal of pharmacology	2004	75
15107844	Glucose	Koo SH	PGC-1 promotes insulin resistance in liver through PPAR-alpha-dependent induction of TRB-3.	Nature medicine	2004	164
15118095	Glucose	Paterson JM	Metabolic syndrome without obesity: Hepatic overexpression of 11beta-hydroxysteroid dehydrogenase type 1 in transgenic mice.	Proceedings of the National Academy of Sciences of the United States of America	2004	85
15143161	Glucose	Salma N	Temporal recruitment of transcription factors and SWI/SNF chromatin-remodeling enzymes during adipogenic induction of the peroxisome proliferator-activated receptor gamma nuclear hormone receptor.	Molecular and cellular biology	2004	73
15161770	Glucose	Heise T	Lower within-subject variability of insulin detemir in comparison to NPH insulin and insulin glargine in people with type 1 diabetes.	Diabetes	2004	81
15181024	Glucose	Goldstein BJ	Adiponectin: A novel adipokine linking adipocytes and vascular function.	The Journal of clinical endocrinology and metabolism	2004	107
15272020	Glucose	Kamei Y	Skeletal muscle FOXO1 (FKHR) transgenic mice have less skeletal muscle mass, down-regulated Type I (slow twitch/red muscle) fiber genes, and impaired glycemic control.	The Journal of biological chemistry	2004	146
15331562	Glucose	Duncan BB	Adiponectin and the development of type 2 diabetes: the atherosclerosis risk in communities study.	Diabetes	2004	75
15353412	Glucose	Punjabi NM	Sleep-disordered breathing, glucose intolerance, and insulin resistance: the Sleep Heart Health Study.	American journal of epidemiology	2004	217
15448079	Glucose	Levin BE	Neuronal glucosensing: what do we know after 50 years?	Diabetes	2004	116
15548778	Glucose	Hofman PL	Premature birth and later insulin resistance.	The New England journal of medicine	2004	80
15629253	Glucose	Kota BP	An overview on biological mechanisms of PPARs.	Pharmacological research	2005	120
15662004	Glucose	Lowell BB	Mitochondrial dysfunction and type 2 diabetes.	Science	2005	502
15705778	Glucose	Minn AH	Thioredoxin-interacting protein is stimulated by glucose through a carbohydrate response element and induces beta-cell apoptosis.	Endocrinology	2005	108
15734833	Glucose	Petersen KF	Reversal of nonalcoholic hepatic steatosis, hepatic insulin resistance, and hyperglycemia by moderate weight reduction in patients with type 2 diabetes.	Diabetes	2005	194
15750215	Glucose	Steen E	Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease--is this type 3 diabetes?	Journal of Alzheimer's disease 	2005	298
15814847	Glucose	Srivastava SK	Role of aldose reductase and oxidative damage in diabetes and the consequent potential for therapeutic options.	Endocrine reviews	2005	97
15914121	Glucose	Valle I	PGC-1alpha regulates the mitochondrial antioxidant defense system in vascular endothelial cells.	Cardiovascular research	2005	123
15938030	Glucose	Schena FP	Pathogenetic mechanisms of diabetic nephropathy.	Journal of the American Society of Nephrology 	2005	85
15946424	Glucose	Wickremesekera K	Loss of insulin resistance after Roux-en-Y gastric bypass surgery: a time course study.	Obesity surgery	2005	74
16026270	Glucose	Caldwell RB	Vascular endothelial growth factor and diabetic retinopathy: role of oxidative stress.	Current drug targets	2005	65
16054085	Glucose	Lin J	Metabolic control through the PGC-1 family of transcription coactivators.	Cell metabolism	2005	546
16091421	Glucose	Wang H	ER stress and SREBP-1 activation are implicated in beta-cell glucolipotoxicity.	Journal of cell science	2005	82
16096055	Glucose	Gunton JE	Loss of ARNT/HIF1beta mediates altered gene expression and pancreatic-islet dysfunction in human type 2 diabetes.	Cell	2005	149
16123357	Glucose	Tremblay F	Overactivation of S6 kinase 1 as a cause of human insulin resistance during increased amino acid availability.	Diabetes	2005	98
16144950	Glucose	Fehse F	Exenatide augments first- and second-phase insulin secretion in response to intravenous glucose in subjects with type 2 diabetes.	The Journal of clinical endocrinology and metabolism	2005	68
16148943	Glucose	Koo SH	The CREB coactivator TORC2 is a key regulator of fasting glucose metabolism.	Nature	2005	306
16186396	Glucose	Plomgaard P	Tumor necrosis factor-alpha induces skeletal muscle insulin resistance in healthy human subjects via inhibition of Akt substrate 160 phosphorylation.	Diabetes	2005	96
16227461	Glucose	Punjabi NM	Disorders of glucose metabolism in sleep apnea.	Journal of applied physiology	2005	88
16227462	Glucose	Spiegel K	Sleep loss: a novel risk factor for insulin resistance and Type 2 diabetes.	Journal of applied physiology	2005	277
16306329	Glucose	Kristiansen OP	Interleukin-6 and diabetes: the good, the bad, or the indifferent?	Diabetes	2005	106
16306358	Glucose	Rahmoune H	Glucose transporters in human renal proximal tubular cells isolated from the urine of patients with non-insulin-dependent diabetes.	Diabetes	2005	113
16311215	Glucose	Koerner A	Adipocytokines: leptin--the classical, resistin--the controversical, adiponectin--the promising, and more to come.	Best practice & research. Clinical endocrinology & metabolism	2005	79
16380500	Glucose	Lara-Castro C	Adiponectin multimeric complexes and the metabolic syndrome trait cluster.	Diabetes	2006	108
16385087	Glucose	Isoda K	Metformin inhibits proinflammatory responses and nuclear factor-kappaB in human vascular wall cells.	Arteriosclerosis, thrombosis, and vascular biology	2006	88
16409152	Glucose	Beaven SW	Nuclear receptors in lipid metabolism: targeting the heart of dyslipidemia.	Annual review of medicine	2006	78
16412224	Glucose	Baker AR	Human epicardial adipose tissue expresses a pathogenic profile of adipocytokines in patients with cardiovascular disease.	Cardiovascular diabetology	2006	129
16415884	Glucose	Grant SF	Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes.	Nature genetics	2006	563
16443786	Glucose	Davis BJ	Activation of the AMP-activated kinase by antidiabetes drug metformin stimulates nitric oxide synthesis in vivo by promoting the association of heat shock protein 90 and endothelial nitric oxide synthase.	Diabetes	2006	114
16463046	Glucose	Adiels M	Overproduction of large VLDL particles is driven by increased liver fat content in man.	Diabetologia	2006	110
16492903	Glucose	Nigro J	Insulin resistance and atherosclerosis.	Endocrine reviews	2006	63
16550171	Glucose	Coucke PJ	Mutations in the facilitative glucose transporter GLUT10 alter angiogenesis and cause arterial tortuosity syndrome.	Nature genetics	2006	77
16567536	Glucose	Festa A	The natural course of beta-cell function in nondiabetic and diabetic individuals: the Insulin Resistance Atherosclerosis Study.	Diabetes	2006	78
16567827	Glucose	Stefan N	Alpha2-Heremans-Schmid glycoprotein/fetuin-A is associated with insulin resistance and fat accumulation in the liver in humans.	Diabetes care	2006	96
16570048	Glucose	Kelesidis I	Adiponectin and cancer: a systematic review.	British journal of cancer	2006	104
16600341	Glucose	Zittermann A	Vitamin D and disease prevention with special reference to cardiovascular disease.	Progress in biophysics and molecular biology	2006	83
16613757	Glucose	Bastard JP	Recent advances in the relationship between obesity, inflammation, and insulin resistance.	European cytokine network	2006	413
16618833	Glucose	Kim JA	Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms.	Circulation	2006	288
16644654	Glucose	Abdul-Ghani MA	Contributions of beta-cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and impaired fasting glucose.	Diabetes care	2006	150
16644701	Glucose	Abdul-Ghani MA	Insulin secretion and action in subjects with impaired fasting glucose and impaired glucose tolerance: results from the Veterans Administration Genetic Epidemiology Study.	Diabetes	2006	110
16644802	Glucose	Viollet B	Activation of AMP-activated protein kinase in the liver: a new strategy for the management of metabolic hepatic disorders.	The Journal of physiology	2006	96
16709629	Glucose	Xue B	AMPK integrates nutrient and hormonal signals to regulate food intake and energy balance through effects in the hypothalamus and peripheral tissues.	The Journal of physiology	2006	78
16822958	Glucose	Fujii N	AMP-activated protein kinase and the regulation of glucose transport.	American journal of physiology. Endocrinology and metabolism	2006	67
16823475	Glucose	Long YC	AMP-activated protein kinase signaling in metabolic regulation.	The Journal of clinical investigation	2006	179
16979422	Glucose	McEwen BS	Sleep deprivation as a neurobiologic and physiologic stressor: Allostasis and allostatic load.	Metabolism	2006	110
17010638	Glucose	Howard JK	Attenuation of leptin and insulin signaling by SOCS proteins.	Trends in endocrinology and metabolism	2006	98
17038556	Glucose	Jager J	Interleukin-1beta-induced insulin resistance in adipocytes through down-regulation of insulin receptor substrate-1 expression.	Endocrinology	2007	134
17043079	Glucose	Fitzpatrick AL	Leukocyte telomere length and cardiovascular disease in the cardiovascular health study.	American journal of epidemiology	2007	219
17065679	Glucose	Lee JM	Prevalence and determinants of insulin resistance among U.S. adolescents: a population-based study.	Diabetes care	2006	103
17065684	Glucose	Cho YM	Plasma retinol-binding protein-4 concentrations are elevated in human subjects with impaired glucose tolerance and type 2 diabetes.	Diabetes care	2006	85
17093941	Glucose	Chandak GR	Common variants in the TCF7L2 gene are strongly associated with type 2 diabetes mellitus in the Indian population.	Diabetologia	2007	61
17101823	Glucose	Akomolafe A	Diabetes mellitus and risk of developing Alzheimer disease: results from the Framingham Study.	Archives of neurology	2006	68
17114290	Glucose	Petersen KF	Increased prevalence of insulin resistance and nonalcoholic fatty liver disease in Asian-Indian men.	Proceedings of the National Academy of Sciences of the United States of America	2006	89
17130196	Glucose	Aschner P	Effect of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy on glycemic control in patients with type 2 diabetes.	Diabetes care	2006	161
17141632	Glucose	Zhang W	PERK EIF2AK3 control of pancreatic beta cell differentiation and proliferation is required for postnatal glucose homeostasis.	Cell metabolism	2006	99
17148564	Glucose	Sharma AM	Review: Peroxisome proliferator-activated receptor gamma and adipose tissue--understanding obesity-related changes in regulation of lipid and glucose metabolism.	The Journal of clinical endocrinology and metabolism	2007	107
17202130	Glucose	Popa C	The role of TNF-alpha in chronic inflammatory conditions, intermediary metabolism, and cardiovascular risk.	Journal of lipid research	2007	95
17222166	Glucose	Wright EM	Active sugar transport in health and disease.	Journal of internal medicine	2007	97
17261637	Glucose	Gromada J	Alpha-cells of the endocrine pancreas: 35 years of research but the enigma remains.	Endocrine reviews	2007	158
17267743	Glucose	Inaba M	Glycated albumin is a better glycemic indicator than glycated hemoglobin values in hemodialysis patients with diabetes: effect of anemia and erythropoietin injection.	Journal of the American Society of Nephrology 	2007	82
17311546	Glucose	Maiese K	Oxidative stress biology and cell injury during type 1 and type 2 diabetes mellitus.	Current neurovascular research	2007	62
17327345	Glucose	Kilpatrick ES	Insulin resistance, the metabolic syndrome, and complication risk in type 1 diabetes: "double diabetes" in the Diabetes Control and Complications Trial.	Diabetes care	2007	56
17327428	Glucose	Mallone R	CD8+ T-cell responses identify beta-cell autoimmunity in human type 1 diabetes.	Diabetes	2007	72
17329620	Glucose	Krebs M	The Mammalian target of rapamycin pathway regulates nutrient-sensitive glucose uptake in man.	Diabetes	2007	59
17334651	Glucose	Boushel R	Patients with type 2 diabetes have normal mitochondrial function in skeletal muscle.	Diabetologia	2007	118
17374712	Glucose	Harman-Boehm I	Macrophage infiltration into omental versus subcutaneous fat across different populations: effect of regional adiposity and the comorbidities of obesity.	The Journal of clinical endocrinology and metabolism	2007	114
17389326	Glucose	Chen YH	High glucose impairs early and late endothelial progenitor cells by modifying nitric oxide-related but not oxidative stress-mediated mechanisms.	Diabetes	2007	78
17429083	Glucose	Larsen CM	Interleukin-1-receptor antagonist in type 2 diabetes mellitus.	The New England journal of medicine	2007	437
17463248	Glucose	Scott LJ	A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants.	Science	2007	1016
17498512	Glucose	Parekh S	Abnormal lipid and glucose metabolism in obesity: implications for nonalcoholic fatty liver disease.	Gastroenterology	2007	76
17618108	Glucose	Galisteo M	Effects of dietary fibers on disturbances clustered in the metabolic syndrome.	The Journal of nutritional biochemistry	2008	58
17618858	Glucose	Klöting N	Serum retinol-binding protein is more highly expressed in visceral than in subcutaneous adipose tissue and is a marker of intra-abdominal fat mass.	Cell metabolism	2007	92
17620449	Glucose	Tso AW	Serum adipocyte fatty acid binding protein as a new biomarker predicting the development of type 2 diabetes: a 10-year prospective study in a Chinese cohort.	Diabetes care	2007	57
17627510	Glucose	Maiese K	Mechanistic insights into diabetes mellitus and oxidative stress.	Current medicinal chemistry	2007	63
17640997	Glucose	Bozaoglu K	Chemerin is a novel adipokine associated with obesity and metabolic syndrome.	Endocrinology	2007	147
17666010	Glucose	Tremblay F	Role of dietary proteins and amino acids in the pathogenesis of insulin resistance.	Annual review of nutrition	2007	60
17671651	Glucose	Lyssenko V	Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes.	The Journal of clinical investigation	2007	204
17690317	Glucose	Kotronen A	Fatty liver: a novel component of the metabolic syndrome.	Arteriosclerosis, thrombosis, and vascular biology	2008	167
17724330	Glucose	Jang HJ	Gut-expressed gustducin and taste receptors regulate secretion of glucagon-like peptide-1.	Proceedings of the National Academy of Sciences of the United States of America	2007	228
17804762	Glucose	Pascoe L	Common variants of the novel type 2 diabetes genes CDKAL1 and HHEX/IDE are associated with decreased pancreatic beta-cell function.	Diabetes	2007	79
17846126	Glucose	Rampersaud E	Identification of novel candidate genes for type 2 diabetes from a genome-wide association scan in the Old Order Amish: evidence for replication from diabetes-related quantitative traits and from independent populations.	Diabetes	2007	61
17906960	Glucose	Marchetti P	The endoplasmic reticulum in pancreatic beta cells of type 2 diabetes patients.	Diabetologia	2007	110
17926672	Glucose	Dalla Man C	Meal simulation model of the glucose-insulin system.	IEEE transactions on bio-medical engineering	2007	88
17932564	Glucose	Handschin C	Abnormal glucose homeostasis in skeletal muscle-specific PGC-1alpha knockout mice reveals skeletal muscle-pancreatic beta cell crosstalk.	The Journal of clinical investigation	2007	126
17933414	Glucose	Nonaka K	Efficacy and safety of sitagliptin monotherapy in Japanese patients with type 2 diabetes.	Diabetes research and clinical practice	2008	60
17940659	Glucose	Dias WB	O-GlcNAc modification in diabetes and Alzheimer's disease.	Molecular bioSystems	2007	77
17942823	Glucose	Andreasen CH	Low physical activity accentuates the effect of the FTO rs9939609 polymorphism on body fat accumulation.	Diabetes	2008	133
17957034	Glucose	Muniyappa R	Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage.	American journal of physiology. Endocrinology and metabolism	2008	275
17959933	Glucose	Li H	Variants in the fat mass- and obesity-associated (FTO) gene are not associated with obesity in a Chinese Han population.	Diabetes	2008	74
17977958	Glucose	Vaxillaire M	Impact of common type 2 diabetes risk polymorphisms in the DESIR prospective study.	Diabetes	2008	59
17981116	Glucose	Pospisilik JA	Targeted deletion of AIF decreases mitochondrial oxidative phosphorylation and protects from obesity and diabetes.	Cell	2007	154
17991760	Glucose	Youn BS	Serum vaspin concentrations in human obesity and type 2 diabetes.	Diabetes	2008	64
18039092	Glucose	Waki H	Endocrine functions of adipose tissue.	Annual review of pathology	2007	83
18048764	Glucose	Eizirik DL	The role for endoplasmic reticulum stress in diabetes mellitus.	Endocrine reviews	2008	306
18055507	Glucose	Jensen RT	International Union of Pharmacology. LXVIII. Mammalian bombesin receptors: nomenclature, distribution, pharmacology, signaling, and functions in normal and disease states.	Pharmacological reviews	2008	103
18071026	Glucose	Shu L	Transcription factor 7-like 2 regulates beta-cell survival and function in human pancreatic islets.	Diabetes	2008	88
18091002	Glucose	Auchincloss AH	Neighborhood resources for physical activity and healthy foods and their association with insulin resistance.	Epidemiology	2008	58
18094705	Glucose	Tomlinson DR	Glucose neurotoxicity.	Nature reviews. Neuroscience	2008	102
18212116	Glucose	Aguiari P	High glucose induces adipogenic differentiation of muscle-derived stem cells.	Proceedings of the National Academy of Sciences of the United States of America	2008	67
18220619	Glucose	Simó R	Angiogenic and antiangiogenic factors in proliferative diabetic retinopathy.	Current diabetes reviews	2006	79
18220694	Glucose	Ziyadeh FN	Pathogenesis of the podocytopathy and proteinuria in diabetic glomerulopathy.	Current diabetes reviews	2008	91
18230953	Glucose	Aronson D	Hyperglycemia and the pathobiology of diabetic complications.	Advances in cardiology	2008	69
18250214	Glucose	Tasali E	Obstructive sleep apnea and metabolic syndrome: alterations in glucose metabolism and inflammation.	Proceedings of the American Thoracic Society	2008	78
18288110	Glucose	Kroon E	Pancreatic endoderm derived from human embryonic stem cells generates glucose-responsive insulin-secreting cells in vivo.	Nature biotechnology	2008	510
18297260	Glucose	Ellard S	Best practice guidelines for the molecular genetic diagnosis of maturity-onset diabetes of the young.	Diabetologia	2008	53
18316358	Glucose	Do R	Genetic variants of FTO influence adiposity, insulin sensitivity, leptin levels, and resting metabolic rate in the Quebec Family Study.	Diabetes	2008	58
18323454	Glucose	Dentin R	Hepatic glucose sensing via the CREB coactivator CRTC2.	Science	2008	119
18323464	Glucose	Solomon TP	Exercise and diet enhance fat oxidation and reduce insulin resistance in older obese adults.	Journal of applied physiology	2008	52
18332897	Glucose	Yan SF	Mechanisms of disease: advanced glycation end-products and their receptor in inflammation and diabetes complications.	Nature clinical practice. Endocrinology & metabolism	2008	92
18347614	Glucose	Lawrence MC	The roles of MAPKs in disease.	Cell research	2008	60
18378618	Glucose	Schramm TK	Diabetes patients requiring glucose-lowering therapy and nondiabetics with a prior myocardial infarction carry the same cardiovascular risk: a population study of 3.3 million people.	Circulation	2008	79
18391974	Glucose	Gross DN	The role of FoxO in the regulation of metabolism.	Oncogene	2008	152
18393659	Glucose	Kellett GL	Sugar absorption in the intestine: the role of GLUT2.	Annual review of nutrition	2008	76
18397542	Glucose	Trayhurn P	Hypoxia in adipose tissue: a basis for the dysregulation of tissue function in obesity?	The British journal of nutrition	2008	87
18420487	Glucose	Busik JV	Hyperglycemia-induced reactive oxygen species toxicity to endothelial cells is dependent on paracrine mediators.	Diabetes	2008	80
18460560	Glucose	Saudek CD	A new look at screening and diagnosing diabetes mellitus.	The Journal of clinical endocrinology and metabolism	2008	100
18544448	Glucose	Shaw JE	Sleep-disordered breathing and type 2 diabetes: a report from the International Diabetes Federation Taskforce on Epidemiology and Prevention.	Diabetes research and clinical practice	2008	65
18563385	Glucose	Di Marzo V	The endocannabinoid system in obesity and type 2 diabetes.	Diabetologia	2008	57
18579779	Glucose	Villeneuve LM	Epigenetic histone H3 lysine 9 methylation in metabolic memory and inflammatory phenotype of vascular smooth muscle cells in diabetes.	Proceedings of the National Academy of Sciences of the United States of America	2008	106
18633108	Glucose	Wu Y	Common variants in CDKAL1, CDKN2A/B, IGF2BP2, SLC30A8, and HHEX/IDE genes are associated with type 2 diabetes and impaired fasting glucose in a Chinese Han population.	Diabetes	2008	80
18650365	Glucose	Dasu MR	High glucose induces toll-like receptor expression in human monocytes: mechanism of activation.	Diabetes	2008	90
18664535	Glucose	Böni-Schnetzler M	Increased interleukin (IL)-1beta messenger ribonucleic acid expression in beta -cells of individuals with type 2 diabetes and regulation of IL-1beta in human islets by glucose and autostimulation.	The Journal of clinical endocrinology and metabolism	2008	65
18689695	Glucose	Balkau B	Predicting diabetes: clinical, biological, and genetic approaches: data from the Epidemiological Study on the Insulin Resistance Syndrome (DESIR).	Diabetes care	2008	56
18700811	Glucose	Brunner EJ	Inflammation, insulin resistance, and diabetes--Mendelian randomization using CRP haplotypes points upstream.	PLoS medicine	2008	50
18716028	Glucose	Wang Q	MicroRNA-377 is up-regulated and can lead to increased fibronectin production in diabetic nephropathy.	FASEB journal 	2008	128
18726182	Glucose	Iynedjian PB	Molecular physiology of mammalian glucokinase.	Cellular and molecular life sciences 	2009	80
18752331	Glucose	Fracanzani AL	Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes.	Hepatology	2008	105
18776125	Glucose	Lindenmeyer MT	Proteinuria and hyperglycemia induce endoplasmic reticulum stress.	Journal of the American Society of Nephrology 	2008	62
18776141	Glucose	Hivert MF	Common variants in the adiponectin gene (ADIPOQ) associated with plasma adiponectin levels, type 2 diabetes, and diabetes-related quantitative traits: the Framingham Offspring Study.	Diabetes	2008	52
18782754	Glucose	Tateishi K	Generation of insulin-secreting islet-like clusters from human skin fibroblasts.	The Journal of biological chemistry	2008	104
18810325	Glucose	Witczak CA	AMP-activated protein kinase in skeletal muscle: from structure and localization to its role as a master regulator of cellular metabolism.	Cellular and molecular life sciences 	2008	70
18823409	Glucose	Mahon JL	The TrialNet Natural History Study of the Development of Type 1 Diabetes: objectives, design, and initial results.	Pediatric diabetes	2009	60
18834431	Glucose	Rahier J	Pancreatic beta-cell mass in European subjects with type 2 diabetes.	Diabetes, obesity & metabolism	2008	191
18852465	Glucose	Lewis EC	alpha1-Antitrypsin monotherapy induces immune tolerance during islet allograft transplantation in mice.	Proceedings of the National Academy of Sciences of the United States of America	2008	54
18854421	Glucose	Deepa SS	APPL1: role in adiponectin signaling and beyond.	American journal of physiology. Endocrinology and metabolism	2009	65
18931681	Glucose	Chadt A	Tbc1d1 mutation in lean mouse strain confers leanness and protects from diet-induced obesity.	Nature genetics	2008	64
18984661	Glucose	Kanazawa I	Serum osteocalcin level is associated with glucose metabolism and atherosclerosis parameters in type 2 diabetes mellitus.	The Journal of clinical endocrinology and metabolism	2009	70
18984664	Glucose	Lauenborg J	Common type 2 diabetes risk gene variants associate with gestational diabetes.	The Journal of clinical endocrinology and metabolism	2009	52
18984776	Glucose	Ferrara A	Trends in postpartum diabetes screening and subsequent diabetes and impaired fasting glucose among women with histories of gestational diabetes mellitus: A report from the Translating Research Into Action for Diabetes (TRIAD) Study.	Diabetes care	2009	46
19026743	Glucose	Zhao WQ	Insulin resistance and amyloidogenesis as common molecular foundation for type 2 diabetes and Alzheimer's disease.	Biochimica et biophysica acta	2009	59
19074620	Glucose	Kim W	The role of incretins in glucose homeostasis and diabetes treatment.	Pharmacological reviews	2008	141
19088155	Glucose	Cryer PE	Evaluation and management of adult hypoglycemic disorders: an Endocrine Society Clinical Practice Guideline.	The Journal of clinical endocrinology and metabolism	2009	116
19136653	Glucose	Fiaschi-Taesch N	Survey of the human pancreatic beta-cell G1/S proteome reveals a potential therapeutic role for cdk-6 and cyclin D1 in enhancing human beta-cell replication and function in vivo.	Diabetes	2009	58
19189073	Glucose	Yan SF	Receptor for AGE (RAGE) and its ligands-cast into leading roles in diabetes and the inflammatory response.	Journal of molecular medicine	2009	54
19208907	Glucose	Brasacchio D	Hyperglycemia induces a dynamic cooperativity of histone methylase and demethylase enzymes associated with gene-activating epigenetic marks that coexist on the lysine tail.	Diabetes	2009	113
19238145	Glucose	Lynch LA	Are natural killer cells protecting the metabolically healthy obese patient?	Obesity	2009	48
19240267	Glucose	Møller N	Effects of growth hormone on glucose, lipid, and protein metabolism in human subjects.	Endocrine reviews	2009	147
19245656	Glucose	Viollet B	AMP-activated protein kinase in the regulation of hepatic energy metabolism: from physiology to therapeutic perspectives.	Acta physiologica	2009	89
19251047	Glucose	Hou JC	Insulin granule biogenesis, trafficking and exocytosis.	Vitamins and hormones	2009	47
19259271	Glucose	Klöting N	MicroRNA expression in human omental and subcutaneous adipose tissue.	PloS one	2009	77
19265200	Glucose	Lin HM	Transforming growth factor-beta/Smad3 signaling regulates insulin gene transcription and pancreatic islet beta-cell function.	The Journal of biological chemistry	2009	49
19272486	Glucose	Buchwald H	Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis.	The American journal of medicine	2009	369
19273282	Glucose	Viollet B	Targeting the AMPK pathway for the treatment of Type 2 diabetes.	Frontiers in bioscience	2009	52
19283361	Glucose	Barrett EJ	The vascular actions of insulin control its delivery to muscle and regulate the rate-limiting step in skeletal muscle insulin action.	Diabetologia	2009	82
19286634	Glucose	Orimo M	Protective role of SIRT1 in diabetic vascular dysfunction.	Arteriosclerosis, thrombosis, and vascular biology	2009	52
19295913	Glucose	Guo T	Myostatin inhibition in muscle, but not adipose tissue, decreases fat mass and improves insulin sensitivity.	PloS one	2009	76
19332493	Glucose	Brøns C	Impact of short-term high-fat feeding on glucose and insulin metabolism in young healthy men.	The Journal of physiology	2009	52
19357717	Glucose	Bakris GL	Renal sodium-glucose transport: role in diabetes mellitus and potential clinical implications.	Kidney international	2009	52
19358976	Glucose	Profenno LA	Meta-analysis of Alzheimer's disease risk with obesity, diabetes, and related disorders.	Biological psychiatry	2010	123
19363506	Glucose	Cummings DE	Endocrine mechanisms mediating remission of diabetes after gastric bypass surgery.	International journal of obesity	2009	52
19365392	Glucose	Ahrén B	Islet G protein-coupled receptors as potential targets for treatment of type 2 diabetes.	Nature reviews. Drug discovery	2009	115
19372197	Glucose	Thaler JP	Minireview: Hormonal and metabolic mechanisms of diabetes remission after gastrointestinal surgery.	Endocrinology	2009	93
19399017	Glucose	Fève B	The role of interleukins in insulin resistance and type 2 diabetes mellitus.	Nature reviews. Endocrinology	2009	48
19411249	Glucose	Cha-Molstad H	Glucose-stimulated expression of Txnip is mediated by carbohydrate response element-binding protein, p300, and histone H4 acetylation in pancreatic beta cells.	The Journal of biological chemistry	2009	68
19455179	Glucose	Liang F	SIRT1 and insulin resistance.	Nature reviews. Endocrinology	2009	71
19478200	Glucose	Verschuren L	MIF deficiency reduces chronic inflammation in white adipose tissue and impairs the development of insulin resistance, glucose intolerance, and associated atherosclerotic disease.	Circulation research	2009	47
19487637	Glucose	Chavez AO	Circulating fibroblast growth factor-21 is elevated in impaired glucose tolerance and type 2 diabetes and correlates with muscle and hepatic insulin resistance.	Diabetes care	2009	71
19502414	Glucose	Stancáková A	Association of 18 confirmed susceptibility loci for type 2 diabetes with indices of insulin release, proinsulin conversion, and insulin sensitivity in 5,327 nondiabetic Finnish men.	Diabetes	2009	55
19542260	Glucose	Stamatakis KA	Effects of sleep fragmentation on glucose metabolism in normal subjects.	Chest	2010	133
19567526	Glucose	Nedeltcheva AV	Exposure to recurrent sleep restriction in the setting of high caloric intake and physical inactivity results in increased insulin resistance and reduced glucose tolerance.	The Journal of clinical endocrinology and metabolism	2009	86
19581401	Glucose	Kato M	MicroRNAs and their role in progressive kidney diseases.	Clinical journal of the American Society of Nephrology 	2009	67
19581419	Glucose	Molina AJ	Mitochondrial networking protects beta-cells from nutrient-induced apoptosis.	Diabetes	2009	84
19584347	Glucose	Li S	Adiponectin levels and risk of type 2 diabetes: a systematic review and meta-analysis.	JAMA	2009	228
19602480	Glucose	Prokunina-Olsson L	Tissue-specific alternative splicing of TCF7L2.	Human molecular genetics	2009	45
19643913	Glucose	Beer NL	The P446L variant in GCKR associated with fasting plasma glucose and triglyceride levels exerts its effect through increased glucokinase activity in liver.	Human molecular genetics	2009	100
19706465	Glucose	Lemaire K	Insulin crystallization depends on zinc transporter ZnT8 expression, but is not required for normal glucose homeostasis in mice.	Proceedings of the National Academy of Sciences of the United States of America	2009	91
19720798	Glucose	Sell H	Chemerin is a novel adipocyte-derived factor inducing insulin resistance in primary human skeletal muscle cells.	Diabetes	2009	59
19759171	Glucose	Catalano PM	Perinatal risk factors for childhood obesity and metabolic dysregulation.	The American journal of clinical nutrition	2009	105
19790256	Glucose	Osbak KK	Update on mutations in glucokinase (GCK), which cause maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemic hypoglycemia.	Human mutation	2009	82
19794059	Glucose	Mehta NN	Experimental endotoxemia induces adipose inflammation and insulin resistance in humans.	Diabetes	2010	88
19800254	Glucose	Lynn FC	Meta-regulation: microRNA regulation of glucose and lipid metabolism.	Trends in endocrinology and metabolism	2009	59
19808920	Glucose	Carson AP	Comparison of A1C and fasting glucose criteria to diagnose diabetes among U.S. adults.	Diabetes care	2010	55
19808921	Glucose	Brown RJ	Ingestion of diet soda before a glucose load augments glucagon-like peptide-1 secretion.	Diabetes care	2009	52
19833888	Glucose	Simonis-Bik AM	Gene variants in the novel type 2 diabetes loci CDC123/CAMK1D, THADA, ADAMTS9, BCL11A, and MTNR1B affect different aspects of pancreatic beta-cell function.	Diabetes	2010	45
19833897	Glucose	Yao D	Hyperglycemia-induced reactive oxygen species increase expression of the receptor for advanced glycation end products (RAGE) and RAGE ligands.	Diabetes	2010	99
19862325	Glucose	Hu C	PPARG, KCNJ11, CDKAL1, CDKN2A-CDKN2B, IDE-KIF11-HHEX, IGF2BP2 and SLC30A8 are associated with type 2 diabetes in a Chinese population.	PloS one	2009	60
19864158	Glucose	Pinney SE	Epigenetic mechanisms in the development of type 2 diabetes.	Trends in endocrinology and metabolism	2010	44
19897009	Glucose	Saji M	The PI3K-Akt-mTOR pathway in initiation and progression of thyroid tumors.	Molecular and cellular endocrinology	2010	47
19903865	Glucose	Chen S	Transcriptional coactivator p300 regulates glucose-induced gene expression in endothelial cells.	American journal of physiology. Endocrinology and metabolism	2010	50
19934006	Glucose	Oudit GY	Human recombinant ACE2 reduces the progression of diabetic nephropathy.	Diabetes	2010	71
19958890	Glucose	Botros N	Obstructive sleep apnea as a risk factor for type 2 diabetes.	The American journal of medicine	2009	68
20005308	Glucose	Dominy JE Jr	Nutrient-dependent regulation of PGC-1alpha's acetylation state and metabolic function through the enzymatic activities of Sirt1/GCN5.	Biochimica et biophysica acta	2010	53
20007948	Glucose	Holzinger U	Real-time continuous glucose monitoring in critically ill patients: a prospective randomized trial.	Diabetes care	2010	52
20067961	Glucose	Deopurkar R	Differential effects of cream, glucose, and orange juice on inflammation, endotoxin, and the expression of Toll-like receptor-4 and suppressor of cytokine signaling-3.	Diabetes care	2010	55
20080987	Glucose	Lu H	MicroRNA-223 regulates Glut4 expression and cardiomyocyte glucose metabolism.	Cardiovascular research	2010	68
20081857	Glucose	Saxena R	Genetic variation in GIPR influences the glucose and insulin responses to an oral glucose challenge.	Nature genetics	2010	218
20081858	Glucose	Dupuis J	New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk.	Nature genetics	2010	750
20086228	Glucose	Roggli E	Involvement of microRNAs in the cytotoxic effects exerted by proinflammatory cytokines on pancreatic beta-cells.	Diabetes	2010	83
20092409	Glucose	Jain SK	Low levels of hydrogen sulfide in the blood of diabetes patients and streptozotocin-treated rats causes vascular inflammation?	Antioxidants & redox signaling	2010	56
20103708	Glucose	Jiang T	The protective role of Nrf2 in streptozotocin-induced diabetic nephropathy.	Diabetes	2010	78
20129687	Glucose	Pan HY	Changes of serum omentin-1 levels in normal subjects and in patients with impaired glucose regulation and with newly diagnosed and untreated type 2 diabetes.	Diabetes research and clinical practice	2010	43
20150287	Glucose	Curtis JM	Downregulation of adipose glutathione S-transferase A4 leads to increased protein carbonylation, oxidative stress, and mitochondrial dysfunction.	Diabetes	2010	69
20159883	Glucose	Moran LJ	Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis.	Human reproduction update	2010	100
20165834	Glucose	Kanazawa I	Serum undercarboxylated osteocalcin was inversely associated with plasma glucose level and fat mass in type 2 diabetes mellitus.	Osteoporosis international 	2011	44
20182580	Glucose	Liao Y	Physiological regulation of Akt activity and stability.	American journal of translational research	2010	103
20185635	Glucose	Ortiz-Muñoz G	Suppressors of cytokine signaling abrogate diabetic nephropathy.	Journal of the American Society of Nephrology 	2010	40
20185807	Glucose	Ingelsson E	Detailed physiologic characterization reveals diverse mechanisms for novel genetic Loci regulating glucose and insulin metabolism in humans.	Diabetes	2010	89
20215450	Glucose	Kayaniyil S	Association of vitamin D with insulin resistance and beta-cell dysfunction in subjects at risk for type 2 diabetes.	Diabetes care	2010	67
20226138	Glucose	Clar C	Self-monitoring of blood glucose in type 2 diabetes: systematic review.	Health technology assessment	2010	53
20299473	Glucose	An D	TBC1D1 regulates insulin- and contraction-induced glucose transport in mouse skeletal muscle.	Diabetes	2010	44
20336705	Glucose	Speliotes EK	Fatty liver is associated with dyslipidemia and dysglycemia independent of visceral fat: the Framingham Heart Study.	Hepatology	2010	86
20353613	Glucose	Gallagher IJ	Integration of microRNA changes in vivo identifies novel molecular features of muscle insulin resistance in type 2 diabetes.	Genome medicine	2010	61
20357360	Glucose	Wentworth JM	Pro-inflammatory CD11c+CD206+ adipose tissue macrophages are associated with insulin resistance in human obesity.	Diabetes	2010	123
20357361	Glucose	Velthuis JH	Simultaneous detection of circulating autoreactive CD8+ T-cells specific for different islet cell-associated epitopes using combinatorial MHC multimers.	Diabetes	2010	58
20372150	Glucose	Freathy RM	Variants in ADCY5 and near CCNL1 are associated with fetal growth and birth weight.	Nature genetics	2010	75
20376506	Glucose	Nicolucci A	Epidemiological aspects of neoplasms in diabetes.	Acta diabetologica	2010	48
20388123	Glucose	Warner MJ	Mechanisms involved in the developmental programming of adulthood disease.	The Biochemical journal	2010	72
20418489	Glucose	Qi L	Genetic variants at 2q24 are associated with susceptibility to type 2 diabetes.	Human molecular genetics	2010	95
20440072	Glucose	Cheng K	Hypoxia-inducible factor-1alpha regulates beta cell function in mouse and human islets.	The Journal of clinical investigation	2010	63
20445742	Glucose	Abdul-Ghani MA	Pathogenesis of insulin resistance in skeletal muscle.	Journal of biomedicine & biotechnology	2010	97
20480025	Glucose	Hanhineva K	Impact of dietary polyphenols on carbohydrate metabolism.	International journal of molecular sciences	2010	83
20497976	Glucose	Widyantoro B	Endothelial cell-derived endothelin-1 promotes cardiac fibrosis in diabetic hearts through stimulation of endothelial-to-mesenchymal transition.	Circulation	2010	85
20501948	Glucose	Maier B	The unique hypusine modification of eIF5A promotes islet beta cell inflammation and dysfunction in mice.	The Journal of clinical investigation	2010	60
20508640	Glucose	Chao EC	SGLT2 inhibition--a novel strategy for diabetes treatment.	Nature reviews. Drug discovery	2010	80
20534540	Glucose	Mankouri J	Enhanced hepatitis C virus genome replication and lipid accumulation mediated by inhibition of AMP-activated protein kinase.	Proceedings of the National Academy of Sciences of the United States of America	2010	51
20546255	Glucose	Gerich JE	Role of the kidney in normal glucose homeostasis and in the hyperglycaemia of diabetes mellitus: therapeutic implications.	Diabetic medicine 	2010	82
20584998	Glucose	Tong J	Ghrelin suppresses glucose-stimulated insulin secretion and deteriorates glucose tolerance in healthy humans.	Diabetes	2010	82
20585248	Glucose	Bournat JC	Mitochondrial dysfunction in obesity.	Current opinion in endocrinology, diabetes, and obesity	2010	54
20664016	Glucose	Brown TT	Association between systemic inflammation and incident diabetes in HIV-infected patients after initiation of antiretroviral therapy.	Diabetes care	2010	63
20724651	Glucose	Bouchard L	Leptin gene epigenetic adaptation to impaired glucose metabolism during pregnancy.	Diabetes care	2010	52
20817486	Glucose	Ernst MC	Chemerin: at the crossroads of inflammation and obesity.	Trends in endocrinology and metabolism	2010	60
20829514	Glucose	Lima FO	The pattern of leptomeningeal collaterals on CT angiography is a strong predictor of long-term functional outcome in stroke patients with large vessel intracranial occlusion.	Stroke	2010	48
20837822	Glucose	Baker LD	Insulin resistance and Alzheimer-like reductions in regional cerebral glucose metabolism for cognitively normal adults with prediabetes or early type 2 diabetes.	Archives of neurology	2011	138
20842602	Glucose	Yessoufou A	Multifaceted roles of peroxisome proliferator-activated receptors (PPARs) at the cellular and whole organism levels.	Swiss medical weekly	2010	40
20857148	Glucose	Kong L	Significance of serum microRNAs in pre-diabetes and newly diagnosed type 2 diabetes: a clinical study.	Acta diabetologica	2011	102
20876708	Glucose	Musso G	Obesity, diabetes, and gut microbiota: the hygiene hypothesis expanded?	Diabetes care	2010	119
20932932	Glucose	Fenton TR	Functions and regulation of the 70kDa ribosomal S6 kinases.	The international journal of biochemistry & cell biology	2011	86
20947447	Glucose	Gill RS	Sleeve gastrectomy and type 2 diabetes mellitus: a systematic review.	Surgery for obesity and related diseases 	2010	40
20980548	Glucose	Hummel CS	Glucose transport by human renal Na+/D-glucose cotransporters SGLT1 and SGLT2.	American journal of physiology. Cell physiology	2011	49
21035759	Glucose	Misu H	A liver-derived secretory protein, selenoprotein P, causes insulin resistance.	Cell metabolism	2010	69
21193740	Glucose	Boström KI	Activation of vascular bone morphogenetic protein signaling in diabetes mellitus.	Circulation research	2011	57
21195350	Glucose	Chen S	Mice with AS160/TBC1D4-Thr649Ala knockin mutation are glucose intolerant with reduced insulin sensitivity and altered GLUT4 trafficking.	Cell metabolism	2011	42
21205122	Glucose	Del Prato S	Effect of linagliptin monotherapy on glycaemic control and markers of β-cell function in patients with inadequately controlled type 2 diabetes: a randomized controlled trial.	Diabetes, obesity & metabolism	2011	71
21220732	Glucose	Caporali A	Deregulation of microRNA-503 contributes to diabetes mellitus-induced impairment of endothelial function and reparative angiogenesis after limb ischemia.	Circulation	2011	108
21233852	Glucose	Donath MY	Type 2 diabetes as an inflammatory disease.	Nature reviews. Immunology	2011	545
21266331	Glucose	Elbein SC	Global gene expression profiles of subcutaneous adipose and muscle from glucose-tolerant, insulin-sensitive, and insulin-resistant individuals matched for BMI.	Diabetes	2011	38
21270263	Glucose	Koenen TB	Hyperglycemia activates caspase-1 and TXNIP-mediated IL-1beta transcription in human adipose tissue.	Diabetes	2011	43
21270272	Glucose	Tan Y	Diabetic downregulation of Nrf2 activity via ERK contributes to oxidative stress-induced insulin resistance in cardiac cells in vitro and in vivo.	Diabetes	2011	90
21288303	Glucose	Ramachandran D	Sirt1 and mir-9 expression is regulated during glucose-stimulated insulin secretion in pancreatic β-islets.	The FEBS journal	2011	35
21288502	Glucose	Catalano PM	Is it time to revisit the Pedersen hypothesis in the face of the obesity epidemic?	American journal of obstetrics and gynecology	2011	73
21309058	Glucose	Mashili FL	Direct effects of FGF21 on glucose uptake in human skeletal muscle: implications for type 2 diabetes and obesity.	Diabetes/metabolism research and reviews	2011	40
21325336	Glucose	Liu C	PGC-1 coactivators in the control of energy metabolism.	Acta biochimica et biophysica Sinica	2011	50
21356520	Glucose	Song WJ	Snapin mediates incretin action and augments glucose-dependent insulin secretion.	Cell metabolism	2011	35
21358696	Glucose	Mather A	Glucose handling by the kidney.	Kidney international. Supplement	2011	42
21375707	Glucose	Nedergaard J	Three years with adult human brown adipose tissue.	Annals of the New York Academy of Sciences	2010	51
21435176	Glucose	Bosco D	Possible implications of insulin resistance and glucose metabolism in Alzheimer's disease pathogenesis.	Journal of cellular and molecular medicine	2011	45
21481590	Glucose	Gurzov EN	Bcl-2 proteins in diabetes: mitochondrial pathways of β-cell death and dysfunction.	Trends in cell biology	2011	50
21489811	Glucose	Marino JS	Central insulin and leptin-mediated autonomic control of glucose homeostasis.	Trends in endocrinology and metabolism	2011	40
21527729	Glucose	Morton GJ	Leptin and the central nervous system control of glucose metabolism.	Physiological reviews	2011	81
21599535	Glucose	Leavens KF	Insulin signaling to hepatic lipid metabolism in health and disease.	Critical reviews in biochemistry and molecular biology	2011	41
21606218	Glucose	Abdul-Ghani MA	Role of sodium-glucose cotransporter 2 (SGLT 2) inhibitors in the treatment of type 2 diabetes.	Endocrine reviews	2011	69
21614570	Glucose	Camastra S	Early and longer term effects of gastric bypass surgery on tissue-specific insulin sensitivity and beta cell function in morbidly obese patients with and without type 2 diabetes.	Diabetologia	2011	41
21633176	Glucose	Gautron L	Sixteen years and counting: an update on leptin in energy balance.	The Journal of clinical investigation	2011	117
21638209	Glucose	Samarakoon R	TGF-β1 → SMAD/p53/USF2 → PAI-1 transcriptional axis in ureteral obstruction-induced renal fibrosis.	Cell and tissue research	2012	39
21646425	Glucose	Pullen TJ	miR-29a and miR-29b contribute to pancreatic beta-cell-specific silencing of monocarboxylate transporter 1 (Mct1).	Molecular and cellular biology	2011	75
21677052	Glucose	Aeberli I	Low to moderate sugar-sweetened beverage consumption impairs glucose and lipid metabolism and promotes inflammation in healthy young men: a randomized controlled trial.	The American journal of clinical nutrition	2011	51
21697254	Glucose	DeFronzo RA	Preservation of β-cell function: the key to diabetes prevention.	The Journal of clinical endocrinology and metabolism	2011	55
21723505	Glucose	Yadav H	Protection from obesity and diabetes by blockade of TGF-β/Smad3 signaling.	Cell metabolism	2011	117
21726808	Glucose	Jiang W	Acetylation regulates gluconeogenesis by promoting PEPCK1 degradation via recruiting the UBR5 ubiquitin ligase.	Molecular cell	2011	107
21747057	Glucose	Shenouda SM	Altered mitochondrial dynamics contributes to endothelial dysfunction in diabetes mellitus.	Circulation	2011	105
21778224	Glucose	Srikanthan P	Relative muscle mass is inversely associated with insulin resistance and prediabetes. Findings from the third National Health and Nutrition Examination Survey.	The Journal of clinical endocrinology and metabolism	2011	111
21778425	Glucose	Zhou S	Repression of P66Shc expression by SIRT1 contributes to the prevention of hyperglycemia-induced endothelial dysfunction.	Circulation research	2011	49
21809358	Glucose	Cardinale V	Multipotent stem/progenitor cells in human biliary tree give rise to hepatocytes, cholangiocytes, and pancreatic islets.	Hepatology	2011	75
21811631	Glucose	Jeong YS	Integrated expression profiling and genome-wide analysis of ChREBP targets reveals the dual role for ChREBP in glucose-regulated gene expression.	PloS one	2011	41
21816244	Glucose	Kousteni S	FoxO1, the transcriptional chief of staff of energy metabolism.	Bone	2012	43
21855697	Glucose	Reaven GM	Insulin resistance: the link between obesity and cardiovascular disease.	The Medical clinics of North America	2011	93
21864748	Glucose	Henquin JC	The dual control of insulin secretion by glucose involves triggering and amplifying pathways in β-cells.	Diabetes research and clinical practice	2011	47
21865645	Glucose	Ravassard P	A genetically engineered human pancreatic β cell line exhibiting glucose-inducible insulin secretion.	The Journal of clinical investigation	2011	90
21890681	Glucose	Pirola L	Genome-wide analysis distinguishes hyperglycemia regulated epigenetic signatures of primary vascular cells.	Genome research	2011	43
21911743	Glucose	Eller K	Potential role of regulatory T cells in reversing obesity-linked insulin resistance and diabetic nephropathy.	Diabetes	2011	58
21917523	Glucose	Diano S	Mitochondrial uncoupling protein 2 (UCP2) in glucose and lipid metabolism.	Trends in molecular medicine	2012	46
21933988	Glucose	Kowluru RA	Abrogation of MMP-9 gene protects against the development of retinopathy in diabetic mice by preventing mitochondrial damage.	Diabetes	2011	43
21950636	Glucose	Donnelly D	The structure and function of the glucagon-like peptide-1 receptor and its ligands.	British journal of pharmacology	2012	37
21962509	Glucose	Zhu H	The Lin28/let-7 axis regulates glucose metabolism.	Cell	2011	235
21965330	Glucose	Wang RH	Hepatic Sirt1 deficiency in mice impairs mTorc2/Akt signaling and results in hyperglycemia, oxidative damage, and insulin resistance.	The Journal of clinical investigation	2011	91
21969371	Glucose	Wang Z	Inhibition or ablation of p21-activated kinase (PAK1) disrupts glucose homeostatic mechanisms in vivo.	The Journal of biological chemistry	2011	43
21976745	Glucose	Klonoff DC	Continuous glucose monitoring: an Endocrine Society Clinical Practice Guideline.	The Journal of clinical endocrinology and metabolism	2011	41
21978918	Glucose	Qin Z	The use of THP-1 cells as a model for mimicking the function and regulation of monocytes and macrophages in the vasculature.	Atherosclerosis	2012	62
22001757	Glucose	Chambers JC	Genome-wide association study identifies loci influencing concentrations of liver enzymes in plasma.	Nature genetics	2011	141
22008454	Glucose	Ryan AS	Exercise with calorie restriction improves insulin sensitivity and glycogen synthase activity in obese postmenopausal women with impaired glucose tolerance.	American journal of physiology. Endocrinology and metabolism	2012	32
22021706	Glucose	Lin M	Toll-like receptor 4 promotes tubular inflammation in diabetic nephropathy.	Journal of the American Society of Nephrology 	2012	69
22038520	Glucose	Rees MG	Cellular characterisation of the GCKR P446L variant associated with type 2 diabetes risk.	Diabetologia	2012	31
22158537	Glucose	Cho YS	Meta-analysis of genome-wide association studies identifies eight new loci for type 2 diabetes in east Asians.	Nature genetics	2011	202
22191795	Glucose	de la Monte SM	Contributions of brain insulin resistance and deficiency in amyloid-related neurodegeneration in Alzheimer's disease.	Drugs	2012	43
22258980	Glucose	Langendam M	Continuous glucose monitoring systems for type 1 diabetes mellitus.	The Cochrane database of systematic reviews	2012	44
22335797	Glucose	Vallon V	Renal function in diabetic disease models: the tubular system in the pathophysiology of the diabetic kidney.	Annual review of physiology	2012	54
22340904	Glucose	Elliott B	The central role of myostatin in skeletal muscle and whole body homeostasis.	Acta physiologica	2012	30
22344039	Glucose	Fraser A	Associations of pregnancy complications with calculated cardiovascular disease risk and cardiovascular risk factors in middle age: the Avon Longitudinal Study of Parents and Children.	Circulation	2012	59
22396530	Glucose	Ji Y	Activation of natural killer T cells promotes M2 Macrophage polarization in adipose tissue and improves systemic glucose tolerance via interleukin-4 (IL-4)/STAT6 protein signaling axis in obesity.	The Journal of biological chemistry	2012	60
22399527	Glucose	Kristiansson K	Genome-wide screen for metabolic syndrome susceptibility Loci reveals strong lipid gene contribution but no evidence for common genetic basis for clustering of metabolic syndrome traits.	Circulation. Cardiovascular genetics	2012	65
22421977	Glucose	Srikanthan P	Sarcopenia exacerbates obesity-associated insulin resistance and dysglycemia: findings from the National Health and Nutrition Examination Survey III.	PloS one	2010	80
22427379	Glucose	Greco S	MicroRNA dysregulation in diabetic ischemic heart failure patients.	Diabetes	2012	58
22457523	Glucose	Bose SK	Hepatitis C virus activates the mTOR/S6K1 signaling pathway in inhibiting IRS-1 function for insulin resistance.	Journal of virology	2012	31
22466288	Glucose	Herman MA	A novel ChREBP isoform in adipose tissue regulates systemic glucose metabolism.	Nature	2012	138
22476949	Glucose	Zhou B	Downregulation of miR-181a upregulates sirtuin-1 (SIRT1) and improves hepatic insulin sensitivity.	Diabetologia	2012	42
22482906	Glucose	Bogan JS	Regulation of glucose transporter translocation in health and diabetes.	Annual review of biochemistry	2012	56
22486204	Glucose	George PS	Effect of vitamin D supplementation on glycaemic control and insulin resistance: a systematic review and meta-analysis.	Diabetic medicine 	2012	64
22496545	Glucose	Buxton OM	Adverse metabolic consequences in humans of prolonged sleep restriction combined with circadian disruption.	Science translational medicine	2012	154
22500228	Glucose	Duarte AI	Insulin in central nervous system: more than just a peripheral hormone.	Journal of aging research	2012	50
22537941	Glucose	Roggli E	Changes in microRNA expression contribute to pancreatic β-cell dysfunction in prediabetic NOD mice.	Diabetes	2012	45
22547887	Glucose	Weinstock TG	A controlled trial of CPAP therapy on metabolic control in individuals with impaired glucose tolerance and sleep apnea.	Sleep	2012	41
22553379	Glucose	Stancáková A	Hyperglycemia and a common variant of GCKR are associated with the levels of eight amino acids in 9,369 Finnish men.	Diabetes	2012	60
22563482	Glucose	Martino L	Palmitate activates autophagy in INS-1E β-cells and in isolated rat and human pancreatic islets.	PloS one	2012	37
22570331	Glucose	Yang BT	Increased DNA methylation and decreased expression of PDX-1 in pancreatic islets from patients with type 2 diabetes.	Molecular endocrinology	2012	55
22572877	Glucose	Cani PD	Involvement of gut microbiota in the development of low-grade inflammation and type 2 diabetes associated with obesity.	Gut microbes	2012	81
22586588	Glucose	Metukuri MR	ChREBP mediates glucose-stimulated pancreatic β-cell proliferation.	Diabetes	2012	35
22617471	Glucose	Leto D	Regulation of glucose transport by insulin: traffic control of GLUT4.	Nature reviews. Molecular cell biology	2012	134
22683134	Glucose	Perreault L	Effect of regression from prediabetes to normal glucose regulation on long-term reduction in diabetes risk: results from the Diabetes Prevention Program Outcomes Study.	Lancet	2012	81
22693349	Glucose	Paneni F	Gene silencing of the mitochondrial adaptor p66(Shc) suppresses vascular hyperglycemic memory in diabetes.	Circulation research	2012	38
22773666	Glucose	Cunha DA	Death protein 5 and p53-upregulated modulator of apoptosis mediate the endoplasmic reticulum stress-mitochondrial dialog triggering lipotoxic rodent and human β-cell apoptosis.	Diabetes	2012	36
22827862	Glucose	Lucassen EA	Interacting epidemics? Sleep curtailment, insulin resistance, and obesity.	Annals of the New York Academy of Sciences	2012	39
22876189	Glucose	Voight BF	The metabochip, a custom genotyping array for genetic studies of metabolic, cardiovascular, and anthropometric traits.	PLoS genetics	2012	208
22883232	Glucose	Ruan HB	O-GlcNAc transferase/host cell factor C1 complex regulates gluconeogenesis by modulating PGC-1α stability.	Cell metabolism	2012	55
22960655	Glucose	Aggarwal G	Adrenomedullin is up-regulated in patients with pancreatic cancer and causes insulin resistance in β cells and mice.	Gastroenterology	2012	31
22961080	Glucose	Li H	A genome-wide association study identifies GRK5 and RASGRP1 as type 2 diabetes loci in Chinese Hans.	Diabetes	2013	49
22970944	Glucose	Pal A	PTEN mutations as a cause of constitutive insulin sensitivity and obesity.	The New England journal of medicine	2012	48
22974438	Glucose	Rorsman P	Regulation of insulin secretion in human pancreatic islets.	Annual review of physiology	2013	89
22997257	Glucose	Yuen DA	eNOS deficiency predisposes podocytes to injury in diabetes.	Journal of the American Society of Nephrology 	2012	39
23032062	Glucose	Karolina DS	Circulating miRNA profiles in patients with metabolic syndrome.	The Journal of clinical endocrinology and metabolism	2012	64
23061800	Glucose	Passtoors WM	Gene expression analysis of mTOR pathway: association with human longevity.	Aging cell	2013	38
23063129	Glucose	Teperino R	Hedgehog partial agonism drives Warburg-like metabolism in muscle and brown fat.	Cell	2012	65
23069842	Glucose	Willette AA	Insulin resistance, brain atrophy, and cognitive performance in late middle-aged adults.	Diabetes care	2013	42
23129134	Glucose	Würtz P	Branched-chain and aromatic amino acids are predictors of insulin resistance in young adults.	Diabetes care	2013	79
23134073	Glucose	Woo YC	Fibroblast growth factor 21 as an emerging metabolic regulator: clinical perspectives.	Clinical endocrinology	2013	47
23139352	Glucose	Boon J	Ceramides contained in LDL are elevated in type 2 diabetes and promote inflammation and skeletal muscle insulin resistance.	Diabetes	2013	45
23144172	Glucose	Mocharla P	AngiomiR-126 expression and secretion from circulating CD34(+) and CD14(+) PBMCs: role for proangiogenic effects and alterations in type 2 diabetics.	Blood	2013	37
23159449	Glucose	Zechner JF	Weight-independent effects of roux-en-Y gastric bypass on glucose homeostasis via melanocortin-4 receptors in mice and humans.	Gastroenterology	2013	29
23221071	Glucose	Zhong Q	Epigenetic modification of Sod2 in the development of diabetic retinopathy and in the metabolic memory: role of histone methylation.	Investigative ophthalmology & visual science	2013	28
23265947	Glucose	Vogt MC	CNS insulin signaling in the control of energy homeostasis and glucose metabolism - from embryo to old age.	Trends in endocrinology and metabolism	2013	39
23269411	Glucose	Ye J	Inflammation during obesity is not all bad: evidence from animal and human studies.	American journal of physiology. Endocrinology and metabolism	2013	32
23273980	Glucose	Chocarro-Calvo A	Glucose-induced β-catenin acetylation enhances Wnt signaling in cancer.	Molecular cell	2013	32
23274900	Glucose	Sylow L	Rac1 is a novel regulator of contraction-stimulated glucose uptake in skeletal muscle.	Diabetes	2013	25
23277185	Glucose	Pillon NJ	Cross-talk between skeletal muscle and immune cells: muscle-derived mediators and metabolic implications.	American journal of physiology. Endocrinology and metabolism	2013	44
23315061	Glucose	Stepto NK	Women with polycystic ovary syndrome have intrinsic insulin resistance on euglycaemic-hyperinsulaemic clamp.	Human reproduction	2013	67
23325474	Glucose	Fernández-Hernando C	MicroRNAs in metabolic disease.	Arteriosclerosis, thrombosis, and vascular biology	2013	57
23337953	Glucose	Stefan N	The role of hepatokines in metabolism.	Nature reviews. Endocrinology	2013	42
23342163	Glucose	Mortuza R	High glucose induced alteration of SIRTs in endothelial cells causes rapid aging in a p300 and FOXO regulated pathway.	PloS one	2013	40
23344728	Glucose	Kim YG	Differences in the glucose-lowering efficacy of dipeptidyl peptidase-4 inhibitors between Asians and non-Asians: a systematic review and meta-analysis.	Diabetologia	2013	71
23349487	Glucose	Kimple ME	Prostaglandin E2 receptor, EP3, is induced in diabetic islets and negatively regulates glucose- and hormone-stimulated insulin secretion.	Diabetes	2013	26
23369227	Glucose	Choi YK	Serum irisin levels in new-onset type 2 diabetes.	Diabetes research and clinical practice	2013	63
23372846	Glucose	van de Bunt M	The miRNA profile of human pancreatic islets and beta-cells and relationship to type 2 diabetes pathogenesis.	PloS one	2013	40
23386232	Glucose	Matsubara J	Dipeptidyl peptidase-4 inhibitor, sitagliptin, improves endothelial dysfunction in association with its anti-inflammatory effects in patients with coronary artery disease and uncontrolled diabetes.	Circulation journal 	2013	34
23388637	Glucose	Qian SW	BMP4-mediated brown fat-like changes in white adipose tissue alter glucose and energy homeostasis.	Proceedings of the National Academy of Sciences of the United States of America	2013	59
23400783	Glucose	Brännmark C	Insulin signaling in type 2 diabetes: experimental and modeling analyses reveal mechanisms of insulin resistance in human adipocytes.	The Journal of biological chemistry	2013	33
23423566	Glucose	Zhong Q	Regulation of matrix metalloproteinase-9 by epigenetic modifications and the development of diabetic retinopathy.	Diabetes	2013	31
23431266	Glucose	Girousse A	Partial inhibition of adipose tissue lipolysis improves glucose metabolism and insulin sensitivity without alteration of fat mass.	PLoS biology	2013	41
23434589	Glucose	Bramswig NC	Epigenomic plasticity enables human pancreatic α to β cell reprogramming.	The Journal of clinical investigation	2013	110
23439261	Glucose	Safar Zadeh E	The liver diseases of lipodystrophy: the long-term effect of leptin treatment.	Journal of hepatology	2013	26
23475416	Glucose	Moon HS	Leptin's role in lipodystrophic and nonlipodystrophic insulin-resistant and diabetic individuals.	Endocrine reviews	2013	25
23493574	Glucose	Chen YH	miRNA-93 inhibits GLUT4 and is overexpressed in adipose tissue of polycystic ovary syndrome patients and women with insulin resistance.	Diabetes	2013	35
23516412	Glucose	de Bock M	Olive (Olea europaea L.) leaf polyphenols improve insulin sensitivity in middle-aged overweight men: a randomized, placebo-controlled, crossover trial.	PloS one	2013	25
23528347	Glucose	Sah RP	New insights into pancreatic cancer-induced paraneoplastic diabetes.	Nature reviews. Gastroenterology & hepatology	2013	45
23539729	Glucose	Yoneda S	Predominance of β-cell neogenesis rather than replication in humans with an impaired glucose tolerance and newly diagnosed diabetes.	The Journal of clinical endocrinology and metabolism	2013	28
23568441	Glucose	Berryman DE	The GH/IGF-1 axis in obesity: pathophysiology and therapeutic considerations.	Nature reviews. Endocrinology	2013	34
23582329	Glucose	Lee YS	The fractalkine/CX3CR1 system regulates β cell function and insulin secretion.	Cell	2013	31
23594109	Glucose	Monami M	Cardiovascular safety of sulfonylureas: a meta-analysis of randomized clinical trials.	Diabetes, obesity & metabolism	2013	31
23603815	Glucose	Cypess AM	Anatomical localization, gene expression profiling and functional characterization of adult human neck brown fat.	Nature medicine	2013	170
23663483	Glucose	Karnevi E	Metformin-mediated growth inhibition involves suppression of the IGF-I receptor signalling pathway in human pancreatic cancer cells.	BMC cancer	2013	31
23823329	Glucose	Bouchonville M	Weight loss, exercise or both and cardiometabolic risk factors in obese older adults: results of a randomized controlled trial.	International journal of obesity	2014	30
23826303	Glucose	Wang X	Regional differences in islet distribution in the human pancreas--preferential beta-cell loss in the head region in patients with type 2 diabetes.	PloS one	2013	27
23850509	Glucose	Chen Z	Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies.	Progress in neurobiology	2013	66
23852538	Glucose	Yao Y	A role for the endothelium in vascular calcification.	Circulation research	2013	44
23886976	Glucose	Geurts L	Gut microbiota controls adipose tissue expansion, gut barrier and glucose metabolism: novel insights into molecular targets and interventions using prebiotics.	Beneficial microbes	2014	46
23895803	Glucose	Neal B	Rationale, design, and baseline characteristics of the Canagliflozin Cardiovascular Assessment Study (CANVAS)--a randomized placebo-controlled trial.	American heart journal	2013	72
23897760	Glucose	Rezania A	Enrichment of human embryonic stem cell-derived NKX6.1-expressing pancreatic progenitor cells accelerates the maturation of insulin-secreting cells in vivo.	Stem cells	2013	48
23900589	Glucose	Lipska KJ	HbA1c and risk of severe hypoglycemia in type 2 diabetes: the Diabetes and Aging Study.	Diabetes care	2013	33
23932046	Glucose	Palomer X	An overview of the crosstalk between inflammatory processes and metabolic dysregulation during diabetic cardiomyopathy.	International journal of cardiology	2013	35
24014835	Glucose	Jansen F	Endothelial microparticle-mediated transfer of MicroRNA-126 promotes vascular endothelial cell repair via SPRED1 and is abrogated in glucose-damaged endothelial microparticles.	Circulation	2013	77
24018562	Glucose	Hodson DJ	Lipotoxicity disrupts incretin-regulated human β cell connectivity.	The Journal of clinical investigation	2013	53
24030890	Glucose	Fink LN	Pro-inflammatory macrophages increase in skeletal muscle of high fat-fed mice and correlate with metabolic risk markers in humans.	Obesity	2014	30
24037093	Glucose	Taniguchi CM	Cross-talk between hypoxia and insulin signaling through Phd3 regulates hepatic glucose and lipid metabolism and ameliorates diabetes.	Nature medicine	2013	33
24049067	Glucose	García-Jiménez C	A new link between diabetes and cancer: enhanced WNT/β-catenin signaling by high glucose.	Journal of molecular endocrinology	2014	27
24065789	Glucose	Abdul-Ghani MA	Novel hypothesis to explain why SGLT2 inhibitors inhibit only 30-50% of filtered glucose load in humans.	Diabetes	2013	27
24073995	Glucose	Stenlöf K	Long-term efficacy and safety of canagliflozin monotherapy in patients with type 2 diabetes inadequately controlled with diet and exercise: findings from the 52-week CANTATA-M study.	Current medical research and opinion	2014	30
24077098	Glucose	Erickson JR	Diabetic hyperglycaemia activates CaMKII and arrhythmias by O-linked glycosylation.	Nature	2013	117
24089513	Glucose	Shah M	Contribution of endogenous glucagon-like peptide 1 to glucose metabolism after Roux-en-Y gastric bypass.	Diabetes	2014	28
24113348	Glucose	Liu J	Receptor for advanced glycation end-products promotes premature senescence of proximal tubular epithelial cells via activation of endoplasmic reticulum stress-dependent p21 signaling.	Cellular signalling	2014	23
24127133	Glucose	Winer DA	B Lymphocytes in obesity-related adipose tissue inflammation and insulin resistance.	Cellular and molecular life sciences 	2014	22
24204837	Glucose	Alvarez ML	Role of microRNA 1207-5P and its host gene, the long non-coding RNA Pvt1, as mediators of extracellular matrix accumulation in the kidney: implications for diabetic nephropathy.	PloS one	2013	25
24215793	Glucose	Mezza T	Insulin resistance alters islet morphology in nondiabetic humans.	Diabetes	2014	31
24223694	Glucose	Barutta F	Urinary exosomal microRNAs in incipient diabetic nephropathy.	PloS one	2013	49
24238363	Glucose	Oh KJ	CREB and FoxO1: two transcription factors for the regulation of hepatic gluconeogenesis.	BMB reports	2013	32
24245943	Glucose	Cho YM	Glucagon-like peptide-1: glucose homeostasis and beyond.	Annual review of physiology	2014	21
24315620	Glucose	Kahn SE	Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future.	Lancet	2014	141
24335483	Glucose	Palmer CS	Increased glucose metabolic activity is associated with CD4+ T-cell activation and depletion during chronic HIV infection.	AIDS	2014	24
24355926	Glucose	Gebremariam T	CotH3 mediates fungal invasion of host cells during mucormycosis.	The Journal of clinical investigation	2014	25
24356594	Glucose	de Boer IH	Kidney disease and related findings in the diabetes control and complications trial/epidemiology of diabetes interventions and complications study.	Diabetes care	2014	26
24370923	Glucose	Daniele G	The inflammatory status score including IL-6, TNF-α, osteopontin, fractalkine, MCP-1 and adiponectin underlies whole-body insulin resistance and hyperglycemia in type 2 diabetes mellitus.	Acta diabetologica	2014	26
24371138	Glucose	Das A	Mammalian target of rapamycin (mTOR) inhibition with rapamycin improves cardiac function in type 2 diabetic mice: potential role of attenuated oxidative stress and altered contractile protein expression.	The Journal of biological chemistry	2014	29
24373234	Glucose	Nadkarni P	Regulation of glucose homeostasis by GLP-1.	Progress in molecular biology and translational science	2014	23
24384568	Glucose	Boucher J	Insulin receptor signaling in normal and insulin-resistant states.	Cold Spring Harbor perspectives in biology	2014	78
24395786	Glucose	Vozza A	UCP2 transports C4 metabolites out of mitochondria, regulating glucose and glutamine oxidation.	Proceedings of the National Academy of Sciences of the United States of America	2014	64
24411018	Glucose	Morris JK	Impaired glycemia increases disease progression in mild cognitive impairment.	Neurobiology of aging	2014	23
24417942	Glucose	Yamauchi T	Adiponectin receptors: a review of their structure, function and how they work.	Best practice & research. Clinical endocrinology & metabolism	2014	32
24429158	Glucose	Aurora RN	Obstructive sleep apnoea and type 2 diabetes mellitus: a bidirectional association.	The Lancet. Respiratory medicine	2013	35
24438746	Glucose	Kugel S	Chromatin and beyond: the multitasking roles for SIRT6.	Trends in biochemical sciences	2014	56
24520123	Glucose	Dalmas E	T cell-derived IL-22 amplifies IL-1β-driven inflammation in human adipose tissue: relevance to obesity and type 2 diabetes.	Diabetes	2014	32
24529566	Glucose	Geerlings S	Genital and urinary tract infections in diabetes: impact of pharmacologically-induced glucosuria.	Diabetes research and clinical practice	2014	22
24558077	Glucose	Bakris GL	Microalbuminuria as a risk predictor in diabetes: the continuing saga.	Diabetes care	2014	22
24561261	Glucose	Brissova M	Islet microenvironment, modulated by vascular endothelial growth factor-A signaling, promotes β cell regeneration.	Cell metabolism	2014	32
24563869	Glucose	Golbidi S	Exercise induced adipokine changes and the metabolic syndrome.	Journal of diabetes research	2014	25
24570140	Glucose	Mortuza R	miR-195 regulates SIRT1-mediated changes in diabetic retinopathy.	Diabetologia	2014	27
24584071	Glucose	Flannick J	Loss-of-function mutations in SLC30A8 protect against type 2 diabetes.	Nature genetics	2014	118
24622320	Glucose	Tahrani AA	SGLT inhibitors in management of diabetes.	The lancet. Diabetes & endocrinology	2013	28
24622415	Glucose	Hartemann A	Low-dose interleukin 2 in patients with type 1 diabetes: a phase 1/2 randomised, double-blind, placebo-controlled trial.	The lancet. Diabetes & endocrinology	2013	55
24628249	Glucose	Reutrakul S	Interactions between sleep, circadian function, and glucose metabolism: implications for risk and severity of diabetes.	Annals of the New York Academy of Sciences	2014	39
24651807	Glucose	Cobelli C	The oral minimal model method.	Diabetes	2014	28
24662521	Glucose	Karnevi E	Tumour-educated macrophages display a mixed polarisation and enhance pancreatic cancer cell invasion.	Immunology and cell biology	2014	24
24673844	Glucose	De Nicola L	Sodium/glucose cotransporter 2 inhibitors and prevention of diabetic nephropathy: targeting the renal tubule in diabetes.	American journal of kidney diseases 	2014	24
24676639	Glucose	Fiorina P	Role of podocyte B7-1 in diabetic nephropathy.	Journal of the American Society of Nephrology 	2014	31
24699409	Glucose	Prokopenko I	A central role for GRB10 in regulation of islet function in man.	PLoS genetics	2014	28
24708805	Glucose	Sajja RK	Impact of altered glycaemia on blood-brain barrier endothelium: an in vitro study using the hCMEC/D3 cell line.	Fluids and barriers of the CNS	2014	20
24740569	Glucose	Hodson DJ	ADCY5 couples glucose to insulin secretion in human islets.	Diabetes	2014	23
24750644	Glucose	Wu S	Dipeptidyl peptidase-4 inhibitors and cardiovascular outcomes: meta-analysis of randomized clinical trials with 55,141 participants.	Cardiovascular therapeutics	2014	29
24781596	Glucose	Paneni F	Insulin resistance, diabetes, and cardiovascular risk.	Current atherosclerosis reports	2014	23
24813368	Glucose	Gallego-Escuredo JM	Opposite alterations in FGF21 and FGF19 levels and disturbed expression of the receptor machinery for endocrine FGFs in obese patients.	International journal of obesity	2015	18
24846769	Glucose	Ghosh S	Elevated muscle TLR4 expression and metabolic endotoxemia in human aging.	The journals of gerontology. Series A, Biological sciences and medical sciences	2015	25
24911120	Glucose	Shalev A	Minireview: Thioredoxin-interacting protein: regulation and function in the pancreatic β-cell.	Molecular endocrinology	2014	21
24925721	Glucose	Yoo TH	Sphingomyelinase-like phosphodiesterase 3b expression levels determine podocyte injury phenotypes in glomerular disease.	Journal of the American Society of Nephrology 	2015	25
24927146	Glucose	Liu Y	The role of circulating microRNA-126 (miR-126): a novel biomarker for screening prediabetes and newly diagnosed type 2 diabetes mellitus.	International journal of molecular sciences	2014	23
24930970	Glucose	Macintyre AN	The glucose transporter Glut1 is selectively essential for CD4 T cell activation and effector function.	Cell metabolism	2014	137
24949970	Glucose	Soleimanpour SA	The diabetes susceptibility gene Clec16a regulates mitophagy.	Cell	2014	34
24954193	Glucose	Lee P	Temperature-acclimated brown adipose tissue modulates insulin sensitivity in humans.	Diabetes	2014	60
24981880	Glucose	Yang Z	Serum miR-23a, a potential biomarker for diagnosis of pre-diabetes and type 2 diabetes.	Acta diabetologica	2014	24
24993615	Glucose	Barnosky AR	Intermittent fasting vs daily calorie restriction for type 2 diabetes prevention: a review of human findings.	Translational research 	2014	23
24995977	Glucose	Lo JC	Adipsin is an adipokine that improves β cell function in diabetes.	Cell	2014	33
25009184	Glucose	Zhang P	Tumor suppressor p53 cooperates with SIRT6 to regulate gluconeogenesis by promoting FoxO1 nuclear exclusion.	Proceedings of the National Academy of Sciences of the United States of America	2014	42
25019091	Glucose	Yan LJ	Pathogenesis of chronic hyperglycemia: from reductive stress to oxidative stress.	Journal of diabetes research	2014	30
25025956	Glucose	Guo JH	Glucose-induced electrical activities and insulin secretion in pancreatic islet β-cells are modulated by CFTR.	Nature communications	2014	30
25043058	Glucose	Suh JM	Endocrinization of FGF1 produces a neomorphic and potent insulin sensitizer.	Nature	2014	32
25056438	Glucose	Chondronikola M	Brown adipose tissue improves whole-body glucose homeostasis and insulin sensitivity in humans.	Diabetes	2014	114
25102180	Glucose	Ng MC	Meta-analysis of genome-wide association studies in African Americans provides insights into the genetic architecture of type 2 diabetes.	PLoS genetics	2014	46
25104103	Glucose	Wilding JP	The role of the kidneys in glucose homeostasis in type 2 diabetes: clinical implications and therapeutic significance through sodium glucose co-transporter 2 inhibitors.	Metabolism	2014	23
25185947	Glucose	Cypess AM	Brown fat in humans: consensus points and experimental guidelines.	Cell metabolism	2014	38
25201977	Glucose	Fadista J	Global genomic and transcriptomic analysis of human pancreatic islets reveals novel genes influencing glucose metabolism.	Proceedings of the National Academy of Sciences of the United States of America	2014	74
25204974	Glucose	Carlsson PO	Preserved β-cell function in type 1 diabetes by mesenchymal stromal cells.	Diabetes	2015	22
25204977	Glucose	Diabetes Control and Complications Trial (DCCT)/Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group.	Effect of intensive diabetes therapy on the progression of diabetic retinopathy in patients with type 1 diabetes: 18 years of follow-up in the DCCT/EDIC.	Diabetes	2015	33
25211370	Glucose	Rezania A	Reversal of diabetes with insulin-producing cells derived in vitro from human pluripotent stem cells.	Nature biotechnology	2014	165
25212743	Glucose	Zhang R	A dual role of lipasin (betatrophin) in lipid metabolism and glucose homeostasis: consensus and controversy.	Cardiovascular diabetology	2014	22
25220191	Glucose	Eng C	Glucagon-like peptide-1 receptor agonist and basal insulin combination treatment for the management of type 2 diabetes: a systematic review and meta-analysis.	Lancet	2014	44
25239387	Glucose	Gilon P	Calcium signaling in pancreatic β-cells in health and in Type 2 diabetes.	Cell calcium	2014	23
25262977	Glucose	Hodgson K	Immunological mechanisms contributing to the double burden of diabetes and intracellular bacterial infections.	Immunology	2015	27
25281430	Glucose	Murahovschi V	WISP1 is a novel adipokine linked to inflammation in obesity.	Diabetes	2015	16
25287317	Glucose	Crujeiras AB	Irisin: 'fat' or artefact.	Clinical endocrinology	2015	16
25287711	Glucose	Rutter GA	SLC30A8 mutations in type 2 diabetes.	Diabetologia	2015	19
25295788	Glucose	Turpin SM	Obesity-induced CerS6-dependent C16:0 ceramide production promotes weight gain and glucose intolerance.	Cell metabolism	2014	80
25303484	Glucose	Chen X	Circulating betatrophin levels are increased in patients with type 2 diabetes and associated with insulin resistance.	The Journal of clinical endocrinology and metabolism	2015	29
25305282	Glucose	Basu A	Time lag of glucose from intravascular to interstitial compartment in type 1 diabetes.	Journal of diabetes science and technology	2015	20
25307742	Glucose	Haeusler RA	Integrated control of hepatic lipogenesis versus glucose production requires FoxO transcription factors.	Nature communications	2014	32
25324472	Glucose	Olivieri F	Age- and glycemia-related miR-126-3p levels in plasma and endothelial cells.	Aging	2014	22
25329075	Glucose	Rangasamy S	Chemokine mediated monocyte trafficking into the retina: role of inflammation in alteration of the blood-retinal barrier in diabetic retinopathy.	PloS one	2014	24
25342129	Glucose	Kapogiannis D	Dysfunctionally phosphorylated type 1 insulin receptor substrate in neural-derived blood exosomes of preclinical Alzheimer's disease.	FASEB journal 	2015	49
25348128	Glucose	Leproult R	Beneficial impact of sleep extension on fasting insulin sensitivity in adults with habitual sleep restriction.	Sleep	2015	20
25352637	Glucose	Fuster JJ	Noncanonical Wnt signaling promotes obesity-induced adipose tissue inflammation and metabolic dysfunction independent of adipose tissue expansion.	Diabetes	2015	24
25387570	Glucose	Menegazzo L	NETosis is induced by high glucose and associated with type 2 diabetes.	Acta diabetologica	2015	17
25392482	Glucose	van Praag H	Exercise, energy intake, glucose homeostasis, and the brain.	The Journal of neuroscience 	2014	25
25399420	Glucose	Gao Y	The H19/let-7 double-negative feedback loop contributes to glucose metabolism in muscle cells.	Nucleic acids research	2014	42
25408296	Glucose	Sebastiani G	MicroRNA-124a is hyperexpressed in type 2 diabetic human pancreatic islets and negatively regulates insulin secretion.	Acta diabetologica	2015	19
25421524	Glucose	Thorens B	GLUT2, glucose sensing and glucose homeostasis.	Diabetologia	2015	42
25437406	Glucose	Rawlings AM	Diabetes in midlife and cognitive change over 20 years: a cohort study.	Annals of internal medicine	2014	47
25472959	Glucose	Paneni F	Adverse epigenetic signatures by histone methyltransferase Set7 contribute to vascular dysfunction in patients with type 2 diabetes mellitus.	Circulation. Cardiovascular genetics	2015	20
25476696	Glucose	Everard A	Intestinal epithelial MyD88 is a sensor switching host metabolism towards obesity according to nutritional status.	Nature communications	2014	42
25480564	Glucose	Reinert-Hartwall L	Th1/Th17 plasticity is a marker of advanced β cell autoimmunity and impaired glucose tolerance in humans.	Journal of immunology	2015	16
25497096	Glucose	Piccand J	Rfx6 maintains the functional identity of adult pancreatic β cells.	Cell reports	2014	25
25497344	Glucose	Blüher M	From leptin to other adipokines in health and disease: facts and expectations at the beginning of the 21st century.	Metabolism	2015	46
25499872	Glucose	Holmen H	A Mobile Health Intervention for Self-Management and Lifestyle Change for Persons With Type 2 Diabetes, Part 2: One-Year Results From the Norwegian Randomized Controlled Trial RENEWING HEALTH.	JMIR mHealth and uHealth	2014	28
25524916	Glucose	Palmer ND	Genetic Variants Associated With Quantitative Glucose Homeostasis Traits Translate to Type 2 Diabetes in Mexican Americans: The GUARDIAN (Genetics Underlying Diabetes in Hispanics) Consortium.	Diabetes	2015	18
25528528	Glucose	Savarese G	Cardiovascular effects of dipeptidyl peptidase-4 inhibitors in diabetic patients: A meta-analysis.	International journal of cardiology	2015	19
25587098	Glucose	Yan B	lncRNA-MIAT regulates microvascular dysfunction by functioning as a competing endogenous RNA.	Circulation research	2015	65
25637831	Glucose	Satin LS	Pulsatile insulin secretion, impaired glucose tolerance and type 2 diabetes.	Molecular aspects of medicine	2015	19
25668019	Glucose	Valdearcos M	Hypothalamic inflammation in the control of metabolic function.	Annual review of physiology	2015	25
25688211	Glucose	Poher AL	Brown adipose tissue activity as a target for the treatment of obesity/insulin resistance.	Frontiers in physiology	2015	35
25688231	Glucose	Ma X	Control of adipocyte differentiation in different fat depots; implications for pathophysiology or therapy.	Frontiers in endocrinology	2015	17
25695398	Glucose	Jensen TE	PT-1 selectively activates AMPK-γ1 complexes in mouse skeletal muscle, but activates all three γ subunit complexes in cultured human cells by inhibiting the respiratory chain.	The Biochemical journal	2015	15
25703085	Glucose	Francque S	PPARα gene expression correlates with severity and histological treatment response in patients with non-alcoholic steatohepatitis.	Journal of hepatology	2015	24
25726255	Glucose	Higuchi C	Identification of circulating miR-101, miR-375 and miR-802 as biomarkers for type 2 diabetes.	Metabolism	2015	26
25733469	Glucose	van Bussel BC	A healthy diet is associated with less endothelial dysfunction and less low-grade inflammation over a 7-year period in adults at risk of cardiovascular disease.	The Journal of nutrition	2015	16
25787249	Glucose	Puthanveetil P	Long non-coding RNA MALAT1 regulates hyperglycaemia induced inflammatory process in the endothelial cells.	Journal of cellular and molecular medicine	2015	32
25800063	Glucose	Allard C	Mendelian randomization supports causality between maternal hyperglycemia and epigenetic regulation of leptin gene in newborns.	Epigenetics	2015	17
25844899	Glucose	Santulli G	Calcium release channel RyR2 regulates insulin release and glucose homeostasis.	The Journal of clinical investigation	2015	52
25915599	Glucose	Li AH	Analysis of loss-of-function variants and 20 risk factor phenotypes in 8,554 individuals identifies loci influencing chronic disease.	Nature genetics	2015	21
25998289	Glucose	Miller KM	Current state of type 1 diabetes treatment in the U.S.: updated data from the T1D Exchange clinic registry.	Diabetes care	2015	114
26013143	Glucose	Latreille M	miR-375 gene dosage in pancreatic β-cells: implications for regulation of β-cell mass and biomarker development.	Journal of molecular medicine	2015	21
26050668	Glucose	Stanford KI	Exercise Effects on White Adipose Tissue: Beiging and Metabolic Adaptations.	Diabetes	2015	35
26109024	Glucose	NCD Risk Factor Collaboration (NCD-RisC).	Effects of diabetes definition on global surveillance of diabetes prevalence and diagnosis: a pooled analysis of 96 population-based studies with 331,288 participants.	The lancet. Diabetes & endocrinology	2015	18
26112890	Glucose	Fadini GP	Risk of hospitalization for heart failure in patients with type 2 diabetes newly treated with DPP-4 inhibitors or other oral glucose-lowering medications: a retrospective registry study on 127,555 patients from the Nationwide OsMed Health-DB Database.	European heart journal	2015	21
26147760	Glucose	Hanssen MJ	Short-term cold acclimation improves insulin sensitivity in patients with type 2 diabetes mellitus.	Nature medicine	2015	48
26160912	Glucose	Mohlke KL	Recent advances in understanding the genetic architecture of type 2 diabetes.	Human molecular genetics	2015	30
26214150	Glucose	Willette AA	Association of Insulin Resistance With Cerebral Glucose Uptake in Late Middle-Aged Adults at Risk for Alzheimer Disease.	JAMA neurology	2015	36
26241401	Glucose	Mishra M	Epigenetic Modification of Mitochondrial DNA in the Development of Diabetic Retinopathy.	Investigative ophthalmology & visual science	2015	19
26248647	Glucose	Pajvani UB	The new biology of diabetes.	Diabetologia	2015	17
26305874	Glucose	Rosenthal N	Canagliflozin: a sodium glucose co-transporter 2 inhibitor for the treatment of type 2 diabetes mellitus.	Annals of the New York Academy of Sciences	2015	24
26369473	Glucose	Mingrone G	Bariatric-metabolic surgery versus conventional medical treatment in obese patients with type 2 diabetes: 5 year follow-up of an open-label, single-centre, randomised controlled trial.	Lancet	2015	62
26386349	Glucose	Munasinghe PE	Type-2 diabetes increases autophagy in the human heart through promotion of Beclin-1 mediated pathway.	International journal of cardiology	2016	12
26387865	Glucose	Altman BJ	MYC Disrupts the Circadian Clock and Metabolism in Cancer Cells.	Cell metabolism	2015	34
26422395	Glucose	Cao Y	SIRT1 and insulin resistance.	Journal of diabetes and its complications	2016	10
26433941	Glucose	Florath I	Type 2 diabetes and leucocyte DNA methylation: an epigenome-wide association study in over 1,500 older adults.	Diabetologia	2016	20
26445512	Glucose	Kajimura S	Brown and Beige Fat: Physiological Roles beyond Heat Generation.	Cell metabolism	2015	88
26461112	Glucose	Chastin SF	Combined Effects of Time Spent in Physical Activity, Sedentary Behaviors and Sleep on Obesity and Cardio-Metabolic Health Markers: A Novel Compositional Data Analysis Approach.	PloS one	2015	42
26511102	Glucose	Madsbad S	Review of head-to-head comparisons of glucagon-like peptide-1 receptor agonists.	Diabetes, obesity & metabolism	2016	16
26513002	Glucose	Martino J	Maternal Body Weight and Gestational Diabetes Differentially Influence Placental and Pregnancy Outcomes.	The Journal of clinical endocrinology and metabolism	2016	13
26598716	Glucose	Ranger TA	Is there an association between tendinopathy and diabetes mellitus? A systematic review with meta-analysis.	British journal of sports medicine	2016	12
26604280	Glucose	Mudaliar S	Sodium-Glucose Cotransporter Inhibitors: Effects on Renal and Intestinal Glucose Transport: From Bench to Bedside.	Diabetes care	2015	25
26624892	Glucose	van de Bunt M	Transcript Expression Data from Human Islets Links Regulatory Signals from Genome-Wide Association Studies for Type 2 Diabetes and Glycemic Traits to Their Downstream Effectors.	PLoS genetics	2015	31
26643952	Glucose	Soriano-Tárraga C	Epigenome-wide association study identifies TXNIP gene associated with type 2 diabetes mellitus and sustained hyperglycemia.	Human molecular genetics	2016	17
26662838	Glucose	Terauchi Y	New insulin glargine 300 U/ml versus glargine 100 U/ml in Japanese people with type 2 diabetes using basal insulin and oral antihyperglycaemic drugs: glucose control and hypoglycaemia in a randomized controlled trial (EDITION JP 2).	Diabetes, obesity & metabolism	2016	13
26718499	Glucose	Hanssen MJ	Short-term Cold Acclimation Recruits Brown Adipose Tissue in Obese Humans.	Diabetes	2016	20
26718502	Glucose	Long M	An Essential Role of NRF2 in Diabetic Wound Healing.	Diabetes	2016	14
26727229	Glucose	Samuel VT	The pathogenesis of insulin resistance: integrating signaling pathways and substrate flux.	The Journal of clinical investigation	2016	78
26740601	Glucose	Stamateris RE	Glucose Induces Mouse β-Cell Proliferation via IRS2, MTOR, and Cyclin D2 but Not the Insulin Receptor.	Diabetes	2016	12
26740634	Glucose	Tauschmann M	Day-and-Night Hybrid Closed-Loop Insulin Delivery in Adolescents With Type 1 Diabetes: A Free-Living, Randomized Clinical Trial.	Diabetes care	2016	18
26742071	Glucose	Kim Y	Polyphenols and Glycemic Control.	Nutrients	2016	19
26743041	Glucose	Akhtar MW	Elevated glucose and oligomeric β-amyloid disrupt synapses via a common pathway of aberrant protein S-nitrosylation.	Nature communications	2016	15
26743209	Glucose	An H	Current understanding of metformin effect on the control of hyperglycemia in diabetes.	The Journal of endocrinology	2016	14
26801191	Glucose	Patching SG	Glucose Transporters at the Blood-Brain Barrier: Function, Regulation and Gateways for Drug Delivery.	Molecular neurobiology	2017	7
26814590	Glucose	Krashes MJ	Melanocortin-4 receptor-regulated energy homeostasis.	Nature neuroscience	2016	26
26907513	Glucose	Choudhary P	Hypoglycemia Prevention and User Acceptance of an Insulin Pump System with Predictive Low Glucose Management.	Diabetes technology & therapeutics	2016	19
26912151	Glucose	Kim SH	Brown Fat and Browning for the Treatment of Obesity and Related Metabolic Disorders.	Diabetes & metabolism journal	2016	20
26919392	Glucose	Klemann C	Cut to the chase: a review of CD26/dipeptidyl peptidase-4's (DPP4) entanglement in the immune system.	Clinical and experimental immunology	2016	12
26942205	Glucose	Jia Y	miRNAs in Urine Extracellular Vesicles as Predictors of Early-Stage Diabetic Nephropathy.	Journal of diabetes research	2016	15
26947067	Glucose	Kung CP	The P72R Polymorphism of p53 Predisposes to Obesity and Metabolic Dysfunction.	Cell reports	2016	18
26950362	Glucose	Helman A	p16(Ink4a)-induced senescence of pancreatic beta cells enhances insulin secretion.	Nature medicine	2016	30
26972823	Glucose	Lee P	Brown Adipose Tissue Exhibits a Glucose-Responsive Thermogenic Biorhythm in Humans.	Cell metabolism	2016	15
26977395	Glucose	Ackermann AM	Integration of ATAC-seq and RNA-seq identifies human alpha cell and beta cell signature genes.	Molecular metabolism	2016	21
26993047	Glucose	Wang ZV	Adiponectin, the past two decades.	Journal of molecular cell biology	2016	18
27002059	Glucose	Steven S	Very Low-Calorie Diet and 6 Months of Weight Stability in Type 2 Diabetes: Pathophysiological Changes in Responders and Nonresponders.	Diabetes care	2016	12
27027351	Glucose	D'Esposito V	Adipose microenvironment promotes triple negative breast cancer cell invasiveness and dissemination by producing CCL5.	Oncotarget	2016	12
27034277	Glucose	Riehle C	Insulin Signaling and Heart Failure.	Circulation research	2016	19
27063289	Glucose	Saxena P	A programmable synthetic lineage-control network that differentiates human IPSCs into glucose-sensitive insulin-secreting beta-like cells.	Nature communications	2016	10
27064285	Glucose	Dai C	Stress-impaired transcription factor expression and insulin secretion in transplanted human islets.	The Journal of clinical investigation	2016	10
27073002	Glucose	Rayanagoudar G	Quantification of the type 2 diabetes risk in women with gestational diabetes: a systematic review and meta-analysis of 95,750 women.	Diabetologia	2016	12
27075628	Glucose	Ribas V	Skeletal muscle action of estrogen receptor α is critical for the maintenance of mitochondrial function and metabolic homeostasis in females.	Science translational medicine	2016	15
27076077	Glucose	Yoshihara E	ERRγ Is Required for the Metabolic Maturation of Therapeutically Functional Glucose-Responsive β Cells.	Cell metabolism	2016	14
27099265	Glucose	Willeit P	Liver microRNAs: potential mediators and biomarkers for metabolic and cardiovascular disease?	European heart journal	2016	11
27159554	Glucose	Wong TY	Diabetic retinopathy.	Nature reviews. Disease primers	2016	21
27162351	Glucose	Chen Z	Epigenomic profiling reveals an association between persistence of DNA methylation and metabolic memory in the DCCT/EDIC type 1 diabetes cohort.	Proceedings of the National Academy of Sciences of the United States of America	2016	14
27185156	Glucose	Tuomi T	Increased Melatonin Signaling Is a Risk Factor for Type 2 Diabetes.	Cell metabolism	2016	20
27188262	Glucose	Gómez-Ambrosi J	FGF19 and FGF21 serum concentrations in human obesity and type 2 diabetes behave differently after diet- or surgically-induced weight loss.	Clinical nutrition	2017	6
27199291	Glucose	López M	Hypothalamic AMPK: a canonical regulator of whole-body energy balance.	Nature reviews. Endocrinology	2016	15
27214060	Glucose	Fonseca VA	CONTINUOUS GLUCOSE MONITORING: A CONSENSUS CONFERENCE OF THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY.	Endocrine practice 	2016	18
27245224	Glucose	Peiró C	Inflammation, glucose, and vascular cell damage: the role of the pentose phosphate pathway.	Cardiovascular diabetology	2016	11
27256476	Glucose	Kusminski CM	Targeting adipose tissue in the treatment of obesity-associated diabetes.	Nature reviews. Drug discovery	2016	29
27273792	Glucose	McCoy RG	Intensive Treatment and Severe Hypoglycemia Among Adults With Type 2 Diabetes.	JAMA internal medicine	2016	18
27286737	Glucose	Hsiao TJ	A common rs7903146 variant of the transcription factor 7-like 2 gene is associated with type 2 diabetes mellitus and fasting glucose in a Taiwanese population.	Diabetes & metabolism	2017	8
27330126	Glucose	Maahs DM	Outcome Measures for Artificial Pancreas Clinical Trials: A Consensus Report.	Diabetes care	2016	19
27347932	Glucose	Laganà AS	Pleiotropic Actions of Peroxisome Proliferator-Activated Receptors (PPARs) in Dysregulated Metabolic Homeostasis, Inflammation and Cancer: Current Evidence and Future Perspectives.	International journal of molecular sciences	2016	12
27364997	Glucose	Thabit H	Coming of age: the artificial pancreas for type 1 diabetes.	Diabetologia	2016	26
27398620	Glucose	Bader E	Identification of proliferative and mature β-cells in the islets of Langerhans.	Nature	2016	41
27399229	Glucose	Dorrell C	Human islets contain four distinct subtypes of β cells.	Nature communications	2016	39
27473078	Glucose	Polak K	New markers of insulin resistance in polycystic ovary syndrome.	Journal of endocrinological investigation	2017	6
27544896	Glucose	Kishi S	Association of Insulin Resistance and Glycemic Metabolic Abnormalities With LV Structure and Function in Middle Age: The CARDIA Study.	JACC. Cardiovascular imaging	2017	9
27616452	Glucose	Villarroya F	Brown adipose tissue as a secretory organ.	Nature reviews. Endocrinology	2017	21
27636730	Glucose	Gross B	PPARs in obesity-induced T2DM, dyslipidaemia and NAFLD.	Nature reviews. Endocrinology	2017	26
27709762	Glucose	Heise T	Pharmacological properties of faster-acting insulin aspart vs insulin aspart in patients with type 1 diabetes receiving continuous subcutaneous insulin infusion: A randomized, double-blind, crossover trial.	Diabetes, obesity & metabolism	2017	5
27739515	Glucose	Sylow L	Exercise-stimulated glucose uptake - regulation and implications for glycaemic control.	Nature reviews. Endocrinology	2017	10
27745828	Glucose	Rehman MB	Efficacy and safety of DPP-4 inhibitors in patients with type 2 diabetes: Meta-analysis of placebo-controlled randomized clinical trials.	Diabetes & metabolism	2017	5
27761984	Glucose	Wu T	Metformin reduces the rate of small intestinal glucose absorption in type 2 diabetes.	Diabetes, obesity & metabolism	2017	5
27796346	Glucose	Li X	lncRNA H19/miR-675 axis regulates cardiomyocyte apoptosis by targeting VDAC1 in diabetic cardiomyopathy.	Scientific reports	2016	11
27797909	Glucose	Kjøbsted R	Enhanced Muscle Insulin Sensitivity After Contraction/Exercise Is Mediated by AMPK.	Diabetes	2017	7
27860160	Glucose	Mokhlesi B	Effect of one week of CPAP treatment of obstructive sleep apnoea on 24-hour profiles of glucose, insulin and counter-regulatory hormones in type 2 diabetes.	Diabetes, obesity & metabolism	2017	8
27878566	Glucose	Heise T	Pharmacokinetic and Pharmacodynamic Properties of Faster-Acting Insulin Aspart versus Insulin Aspart Across a Clinically Relevant Dose Range in Subjects with Type 1 Diabetes Mellitus.	Clinical pharmacokinetics	2017	6
27928162	Glucose	Hashimoto N	Role of miRNAs in the pathogenesis and susceptibility of diabetes mellitus.	Journal of human genetics	2017	6
27935822	Glucose	Luo L	Adipose tissue in control of metabolism.	The Journal of endocrinology	2016	16
27941935	Glucose	DeFronzo RA	Renal, metabolic and cardiovascular considerations of SGLT2 inhibition.	Nature reviews. Nephrology	2017	8
27964927	Glucose	Li X	Long noncoding RNA MALAT1 regulates renal tubular epithelial pyroptosis by modulated miR-23c targeting of ELAVL1 in diabetic nephropathy.	Experimental cell research	2017	5
27982707	Glucose	Kovatchev B	Feasibility of Long-Term Closed-Loop Control: A Multicenter 6-Month Trial of 24/7 Automated Insulin Delivery.	Diabetes technology & therapeutics	2017	10
28007348	Glucose	El-Khatib FH	Home use of a bihormonal bionic pancreas versus insulin pump therapy in adults with type 1 diabetes: a multicentre randomised crossover trial.	Lancet	2017	10
28011087	Glucose	Mansueto G	Transcription Factor EB Controls Metabolic Flexibility during Exercise.	Cell metabolism	2017	17
28039838	Glucose	Gómez-Sámano MÁ	Fibroblast growth factor 21 and its novel association with oxidative stress.	Redox biology	2017	7
28041957	Glucose	Akerman I	Human Pancreatic β Cell lncRNAs Control Cell-Specific Regulatory Networks.	Cell metabolism	2017	11
28065883	Glucose	Rawal S	Down-regulation of proangiogenic microRNA-126 and microRNA-132 are early modulators of diabetic cardiac microangiopathy.	Cardiovascular research	2017	7
28093853	Glucose	Goldenberg R	Randomized clinical trial comparing the efficacy and safety of treatment with the once-weekly dipeptidyl peptidase-4 (DPP-4) inhibitor omarigliptin or the once-daily DPP-4 inhibitor sitagliptin in patients with type 2 diabetes inadequately controlled on metformin monotherapy.	Diabetes, obesity & metabolism	2017	5
28120497	Glucose	Neal B	Rationale, design and baseline characteristics of the CANagliflozin cardioVascular Assessment Study-Renal (CANVAS-R): A randomized, placebo-controlled trial.	Diabetes, obesity & metabolism	2017	12
28126459	Glucose	Riddell MC	Exercise management in type 1 diabetes: a consensus statement.	The lancet. Diabetes & endocrinology	2017	13
28134564	Glucose	Garg SK	Glucose Outcomes with the In-Home Use of a Hybrid Closed-Loop Insulin Delivery System in Adolescents and Adults with Type 1 Diabetes.	Diabetes technology & therapeutics	2017	21
28211512	Glucose	Perakakis N	Physiology and role of irisin in glucose homeostasis.	Nature reviews. Endocrinology	2017	10
28237263	Glucose	le Roux CW	3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial.	Lancet	2017	12
28244644	Glucose	Neal B	Optimizing the analysis strategy for the CANVAS Program: A prespecified plan for the integrated analyses of the CANVAS and CANVAS-R trials.	Diabetes, obesity & metabolism	2017	12
28314735	Glucose	Adams LA	Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases.	Gut	2017	12
28356319	Glucose	Russell-Jones D	Fast-Acting Insulin Aspart Improves Glycemic Control in Basal-Bolus Treatment for Type 1 Diabetes: Results of a 26-Week Multicenter, Active-Controlled, Treat-to-Target, Randomized, Parallel-Group Trial (onset 1).	Diabetes care	2017	9
28436964	Glucose	Zhang Y	SWELL1 is a regulator of adipocyte size, insulin signalling and glucose homeostasis.	Nature cell biology	2017	6
28462931	Glucose	Hasel P	Neurons and neuronal activity control gene expression in astrocytes to regulate their development and metabolism.	Nature communications	2017	9
28559417	Glucose	Kleinberger G	The FTD-like syndrome causing TREM2 T66M mutation impairs microglia function, brain perfusion, and glucose metabolism.	The EMBO journal	2017	6
28846098	Glucose	Emmerson PJ	The metabolic effects of GDF15 are mediated by the orphan receptor GFRAL.	Nature medicine	2017	12
11466099	Ethanol	Pradhan AD	C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus.	JAMA	2001	749
12395331	Ethanol	Hassan MM	Risk factors for hepatocellular carcinoma: synergism of alcohol with viral hepatitis and diabetes mellitus.	Hepatology	2002	143
12547549	Ethanol	Spranger J	Adiponectin and protection against type 2 diabetes mellitus.	Lancet	2003	167
12881453	Ethanol	Lee DH	Gamma-glutamyltransferase is a predictor of incident diabetes and hypertension: the Coronary Artery Risk Development in Young Adults (CARDIA) Study.	Clinical chemistry	2003	77
15082700	Ethanol	Pischon T	Plasma adiponectin levels and risk of myocardial infarction in men.	JAMA	2004	314
15113816	Ethanol	Meigs JB	Biomarkers of endothelial dysfunction and risk of type 2 diabetes mellitus.	JAMA	2004	142
15364185	Ethanol	Yusuf S	Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study.	Lancet	2004	1464
15447916	Ethanol	Lopez-Garcia E	Major dietary patterns are related to plasma concentrations of markers of inflammation and endothelial dysfunction.	The American journal of clinical nutrition	2004	151
15827312	Ethanol	Shlipak MG	Cardiovascular mortality risk in chronic kidney disease: comparison of traditional and novel risk factors.	JAMA	2005	162
15911795	Ethanol	Enzinger C	Risk factors for progression of brain atrophy in aging: six-year follow-up of normal subjects.	Neurology	2005	80
16723443	Ethanol	Wong TY	Retinal vascular caliber, cardiovascular risk factors, and inflammation: the multi-ethnic study of atherosclerosis (MESA).	Investigative ophthalmology & visual science	2006	100
17127183	Ethanol	Shaffer EA	Gallstone disease: Epidemiology of gallbladder stone disease.	Best practice & research. Clinical gastroenterology	2006	94
17227980	Ethanol	Joshi P	Risk factors for early myocardial infarction in South Asians compared with individuals in other countries.	JAMA	2007	162
17466744	Ethanol	Witt H	Chronic pancreatitis: challenges and advances in pathogenesis, genetics, diagnosis, and therapy.	Gastroenterology	2007	95
17728149	Ethanol	Adams LA	Nonalcoholic fatty liver disease.	Annals of epidemiology	2007	70
18003755	Ethanol	Hyppönen E	25-hydroxyvitamin D, IGF-1, and metabolic syndrome at 45 years of age: a cross-sectional study in the 1958 British Birth Cohort.	Diabetes	2008	93
18703981	Ethanol	Purnell C	Cardiovascular risk factors and incident Alzheimer disease: a systematic review of the literature.	Alzheimer disease and associated disorders	2009	47
19802349	Ethanol	Finkelstein J	Chronic obstructive pulmonary disease as an independent risk factor for cardiovascular morbidity.	International journal of chronic obstructive pulmonary disease	2009	48
20097779	Ethanol	Bertoni AG	Inflammation and the incidence of type 2 diabetes: the Multi-Ethnic Study of Atherosclerosis (MESA).	Diabetes care	2010	51
20561675	Ethanol	O'Donnell MJ	Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study.	Lancet	2010	439
20569726	Ethanol	Soliman EZ	Chronic kidney disease and prevalent atrial fibrillation: the Chronic Renal Insufficiency Cohort (CRIC).	American heart journal	2010	51
21091952	Ethanol	Kalaria RN	Vascular basis for brain degeneration: faltering controls and risk factors for dementia.	Nutrition reviews	2010	60
21397320	Ethanol	Braganza JM	Chronic pancreatitis.	Lancet	2011	93
23364087	Ethanol	Gómez-Olivé FX	Self-reported health and health care use in an ageing population in the Agincourt sub-district of rural South Africa.	Global health action	2013	27
23919770	Ethanol	Jiang T	Epidemiology and etiology of Alzheimer's disease: from genetic to non-genetic factors.	Current Alzheimer research	2013	27
24382882	Ethanol	Chen CH	Targeting aldehyde dehydrogenase 2: new therapeutic opportunities.	Physiological reviews	2014	62
25390655	Ethanol	Willeit P	Leucocyte telomere length and risk of type 2 diabetes mellitus: new prospective cohort study and literature-based meta-analysis.	PloS one	2014	29
25672924	Ethanol	Wang R	Effects of vascular risk factors and APOE ε4 on white matter integrity and cognitive decline.	Neurology	2015	20
25880521	Ethanol	Alexander BT	Fetal programming and cardiovascular pathology.	Comprehensive Physiology	2015	17
25886472	Ethanol	Stanifer JW	The epidemiology of chronic kidney disease in Northern Tanzania: a population-based survey.	PloS one	2015	19
25886648	Ethanol	Dare S	Relationship between smoking and obesity: a cross-sectional study of 499,504 middle-aged adults in the UK general population.	PloS one	2015	17
27431356	Ethanol	O'Donnell MJ	Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study.	Lancet	2016	48
28467924	Ethanol	Søberg S	FGF21 Is a Sugar-Induced Hormone Associated with Sweet Intake and Preference in Humans.	Cell metabolism	2017	9
10458613	Zinc	Bell AC	The protein CTCF is required for the enhancer blocking activity of vertebrate insulators.	Cell	1999	357
17293876	Zinc	Sladek R	A genome-wide association study identifies novel risk loci for type 2 diabetes.	Nature	2007	901
17928989	Zinc	Horikoshi M	Variations in the HHEX gene are associated with increased risk of type 2 diabetes in the Japanese population.	Diabetologia	2007	63
17942684	Zinc	Wenzlau JM	The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes.	Proceedings of the National Academy of Sciences of the United States of America	2007	237
18622393	Zinc	Mackay DJ	Hypomethylation of multiple imprinted loci in individuals with transient neonatal diabetes is associated with mutations in ZFP57.	Nature genetics	2008	126
19400752	Zinc	Lichten LA	Mammalian zinc transporters: nutritional and physiologic regulation.	Annual review of nutrition	2009	170
19442898	Zinc	Jansen J	Zinc and diabetes--clinical links and molecular mechanisms.	The Journal of nutritional biochemistry	2009	47
19566488	Zinc	Niu J	Role of MCP-1 in cardiovascular disease: molecular mechanisms and clinical implications.	Clinical science	2009	46
21067382	Zinc	Knip M	Dietary intervention in infancy and later signs of beta-cell autoimmunity.	The New England journal of medicine	2010	61
21599891	Zinc	Thirumoorthy N	A review of metallothionein isoforms and their role in pathophysiology.	World journal of surgical oncology	2011	39
22223213	Zinc	Kolattukudy PE	Inflammation, endoplasmic reticulum stress, autophagy, and the monocyte chemoattractant protein-1/CCR2 pathway.	Circulation research	2012	54
22332039	Zinc	Kelleher SL	Zinc in specialized secretory tissues: roles in the pancreas, prostate, and mammary gland.	Advances in nutrition	2011	53
23059534	Zinc	Liu Y	An atomic model of Zfp57 recognition of CpG methylation within a specific DNA sequence.	Genes & development	2012	44
23248199	Zinc	Hawa MI	Adult-onset autoimmune diabetes in Europe is prevalent with a broad clinical phenotype: Action LADA 7.	Diabetes care	2013	31
24315485	Zinc	Hu L	Crystal structure of TET2-DNA complex: insight into TET-mediated 5mC oxidation.	Cell	2013	71
24603074	Zinc	Kong SM	Parkinson's disease-linked human PARK9/ATP13A2 maintains zinc homeostasis and promotes α-Synuclein externalization via exosomes.	Human molecular genetics	2014	48
25126789	Zinc	Deng W	Reactivation of developmentally silenced globin genes by forced chromatin looping.	Cell	2014	82
25855295	Zinc	Tanabe H	Crystal structures of the human adiponectin receptors.	Nature	2015	24
26025256	Zinc	Strogantsev R	Allele-specific binding of ZFP57 in the epigenetic regulation of imprinted and non-imprinted monoallelic expression.	Genome biology	2015	22
26840484	Zinc	Davies B	Re-engineering the zinc fingers of PRDM9 reverses hybrid sterility in mice.	Nature	2016	29
27083996	Zinc	Ghirlando R	CTCF: making the right connections.	Genes & development	2016	39
27274087	Zinc	Taylor KM	Zinc transporter ZIP10 forms a heteromer with ZIP6 which regulates embryonic development and cell migration.	The Biochemical journal	2016	13
10573511	Iron	Angulo P	Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis.	Hepatology	1999	237
10756000	Iron	Ribes JA	Zygomycetes in human disease.	Clinical microbiology reviews	2000	214
11175786	Iron	Puccio H	Mouse models for Friedreich ataxia exhibit cardiomyopathy, sensory nerve defect and Fe-S enzyme deficiency followed by intramitochondrial iron deposits.	Nature genetics	2001	159
11812557	Iron	Beutler E	Penetrance of 845G--> A (C282Y) HFE hereditary haemochromatosis mutation in the USA.	Lancet	2002	119
12809815	Iron	Clark JM	The prevalence and etiology of elevated aminotransferase levels in the United States.	The American journal of gastroenterology	2003	274
14647275	Iron	Papanikolaou G	Mutations in HFE2 cause iron overload in chromosome 1q-linked juvenile hemochromatosis.	Nature genetics	2004	207
14871914	Iron	Jiang R	Body iron stores in relation to risk of type 2 diabetes in apparently healthy women.	JAMA	2004	102
15625418	Iron	Hill ID	Guideline for the diagnosis and treatment of celiac disease in children: recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition.	Journal of pediatric gastroenterology and nutrition	2005	145
15858186	Iron	Adams PC	Hemochromatosis and iron-overload screening in a racially diverse population.	The New England journal of medicine	2005	136
16952548	Iron	Bekri S	Increased adipose tissue expression of hepcidin in severe obesity is independent from diabetes and NASH.	Gastroenterology	2006	92
17721544	Iron	Tanno T	High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin.	Nature medicine	2007	193
17891154	Iron	Hierro A	Functional architecture of the retromer cargo-recognition complex.	Nature	2007	85
18511687	Iron	Shi H	A cytosolic iron chaperone that delivers iron to ferritin.	Science	2008	105
19414861	Iron	Tanno T	Identification of TWSG1 as a second novel erythroid regulator of hepcidin expression in murine and human cells.	Blood	2009	109
20053755	Iron	Sasu BJ	Antihepcidin antibody treatment modulates iron metabolism and is effective in a mouse model of inflammation-induced anemia.	Blood	2010	68
20156111	Iron	Santos R	Friedreich ataxia: molecular mechanisms, redox considerations, and therapeutic opportunities.	Antioxidants & redox signaling	2010	51
20484814	Iron	Liu M	The endothelial cell receptor GRP78 is required for mucormycosis pathogenesis in diabetic mice.	The Journal of clinical investigation	2010	42
20542038	Iron	Pietrangelo A	Hereditary hemochromatosis: pathogenesis, diagnosis, and treatment.	Gastroenterology	2010	87
20858683	Iron	Soranzo N	Common variants at 10 genomic loci influence hemoglobin A₁(C) levels via glycemic and nonglycemic pathways.	Diabetes	2010	130
21718726	Iron	Dongiovanni P	Iron in fatty liver and in the metabolic syndrome: a promising therapeutic target.	Journal of hepatology	2011	61
22055506	Iron	Nandal A	Activation of the HIF prolyl hydroxylase by the iron chaperones PCBP1 and PCBP2.	Cell metabolism	2011	43
22306201	Iron	Poulsen HE	RNA modifications by oxidation: a novel disease mechanism?	Free radical biology & medicine	2012	39
22327295	Iron	Noinaj N	Structural basis for iron piracy by pathogenic Neisseria.	Nature	2012	58
22996660	Iron	Gabrielsen JS	Adipocyte iron regulates adiponectin and insulin sensitivity.	The Journal of clinical investigation	2012	50
24705334	Iron	Perdomini M	Prevention and reversal of severe mitochondrial cardiomyopathy by gene therapy in a mouse model of Friedreich's ataxia.	Nature medicine	2014	32
24843120	Iron	Frey AG	Iron chaperones PCBP1 and PCBP2 mediate the metallation of the dinuclear iron enzyme deoxyhypusine hydroxylase.	Proceedings of the National Academy of Sciences of the United States of America	2014	24
25448035	Iron	Tamir S	Structure-function analysis of NEET proteins uncovers their role as key regulators of iron and ROS homeostasis in health and disease.	Biochimica et biophysica acta	2015	23
28060743	Iron	González N	2017 update on the relationship between diabetes and colorectal cancer: epidemiology, potential molecular mechanisms and therapeutic implications.	Oncotarget	2017	5
12223530	Adenosine Diphosphate	Virág L	The therapeutic potential of poly(ADP-ribose) polymerase inhibitors.	Pharmacological reviews	2002	280
12440774	Adenosine Diphosphate	Hassa PO	The functional role of poly(ADP-ribose)polymerase 1 as novel coactivator of NF-kappaB in inflammatory disorders.	Cellular and molecular life sciences 	2002	100
12960015	Adenosine Diphosphate	Hardie DG	Minireview: the AMP-activated protein kinase cascade: the key sensor of cellular energy status.	Endocrinology	2003	219
18678616	Adenosine Diphosphate	Phielix E	Lower intrinsic ADP-stimulated mitochondrial respiration underlies in vivo mitochondrial dysfunction in muscle of male type 2 diabetic patients.	Diabetes	2008	68
19220204	Adenosine Diphosphate	Vanhoutte PM	Endothelial dysfunction and vascular disease.	Acta physiologica	2009	134
20011104	Adenosine Diphosphate	Richards JB	A genome-wide association study reveals variants in ARL15 that influence adiponectin levels.	PLoS genetics	2009	62
21803289	Adenosine Diphosphate	Birkenfeld AL	Deletion of the mammalian INDY homolog mimics aspects of dietary restriction and protects against adiposity and insulin resistance in mice.	Cell metabolism	2011	54
21912398	Adenosine Diphosphate	Szendroedi J	The role of mitochondria in insulin resistance and type 2 diabetes mellitus.	Nature reviews. Endocrinology	2011	107
23747347	Adenosine Diphosphate	Russo GL	AMP-activated protein kinase: a target for old drugs against diabetes and cancer.	Biochemical pharmacology	2013	35
26112889	Adenosine Diphosphate	Winnik S	Protective effects of sirtuins in cardiovascular diseases: from bench to bedside.	European heart journal	2015	42
10204114	Adenosine Triphosphate	Aguilar-Bryan L	Molecular biology of adenosine triphosphate-sensitive potassium channels.	Endocrine reviews	1999	151
10346816	Adenosine Triphosphate	Paull TT	Nbs1 potentiates ATP-driven DNA unwinding and endonuclease cleavage by the Mre11/Rad50 complex.	Genes & development	1999	172
10868964	Adenosine Triphosphate	Hohmeier HE	Isolation of INS-1-derived cell lines with robust ATP-sensitive K+ channel-dependent and -independent glucose-stimulated insulin secretion.	Diabetes	2000	299
12469359	Adenosine Triphosphate	Straub SG	Glucose-stimulated signaling pathways in biphasic insulin secretion.	Diabetes/metabolism research and reviews	2002	86
12540637	Adenosine Triphosphate	Gloyn AL	Large-scale association studies of variants in genes encoding the pancreatic beta-cell KATP channel subunits Kir6.2 (KCNJ11) and SUR1 (ABCC8) confirm that the KCNJ11 E23K variant is associated with type 2 diabetes.	Diabetes	2003	165
12717402	Adenosine Triphosphate	Neuschwander-Tetri BA	Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference.	Hepatology	2003	371
12808136	Adenosine Triphosphate	Stump CS	Effect of insulin on human skeletal muscle mitochondrial ATP production, protein synthesis, and mRNA transcripts.	Proceedings of the National Academy of Sciences of the United States of America	2003	106
14749273	Adenosine Triphosphate	Duchen MR	Roles of mitochondria in health and disease.	Diabetes	2004	75
15109305	Adenosine Triphosphate	Praskova M	Regulation of the MST1 kinase by autophosphorylation, by the growth inhibitory proteins, RASSF1 and NORE1, and by Ras.	The Biochemical journal	2004	114
15115830	Adenosine Triphosphate	Gloyn AL	Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes.	The New England journal of medicine	2004	248
15375023	Adenosine Triphosphate	Huss JM	Nuclear receptor signaling and cardiac energetics.	Circulation research	2004	111
15559249	Adenosine Triphosphate	Meijer L	Pharmacological inhibitors of glycogen synthase kinase 3.	Trends in pharmacological sciences	2004	136
15883415	Adenosine Triphosphate	Nair KS	Aging muscle.	The American journal of clinical nutrition	2005	89
16123337	Adenosine Triphosphate	Hattersley AT	Activating mutations in Kir6.2 and neonatal diabetes: new clinical syndromes, new scientific insights, and new therapy.	Diabetes	2005	95
16169595	Adenosine Triphosphate	Inoue K	The function of microglia through purinergic receptors: neuropathic pain and cytokine release.	Pharmacology & therapeutics	2006	81
16246006	Adenosine Triphosphate	Brand MD	The efficiency and plasticity of mitochondrial energy transduction.	Biochemical Society transactions	2005	87
16556766	Adenosine Triphosphate	Wiederkehr A	Minireview: implication of mitochondria in insulin secretion and action.	Endocrinology	2006	70
17446535	Adenosine Triphosphate	Flanagan SE	Mutations in ATP-sensitive K+ channel genes cause transient neonatal diabetes and permanent diabetes in childhood or adulthood.	Diabetes	2007	76
18025408	Adenosine Triphosphate	Rafiq M	Effective treatment with oral sulfonylureas in patients with diabetes due to sulfonylurea receptor 1 (SUR1) mutations.	Diabetes care	2008	54
18048761	Adenosine Triphosphate	Ferdinandy P	Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning.	Pharmacological reviews	2007	157
18162506	Adenosine Triphosphate	Edghill EL	Insulin mutation screening in 1,044 patients with diabetes: mutations in the INS gene are a common cause of neonatal diabetes but a rare cause of diabetes diagnosed in childhood or adulthood.	Diabetes	2008	84
18285554	Adenosine Triphosphate	Nair KS	Asian Indians have enhanced skeletal muscle mitochondrial capacity to produce ATP in association with severe insulin resistance.	Diabetes	2008	60
18301398	Adenosine Triphosphate	Murphy R	Clinical implications of a molecular genetic classification of monogenic beta-cell diabetes.	Nature clinical practice. Endocrinology & metabolism	2008	95
18521185	Adenosine Triphosphate	Chen WM	Variations in the G6PC2/ABCB11 genomic region are associated with fasting glucose levels.	The Journal of clinical investigation	2008	75
18716044	Adenosine Triphosphate	Lanza IR	Endurance exercise as a countermeasure for aging.	Diabetes	2008	148
18767144	Adenosine Triphosphate	Flanagan SE	Update of mutations in the genes encoding the pancreatic beta-cell K(ATP) channel subunits Kir6.2 (KCNJ11) and sulfonylurea receptor 1 (ABCC8) in diabetes mellitus and hyperinsulinism.	Human mutation	2009	71
19158351	Adenosine Triphosphate	Cirillo P	Ketohexokinase-dependent metabolism of fructose induces proinflammatory mediators in proximal tubular cells.	Journal of the American Society of Nephrology 	2009	59
19778642	Adenosine Triphosphate	Fogarty S	Development of protein kinase activators: AMPK as a target in metabolic disorders and cancer.	Biochimica et biophysica acta	2010	100
19805629	Adenosine Triphosphate	Lamkanfi M	Glyburide inhibits the Cryopyrin/Nalp3 inflammasome.	The Journal of cell biology	2009	176
19833885	Adenosine Triphosphate	Karakelides H	Age, obesity, and sex effects on insulin sensitivity and skeletal muscle mitochondrial function.	Diabetes	2010	68
19887595	Adenosine Triphosphate	Costford SR	Skeletal muscle NAMPT is induced by exercise in humans.	American journal of physiology. Endocrinology and metabolism	2010	49
19900593	Adenosine Triphosphate	Bogoyevitch MA	c-Jun N-terminal kinase (JNK) signaling: recent advances and challenges.	Biochimica et biophysica acta	2010	69
20032281	Adenosine Triphosphate	Hernández-Alvarez MI	Subjects with early-onset type 2 diabetes show defective activation of the skeletal muscle PGC-1{alpha}/Mitofusin-2 regulatory pathway in response to physical activity.	Diabetes care	2010	48
20081827	Adenosine Triphosphate	Berndt A	The p110 delta structure: mechanisms for selectivity and potency of new PI(3)K inhibitors.	Nature chemical biology	2010	44
20386866	Adenosine Triphosphate	Ost A	Attenuated mTOR signaling and enhanced autophagy in adipocytes from obese patients with type 2 diabetes.	Molecular medicine	2010	65
21196229	Adenosine Triphosphate	Richard D	Brown fat biology and thermogenesis.	Frontiers in bioscience	2011	60
21216854	Adenosine Triphosphate	Schmid AI	Liver ATP synthesis is lower and relates to insulin sensitivity in patients with type 2 diabetes.	Diabetes care	2011	39
21265739	Adenosine Triphosphate	Hardie DG	AMP-activated protein kinase: a cellular energy sensor with a key role in metabolic disorders and in cancer.	Biochemical Society transactions	2011	41
21620960	Adenosine Triphosphate	Hers I	Akt signalling in health and disease.	Cellular signalling	2011	223
21690355	Adenosine Triphosphate	Forsyth AM	Multiscale approach to link red blood cell dynamics, shear viscosity, and ATP release.	Proceedings of the National Academy of Sciences of the United States of America	2011	38
22110477	Adenosine Triphosphate	Ma ZA	Mitochondrial dysfunction and β-cell failure in type 2 diabetes mellitus.	Experimental diabetes research	2012	43
22179786	Adenosine Triphosphate	Gupta S	Mechanism of mismatch recognition revealed by human MutSβ bound to unpaired DNA loops.	Nature structural & molecular biology	2011	50
22948162	Adenosine Triphosphate	Juliana C	Non-transcriptional priming and deubiquitination regulate NLRP3 inflammasome activation.	The Journal of biological chemistry	2012	116
23018146	Adenosine Triphosphate	Huh JY	FNDC5 and irisin in humans: I. Predictors of circulating concentrations in serum and plasma and II. mRNA expression and circulating concentrations in response to weight loss and exercise.	Metabolism	2012	140
23432475	Adenosine Triphosphate	Cheng Z	Mitochondria and metabolic homeostasis.	Antioxidants & redox signaling	2013	34
23434541	Adenosine Triphosphate	Chen K	ATP-P2X4 signaling mediates NLRP3 inflammasome activation: a novel pathway of diabetic nephropathy.	The international journal of biochemistry & cell biology	2013	33
23852728	Adenosine Triphosphate	Betz C	Feature Article: mTOR complex 2-Akt signaling at mitochondria-associated endoplasmic reticulum membranes (MAM) regulates mitochondrial physiology.	Proceedings of the National Academy of Sciences of the United States of America	2013	77
23994581	Adenosine Triphosphate	Rettberg JR	Estrogen: a master regulator of bioenergetic systems in the brain and body.	Frontiers in neuroendocrinology	2014	43
24206664	Adenosine Triphosphate	Morita M	mTORC1 controls mitochondrial activity and biogenesis through 4E-BP-dependent translational regulation.	Cell metabolism	2013	119
24265069	Adenosine Triphosphate	Burnstock G	Purinergic signalling in the urinary tract in health and disease.	Purinergic signalling	2014	29
24332968	Adenosine Triphosphate	Tornovsky-Babeay S	Type 2 diabetes and congenital hyperinsulinism cause DNA double-strand breaks and p53 activity in β cells.	Cell metabolism	2014	32
24338270	Adenosine Triphosphate	Singh P	Insulin receptor (IR) and insulin-like growth factor receptor 1 (IGF-1R) signaling systems: novel treatment strategies for cancer.	Medical oncology	2014	45
24363178	Adenosine Triphosphate	Gray LR	Regulation of pyruvate metabolism and human disease.	Cellular and molecular life sciences 	2014	42
24385509	Adenosine Triphosphate	Westerterp M	ATP-binding cassette transporters, atherosclerosis, and inflammation.	Circulation research	2014	55
24614098	Adenosine Triphosphate	Huh JY	Irisin stimulates muscle growth-related genes and regulates adipocyte differentiation and metabolism in humans.	International journal of obesity	2014	24
24746669	Adenosine Triphosphate	Wang Z	Cyclin B1/Cdk1 coordinates mitochondrial respiration for cell-cycle G2/M progression.	Developmental cell	2014	37
24770881	Adenosine Triphosphate	Nelson PT	ABCC9 gene polymorphism is associated with hippocampal sclerosis of aging pathology.	Acta neuropathologica	2014	23
25475361	Adenosine Triphosphate	Nigam SK	What do drug transporters really do?	Nature reviews. Drug discovery	2015	55
25879284	Adenosine Triphosphate	Goldberg EL	Drivers of age-related inflammation and strategies for healthspan extension.	Immunological reviews	2015	18
26002551	Adenosine Triphosphate	Loubière C	Metformin-induced energy deficiency leads to the inhibition of lipogenesis in prostate cancer cells.	Oncotarget	2015	15
26322680	Adenosine Triphosphate	Doménech E	AMPK and PFKFB3 mediate glycolysis and survival in response to mitophagy during mitotic arrest.	Nature cell biology	2015	29
26323267	Adenosine Triphosphate	Rosenson RS	Dysfunctional HDL and atherosclerotic cardiovascular disease.	Nature reviews. Cardiology	2016	51
26808348	Adenosine Triphosphate	Min SY	Human 'brite/beige' adipocytes develop from capillary networks, and their implantation improves metabolic homeostasis in mice.	Nature medicine	2016	21
26818947	Adenosine Triphosphate	Imamura M	Genome-wide association studies in the Japanese population identify seven novel loci for type 2 diabetes.	Nature communications	2016	13
27350397	Adenosine Triphosphate	Daulatzai MA	Cerebral hypoperfusion and glucose hypometabolism: Key pathophysiological modulators promote neurodegeneration, cognitive impairment, and Alzheimer's disease.	Journal of neuroscience research	2017	14
28437620	Adenosine Triphosphate	Jellinger PS	AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF DYSLIPIDEMIA AND PREVENTION OF CARDIOVASCULAR DISEASE.	Endocrine practice 	2017	14
15111517	Testosterone	Laaksonen DE	Testosterone and sex hormone-binding globulin predict the metabolic syndrome and diabetes in middle-aged men.	Diabetes care	2004	126
15531498	Testosterone	Dhindsa S	Frequent occurrence of hypogonadotropic hypogonadism in type 2 diabetes.	The Journal of clinical endocrinology and metabolism	2004	78
17911176	Testosterone	Laughlin GA	Low serum testosterone and mortality in older men.	The Journal of clinical endocrinology and metabolism	2008	132
18319314	Testosterone	Grossmann M	Low testosterone levels are common and associated with insulin resistance in men with diabetes.	The Journal of clinical endocrinology and metabolism	2008	64
19859074	Testosterone	Zitzmann M	Testosterone deficiency, insulin resistance and the metabolic syndrome.	Nature reviews. Endocrinology	2009	52
21195217	Testosterone	Bredella MA	Determinants of bone mineral density in obese premenopausal women.	Bone	2011	44
21386088	Testosterone	Jones TH	Testosterone replacement in hypogonadal men with type 2 diabetes and/or metabolic syndrome (the TIMES2 study).	Diabetes care	2011	76
21646372	Testosterone	Grossmann M	Low testosterone in men with type 2 diabetes: significance and treatment.	The Journal of clinical endocrinology and metabolism	2011	39
23118429	Testosterone	Groth KA	Clinical review: Klinefelter syndrome--a clinical update.	The Journal of clinical endocrinology and metabolism	2013	39
23425925	Testosterone	Camacho EM	Age-associated changes in hypothalamic-pituitary-testicular function in middle-aged and older men are modified by weight change and lifestyle factors: longitudinal results from the European Male Ageing Study.	European journal of endocrinology	2013	42
24158761	Testosterone	Bachman E	Testosterone induces erythrocytosis via increased erythropoietin and suppressed hepcidin: evidence for a new erythropoietin/hemoglobin set point.	The journals of gerontology. Series A, Biological sciences and medical sciences	2014	32
26055108	Testosterone	Zoch ML	New insights into the biology of osteocalcin.	Bone	2016	14
26262795	Testosterone	Basaria S	Effects of Testosterone Administration for 3 Years on Subclinical Atherosclerosis Progression in Older Men With Low or Low-Normal Testosterone Levels: A Randomized Clinical Trial.	JAMA	2015	19
26865584	Testosterone	Turcu AF	Adrenal-derived 11-oxygenated 19-carbon steroids are the dominant androgens in classic 21-hydroxylase deficiency.	European journal of endocrinology	2016	13
26909800	Testosterone	Antonio L	Low Free Testosterone Is Associated with Hypogonadal Signs and Symptoms in Men with Normal Total Testosterone.	The Journal of clinical endocrinology and metabolism	2016	10
12021247	Aspirin	Hundal RS	Mechanism by which high-dose aspirin improves glucose metabolism in type 2 diabetes.	The Journal of clinical investigation	2002	148
14988310	Aspirin	Pickup JC	Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes.	Diabetes care	2004	224
15677512	Aspirin	Schulze MB	Adiponectin and future coronary heart disease events among men with type 2 diabetes.	Diabetes	2005	69
16612330	Aspirin	Parving HH	Prevalence and risk factors for microalbuminuria in a referred cohort of type II diabetic patients: a global perspective.	Kidney international	2006	71
17546309	Aspirin	Mendis S	The availability and affordability of selected essential medicines for chronic diseases in six low- and middle-income countries.	Bulletin of the World Health Organization	2007	85
17709633	Aspirin	Pou KM	Visceral and subcutaneous adipose tissue volumes are cross-sectionally related to markers of inflammation and oxidative stress: the Framingham Heart Study.	Circulation	2007	205
18256393	Aspirin	Gaede P	Effect of a multifactorial intervention on mortality in type 2 diabetes.	The New England journal of medicine	2008	548
18832751	Aspirin	Shaw JA	Infusion of reconstituted high-density lipoprotein leads to acute changes in human atherosclerotic plaque.	Circulation research	2008	68
23283721	Aspirin	Willeit P	Circulating microRNAs as novel biomarkers for platelet activation.	Circulation research	2013	57
23792451	Aspirin	Ogino S	Discovery of colorectal cancer PIK3CA mutation as potential predictive biomarker: power and promise of molecular pathological epidemiology.	Oncogene	2014	43
24302675	Aspirin	Adappa ND	The bitter taste receptor T2R38 is an independent risk factor for chronic rhinosinusitis requiring sinus surgery.	International forum of allergy & rhinology	2014	36
25742316	Aspirin	Ford RJ	Metformin and salicylate synergistically activate liver AMPK, inhibit lipogenesis and improve insulin sensitivity.	The Biochemical journal	2015	19
15814832	Parathyroid Hormone	Slinin Y	Calcium, phosphorus, parathyroid hormone, and cardiovascular disease in hemodialysis patients: the USRDS waves 1, 3, and 4 study.	Journal of the American Society of Nephrology 	2005	79
16549493	Parathyroid Hormone	Harris SS	Vitamin D and African Americans.	The Journal of nutrition	2006	76
17091124	Parathyroid Hormone	Levin A	Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease.	Kidney international	2007	262
17351276	Parathyroid Hormone	Reis JP	Vitamin D, parathyroid hormone levels, and the prevalence of metabolic syndrome in community-dwelling older adults.	Diabetes care	2007	64
18426812	Parathyroid Hormone	Reis JP	Relation of 25-hydroxyvitamin D and parathyroid hormone levels with metabolic syndrome among US adults.	European journal of endocrinology	2008	53
19451355	Parathyroid Hormone	Hagström E	Plasma parathyroid hormone and the risk of cardiovascular mortality in the community.	Circulation	2009	86
20466670	Parathyroid Hormone	Floege J	Serum iPTH, calcium and phosphate, and the risk of mortality in a European haemodialysis population.	Nephrology, dialysis, transplantation 	2011	70
21570529	Parathyroid Hormone	Taylor EN	Plasma fibroblast growth factor 23, parathyroid hormone, phosphorus, and risk of coronary heart disease.	American heart journal	2011	37
22648296	Parathyroid Hormone	Bosworth CR	The serum 24,25-dihydroxyvitamin D concentration, a marker of vitamin D catabolism, is reduced in chronic kidney disease.	Kidney international	2012	35
22745236	Parathyroid Hormone	Wysolmerski JJ	Parathyroid hormone-related protein: an update.	The Journal of clinical endocrinology and metabolism	2012	35
18387000	Ampicillin	Huang X	Important role of the LKB1-AMPK pathway in suppressing tumorigenesis in PTEN-deficient mice.	The Biochemical journal	2008	133
19387610	Ampicillin	Matthews VB	Brain-derived neurotrophic factor is produced by skeletal muscle cells in response to contraction and enhances fat oxidation via activation of AMP-activated protein kinase.	Diabetologia	2009	72
20444885	Ampicillin	Kim AY	Adiponectin represses colon cancer cell proliferation via AdipoR1- and -R2-mediated AMPK activation.	Molecular endocrinology	2010	52
21840335	Ampicillin	Speakman JR	Caloric restriction.	Molecular aspects of medicine	2011	152
22017684	Ampicillin	Inoki K	AMPK and mTOR in cellular energy homeostasis and drug targets.	Annual review of pharmacology and toxicology	2012	149
23298225	Ampicillin	Bijland S	Role of AMP-activated protein kinase in adipose tissue metabolism and inflammation.	Clinical science	2013	39
23863634	Ampicillin	Ruderman NB	AMPK, insulin resistance, and the metabolic syndrome.	The Journal of clinical investigation	2013	141
24055102	Ampicillin	Lee JH	Sestrins orchestrate cellular metabolism to attenuate aging.	Cell metabolism	2013	61
24677093	Ampicillin	Rehman G	Role of AMP-activated protein kinase in cancer therapy.	Archiv der Pharmazie	2014	24
24824502	Ampicillin	Grahame Hardie D	AMP-activated protein kinase: a key regulator of energy balance with many roles in human disease.	Journal of internal medicine	2014	39
25686106	Ampicillin	Youm YH	The ketone metabolite β-hydroxybutyrate blocks NLRP3 inflammasome-mediated inflammatory disease.	Nature medicine	2015	105
26160707	Ampicillin	Qi D	AMPK: energy sensor and survival mechanism in the ischemic heart.	Trends in endocrinology and metabolism	2015	24
26711141	Ampicillin	Dasgupta B	Evolving Lessons on the Complex Role of AMPK in Normal Physiology and Cancer.	Trends in pharmacological sciences	2016	20
26772531	Ampicillin	Daskalopoulos EP	AMPK in cardiac fibrosis and repair: Actions beyond metabolic regulation.	Journal of molecular and cellular cardiology	2016	10
26931135	Ampicillin	Cleasby ME	Insulin resistance and sarcopenia: mechanistic links between common co-morbidities.	The Journal of endocrinology	2016	15
27230643	Ampicillin	Shah MS	Molecular and Cellular Mechanisms of Cardiovascular Disorders in Diabetes.	Circulation research	2016	24
27416781	Ampicillin	Jeon SM	Regulation and function of AMPK in physiology and diseases.	Experimental & molecular medicine	2016	30
27577854	Ampicillin	Smith BK	Treatment of nonalcoholic fatty liver disease: role of AMPK.	American journal of physiology. Endocrinology and metabolism	2016	15
28232179	Ampicillin	Carling D	AMPK signalling in health and disease.	Current opinion in cell biology	2017	15
28467931	Ampicillin	Cokorinos EC	Activation of Skeletal Muscle AMPK Promotes Glucose Disposal and Glucose Lowering in Non-human Primates and Mice.	Cell metabolism	2017	9
16541101	Bile Acids and Salts	Houten SM	Endocrine functions of bile acids.	The EMBO journal	2006	120
16908160	Bile Acids and Salts	Lee FY	FXR, a multipurpose nuclear receptor.	Trends in biochemical sciences	2006	67
17116003	Bile Acids and Salts	Lundåsen T	Circulating intestinal fibroblast growth factor 19 has a pronounced diurnal variation and modulates hepatic bile acid synthesis in man.	Journal of internal medicine	2006	96
19346330	Bile Acids and Salts	Chiang JY	Bile acids: regulation of synthesis.	Journal of lipid research	2009	245
20623580	Bile Acids and Salts	Li T	Transgenic expression of cholesterol 7alpha-hydroxylase in the liver prevents high-fat diet-induced obesity and insulin resistance in mice.	Hepatology	2010	59
21145931	Bile Acids and Salts	Pols TW	The bile acid membrane receptor TGR5 as an emerging target in metabolism and inflammation.	Journal of hepatology	2011	68
22134839	Bile Acids and Salts	Beysen C	Effect of bile acid sequestrants on glucose metabolism, hepatic de novo lipogenesis, and cholesterol and bile acid kinetics in type 2 diabetes: a randomised controlled study.	Diabetologia	2012	32
22414897	Bile Acids and Salts	Calkin AC	Transcriptional integration of metabolism by the nuclear sterol-activated receptors LXR and FXR.	Nature reviews. Molecular cell biology	2012	149
22550135	Bile Acids and Salts	Porez G	Bile acid receptors as targets for the treatment of dyslipidemia and cardiovascular disease.	Journal of lipid research	2012	47
22673227	Bile Acids and Salts	Pournaras DJ	The role of bile after Roux-en-Y gastric bypass in promoting weight loss and improving glycaemic control.	Endocrinology	2012	75
23217254	Bile Acids and Salts	Angelin B	Circulating fibroblast growth factors as metabolic regulators--a critical appraisal.	Cell metabolism	2012	55
23801799	Bile Acids and Salts	Gerhard GS	A role for fibroblast growth factor 19 and bile acids in diabetes remission after Roux-en-Y gastric bypass.	Diabetes care	2013	40
23884887	Bile Acids and Salts	Haeusler RA	Human insulin resistance is associated with increased plasma levels of 12α-hydroxylated bile acids.	Diabetes	2013	52
24468803	Bile Acids and Salts	Joyce SA	The gut microbiota and the metabolic health of the host.	Current opinion in gastroenterology	2014	32
24727487	Bile Acids and Salts	Bajor A	Increased colonic bile acid exposure: a relevant factor for symptoms and treatment in IBS.	Gut	2015	19
24821328	Bile Acids and Salts	Kuipers F	Beyond intestinal soap--bile acids in metabolic control.	Nature reviews. Endocrinology	2014	55
24988476	Bile Acids and Salts	Napolitano A	Novel gut-based pharmacology of metformin in patients with type 2 diabetes mellitus.	PloS one	2014	33
25073467	Bile Acids and Salts	Li T	Bile acid signaling in metabolic disease and drug therapy.	Pharmacological reviews	2014	72
25584736	Bile Acids and Salts	Li T	Bile acids as metabolic regulators.	Current opinion in gastroenterology	2015	27
25705637	Bile Acids and Salts	Ali AH	Recent advances in the development of farnesoid X receptor agonists.	Annals of translational medicine	2015	30
26081915	Bile Acids and Salts	Penney NC	The role of bile acids in reducing the metabolic complications of obesity after bariatric surgery: a systematic review.	International journal of obesity	2015	19
26197299	Bile Acids and Salts	Flynn CR	Bile diversion to the distal small intestine has comparable metabolic benefits to bariatric surgery.	Nature communications	2015	19
26481828	Bile Acids and Salts	Fiorucci S	Bile Acid-Activated Receptors, Intestinal Microbiota, and the Treatment of Metabolic Disorders.	Trends in molecular medicine	2015	20
27196572	Bile Acids and Salts	Duparc T	Hepatocyte MyD88 affects bile acids, gut microbiota and metabolome contributing to regulate glucose and lipid metabolism.	Gut	2017	14
27692610	Bile Acids and Salts	Guo C	Bile Acids Control Inflammation and Metabolic Disorder through Inhibition of NLRP3 Inflammasome.	Immunity	2016	17
27780972	Bile Acids and Salts	Wesolowski SR	Developmental origins of NAFLD: a womb with a clue.	Nature reviews. Gastroenterology & hepatology	2017	7
11250914	Glucocorticoids	Seckl JR	Minireview: 11beta-hydroxysteroid dehydrogenase type 1- a tissue-specific amplifier of glucocorticoid action.	Endocrinology	2001	104
15554887	Glucocorticoids	Seckl JR	Prenatal glucocorticoids and long-term programming.	European journal of endocrinology	2004	113
17514590	Glucocorticoids	Chrousos GP	Glucocorticoid action networks and complex psychiatric and/or somatic disorders.	Stress	2007	56
17624658	Glucocorticoids	Vegiopoulos A	Glucocorticoids, metabolism and metabolic diseases.	Molecular and cellular endocrinology	2007	80
18325087	Glucocorticoids	Naranjo A	Cardiovascular disease in patients with rheumatoid arthritis: results from the QUEST-RA study.	Arthritis research & therapy	2008	58
20106676	Glucocorticoids	Nader N	Interactions of the circadian CLOCK system and the HPA axis.	Trends in endocrinology and metabolism	2010	57
20398732	Glucocorticoids	Coutinho AE	The anti-inflammatory and immunosuppressive effects of glucocorticoids, recent developments and mechanistic insights.	Molecular and cellular endocrinology	2011	119
21602312	Glucocorticoids	Schlossmacher G	Glucocorticoid receptor-mediated apoptosis: mechanisms of resistance in cancer cells.	The Journal of endocrinology	2011	48
23735216	Glucocorticoids	Lee MJ	Deconstructing the roles of glucocorticoids in adipose tissue biology and the development of central obesity.	Biochimica et biophysica acta	2014	44
26714851	Glucocorticoids	John K	The glucocorticoid receptor: cause of or cure for obesity?	American journal of physiology. Endocrinology and metabolism	2016	14
17315038	Growth Hormone	LeRoith D	Mechanisms of disease: metabolic effects of growth hormone and insulin-like growth factor 1.	Nature clinical practice. Endocrinology & metabolism	2007	69
22699302	Growth Hormone	Garcia JM	Therapeutic potential of anamorelin, a novel, oral ghrelin mimetic, in patients with cancer-related cachexia: a multicenter, randomized, double-blind, crossover, pilot study.	Supportive care in cancer 	2013	30
23591370	Growth Hormone	Junnila RK	The GH/IGF-1 axis in ageing and longevity.	Nature reviews. Endocrinology	2013	69
25902704	Growth Hormone	Longo VD	Interventions to Slow Aging in Humans: Are We Ready?	Aging cell	2015	77
9389420	Hydrocortisone	Pickup JC	NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X.	Diabetologia	1997	157
12562574	Hydrocortisone	Ryan MC	Impaired fasting glucose tolerance in first-episode, drug-naive patients with schizophrenia.	The American journal of psychiatry	2003	110
15840727	Hydrocortisone	Steptoe A	Positive affect and health-related neuroendocrine, cardiovascular, and inflammatory processes.	Proceedings of the National Academy of Sciences of the United States of America	2005	115
17536998	Hydrocortisone	Jansson T	Role of the placenta in fetal programming: underlying mechanisms and potential interventional approaches.	Clinical science	2007	93
18929315	Hydrocortisone	Van Cauter E	Metabolic consequences of sleep and sleep loss.	Sleep medicine	2008	99
20633104	Hydrocortisone	Oxenkrug GF	Metabolic syndrome, age-associated neuroendocrine disorders, and dysregulation of tryptophan-kynurenine metabolism.	Annals of the New York Academy of Sciences	2010	44
22466348	Hydrocortisone	Fleseriu M	Mifepristone, a glucocorticoid receptor antagonist, produces clinical and metabolic benefits in patients with Cushing's syndrome.	The Journal of clinical endocrinology and metabolism	2012	57
26067718	Hydrocortisone	Pivonello R	The Treatment of Cushing's Disease.	Endocrine reviews	2015	24
26443692	Hydrocortisone	Fontana L	Effects of 2-year calorie restriction on circulating levels of IGF-1, IGF-binding proteins and cortisol in nonobese men and women: a randomized clinical trial.	Aging cell	2016	15
26930227	Hydrocortisone	Tachikawa R	Changes in Energy Metabolism after Continuous Positive Airway Pressure for Obstructive Sleep Apnea.	American journal of respiratory and critical care medicine	2016	10
10688666	Oxygen	Liu H	Activation of apoptosis signal-regulating kinase 1 (ASK1) by tumor necrosis factor receptor-associated factor 2 requires prior dissociation of the ASK1 inhibitor thioredoxin.	Molecular and cellular biology	2000	121
11874812	Oxygen	Ip MS	Obstructive sleep apnea is independently associated with insulin resistance.	American journal of respiratory and critical care medicine	2002	207
11874813	Oxygen	Punjabi NM	Sleep-disordered breathing and insulin resistance in middle-aged and overweight men.	American journal of respiratory and critical care medicine	2002	166
14604834	Oxygen	Delafontaine P	Expression, regulation, and function of IGF-1, IGF-1R, and IGF-1 binding proteins in blood vessels.	Arteriosclerosis, thrombosis, and vascular biology	2004	100
16394109	Oxygen	Galkina E	Leukocyte recruitment and vascular injury in diabetic nephropathy.	Journal of the American Society of Nephrology 	2006	73
17115886	Oxygen	Lillig CH	Thioredoxin and related molecules--from biology to health and disease.	Antioxidants & redox signaling	2007	174
17557769	Oxygen	West SD	Effect of CPAP on insulin resistance and HbA1c in men with obstructive sleep apnoea and type 2 diabetes.	Thorax	2007	87
19074987	Oxygen	Pasarica M	Reduced adipose tissue oxygenation in human obesity: evidence for rarefaction, macrophage chemotaxis, and inflammation without an angiogenic response.	Diabetes	2009	172
19281826	Oxygen	Roberts CK	Oxidative stress and metabolic syndrome.	Life sciences	2009	114
19505186	Oxygen	Sarsour EH	Redox control of the cell cycle in health and disease.	Antioxidants & redox signaling	2009	79
19915016	Oxygen	Nadeau KJ	Insulin resistance in adolescents with type 1 diabetes and its relationship to cardiovascular function.	The Journal of clinical endocrinology and metabolism	2010	82
20718759	Oxygen	Elmarakby AA	Relationship between oxidative stress and inflammatory cytokines in diabetic nephropathy.	Cardiovascular therapeutics	2012	65
20965424	Oxygen	Sengupta S	Regulation of the mTOR complex 1 pathway by nutrients, growth factors, and stress.	Molecular cell	2010	422
21323907	Oxygen	Félétou M	Endothelium-mediated control of vascular tone: COX-1 and COX-2 products.	British journal of pharmacology	2011	65
21335095	Oxygen	Rabbani N	Glyoxalase in diabetes, obesity and related disorders.	Seminars in cell & developmental biology	2011	63
21885599	Oxygen	Giarratana MC	Proof of principle for transfusion of in vitro-generated red blood cells.	Blood	2011	80
21962515	Oxygen	Haque A	Conformation-sensing antibodies stabilize the oxidized form of PTP1B and inhibit its phosphatase activity.	Cell	2011	42
22068265	Oxygen	Simonson TS	Genetic determinants of Tibetan high-altitude adaptation.	Human genetics	2012	31
23181220	Oxygen	Kongara S	The interplay between autophagy and ROS in tumorigenesis.	Frontiers in oncology	2012	40
23181475	Oxygen	Hansell P	Determinants of kidney oxygen consumption and their relationship to tissue oxygen tension in diabetes and hypertension.	Clinical and experimental pharmacology & physiology	2013	28
23959876	Oxygen	Xin X	Hypoxic retinal Muller cells promote vascular permeability by HIF-1-dependent up-regulation of angiopoietin-like 4.	Proceedings of the National Academy of Sciences of the United States of America	2013	30
24608041	Oxygen	Wang H	Negative regulation of Hif1a expression and TH17 differentiation by the hypoxia-regulated microRNA miR-210.	Nature immunology	2014	54
24687582	Oxygen	Fry CS	Fibre type-specific satellite cell response to aerobic training in sedentary adults.	The Journal of physiology	2014	25
25434839	Oxygen	Yang P	Decoding the oxidative stress hypothesis in diabetic embryopathy through proapoptotic kinase signaling.	American journal of obstetrics and gynecology	2015	22
25440060	Oxygen	Walter KM	Hif-2α promotes degradation of mammalian peroxisomes by selective autophagy.	Cell metabolism	2014	20
25595581	Oxygen	Wang F	Advances in revealing the molecular targets downstream of oxidative stress-induced proapoptotic kinase signaling in diabetic embryopathy.	American journal of obstetrics and gynecology	2015	20
25699252	Oxygen	Bocci V	Nrf2 activation as target to implement therapeutic treatments.	Frontiers in chemistry	2015	16
25814684	Oxygen	Eelen G	Endothelial cell metabolism in normal and diseased vasculature.	Circulation research	2015	52
26910598	Oxygen	Martínez-Cerón E	Effect of Continuous Positive Airway Pressure on Glycemic Control in Patients with Obstructive Sleep Apnea and Type 2 Diabetes. A Randomized Clinical Trial.	American journal of respiratory and critical care medicine	2016	18
27356044	Oxygen	Panigrahy SK	Reactive oxygen species: sources, consequences and targeted therapy in type 2 diabetes.	Journal of drug targeting	2017	8
27426517	Oxygen	Fiorese CJ	The Transcription Factor ATF5 Mediates a Mammalian Mitochondrial UPR.	Current biology 	2016	28
27892954	Oxygen	Plovier H	A purified membrane protein from Akkermansia muciniphila or the pasteurized bacterium improves metabolism in obese and diabetic mice.	Nature medicine	2017	36
1671422	Cholesterol	McKeigue PM	Relation of central obesity and insulin resistance with high diabetes prevalence and cardiovascular risk in South Asians.	Lancet	1991	270
2044434	Cholesterol	DeFronzo RA	Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease.	Diabetes care	1991	390
7624391	Cholesterol	Reaven GM	Pathophysiology of insulin resistance in human disease.	Physiological reviews	1995	133
8353913	Cholesterol	Newman AB	Ankle-arm index as a marker of atherosclerosis in the Cardiovascular Health Study. Cardiovascular Heart Study (CHS) Collaborative Research Group.	Circulation	1993	159
8432214	Cholesterol	Stamler J	Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial.	Diabetes care	1993	483
8596596	Cholesterol	Després JP	Hyperinsulinemia as an independent risk factor for ischemic heart disease.	The New England journal of medicine	1996	147
9186882	Cholesterol	Hunsicker LG	Predictors of the progression of renal disease in the Modification of Diet in Renal Disease Study.	Kidney international	1997	122
9673301	Cholesterol	Haffner SM	Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction.	The New England journal of medicine	1998	895
9753305	Cholesterol	Bonora E	Prevalence of insulin resistance in metabolic disorders: the Bruneck Study.	Diabetes	1998	104
9794114	Cholesterol	Pickup JC	Is type II diabetes mellitus a disease of the innate immune system?	Diabetologia	1998	161
9920074	Cholesterol	Banerji MA	Body composition, visceral fat, leptin, and insulin resistance in Asian Indian men.	The Journal of clinical endocrinology and metabolism	1999	105
9987089	Cholesterol	Zimmermann J	Inflammation enhances cardiovascular risk and mortality in hemodialysis patients.	Kidney international	1999	136
10333910	Cholesterol	-	Epidemiology of Diabetes Interventions and Complications (EDIC). Design, implementation, and preliminary results of a long-term follow-up of the Diabetes Control and Complications Trial cohort.	Diabetes care	1999	172
10657556	Cholesterol	Yudkin JS	Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link?	Atherosclerosis	2000	233
10692273	Cholesterol	Yeun JY	C-Reactive protein predicts all-cause and cardiovascular mortality in hemodialysis patients.	American journal of kidney diseases 	2000	95
10722987	Cholesterol	Martin LM	Validation of self-reported chronic conditions and health services in a managed care population.	American journal of preventive medicine	2000	124
10802740	Cholesterol	Tsujishita Y	Structure and lipid transport mechanism of a StAR-related domain.	Nature structural biology	2000	103
11071182	Cholesterol	Anand SS	Differences in risk factors, atherosclerosis, and cardiovascular disease between ethnic groups in Canada: the Study of Health Assessment and Risk in Ethnic groups (SHARE)	Lancet	2000	188
11138003	Cholesterol	Lee MH	Identification of a gene, ABCG5, important in the regulation of dietary cholesterol absorption.	Nature genetics	2001	97
11440984	Cholesterol	Vasa M	Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease.	Circulation research	2001	431
11473047	Cholesterol	Marchesini G	Nonalcoholic fatty liver disease: a feature of the metabolic syndrome.	Diabetes	2001	400
11692019	Cholesterol	Rost NS	Plasma concentration of C-reactive protein and risk of ischemic stroke and transient ischemic attack: the Framingham study.	Stroke	2001	111
11738396	Cholesterol	Dobiásová M	The plasma parameter log (TG/HDL-C) as an atherogenic index: correlation with lipoprotein particle size and esterification rate in apoB-lipoprotein-depleted plasma (FER(HDL)).	Clinical biochemistry	2001	100
11882522	Cholesterol	Eichner JE	Apolipoprotein E polymorphism and cardiovascular disease: a HuGE review.	American journal of epidemiology	2002	159
12020339	Cholesterol	Beckman JA	Diabetes and atherosclerosis: epidemiology, pathophysiology, and management.	JAMA	2002	364
12105842	Cholesterol	Bugianesi E	Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma.	Gastroenterology	2002	260
12518001	Cholesterol	Francis GA	Nuclear receptors and the control of metabolism.	Annual review of physiology	2003	122
12611609	Cholesterol	Díez JJ	The role of the novel adipocyte-derived hormone adiponectin in human disease.	European journal of endocrinology	2003	165
12668987	Cholesterol	Marchesini G	Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome.	Hepatology	2003	457
12788992	Cholesterol	Perkins BA	Regression of microalbuminuria in type 1 diabetes.	The New England journal of medicine	2003	158
14623617	Cholesterol	McLaughlin T	Use of metabolic markers to identify overweight individuals who are insulin resistant.	Annals of internal medicine	2003	162
14704320	Cholesterol	Yajnik CS	Early life origins of insulin resistance and type 2 diabetes in India and other Asian countries.	The Journal of nutrition	2004	84
15136311	Cholesterol	Ford DE	Depression and C-reactive protein in US adults: data from the Third National Health and Nutrition Examination Survey.	Archives of internal medicine	2004	102
15142859	Cholesterol	Burke AP	Morphologic findings of coronary atherosclerotic plaques in diabetics: a postmortem study.	Arteriosclerosis, thrombosis, and vascular biology	2004	94
15159263	Cholesterol	Hu G	Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women.	Archives of internal medicine	2004	129
15197153	Cholesterol	Ridker PM	Should C-reactive protein be added to metabolic syndrome and to assessment of global cardiovascular risk?	Circulation	2004	84
15213209	Cholesterol	Esposito K	Effect of lifestyle changes on erectile dysfunction in obese men: a randomized controlled trial.	JAMA	2004	76
15451911	Cholesterol	Jehn M	Serum ferritin and risk of the metabolic syndrome in U.S. adults.	Diabetes care	2004	74
15625072	Cholesterol	Muntner P	Traditional and nontraditional risk factors predict coronary heart disease in chronic kidney disease: results from the atherosclerosis risk in communities study.	Journal of the American Society of Nephrology 	2005	93
15632335	Cholesterol	Dansinger ML	Comparison of the Atkins, Ornish, Weight Watchers, and Zone diets for weight loss and heart disease risk reduction: a randomized trial.	JAMA	2005	226
15699277	Cholesterol	Oei HH	Lipoprotein-associated phospholipase A2 activity is associated with risk of coronary heart disease and ischemic stroke: the Rotterdam Study.	Circulation	2005	84
15699278	Cholesterol	Desvarieux M	Periodontal microbiota and carotid intima-media thickness: the Oral Infections and Vascular Disease Epidemiology Study (INVEST).	Circulation	2005	116
15766369	Cholesterol	Kiran M	The effect of improved periodontal health on metabolic control in type 2 diabetes mellitus.	Journal of clinical periodontology	2005	66
15768830	Cholesterol	Williams TM	The Caveolin genes: from cell biology to medicine.	Annals of medicine	2004	121
15802102	Cholesterol	Shaffer EA	Epidemiology and risk factors for gallstone disease: has the paradigm changed in the 21st century?	Current gastroenterology reports	2005	73
15925013	Cholesterol	Ginsberg HN	Regulation of plasma triglycerides in insulin resistance and diabetes.	Archives of medical research	2005	88
16030277	Cholesterol	Ridker PM	Non-HDL cholesterol, apolipoproteins A-I and B100, standard lipid measures, lipid ratios, and CRP as risk factors for cardiovascular disease in women.	JAMA	2005	141
16030278	Cholesterol	Ingelsson E	Insulin resistance and risk of congestive heart failure.	JAMA	2005	112
16061755	Cholesterol	Dekker JM	Metabolic syndrome and 10-year cardiovascular disease risk in the Hoorn Study.	Circulation	2005	94
16127462	Cholesterol	Vikramadithyan RK	Human aldose reductase expression accelerates diabetic atherosclerosis in transgenic mice.	The Journal of clinical investigation	2005	68
16183915	Cholesterol	Oram JF	ATP-binding cassette transporter A1: a cell cholesterol exporter that protects against cardiovascular disease.	Physiological reviews	2005	128
16249437	Cholesterol	Hanley AJ	Liver markers and development of the metabolic syndrome: the insulin resistance atherosclerosis study.	Diabetes	2005	85
16314544	Cholesterol	Ballantyne CM	Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident ischemic stroke in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study.	Archives of internal medicine	2005	66
16344423	Cholesterol	Wannamethee SG	Metabolic syndrome vs Framingham Risk Score for prediction of coronary heart disease, stroke, and type 2 diabetes mellitus.	Archives of internal medicine	2005	129
16442908	Cholesterol	Kizer JR	Left atrial diameter as an independent predictor of first clinical cardiovascular events in middle-aged and elderly adults: the Strong Heart Study (SHS).	American heart journal	2006	68
16476102	Cholesterol	Barter PJ	Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty-person/ten-country panel.	Journal of internal medicine	2006	71
16534530	Cholesterol	Kim CS	Circulating levels of MCP-1 and IL-8 are elevated in human obese subjects and associated with obesity-related parameters.	International journal of obesity	2006	79
16629855	Cholesterol	Walldius G	The apoB/apoA-I ratio: a strong, new risk factor for cardiovascular disease and a target for lipid-lowering therapy--a review of the evidence.	Journal of internal medicine	2006	79
16773565	Cholesterol	Saxena R	Comprehensive association testing of common mitochondrial DNA variation in metabolic disease.	American journal of human genetics	2006	81
16786033	Cholesterol	Martins IJ	Apolipoprotein E, cholesterol metabolism, diabetes, and the convergence of risk factors for Alzheimer's disease and cardiovascular disease.	Molecular psychiatry	2006	80
16801565	Cholesterol	Knopp RH	Efficacy and safety of atorvastatin in the prevention of cardiovascular end points in subjects with type 2 diabetes: the Atorvastatin Study for Prevention of Coronary Heart Disease Endpoints in non-insulin-dependent diabetes mellitus (ASPEN).	Diabetes care	2006	73
16918589	Cholesterol	Salpeter SR	Meta-analysis: effect of hormone-replacement therapy on components of the metabolic syndrome in postmenopausal women.	Diabetes, obesity & metabolism	2006	61
16968945	Cholesterol	Kontush A	Functionally defective high-density lipoprotein: a new therapeutic target at the crossroads of dyslipidemia, inflammation, and atherosclerosis.	Pharmacological reviews	2006	160
17095732	Cholesterol	Oram JF	ATP-Binding cassette cholesterol transporters and cardiovascular disease.	Circulation research	2006	115
17192343	Cholesterol	Samaras K	Prevalence of metabolic syndrome in HIV-infected patients receiving highly active antiretroviral therapy using International Diabetes Foundation and Adult Treatment Panel III criteria: associations with insulin resistance, disturbed body fat compartmentalization, elevated C-reactive protein, and corrected hypoadiponectinemia.	Diabetes care	2007	62
17259501	Cholesterol	Bonora E	Insulin resistance as estimated by homeostasis model assessment predicts incident symptomatic cardiovascular disease in caucasian subjects from the general population: the Bruneck study.	Diabetes care	2007	57
17322482	Cholesterol	Williams CJ	Sleep duration and snoring in relation to biomarkers of cardiovascular disease risk among women with type 2 diabetes.	Diabetes care	2007	59
17339582	Cholesterol	Solomon A	Serum cholesterol changes after midlife and late-life cognition: twenty-one-year follow-up study.	Neurology	2007	55
17389279	Cholesterol	Xu A	Circulating adipocyte-fatty acid binding protein levels predict the development of the metabolic syndrome: a 5-year prospective study.	Circulation	2007	80
17485598	Cholesterol	Roman MJ	Central pressure more strongly relates to vascular disease and outcome than does brachial pressure: the Strong Heart Study.	Hypertension	2007	148
17495599	Cholesterol	Lara-Castro C	Adiponectin and the metabolic syndrome: mechanisms mediating risk for metabolic and cardiovascular disease.	Current opinion in lipidology	2007	63
17531663	Cholesterol	Ridker PM	C-reactive protein and the prediction of cardiovascular events among those at intermediate risk: moving an inflammatory hypothesis toward consensus.	Journal of the American College of Cardiology	2007	125
17716297	Cholesterol	Vona-Davis L	Adiposity, type 2 diabetes and the metabolic syndrome in breast cancer.	Obesity reviews 	2007	70
17827399	Cholesterol	Hamilton MT	Role of low energy expenditure and sitting in obesity, metabolic syndrome, type 2 diabetes, and cardiovascular disease.	Diabetes	2007	317
17967770	Cholesterol	Mora S	Physical activity and reduced risk of cardiovascular events: potential mediating mechanisms.	Circulation	2007	150
18048406	Cholesterol	Broadbent HM	Susceptibility to coronary artery disease and diabetes is encoded by distinct, tightly linked SNPs in the ANRIL locus on chromosome 9p.	Human molecular genetics	2008	151
18053320	Cholesterol	Klonoff DC	Exenatide effects on diabetes, obesity, cardiovascular risk factors and hepatic biomarkers in patients with type 2 diabetes treated for at least 3 years.	Current medical research and opinion	2008	153
18065585	Cholesterol	Kabir M	Treatment for 2 mo with n 3 polyunsaturated fatty acids reduces adiposity and some atherogenic factors but does not improve insulin sensitivity in women with type 2 diabetes: a randomized controlled study.	The American journal of clinical nutrition	2007	62
18067118	Cholesterol	Mizrak D	CD133: molecule of the moment.	The Journal of pathology	2008	152
18175744	Cholesterol	Wolever TM	The Canadian Trial of Carbohydrates in Diabetes (CCD), a 1-y controlled trial of low-glycemic-index dietary carbohydrate in type 2 diabetes: no effect on glycated hemoglobin but reduction in C-reactive protein.	The American journal of clinical nutrition	2008	57
18240558	Cholesterol	Ridker PM	Inflammatory biomarkers and risks of myocardial infarction, stroke, diabetes, and total mortality: implications for longevity.	Nutrition reviews	2007	60
18252893	Cholesterol	Zhang X	Serum FGF21 levels are increased in obesity and are independently associated with the metabolic syndrome in humans.	Diabetes	2008	175
18276926	Cholesterol	Duan SZ	Peroxisome proliferator-activated receptor-gamma-mediated effects in the vasculature.	Circulation research	2008	73
18291668	Cholesterol	Raghow R	SREBPs: the crossroads of physiological and pathological lipid homeostasis.	Trends in endocrinology and metabolism	2008	91
18295053	Cholesterol	Zhang L	Prevalence and factors associated with CKD: a population study from Beijing.	American journal of kidney diseases 	2008	59
18317847	Cholesterol	Schmittdiel JA	Why don't diabetes patients achieve recommended risk factor targets? Poor adherence versus lack of treatment intensification.	Journal of general internal medicine	2008	78
18440684	Cholesterol	Foster MC	Overweight, obesity, and the development of stage 3 CKD: the Framingham Heart Study.	American journal of kidney diseases 	2008	62
18452784	Cholesterol	Bahrami H	Novel metabolic risk factors for incident heart failure and their relationship with obesity: the MESA (Multi-Ethnic Study of Atherosclerosis) study.	Journal of the American College of Cardiology	2008	91
18462017	Cholesterol	Schadt EE	Mapping the genetic architecture of gene expression in human liver.	PLoS biology	2008	497
18492747	Cholesterol	Hivert MF	Associations of adiponectin, resistin, and tumor necrosis factor-alpha with insulin resistance.	The Journal of clinical endocrinology and metabolism	2008	73
18584872	Cholesterol	Wong TY	Prevalence and risk factors for diabetic retinopathy: the Singapore Malay Eye Study.	Ophthalmology	2008	71
18598350	Cholesterol	Sanghera DK	Impact of nine common type 2 diabetes risk polymorphisms in Asian Indian Sikhs: PPARG2 (Pro12Ala), IGF2BP2, TCF7L2 and FTO variants confer a significant risk.	BMC medical genetics	2008	88
18612115	Cholesterol	Ix JH	Fetuin-A and incident diabetes mellitus in older persons.	JAMA	2008	67
18633113	Cholesterol	Stefan N	Plasma fetuin-A levels and the risk of type 2 diabetes.	Diabetes	2008	74
18654640	Cholesterol	Reed BD	Genome-wide occupancy of SREBP1 and its partners NFY and SP1 reveals novel functional roles and combinatorial regulation of distinct classes of genes.	PLoS genetics	2008	78
18680716	Cholesterol	Gälman C	The circulating metabolic regulator FGF21 is induced by prolonged fasting and PPARalpha activation in man.	Cell metabolism	2008	118
18682512	Cholesterol	Aguilar-Salinas CA	High adiponectin concentrations are associated with the metabolically healthy obese phenotype.	The Journal of clinical endocrinology and metabolism	2008	56
19029462	Cholesterol	Weikert C	Plasma fetuin-a levels and the risk of myocardial infarction and ischemic stroke.	Circulation	2008	62
19060911	Cholesterol	Aulchenko YS	Loci influencing lipid levels and coronary heart disease risk in 16 European population cohorts.	Nature genetics	2009	343
19074209	Cholesterol	Azadbakht L	Red meat intake is associated with metabolic syndrome and the plasma C-reactive protein concentration in women.	The Journal of nutrition	2009	48
19131384	Cholesterol	de Ruijter W	Use of Framingham risk score and new biomarkers to predict cardiovascular mortality in older people: population based observational cohort study.	BMJ	2009	78
19183311	Cholesterol	Katulanda P	Prevalence and projections of diabetes and pre-diabetes in adults in Sri Lanka--Sri Lanka Diabetes, Cardiovascular Study (SLDCS).	Diabetic medicine 	2008	56
19203419	Cholesterol	Elahi MM	Long-term maternal high-fat feeding from weaning through pregnancy and lactation predisposes offspring to hypertension, raised plasma lipids and fatty liver in mice.	The British journal of nutrition	2009	47
19221221	Cholesterol	McGillicuddy FC	Inflammation impairs reverse cholesterol transport in vivo.	Circulation	2009	118
19231010	Cholesterol	Caballero F	Enhanced free cholesterol, SREBP-2 and StAR expression in human NASH.	Journal of hepatology	2009	62
19273753	Cholesterol	Helzner EP	Contribution of vascular risk factors to the progression in Alzheimer disease.	Archives of neurology	2009	72
19281927	Cholesterol	Patel S	Reconstituted high-density lipoprotein increases plasma high-density lipoprotein anti-inflammatory properties and cholesterol efflux capacity in patients with type 2 diabetes.	Journal of the American College of Cardiology	2009	57
19291789	Cholesterol	Gastaldelli A	Fatty liver is associated with insulin resistance, risk of coronary heart disease, and early atherosclerosis in a large European population.	Hepatology	2009	64
19360495	Cholesterol	Esquirol Y	Shift work and metabolic syndrome: respective impacts of job strain, physical activity, and dietary rhythms.	Chronobiology international	2009	58
19470637	Cholesterol	Bozaoglu K	Chemerin is associated with metabolic syndrome phenotypes in a Mexican-American population.	The Journal of clinical endocrinology and metabolism	2009	52
19471024	Cholesterol	Silverstein RL	CD36, a scavenger receptor involved in immunity, metabolism, angiogenesis, and behavior.	Science signaling	2009	218
19546386	Cholesterol	Waters DD	Lipid treatment assessment project 2: a multinational survey to evaluate the proportion of patients achieving low-density lipoprotein cholesterol goals.	Circulation	2009	67
19629071	Cholesterol	Shackelford DB	The LKB1-AMPK pathway: metabolism and growth control in tumour suppression.	Nature reviews. Cancer	2009	446
19695853	Cholesterol	Balducci S	Anti-inflammatory effect of exercise training in subjects with type 2 diabetes and the metabolic syndrome is dependent on exercise modalities and independent of weight loss.	Nutrition, metabolism, and cardiovascular diseases 	2010	85
19820018	Cholesterol	Smith J	Effects of maternal surgical weight loss in mothers on intergenerational transmission of obesity.	The Journal of clinical endocrinology and metabolism	2009	59
19948145	Cholesterol	Laplante M	An emerging role of mTOR in lipid biosynthesis.	Current biology 	2009	156
20151996	Cholesterol	Elhayany A	A low carbohydrate Mediterranean diet improves cardiovascular risk factors and diabetes control among overweight patients with type 2 diabetes mellitus: a 1-year prospective randomized intervention study.	Diabetes, obesity & metabolism	2010	43
20172445	Cholesterol	Stevens LA	Prevalence of CKD and comorbid illness in elderly patients in the United States: results from the Kidney Early Evaluation Program (KEEP).	American journal of kidney diseases 	2010	58
20375212	Cholesterol	Sell H	Chemerin correlates with markers for fatty liver in morbidly obese patients and strongly decreases after weight loss induced by bariatric surgery.	The Journal of clinical endocrinology and metabolism	2010	51
20392876	Cholesterol	Pearen MA	Minireview: Nuclear hormone receptor 4A signaling: implications for metabolic disease.	Molecular endocrinology	2010	90
20444434	Cholesterol	Frisardi V	Metabolic-cognitive syndrome: a cross-talk between metabolic syndrome and Alzheimer's disease.	Ageing research reviews	2010	46
20466975	Cholesterol	Fryirs MA	Effects of high-density lipoproteins on pancreatic beta-cell insulin secretion.	Arteriosclerosis, thrombosis, and vascular biology	2010	45
20530747	Cholesterol	Sun L	A marker of endotoxemia is associated with obesity and related metabolic disorders in apparently healthy Chinese.	Diabetes care	2010	61
20628408	Cholesterol	Velho S	Metabolically healthy obesity: different prevalences using different criteria.	European journal of clinical nutrition	2010	49
20694148	Cholesterol	Zabaneh D	A genome-wide association study of the metabolic syndrome in Indian Asian men.	PloS one	2010	44
20843952	Cholesterol	Liu J	Impact of abdominal visceral and subcutaneous adipose tissue on cardiometabolic risk factors: the Jackson Heart Study.	The Journal of clinical endocrinology and metabolism	2010	87
20937689	Cholesterol	Calori G	Prevalence, metabolic features, and prognosis of metabolically healthy obese Italian individuals: the Cremona Study.	Diabetes care	2011	65
21151126	Cholesterol	Momozawa Y	Resequencing of positional candidates identifies low frequency IL23R coding variants protecting against inflammatory bowel disease.	Nature genetics	2011	65
21226820	Cholesterol	Tremblay AJ	Effect of sitagliptin therapy on postprandial lipoprotein levels in patients with type 2 diabetes.	Diabetes, obesity & metabolism	2011	41
21232666	Cholesterol	Stamatakis E	Screen-based entertainment time, all-cause mortality, and cardiovascular events: population-based study with ongoing mortality and hospital events follow-up.	Journal of the American College of Cardiology	2011	82
21270197	Cholesterol	Pussinen PJ	Endotoxemia is associated with an increased risk of incident diabetes.	Diabetes care	2011	61
21278760	Cholesterol	Tlaskalová-Hogenová H	The role of gut microbiota (commensal bacteria) and the mucosal barrier in the pathogenesis of inflammatory and autoimmune diseases and cancer: contribution of germ-free and gnotobiotic animal models of human diseases.	Cellular & molecular immunology	2011	109
21347282	Cholesterol	Lettre G	Genome-wide association study of coronary heart disease and its risk factors in 8,090 African Americans: the NHLBI CARe Project.	PLoS genetics	2011	134
21349201	Cholesterol	Su G	Association of glycemic variability and the presence and severity of coronary artery disease in patients with type 2 diabetes.	Cardiovascular diabetology	2011	48
21386085	Cholesterol	Kraja AT	A bivariate genome-wide approach to metabolic syndrome: STAMPEED consortium.	Diabetes	2011	83
21474825	Cholesterol	Murphy AJ	Neutrophil activation is attenuated by high-density lipoprotein and apolipoprotein A-I in in vitro and in vivo models of inflammation.	Arteriosclerosis, thrombosis, and vascular biology	2011	37
21497090	Cholesterol	Bosch M	Caveolin-1 deficiency causes cholesterol-dependent mitochondrial dysfunction and apoptotic susceptibility.	Current biology 	2011	52
21525259	Cholesterol	Azadbakht L	The Dietary Approaches to Stop Hypertension eating plan affects C-reactive protein, coagulation abnormalities, and hepatic function tests among type 2 diabetic patients.	The Journal of nutrition	2011	42
21572415	Cholesterol	Small KS	Identification of an imprinted master trans regulator at the KLF14 locus related to multiple metabolic phenotypes.	Nature genetics	2011	118
21792295	Cholesterol	Kones R	Primary prevention of coronary heart disease: integration of new data, evolving views, revised goals, and role of rosuvastatin in management. A comprehensive survey.	Drug design, development and therapy	2011	42
21818333	Cholesterol	Shiels PG	Accelerated telomere attrition is associated with relative household income, diet and inflammation in the pSoBid cohort.	PloS one	2011	39
21861177	Cholesterol	Wannamethee SG	Do women exhibit greater differences in established and novel risk factors between diabetes and non-diabetes than men? The British Regional Heart Study and British Women's Heart Health Study.	Diabetologia	2012	34
21896895	Cholesterol	Dandona P	Update: Hypogonadotropic hypogonadism in type 2 diabetes and obesity.	The Journal of clinical endocrinology and metabolism	2011	36
21909109	Cholesterol	Kim YJ	Large-scale genome-wide association studies in East Asians identify new genetic loci influencing metabolic traits.	Nature genetics	2011	83
21982649	Cholesterol	Ridker PM	Interleukin-1β inhibition and the prevention of recurrent cardiovascular events: rationale and design of the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS).	American heart journal	2011	184
21987488	Cholesterol	Bambha K	Ethnicity and nonalcoholic fatty liver disease.	Hepatology	2012	40
22005937	Cholesterol	Tenforde M	The association between personal health record use and diabetes quality measures.	Journal of general internal medicine	2012	37
22156303	Cholesterol	Rottiers V	MicroRNAs in metabolism and metabolic diseases.	Cold Spring Harbor symposia on quantitative biology	2011	36
22183689	Cholesterol	Lomonaco R	Effect of adipose tissue insulin resistance on metabolic parameters and liver histology in obese patients with nonalcoholic fatty liver disease.	Hepatology	2012	56
22219194	Cholesterol	Shao B	Myeloperoxidase targets apolipoprotein A-I, the major high density lipoprotein protein, for site-specific oxidation in human atherosclerotic lesions.	The Journal of biological chemistry	2012	48
22271511	Cholesterol	Kim D	Nonalcoholic fatty liver disease is associated with coronary artery calcification.	Hepatology	2012	59
22322078	Cholesterol	Grundy SM	Pre-diabetes, metabolic syndrome, and cardiovascular risk.	Journal of the American College of Cardiology	2012	101
22347441	Cholesterol	Pinto Pereira SM	Sedentary behaviour and biomarkers for cardiovascular disease and diabetes in mid-life: the role of television-viewing and sitting at work.	PloS one	2012	42
22356914	Cholesterol	Oh J	Endoplasmic reticulum stress controls M2 macrophage differentiation and foam cell formation.	The Journal of biological chemistry	2012	63
22412070	Cholesterol	de Koning L	Sweetened beverage consumption, incident coronary heart disease, and biomarkers of risk in men.	Circulation	2012	84
22414775	Cholesterol	Landi F	Sarcopenia as a risk factor for falls in elderly individuals: results from the ilSIRENTE study.	Clinical nutrition	2012	78
22465791	Cholesterol	Kijlstra A	Lutein: more than just a filter for blue light.	Progress in retinal and eye research	2012	47
22479202	Cholesterol	Dastani Z	Novel loci for adiponectin levels and their influence on type 2 diabetes and metabolic traits: a multi-ethnic meta-analysis of 45,891 individuals.	PLoS genetics	2012	149
22508708	Cholesterol	Hamer M	Metabolically healthy obesity and risk of all-cause and cardiovascular disease mortality.	The Journal of clinical endocrinology and metabolism	2012	90
22581228	Cholesterol	Manning AK	A genome-wide approach accounting for body mass index identifies genetic variants influencing fasting glycemic traits and insulin resistance.	Nature genetics	2012	232
22672914	Cholesterol	Feng RN	BMI is strongly associated with hypertension, and waist circumference is strongly associated with type 2 diabetes and dyslipidemia, in northern Chinese adults.	Journal of epidemiology	2012	32
22738663	Cholesterol	Yan S	The expanding burden of cardiometabolic risk in China: the China Health and Nutrition Survey.	Obesity reviews 	2012	47
22741595	Cholesterol	Liu CJ	Prevalence and risk factors for non-alcoholic fatty liver disease in Asian people who are not obese.	Journal of gastroenterology and hepatology	2012	39
22751103	Cholesterol	Strong A	Hepatic sortilin regulates both apolipoprotein B secretion and LDL catabolism.	The Journal of clinical investigation	2012	59
22773877	Cholesterol	Yuan M	Identification of Akt-independent regulation of hepatic lipogenesis by mammalian target of rapamycin (mTOR) complex 2.	The Journal of biological chemistry	2012	49
22858285	Cholesterol	Mehta NN	Abnormal lipoprotein particles and cholesterol efflux capacity in patients with psoriasis.	Atherosclerosis	2012	32
22893714	Cholesterol	Benn M	Familial hypercholesterolemia in the danish general population: prevalence, coronary artery disease, and cholesterol-lowering medication.	The Journal of clinical endocrinology and metabolism	2012	61
23034020	Cholesterol	Emerging Risk Factors Collaboration.	C-reactive protein, fibrinogen, and cardiovascular disease prediction.	The New England journal of medicine	2012	197
23111762	Cholesterol	Buchacz K	Disparities in prevalence of key chronic diseases by gender and race/ethnicity among antiretroviral-treated HIV-infected adults in the US.	Antiviral therapy	2013	39
23111824	Cholesterol	Hallan SI	Age and association of kidney measures with mortality and end-stage renal disease.	JAMA	2012	103
23129601	Cholesterol	Ridker PM	Effects of interleukin-1β inhibition with canakinumab on hemoglobin A1c, lipids, C-reactive protein, interleukin-6, and fibrinogen: a phase IIb randomized, placebo-controlled trial.	Circulation	2012	89
23141484	Cholesterol	Yamamoto S	Dysfunctional high-density lipoprotein in patients on chronic hemodialysis.	Journal of the American College of Cardiology	2012	43
23160641	Cholesterol	Albrechtsen A	Exome sequencing-driven discovery of coding polymorphisms associated with common metabolic phenotypes.	Diabetologia	2013	41
23234628	Cholesterol	Saylor PJ	Metabolic complications of androgen deprivation therapy for prostate cancer.	The Journal of urology	2013	25
23471228	Cholesterol	Shimabukuro M	Epicardial adipose tissue volume and adipocytokine imbalance are strongly linked to human coronary atherosclerosis.	Arteriosclerosis, thrombosis, and vascular biology	2013	25
23584084	Cholesterol	Klop B	Dyslipidemia in obesity: mechanisms and potential targets.	Nutrients	2013	93
23628621	Cholesterol	Stone MA	Quality of care of people with type 2 diabetes in eight European countries: findings from the Guideline Adherence to Enhance Care (GUIDANCE) study.	Diabetes care	2013	26
23663738	Cholesterol	Nagareddy PR	Hyperglycemia promotes myelopoiesis and impairs the resolution of atherosclerosis.	Cell metabolism	2013	71
23727030	Cholesterol	Yamada H	Associations between circulating microRNAs (miR-21, miR-34a, miR-122 and miR-451) and non-alcoholic fatty liver.	Clinica chimica acta; international journal of clinical chemistry	2013	41
23778747	Cholesterol	Ho M	Impact of dietary and exercise interventions on weight change and metabolic outcomes in obese children and adolescents: a systematic review and meta-analysis of randomized trials.	JAMA pediatrics	2013	38
23798679	Cholesterol	McGettrick AF	How metabolism generates signals during innate immunity and inflammation.	The Journal of biological chemistry	2013	47
23817481	Cholesterol	Egan BM	Blood pressure and cholesterol control in hypertensive hypercholesterolemic patients: national health and nutrition examination surveys 1988-2010.	Circulation	2013	27
23884353	Cholesterol	Desai NR	AMG145, a monoclonal antibody against proprotein convertase subtilisin kexin type 9, significantly reduces lipoprotein(a) in hypercholesterolemic patients receiving statin therapy: an analysis from the LDL-C Assessment with Proprotein Convertase Subtilisin Kexin Type 9 Monoclonal Antibody Inhibition Combined with Statin Therapy (LAPLACE)-Thrombolysis in Myocardial Infarction (TIMI) 57 trial.	Circulation	2013	37
23926208	Cholesterol	Varbo A	Elevated remnant cholesterol causes both low-grade inflammation and ischemic heart disease, whereas elevated low-density lipoprotein cholesterol causes ischemic heart disease without inflammation.	Circulation	2013	29
23981342	Cholesterol	Shen Y	Additive relationship between serum fibroblast growth factor 21 level and coronary artery disease.	Cardiovascular diabetology	2013	26
23995691	Cholesterol	Mangravite LM	A statin-dependent QTL for GATM expression is associated with statin-induced myopathy.	Nature	2013	50
24013639	Cholesterol	Westra HJ	Systematic identification of trans eQTLs as putative drivers of known disease associations.	Nature genetics	2013	432
24097125	Cholesterol	Park S	The physiological roles of apolipoprotein J/clusterin in metabolic and cardiovascular diseases.	Reviews in endocrine & metabolic disorders	2014	21
24366527	Cholesterol	McKee AC	The neuropathology of sport.	Acta neuropathologica	2014	56
24371263	Cholesterol	Herman-Edelstein M	Altered renal lipid metabolism and renal lipid accumulation in human diabetic nephropathy.	Journal of lipid research	2014	38
24384645	Cholesterol	Breuer J	Herpes zoster as a risk factor for stroke and TIA: a retrospective cohort study in the UK.	Neurology	2014	27
24422572	Cholesterol	Jesus AA	IL-1 blockade in autoinflammatory syndromes.	Annual review of medicine	2014	41
24497850	Cholesterol	Service SK	Re-sequencing expands our understanding of the phenotypic impact of variants at GWAS loci.	PLoS genetics	2014	23
24558110	Cholesterol	Hoogeveen RC	Small dense low-density lipoprotein-cholesterol concentrations predict risk for coronary heart disease: the Atherosclerosis Risk In Communities (ARIC) study.	Arteriosclerosis, thrombosis, and vascular biology	2014	36
24568896	Cholesterol	Bhindi B	Dissecting the association between metabolic syndrome and prostate cancer risk: analysis of a large clinical cohort.	European urology	2015	20
24602293	Cholesterol	Gacci M	Metabolic syndrome and benign prostatic enlargement: a systematic review and meta-analysis.	BJU international	2015	23
24647144	Cholesterol	Shao B	Humans with atherosclerosis have impaired ABCA1 cholesterol efflux and enhanced high-density lipoprotein oxidation by myeloperoxidase.	Circulation research	2014	45
24663222	Cholesterol	Laakso M	Insulin resistance and hyperglycaemia in cardiovascular disease development.	Nature reviews. Endocrinology	2014	41
24668104	Cholesterol	Emerging Risk Factors Collaboration.	Glycated hemoglobin measurement and prediction of cardiovascular disease.	JAMA	2014	35
24709991	Cholesterol	Yan B	Association of serum irisin with metabolic syndrome in obese Chinese adults.	PloS one	2014	25
24722445	Cholesterol	de Zeeuw D	The endothelin antagonist atrasentan lowers residual albuminuria in patients with type 2 diabetic nephropathy.	Journal of the American Society of Nephrology 	2014	42
24732719	Cholesterol	Carson V	Patterns of sedentary time and cardiometabolic risk among Canadian adults.	Preventive medicine	2014	33
24832097	Cholesterol	Rahman M	Relation of serum lipids and lipoproteins with progression of CKD: The CRIC study.	Clinical journal of the American Society of Nephrology 	2014	22
24861084	Cholesterol	Fornoni A	Lipid biology of the podocyte--new perspectives offer new opportunities.	Nature reviews. Nephrology	2014	22
24918789	Cholesterol	Usiskin K	Safety and tolerability of canagliflozin in patients with type 2 diabetes mellitus: pooled analysis of phase 3 study results.	Postgraduate medicine	2014	29
25037695	Cholesterol	Roth EM	Monotherapy with the PCSK9 inhibitor alirocumab versus ezetimibe in patients with hypercholesterolemia: results of a 24 week, double-blind, randomized Phase 3 trial.	International journal of cardiology	2014	44
25467842	Cholesterol	Chen L	Effect of lifestyle intervention in patients with type 2 diabetes: a meta-analysis.	Metabolism	2015	24
25495720	Cholesterol	Bode B	Long-term efficacy and safety of canagliflozin over 104 weeks in patients aged 55-80 years with type 2 diabetes.	Diabetes, obesity & metabolism	2015	28
25589482	Cholesterol	Inzucchi SE	SGLT-2 inhibitors and cardiovascular risk: proposed pathways and review of ongoing outcome trials.	Diabetes & vascular disease research	2015	58
25675507	Cholesterol	Guillaumond F	Cholesterol uptake disruption, in association with chemotherapy, is a promising combined metabolic therapy for pancreatic adenocarcinoma.	Proceedings of the National Academy of Sciences of the United States of America	2015	34
25725623	Cholesterol	Vergès B	Pathophysiology of diabetic dyslipidaemia: where are we?	Diabetologia	2015	20
25756439	Cholesterol	Besseling J	Association between familial hypercholesterolemia and prevalence of type 2 diabetes mellitus.	JAMA	2015	28
25904599	Cholesterol	Zhang H	Functional analysis and transcriptomic profiling of iPSC-derived macrophages and their application in modeling Mendelian disease.	Circulation research	2015	18
25961943	Cholesterol	Surakka I	The impact of low-frequency and rare variants on lipid levels.	Nature genetics	2015	47
26030325	Cholesterol	Bays H	Alirocumab as Add-On to Atorvastatin Versus Other Lipid Treatment Strategies: ODYSSEY OPTIONS I Randomized Trial.	The Journal of clinical endocrinology and metabolism	2015	31
26079503	Cholesterol	Østergaard SD	Associations between Potentially Modifiable Risk Factors and Alzheimer Disease: A Mendelian Randomization Study.	PLoS medicine	2015	27
26116691	Cholesterol	Lin X	Effects of Exercise Training on Cardiorespiratory Fitness and Biomarkers of Cardiometabolic Health: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.	Journal of the American Heart Association	2015	32
26153245	Cholesterol	Ding J	Alterations of a Cellular Cholesterol Metabolism Network Are a Molecular Feature of Obesity-Related Type 2 Diabetes and Cardiovascular Disease.	Diabetes	2015	19
26227186	Cholesterol	Tsujita K	Impact of Dual Lipid-Lowering Strategy With Ezetimibe and Atorvastatin on Coronary Plaque Regression in Patients With Percutaneous Coronary Intervention: The Multicenter Randomized Controlled PRECISE-IVUS Trial.	Journal of the American College of Cardiology	2015	22
26556368	Cholesterol	Yki-Järvinen H	Nutritional Modulation of Non-Alcoholic Fatty Liver Disease and Insulin Resistance.	Nutrients	2015	16
26693205	Cholesterol	Verdile G	Inflammation and Oxidative Stress: The Molecular Connectivity between Insulin Resistance, Obesity, and Alzheimer's Disease.	Mediators of inflammation	2015	24
26712688	Cholesterol	Iyengar NM	Systemic Correlates of White Adipose Tissue Inflammation in Early-Stage Breast Cancer.	Clinical cancer research 	2016	27
26718096	Cholesterol	Banach M	Lipids, blood pressure and kidney update 2015.	Lipids in health and disease	2015	17
26732026	Cholesterol	Tonucci LB	Clinical application of probiotics in type 2 diabetes mellitus: A randomized, double-blind, placebo-controlled study.	Clinical nutrition	2017	10
26817832	Cholesterol	Ortega Moreno L	Evidence of a causal relationship between high serum adiponectin levels and increased cardiovascular mortality rate in patients with type 2 diabetes.	Cardiovascular diabetology	2016	10
26868195	Cholesterol	Sattar N	Lipid-lowering efficacy of the PCSK9 inhibitor evolocumab (AMG 145) in patients with type 2 diabetes: a meta-analysis of individual patient data.	The lancet. Diabetes & endocrinology	2016	17
26896437	Cholesterol	Leander K	Circulating Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Predicts Future Risk of Cardiovascular Events Independently of Established Risk Factors.	Circulation	2016	14
27009502	Cholesterol	Vienberg S	MicroRNAs in metabolism.	Acta physiologica	2017	20
27009625	Cholesterol	Wu JH	Effects of sodium-glucose cotransporter-2 inhibitors on cardiovascular events, death, and major safety outcomes in adults with type 2 diabetes: a systematic review and meta-analysis.	The lancet. Diabetes & endocrinology	2016	45
27015805	Cholesterol	Pilling LC	Human longevity is influenced by many genetic variants: evidence from 75,000 UK Biobank participants.	Aging	2016	15
27040132	Cholesterol	Yusuf S	Cholesterol Lowering in Intermediate-Risk Persons without Cardiovascular Disease.	The New England journal of medicine	2016	45
27322064	Cholesterol	Volkov P	A Genome-Wide mQTL Analysis in Human Adipose Tissue Identifies Genetic Variants Associated with DNA Methylation, Gene Expression and Metabolic Traits.	PloS one	2016	11
27623982	Cholesterol	Liu F	Effect of inulin-type fructans on blood lipid profile and glucose level: a systematic review and meta-analysis of randomized controlled trials.	European journal of clinical nutrition	2017	9
27701660	Cholesterol	Lotta LA	Association Between Low-Density Lipoprotein Cholesterol-Lowering Genetic Variants and Risk of Type 2 Diabetes: A Meta-analysis.	JAMA	2016	31
27841877	Cholesterol	Lotta LA	Integrative genomic analysis implicates limited peripheral adipose storage capacity in the pathogenesis of human insulin resistance.	Nature genetics	2017	27
27935183	Cholesterol	Petrie JR	Metformin in adults with type 1 diabetes: Design and methods of REducing with MetfOrmin Vascular Adverse Lesions (REMOVAL): An international multicentre trial.	Diabetes, obesity & metabolism	2017	5
27942709	Cholesterol	Berkowitz SA	Addressing Unmet Basic Resource Needs as Part of Chronic Cardiometabolic Disease Management.	JAMA internal medicine	2017	8
27986651	Cholesterol	Reyes-Soffer G	Effects of PCSK9 Inhibition With Alirocumab on Lipoprotein Metabolism in Healthy Humans.	Circulation	2017	12
28031477	Cholesterol	Lordén G	Lipin-2 regulates NLRP3 inflammasome by affecting P2X7 receptor activation.	The Journal of experimental medicine	2017	6
28167322	Cholesterol	Mridha AR	NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice.	Journal of hepatology	2017	12
28208791	Cholesterol	Menezes R	Impact of Flavonols on Cardiometabolic Biomarkers:  A Meta-Analysis of Randomized Controlled Human  Trials to Explore the Role of Inter-Individual  Variability.	Nutrients	2017	7
28334899	Cholesterol	Spracklen CN	Association analyses of East Asian individuals and trans-ancestry analyses with European individuals reveal new loci associated with cholesterol and triglyceride levels.	Human molecular genetics	2017	7
8413456	Creatinine	Lewis EJ	The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group.	The New England journal of medicine	1993	517
10550418	Creatinine	Meyer TW	Podocyte number predicts long-term urinary albumin excretion in Pima Indians with Type II diabetes and microalbuminuria.	Diabetologia	1999	111
10807470	Creatinine	Gottdiener JS	Predictors of congestive heart failure in the elderly: the Cardiovascular Health Study.	Journal of the American College of Cardiology	2000	205
10886574	Creatinine	Muntner P	Plasma lipids and risk of developing renal dysfunction: the atherosclerosis risk in communities study.	Kidney international	2000	108
11916939	Creatinine	Stehouwer CD	Increased urinary albumin excretion, endothelial dysfunction, and chronic low-grade inflammation in type 2 diabetes: progressive, interrelated, and independently associated with risk of death.	Diabetes	2002	103
11961019	Creatinine	Paniagua R	Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective, randomized, controlled trial.	Journal of the American Society of Nephrology 	2002	103
13679476	Creatinine	Hoek FJ	A comparison between cystatin C, plasma creatinine and the Cockcroft and Gault formula for the estimation of glomerular filtration rate.	Nephrology, dialysis, transplantation 	2003	76
14715185	Creatinine	Forman DE	Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure.	Journal of the American College of Cardiology	2004	115
15150204	Creatinine	Merten GJ	Prevention of contrast-induced nephropathy with sodium bicarbonate: a randomized controlled trial.	JAMA	2004	105
15615823	Creatinine	Poggio ED	Performance of the modification of diet in renal disease and Cockcroft-Gault equations in the estimation of GFR in health and in chronic kidney disease.	Journal of the American Society of Nephrology 	2005	99
15788478	Creatinine	Perkins BA	Detection of renal function decline in patients with diabetes and normal or elevated GFR by serial measurements of serum cystatin C concentration: results of a 4-year follow-up study.	Journal of the American Society of Nephrology 	2005	91
16401840	Creatinine	Gurol ME	Plasma beta-amyloid and white matter lesions in AD, MCI, and cerebral amyloid angiopathy.	Neurology	2006	123
16551713	Creatinine	Mora S	Association of physical activity and body mass index with novel and traditional cardiovascular biomarkers in women.	JAMA	2006	77
16971655	Creatinine	Zhao HJ	Endothelial nitric oxide synthase deficiency produces accelerated nephropathy in diabetic mice.	Journal of the American Society of Nephrology 	2006	111
17428730	Creatinine	Rubenstrunk A	Safety issues and prospects for future generations of PPAR modulators.	Biochimica et biophysica acta	2007	70
17962588	Creatinine	Khatri M	Chronic kidney disease is associated with white matter hyperintensity volume: the Northern Manhattan Study (NOMAS).	Stroke	2007	60
18076931	Creatinine	Thompson RH	Radical nephrectomy for pT1a renal masses may be associated with decreased overall survival compared with partial nephrectomy.	The Journal of urology	2008	96
19119287	Creatinine	Stevens LA	Factors other than glomerular filtration rate affect serum cystatin C levels.	Kidney international	2009	120
19838127	Creatinine	Horberg M	Impact of tenofovir on renal function in HIV-infected, antiretroviral-naive patients.	Journal of acquired immune deficiency syndromes	2010	44
20138414	Creatinine	White SL	Comparison of the prevalence and mortality risk of CKD in Australia using the CKD Epidemiology Collaboration (CKD-EPI) and Modification of Diet in Renal Disease (MDRD) Study GFR estimating equations: the AusDiab (Australian Diabetes, Obesity and Lifestyle) Study.	American journal of kidney diseases 	2010	59
20332356	Creatinine	Ficociello LH	High-normal serum uric acid increases risk of early progressive renal function loss in type 1 diabetes: results of a 6-year follow-up.	Diabetes care	2010	48
20385436	Creatinine	Bellomo G	Association of uric acid with change in kidney function in healthy normotensive individuals.	American journal of kidney diseases 	2010	45
20441712	Creatinine	Black C	Early referral strategies for management of people with markers of renal disease: a systematic review of the evidence of clinical effectiveness, cost-effectiveness and economic analysis.	Health technology assessment	2010	47
20522536	Creatinine	Adler SG	Phase 1 study of anti-CTGF monoclonal antibody in patients with diabetes and microalbuminuria.	Clinical journal of the American Society of Nephrology 	2010	48
20557989	Creatinine	Stevens LA	Comparative performance of the CKD Epidemiology Collaboration (CKD-EPI) and the Modification of Diet in Renal Disease (MDRD) Study equations for estimating GFR levels above 60 mL/min/1.73 m2.	American journal of kidney diseases 	2010	112
20686651	Creatinine	Gudbjartsson DF	Association of variants at UMOD with chronic kidney disease and kidney stones-role of age and comorbid diseases.	PLoS genetics	2010	50
21098347	Creatinine	Roussel R	Metformin use and mortality among patients with diabetes and atherothrombosis.	Archives of internal medicine	2010	54
21242477	Creatinine	James MT	Associations between acute kidney injury and cardiovascular and renal outcomes after coronary angiography.	Circulation	2011	49
21338849	Creatinine	Stevens LA	Comparison of the CKD Epidemiology Collaboration (CKD-EPI) and Modification of Diet in Renal Disease (MDRD) study equations: risk factors for and complications of CKD and mortality in the Kidney Early Evaluation Program (KEEP).	American journal of kidney diseases 	2011	40
21355061	Creatinine	Böger CA	CUBN is a gene locus for albuminuria.	Journal of the American Society of Nephrology 	2011	71
21372210	Creatinine	Kohan DE	Addition of atrasentan to renin-angiotensin system blockade reduces albuminuria in diabetic nephropathy.	Journal of the American Society of Nephrology 	2011	46
21632472	Creatinine	Miao Y	Effect of a reduction in uric acid on renal outcomes during losartan treatment: a post hoc analysis of the reduction of endpoints in non-insulin-dependent diabetes mellitus with the Angiotensin II Antagonist Losartan Trial.	Hypertension	2011	36
21672124	Creatinine	Graefe-Mody U	Effect of renal impairment on the pharmacokinetics of the dipeptidyl peptidase-4 inhibitor linagliptin(*).	Diabetes, obesity & metabolism	2011	44
21779943	Creatinine	Fu WJ	Urinary tubular biomarkers in short-term type 2 diabetes mellitus patients: a cross-sectional study.	Endocrine	2012	30
22658574	Creatinine	Anderson AH	Estimating GFR among participants in the Chronic Renal Insufficiency Cohort (CRIC) Study.	American journal of kidney diseases 	2012	68
22762315	Creatinine	Inker LA	Estimating glomerular filtration rate from serum creatinine and cystatin C.	The New England journal of medicine	2012	532
22770927	Creatinine	Roshanravan B	A prospective study of frailty in nephrology-referred patients with CKD.	American journal of kidney diseases 	2012	54
23423253	Creatinine	Rule AD	Estimating the glomerular filtration rate from serum creatinine is better than from cystatin C for evaluating risk factors associated with chronic kidney disease.	Kidney international	2013	40
23464594	Creatinine	Yale JF	Efficacy and safety of canagliflozin in subjects with type 2 diabetes and chronic kidney disease.	Diabetes, obesity & metabolism	2013	94
23540260	Creatinine	Kim HR	Circulating α-klotho levels in CKD and relationship to progression.	American journal of kidney diseases 	2013	30
23619125	Creatinine	Grams ME	Trends in the prevalence of reduced GFR in the United States: a comparison of creatinine- and cystatin C-based estimates.	American journal of kidney diseases 	2013	29
23886566	Creatinine	Sharma SG	The modern spectrum of renal biopsy findings in patients with diabetes.	Clinical journal of the American Society of Nephrology 	2013	31
23887638	Creatinine	Chow WS	Serum fibroblast growth factor-21 levels are associated with carotid atherosclerosis independent of established cardiovascular risk factors.	Arteriosclerosis, thrombosis, and vascular biology	2013	32
23939543	Creatinine	Krolewski AS	Early progressive renal decline precedes the onset of microalbuminuria and its progression to macroalbuminuria.	Diabetes care	2014	50
24206458	Creatinine	Parsa A	APOL1 risk variants, race, and progression of chronic kidney disease.	The New England journal of medicine	2013	175
24211404	Creatinine	Zubiri I	Diabetic nephropathy induces changes in the proteome of human urinary exosomes as revealed by label-free comparative analysis.	Journal of proteomics	2014	32
24904085	Creatinine	Sabbisetti VS	Blood kidney injury molecule-1 is a biomarker of acute and chronic kidney injury and predicts progression to ESRD in type I diabetes.	Journal of the American Society of Nephrology 	2014	45
24965700	Creatinine	Yale JF	Efficacy and safety of canagliflozin over 52 weeks in patients with type 2 diabetes mellitus and chronic kidney disease.	Diabetes, obesity & metabolism	2014	29
25029429	Creatinine	Langefeld CD	Apolipoprotein L1 gene variants associate with prevalent kidney but not prevalent cardiovascular disease in the Systolic Blood Pressure Intervention Trial.	Kidney international	2015	33
25054777	Creatinine	Freedman BI	APOL1 associations with nephropathy, atherosclerosis, and all-cause mortality in African Americans with type 2 diabetes.	Kidney international	2015	30
25063425	Creatinine	An Y	Renal histologic changes and the outcome in patients with diabetic nephropathy.	Nephrology, dialysis, transplantation 	2015	17
25145934	Creatinine	Lai JY	MicroRNA-21 in glomerular injury.	Journal of the American Society of Nephrology 	2015	27
25272234	Creatinine	Pavkov ME	Elevation of circulating TNF receptors 1 and 2 increases the risk of end-stage renal disease in American Indians with type 2 diabetes.	Kidney international	2015	19
25311702	Creatinine	Liu KD	Urine neutrophil gelatinase-associated lipocalin and risk of cardiovascular disease and death in CKD: results from the Chronic Renal Insufficiency Cohort (CRIC) Study.	American journal of kidney diseases 	2015	18
25316431	Creatinine	Fufaa GD	Association of urinary KIM-1, L-FABP, NAG and NGAL with incident end-stage renal disease and mortality in American Indians with type 2 diabetes mellitus.	Diabetologia	2015	21
26180129	Creatinine	Peralta CA	APOL1 Genotype and Race Differences in Incident Albuminuria and Renal Function Decline.	Journal of the American Society of Nephrology 	2016	17
26268910	Creatinine	de Zeeuw D	The effect of CCR2 inhibitor CCX140-B on residual albuminuria in patients with type 2 diabetes and nephropathy: a randomised trial.	The lancet. Diabetes & endocrinology	2015	31
26362696	Creatinine	Inker LA	GFR Estimation Using β-Trace Protein and β2-Microglobulin in CKD.	American journal of kidney diseases 	2016	15
26690912	Creatinine	Heung M	Acute Kidney Injury Recovery Pattern and Subsequent Risk of CKD: An Analysis of Veterans Health Administration Data.	American journal of kidney diseases 	2016	11
26837280	Creatinine	Bai X	MicroRNA-130b improves renal tubulointerstitial fibrosis via repression of Snail-induced epithelial-mesenchymal transition in diabetic nephropathy.	Scientific reports	2016	13
26906014	Creatinine	Billings FT 4th	High-Dose Perioperative Atorvastatin and Acute Kidney Injury Following Cardiac Surgery: A Randomized Clinical Trial.	JAMA	2016	28
27479614	Creatinine	Murphy D	Trends in Prevalence of Chronic Kidney Disease in the United States.	Annals of internal medicine	2016	18
27532915	Creatinine	Afkarian M	Clinical Manifestations of Kidney Disease Among US Adults With Diabetes, 1988-2014.	JAMA	2016	19
27647855	Creatinine	Voelker J	Anti-TGF-β1 Antibody Therapy in Patients with Diabetic Nephropathy.	Journal of the American Society of Nephrology 	2017	7
28186566	Creatinine	Menne J	C-C motif-ligand 2 inhibition with emapticap pegol (NOX-E36) in type 2 diabetic patients with albuminuria.	Nephrology, dialysis, transplantation 	2017	9
28262773	Creatinine	Hocher B	Metabolomics for clinical use and research in chronic kidney disease.	Nature reviews. Nephrology	2017	13
16041161	Uric Acid	Yoo TW	Relationship between serum uric acid concentration and insulin resistance and metabolic syndrome.	Circulation journal 	2005	67
18179892	Uric Acid	Wallace C	Genome-wide association study identifies genes for biomarkers of cardiovascular disease: serum urate and dyslipidemia.	American journal of human genetics	2008	178
18327256	Uric Acid	Döring A	SLC2A9 influences uric acid concentrations with pronounced sex-specific effects.	Nature genetics	2008	136
18337481	Uric Acid	Weiner DE	Uric acid and incident kidney disease in the community.	Journal of the American Society of Nephrology 	2008	80
19503597	Uric Acid	Kolz M	Meta-analysis of 28,141 individuals identifies common variants within five new loci that influence uric acid concentrations.	PLoS genetics	2009	180
19565556	Uric Acid	Kim SY	Hyperuricemia and risk of stroke: a systematic review and meta-analysis.	Arthritis and rheumatism	2009	78
20516647	Uric Acid	So A	Uric acid transport and disease.	The Journal of clinical investigation	2010	88
22028277	Uric Acid	Zoppini G	Serum uric acid levels and incident chronic kidney disease in patients with type 2 diabetes and preserved kidney function.	Diabetes care	2012	37
22629362	Uric Acid	Moreno-Navarrete JM	Circulating zonulin, a marker of intestinal permeability, is increased in association with obesity-associated insulin resistance.	PloS one	2012	35
22945591	Uric Acid	Rock KL	Uric acid as a danger signal in gout and its comorbidities.	Nature reviews. Rheumatology	2013	48
23437258	Uric Acid	Lv Q	High serum uric acid and increased risk of type 2 diabetes: a systemic review and meta-analysis of prospective cohort studies.	PloS one	2013	31
25646370	Uric Acid	Matsuo H	Genome-wide association study of clinically defined gout identifies multiple risk loci and its association with clinical subtypes.	Annals of the rheumatic diseases	2016	22
10426379	Triglycerides	Perseghin G	Intramyocellular triglyceride content is a determinant of in vivo insulin resistance in humans: a 1H-13C nuclear magnetic resonance spectroscopy assessment in offspring of type 2 diabetic parents.	Diabetes	1999	163
11856796	Triglycerides	Oral EA	Leptin-replacement therapy for lipodystrophy.	The New England journal of medicine	2002	203
11967537	Triglycerides	Agarwal AK	AGPAT2 is mutated in congenital generalized lipodystrophy linked to chromosome 9q34.	Nature genetics	2002	104
12225719	Triglycerides	Abbasi F	Relationship between obesity, insulin resistance, and coronary heart disease risk.	Journal of the American College of Cardiology	2002	88
12832613	Triglycerides	Patti ME	Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of PGC1 and NRF1.	Proceedings of the National Academy of Sciences of the United States of America	2003	512
14976145	Triglycerides	Fu L	Fibroblast growth factor 19 increases metabolic rate and reverses dietary and leptin-deficient diabetes.	Endocrinology	2004	134
15522914	Triglycerides	Sharma S	Intramyocardial lipid accumulation in the failing human heart resembles the lipotoxic rat heart.	FASEB journal 	2004	177
15983199	Triglycerides	Javor ED	Long-term efficacy of leptin replacement in patients with generalized lipodystrophy.	Diabetes	2005	65
16641093	Triglycerides	Tuncman G	A genetic variant at the fatty acid-binding protein aP2 locus reduces the risk for hypertriglyceridemia, type 2 diabetes, and cardiovascular disease.	Proceedings of the National Academy of Sciences of the United States of America	2006	64
17068132	Triglycerides	Kharitonenkov A	The metabolic state of diabetic monkeys is regulated by fibroblast growth factor-21.	Endocrinology	2007	166
17463246	Triglycerides	Diabetes Genetics Initiative of Broad Institute of Harvard and MIT, Lund University, and Novartis Institutes of BioMedical Research.	Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels.	Science	2007	1043
18193043	Triglycerides	Willer CJ	Newly identified loci that influence lipid concentrations and risk of coronary artery disease.	Nature genetics	2008	608
18193044	Triglycerides	Kathiresan S	Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans.	Nature genetics	2008	496
18202123	Triglycerides	Ducharme NA	Lipid droplets in lipogenesis and lipolysis.	Endocrinology	2008	138
18384521	Triglycerides	Leite NC	Prevalence and associated factors of non-alcoholic fatty liver disease in patients with type-2 diabetes mellitus.	Liver international 	2009	88
18556336	Triglycerides	Vaxillaire M	The common P446L polymorphism in GCKR inversely modulates fasting glucose and triglyceride levels and reduces type 2 diabetes risk in the DESIR prospective general French population.	Diabetes	2008	55
18678614	Triglycerides	Orho-Melander M	Common missense variant in the glucokinase regulatory protein gene is associated with increased plasma triglyceride and C-reactive protein but lower fasting glucose concentrations.	Diabetes	2008	97
18757836	Triglycerides	Yen CL	Thematic review series: glycerolipids. DGAT enzymes and triacylglycerol biosynthesis.	Journal of lipid research	2008	197
18775362	Triglycerides	Halberg N	The adipocyte as an endocrine cell.	Endocrinology and metabolism clinics of North America	2008	96
19948243	Triglycerides	Unger RH	Lipid homeostasis, lipotoxicity and the metabolic syndrome.	Biochimica et biophysica acta	2010	136
19958841	Triglycerides	Muoio DM	Intramuscular triacylglycerol and insulin resistance: guilty as charged or wrongly accused?	Biochimica et biophysica acta	2010	49
20126310	Triglycerides	Ortega FJ	MiRNA expression profile of human subcutaneous adipose and during adipocyte differentiation.	PloS one	2010	82
20335584	Triglycerides	Petersen KF	Apolipoprotein C3 gene variants in nonalcoholic fatty liver disease.	The New England journal of medicine	2010	98
20648472	Triglycerides	Speliotes EK	PNPLA3 variants specifically confer increased risk for histologic nonalcoholic fatty liver disease but not metabolic disease.	Hepatology	2010	77
20816089	Triglycerides	Kim HS	Hepatic-specific disruption of SIRT6 in mice results in fatty liver formation due to enhanced glycolysis and triglyceride synthesis.	Cell metabolism	2010	128
21345103	Triglycerides	Gandotra S	Perilipin deficiency and autosomal dominant partial lipodystrophy.	The New England journal of medicine	2011	41
21403038	Triglycerides	de Boer IH	Long-term renal outcomes of patients with type 1 diabetes mellitus and microalbuminuria: an analysis of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications cohort.	Archives of internal medicine	2011	76
21515403	Triglycerides	Pérez E	Modulation of RXR function through ligand design.	Biochimica et biophysica acta	2012	50
21636801	Triglycerides	Lassenius MI	Bacterial endotoxin activity in human serum is associated with dyslipidemia, insulin resistance, obesity, and chronic inflammation.	Diabetes care	2011	74
21803291	Triglycerides	Pihlajamäki J	Expression of the splicing factor gene SFRS10 is reduced in human obesity and contributes to enhanced lipogenesis.	Cell metabolism	2011	38
22041985	Triglycerides	Lloyd LJ	Childhood obesity and risk of the adult metabolic syndrome: a systematic review.	International journal of obesity	2012	42
22215383	Triglycerides	Monami M	DPP-4 inhibitors and lipids: systematic review and meta-analysis.	Advances in therapy	2012	39
22302940	Triglycerides	Hugo SE	A monocarboxylate transporter required for hepatocyte secretion of ketone bodies during fasting.	Genes & development	2012	34
22426755	Triglycerides	Montonen J	Consumption of red meat and whole-grain bread in relation to biomarkers of obesity, inflammation, glucose metabolism and oxidative stress.	European journal of nutrition	2013	29
22935803	Triglycerides	Coppari R	Leptin revisited: its mechanism of action and potential for treating diabetes.	Nature reviews. Drug discovery	2012	69
23034965	Triglycerides	Itariu BK	Long-chain n-3 PUFAs reduce adipose tissue and systemic inflammation in severely obese nondiabetic patients: a randomized controlled trial.	The American journal of clinical nutrition	2012	43
23399566	Triglycerides	Grahn TH	FSP27 and PLIN1 interaction promotes the formation of large lipid droplets in human adipocytes.	Biochemical and biophysical research communications	2013	27
23542898	Triglycerides	Graham MJ	Antisense oligonucleotide inhibition of apolipoprotein C-III reduces plasma triglycerides in rodents, nonhuman primates, and humans.	Circulation research	2013	54
24172179	Triglycerides	Scherer J	Issues in hypertriglyceridemic pancreatitis: an update.	Journal of clinical gastroenterology	2014	31
24343240	Triglycerides	Tachmazidou I	A rare functional cardioprotective APOC3 variant has risen in frequency in distinct population isolates.	Nature communications	2013	31
24390345	Triglycerides	SIGMA Type 2 Diabetes Consortium.	Sequence variants in SLC16A11 are a common risk factor for type 2 diabetes in Mexico.	Nature	2014	84
24507774	Triglycerides	Peloso GM	Association of low-frequency and rare coding-sequence variants with blood lipids and coronary heart disease in 56,000 whites and blacks.	American journal of human genetics	2014	80
24722249	Triglycerides	Li N	Pleiotropic effects of lipid genes on plasma glucose, HbA1c, and HOMA-IR levels.	Diabetes	2014	21
25038053	Triglycerides	Goedeke L	Long-term therapeutic silencing of miR-33 increases circulating triglyceride levels and hepatic lipid accumulation in mice.	EMBO molecular medicine	2014	35
25457209	Triglycerides	Zhou Y	Circulating triacylglycerol signatures and insulin sensitivity in NAFLD associated with the E167K variant in TM6SF2.	Journal of hepatology	2015	16
25885947	Triglycerides	Portillo-Sanchez P	High Prevalence of Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes Mellitus and Normal Plasma Aminotransferase Levels.	The Journal of clinical endocrinology and metabolism	2015	27
25913420	Triglycerides	Brocklebank LA	Accelerometer-measured sedentary time and cardiometabolic biomarkers: A systematic review.	Preventive medicine	2015	37
26021296	Triglycerides	Allum F	Characterization of functional methylomes by next-generation capture sequencing identifies novel disease-associated variants.	Nature communications	2015	26
26100857	Triglycerides	Xu Y	A metabolic stress-inducible miR-34a-HNF4α pathway regulates lipid and lipoprotein metabolism.	Nature communications	2015	21
26239609	Triglycerides	Patni N	Congenital generalized lipodystrophies--new insights into metabolic dysfunction.	Nature reviews. Endocrinology	2015	22
27528697	Triglycerides	Cohen P	Cell biology of fat storage.	Molecular biology of the cell	2016	14
22323564	Angiotensinogen	Xu XJ	Insulin sensitive and resistant obesity in humans: AMPK activity, oxidative stress, and depot-specific changes in gene expression in adipose tissue.	Journal of lipid research	2012	45
9335502	Fatty Acids	Uysal KT	Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function.	Nature	1997	438
9916795	Fatty Acids	Aitman TJ	Identification of Cd36 (Fat) as an insulin-resistance gene causing defective fatty acid and glucose metabolism in hypertensive rats.	Nature genetics	1999	120
10794683	Fatty Acids	Knudsen LB	Potent derivatives of glucagon-like peptide-1 with pharmacokinetic properties suitable for once daily administration.	Journal of medicinal chemistry	2000	104
10905472	Fatty Acids	Kelley DE	Fuel selection in human skeletal muscle in insulin resistance: a reexamination.	Diabetes	2000	175
11052966	Fatty Acids	Belke DD	Altered metabolism causes cardiac dysfunction in perfused hearts from diabetic (db/db) mice.	American journal of physiology. Endocrinology and metabolism	2000	94
11237216	Fatty Acids	Kliewer SA	Peroxisome proliferator-activated receptors: from genes to physiology.	Recent progress in hormone research	2001	89
11797013	Fatty Acids	Minokoshi Y	Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase.	Nature	2002	369
11818483	Fatty Acids	Berger J	The mechanisms of action of PPARs.	Annual review of medicine	2002	398
12242452	Fatty Acids	Frayn KN	Adipose tissue as a buffer for daily lipid flux.	Diabetologia	2002	103
12483461	Fatty Acids	Mead JR	Lipoprotein lipase: structure, function, regulation, and role in disease.	Journal of molecular medicine	2002	116
12663460	Fatty Acids	Savage DB	Human metabolic syndrome resulting from dominant-negative mutations in the nuclear receptor peroxisome proliferator-activated receptor-gamma.	Diabetes	2003	80
12959938	Fatty Acids	Kelley DE	Fatty liver in type 2 diabetes mellitus: relation to regional adiposity, fatty acids, and insulin resistance.	American journal of physiology. Endocrinology and metabolism	2003	76
14702425	Fatty Acids	Dwyer JH	Arachidonate 5-lipoxygenase promoter genotype, dietary arachidonic acid, and atherosclerosis.	The New England journal of medicine	2004	115
14960743	Fatty Acids	Petersen KF	Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes.	The New England journal of medicine	2004	490
15132977	Fatty Acids	Bonen A	Triacylglycerol accumulation in human obesity and type 2 diabetes is associated with increased rates of skeletal muscle fatty acid transport and increased sarcolemmal FAT/CD36.	FASEB journal 	2004	81
15165749	Fatty Acids	Rangwala SM	Peroxisome proliferator-activated receptor gamma in diabetes and metabolism.	Trends in pharmacological sciences	2004	77
15592481	Fatty Acids	Heilbronn L	Failure of fat cell proliferation, mitochondrial function and fat oxidation results in ectopic fat storage, insulin resistance and type II diabetes mellitus.	International journal of obesity and related metabolic disorders 	2004	92
15671481	Fatty Acids	Zick Y	Ser/Thr phosphorylation of IRS proteins: a molecular basis for insulin resistance.	Science's STKE 	2005	83
15823385	Fatty Acids	Stumvoll M	Type 2 diabetes: principles of pathogenesis and therapy.	Lancet	2005	356
15836891	Fatty Acids	Eckel RH	The metabolic syndrome.	Lancet	2005	928
15841205	Fatty Acids	Drover VA	CD36 deficiency impairs intestinal lipid secretion and clearance of chylomicrons from the blood.	The Journal of clinical investigation	2005	74
16026420	Fatty Acids	Trayhurn P	Endocrine and signalling role of adipose tissue: new perspectives on fat.	Acta physiologica Scandinavica	2005	82
16098826	Fatty Acids	Brand MD	Physiological functions of the mitochondrial uncoupling proteins UCP2 and UCP3.	Cell metabolism	2005	187
16213227	Fatty Acids	Hulver MW	Elevated stearoyl-CoA desaturase-1 expression in skeletal muscle contributes to abnormal fatty acid partitioning in obese humans.	Cell metabolism	2005	117
16306347	Fatty Acids	Cnop M	Mechanisms of pancreatic beta-cell death in type 1 and type 2 diabetes: many differences, few similarities.	Diabetes	2005	320
16464906	Fatty Acids	Bruce CR	Endurance training in obese humans improves glucose tolerance and mitochondrial fatty acid oxidation and alters muscle lipid content.	American journal of physiology. Endocrinology and metabolism	2006	67
16936205	Fatty Acids	Yoon MJ	Adiponectin increases fatty acid oxidation in skeletal muscle cells by sequential activation of AMP-activated protein kinase, p38 mitogen-activated protein kinase, and peroxisome proliferator-activated receptor alpha.	Diabetes	2006	99
17027526	Fatty Acids	Fain JN	Release of interleukins and other inflammatory cytokines by human adipose tissue is enhanced in obesity and primarily due to the nonfat cells.	Vitamins and hormones	2006	130
17130488	Fatty Acids	Wolins NE	OXPAT/PAT-1 is a PPAR-induced lipid droplet protein that promotes fatty acid utilization.	Diabetes	2006	103
17167471	Fatty Acids	Kahn SE	Mechanisms linking obesity to insulin resistance and type 2 diabetes.	Nature	2006	828
17179929	Fatty Acids	Rask-Madsen C	Mechanisms of Disease: endothelial dysfunction in insulin resistance and diabetes.	Nature clinical practice. Endocrinology & metabolism	2007	108
17704301	Fatty Acids	Westerbacka J	Genes involved in fatty acid partitioning and binding, lipolysis, monocyte/macrophage recruitment, and inflammation are overexpressed in the human fatty liver of insulin-resistant subjects.	Diabetes	2007	80
18334488	Fatty Acids	Keller P	Fat-specific protein 27 regulates storage of triacylglycerol.	The Journal of biological chemistry	2008	72
18390897	Fatty Acids	Bertrand L	Insulin signalling in the heart.	Cardiovascular research	2008	51
18400702	Fatty Acids	Chong MF	Parallel activation of de novo lipogenesis and stearoyl-CoA desaturase activity after 3 d of high-carbohydrate feeding.	The American journal of clinical nutrition	2008	50
18460341	Fatty Acids	Arner P	FGF21 attenuates lipolysis in human adipocytes - a possible link to improved insulin sensitivity.	FEBS letters	2008	58
18565848	Fatty Acids	Adiels M	Overproduction of very low-density lipoproteins is the hallmark of the dyslipidemia in the metabolic syndrome.	Arteriosclerosis, thrombosis, and vascular biology	2008	135
18673007	Fatty Acids	King GL	The role of inflammatory cytokines in diabetes and its complications.	Journal of periodontology	2008	96
18775919	Fatty Acids	Hajer GR	Adipose tissue dysfunction in obesity, diabetes, and vascular diseases.	European heart journal	2008	242
19047759	Fatty Acids	Wakil SJ	Fatty acid metabolism: target for metabolic syndrome.	Journal of lipid research	2009	107
19185504	Fatty Acids	Su X	Cellular fatty acid uptake: a pathway under construction.	Trends in endocrinology and metabolism	2009	74
19421860	Fatty Acids	Kusminski CM	Diabetes and apoptosis: lipotoxicity.	Apoptosis 	2009	71
19442172	Fatty Acids	Cani PD	The role of the gut microbiota in energy metabolism and metabolic disease.	Current pharmaceutical design	2009	149
19715772	Fatty Acids	Poitout V	Glucolipotoxicity of the pancreatic beta cell.	Biochimica et biophysica acta	2010	75
19723495	Fatty Acids	Barrès R	Non-CpG methylation of the PGC-1alpha promoter through DNMT3B controls mitochondrial density.	Cell metabolism	2009	152
19723556	Fatty Acids	Galic S	Adipose tissue as an endocrine organ.	Molecular and cellular endocrinology	2010	309
19782153	Fatty Acids	Schrauwen P	Mitochondrial dysfunction and lipotoxicity.	Biochimica et biophysica acta	2010	47
20065965	Fatty Acids	Manolopoulos KN	Gluteofemoral body fat as a determinant of metabolic health.	International journal of obesity	2010	123
20110572	Fatty Acids	Schwartz EA	Nutrient modification of the innate immune response: a novel mechanism by which saturated fatty acids greatly amplify monocyte inflammation.	Arteriosclerosis, thrombosis, and vascular biology	2010	46
20179247	Fatty Acids	Frisard MI	Toll-like receptor 4 modulates skeletal muscle substrate metabolism.	American journal of physiology. Endocrinology and metabolism	2010	45
20370677	Fatty Acids	Bugianesi E	Insulin resistance in nonalcoholic fatty liver disease.	Current pharmaceutical design	2010	55
20556549	Fatty Acids	Cusi K	The role of adipose tissue and lipotoxicity in the pathogenesis of type 2 diabetes.	Current diabetes reports	2010	79
20588114	Fatty Acids	Dinarello CA	Role of IL-1beta in type 2 diabetes.	Current opinion in endocrinology, diabetes, and obesity	2010	83
20668154	Fatty Acids	D'Adamo E	Central role of fatty liver in the pathogenesis of insulin resistance in obese adolescents.	Diabetes care	2010	52
20978091	Fatty Acids	Schauer IE	Insulin resistance, defective insulin-mediated fatty acid suppression, and coronary artery calcification in subjects with and without type 1 diabetes: The CACTI study.	Diabetes	2011	56
20980488	Fatty Acids	Kröger J	Erythrocyte membrane phospholipid fatty acids, desaturase activity, and dietary fatty acids in relation to risk of type 2 diabetes in the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study.	The American journal of clinical nutrition	2011	60
21029304	Fatty Acids	Ferré P	Hepatic steatosis: a role for de novo lipogenesis and the transcription factor SREBP-1c.	Diabetes, obesity & metabolism	2010	94
21145849	Fatty Acids	Begriche K	Drug-induced toxicity on mitochondria and lipid metabolism: mechanistic diversity and deleterious consequences for the liver.	Journal of hepatology	2011	48
21336841	Fatty Acids	Eckardt K	Obesity-associated insulin resistance in skeletal muscle: role of lipid accumulation and physical inactivity.	Reviews in endocrine & metabolic disorders	2011	36
21349231	Fatty Acids	Cottin SC	The differential effects of EPA and DHA on cardiovascular risk factors.	The Proceedings of the Nutrition Society	2011	37
21664213	Fatty Acids	Aubert J	Increased expression of cytochrome P450 2E1 in nonalcoholic fatty liver disease: mechanisms and pathophysiological role.	Clinics and research in hepatology and gastroenterology	2011	51
21948998	Fatty Acids	Karpe F	Fatty acids, obesity, and insulin resistance: time for a reevaluation.	Diabetes	2011	145
22110092	Fatty Acids	Gillum MP	SirT1 regulates adipose tissue inflammation.	Diabetes	2011	59
22200617	Fatty Acids	Harwood HJ Jr	The adipocyte as an endocrine organ in the regulation of metabolic homeostasis.	Neuropharmacology	2012	51
22302938	Fatty Acids	Krishnan J	Dietary obesity-associated Hif1α activation in adipocytes restricts fatty acid oxidation and energy expenditure via suppression of the Sirt2-NAD+ system.	Genes & development	2012	64
22326434	Fatty Acids	Cusi K	Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: pathophysiology and clinical implications.	Gastroenterology	2012	130
22450341	Fatty Acids	Shehzad A	Adiponectin: regulation of its production and its role in human diseases.	Hormones	2012	46
22485010	Fatty Acids	Jonassen I	Design of the novel protraction mechanism of insulin degludec, an ultra-long-acting basal insulin.	Pharmaceutical research	2012	76
22560213	Fatty Acids	Newgard CB	Interplay between lipids and branched-chain amino acids in development of insulin resistance.	Cell metabolism	2012	185
22704720	Fatty Acids	Wahli W	PPARs at the crossroads of lipid signaling and inflammation.	Trends in endocrinology and metabolism	2012	105
22749135	Fatty Acids	Lottenberg AM	The role of dietary fatty acids in the pathology of metabolic syndrome.	The Journal of nutritional biochemistry	2012	36
22750049	Fatty Acids	O'Neill HM	AMPK regulation of fatty acid metabolism and mitochondrial biogenesis: implications for obesity.	Molecular and cellular endocrinology	2013	45
22753171	Fatty Acids	Matsuzaka T	Elovl6 promotes nonalcoholic steatohepatitis.	Hepatology	2012	37
22895668	Fatty Acids	Abel ED	Insulin resistance: metabolic mechanisms and consequences in the heart.	Arteriosclerosis, thrombosis, and vascular biology	2012	39
23520282	Fatty Acids	Goodpaster BH	Mitochondrial deficiency is associated with insulin resistance.	Diabetes	2013	31
23723111	Fatty Acids	van Greevenbroek MM	Obesity-associated low-grade inflammation in type 2 diabetes mellitus: causes and consequences.	The Netherlands journal of medicine	2013	40
23781214	Fatty Acids	Kwon H	Adipokines mediate inflammation and insulin resistance.	Frontiers in endocrinology	2013	73
23792151	Fatty Acids	Hijmans BS	Zonation of glucose and fatty acid metabolism in the liver: mechanism and metabolic consequences.	Biochimie	2014	32
23995233	Fatty Acids	Freigang S	Fatty acid-induced mitochondrial uncoupling elicits inflammasome-independent IL-1α and sterile vascular inflammation in atherosclerosis.	Nature immunology	2013	56
24187406	Fatty Acids	Jialal I	Toll-like receptor status in obesity and metabolic syndrome: a translational perspective.	The Journal of clinical endocrinology and metabolism	2014	30
24209692	Fatty Acids	Pearce LR	KSR2 mutations are associated with obesity, insulin resistance, and impaired cellular fuel oxidation.	Cell	2013	36
24297848	Fatty Acids	Kurdiova T	Effects of obesity, diabetes and exercise on Fndc5 gene expression and irisin release in human skeletal muscle and adipose tissue: in vivo and in vitro studies.	The Journal of physiology	2014	50
24316260	Fatty Acids	Lambert JE	Increased de novo lipogenesis is a distinct characteristic of individuals with nonalcoholic fatty liver disease.	Gastroenterology	2014	78
24323910	Fatty Acids	Turner N	Fatty acid metabolism, energy expenditure and insulin resistance in muscle.	The Journal of endocrinology	2014	27
24430435	Fatty Acids	Henstridge DC	Activating HSP72 in rodent skeletal muscle increases mitochondrial number and oxidative capacity and decreases insulin resistance.	Diabetes	2014	32
24670948	Fatty Acids	Shao M	Hepatic IRE1α regulates fasting-induced metabolic adaptive programs through the XBP1s-PPARα axis signalling.	Nature communications	2014	24
24692138	Fatty Acids	Rui L	Energy metabolism in the liver.	Comprehensive Physiology	2014	103
24848981	Fatty Acids	Albert JS	Null mutation in hormone-sensitive lipase gene and risk of type 2 diabetes.	The New England journal of medicine	2014	30
24997452	Fatty Acids	Varga ZV	Interplay of oxidative, nitrosative/nitrative stress, inflammation, cell death and autophagy in diabetic cardiomyopathy.	Biochimica et biophysica acta	2015	38
25083607	Fatty Acids	Fisher FM	Fibroblast growth factor 21 limits lipotoxicity by promoting hepatic fatty acid activation in mice on methionine and choline-deficient diets.	Gastroenterology	2014	37
25263561	Fatty Acids	Bensaad K	Fatty acid uptake and lipid storage induced by HIF-1α contribute to cell growth and survival after hypoxia-reoxygenation.	Cell reports	2014	45
25303528	Fatty Acids	Yore MM	Discovery of a class of endogenous mammalian lipids with anti-diabetic and anti-inflammatory effects.	Cell	2014	77
25450819	Fatty Acids	Janani C	PPAR gamma gene--a review.	Diabetes & metabolic syndrome	2015	45
25961460	Fatty Acids	Fu X	MicroRNA-26a regulates insulin sensitivity and metabolism of glucose and lipids.	The Journal of clinical investigation	2015	24
26170839	Fatty Acids	Papaetis GS	Central obesity, type 2 diabetes and insulin: exploring a pathway full of thorns.	Archives of medical science 	2015	16
26355033	Fatty Acids	Boden G	Excessive caloric intake acutely causes oxidative stress, GLUT4 carbonylation, and insulin resistance in healthy men.	Science translational medicine	2015	15
26869380	Fatty Acids	Prieto-Sánchez MT	Placental MFSD2a transporter is related to decreased DHA in cord blood of women with treated gestational diabetes.	Clinical nutrition	2017	6
26971994	Fatty Acids	Robblee MM	Saturated Fatty Acids Engage an IRE1α-Dependent Pathway to Activate the NLRP3 Inflammasome in Myeloid Cells.	Cell reports	2016	13
27083551	Fatty Acids	Cooke AA	Fatty acids and chronic low grade inflammation associated with obesity and the metabolic syndrome.	European journal of pharmacology	2016	13
27738012	Fatty Acids	Ito K	Self-renewal of a purified Tie2+ hematopoietic stem cell population relies on mitochondrial clearance.	Science	2016	15
27761989	Fatty Acids	Pingitore A	The diet-derived short chain fatty acid propionate improves beta-cell function in humans and stimulates insulin secretion from human islets in vitro.	Diabetes, obesity & metabolism	2017	6
28346411	Fatty Acids	Lynes MD	The cold-induced lipokine 12,13-diHOME promotes fatty acid transport into brown adipose tissue.	Nature medicine	2017	14
11423483	Fatty Acids, Nonesterified	Boden G	Effects of acute changes of plasma free fatty acids on intramyocellular fat content and insulin resistance in healthy subjects.	Diabetes	2001	93
11978640	Fatty Acids, Nonesterified	Lupi R	Prolonged exposure to free fatty acids has cytostatic and pro-apoptotic effects on human pancreatic islets: evidence that beta-cell death is caspase mediated, partially dependent on ceramide pathway, and Bcl-2 regulated.	Diabetes	2002	121
12028371	Fatty Acids, Nonesterified	Boden G	Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and beta-cell dysfunction.	European journal of clinical investigation	2002	220
12629551	Fatty Acids, Nonesterified	Itoh Y	Free fatty acids regulate insulin secretion from pancreatic beta cells through GPR40.	Nature	2003	277
12948526	Fatty Acids, Nonesterified	Ruan H	Insulin resistance in adipose tissue: direct and indirect effects of tumor necrosis factor-alpha.	Cytokine & growth factor reviews	2003	78
14633847	Fatty Acids, Nonesterified	Tripathy D	Elevation of free fatty acids induces inflammation and impairs vascular reactivity in healthy subjects.	Diabetes	2003	124
14693694	Fatty Acids, Nonesterified	Adams JM 2nd	Ceramide content is increased in skeletal muscle from obese insulin-resistant humans.	Diabetes	2004	152
15364812	Fatty Acids, Nonesterified	Ghanim H	Circulating mononuclear cells in the obese are in a proinflammatory state.	Circulation	2004	117
15619630	Fatty Acids, Nonesterified	Hirasawa A	Free fatty acids regulate gut incretin glucagon-like peptide-1 secretion through GPR120.	Nature medicine	2005	265
16155268	Fatty Acids, Nonesterified	Robertson MD	Insulin-sensitizing effects of dietary resistant starch and effects on skeletal muscle and adipose tissue metabolism.	The American journal of clinical nutrition	2005	76
16932311	Fatty Acids, Nonesterified	Roden M	Mechanisms of Disease: hepatic steatosis in type 2 diabetes--pathogenesis and clinical relevance.	Nature clinical practice. Endocrinology & metabolism	2006	76
17285001	Fatty Acids, Nonesterified	Delarue J	Free fatty acids and insulin resistance.	Current opinion in clinical nutrition and metabolic care	2007	87
17478729	Fatty Acids, Nonesterified	Kim F	Toll-like receptor-4 mediates vascular inflammation and insulin resistance in diet-induced obesity.	Circulation research	2007	170
17605313	Fatty Acids, Nonesterified	Holland WL	Lipid mediators of insulin resistance.	Nutrition reviews	2007	75
18057091	Fatty Acids, Nonesterified	Vollmer K	Predictors of incretin concentrations in subjects with normal, impaired, and diabetic glucose tolerance.	Diabetes	2008	80
18474251	Fatty Acids, Nonesterified	Kotronen A	Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes.	Gastroenterology	2008	56
18559892	Fatty Acids, Nonesterified	Cunha DA	Initiation and execution of lipotoxic ER stress in pancreatic beta-cells.	Journal of cell science	2008	157
18633101	Fatty Acids, Nonesterified	Reyna SM	Elevated toll-like receptor 4 expression and signaling in muscle from insulin-resistant subjects.	Diabetes	2008	95
18777097	Fatty Acids, Nonesterified	Chang-Chen KJ	Beta-cell failure as a complication of diabetes.	Reviews in endocrine & metabolic disorders	2008	50
19141690	Fatty Acids, Nonesterified	Gwiazda KS	Effects of palmitate on ER and cytosolic Ca2+ homeostasis in beta-cells.	American journal of physiology. Endocrinology and metabolism	2009	54
19401434	Fatty Acids, Nonesterified	Nagasumi K	Overexpression of GPR40 in pancreatic beta-cells augments glucose-stimulated insulin secretion and improves glucose tolerance in normal and diabetic mice.	Diabetes	2009	50
19584191	Fatty Acids, Nonesterified	Nadeau KJ	Insulin resistance in adolescents with type 2 diabetes is associated with impaired exercise capacity.	The Journal of clinical endocrinology and metabolism	2009	51
19819943	Fatty Acids, Nonesterified	Böni-Schnetzler M	Free fatty acids induce a proinflammatory response in islets via the abundantly expressed interleukin-1 receptor I.	Endocrinology	2009	59
20371664	Fatty Acids, Nonesterified	Donga E	A single night of partial sleep deprivation induces insulin resistance in multiple metabolic pathways in healthy subjects.	The Journal of clinical endocrinology and metabolism	2010	79
20959532	Fatty Acids, Nonesterified	Dasu MR	Free fatty acids in the presence of high glucose amplify monocyte inflammation via Toll-like receptors.	American journal of physiology. Endocrinology and metabolism	2011	54
21029303	Fatty Acids, Nonesterified	Cnop M	Causes and cures for endoplasmic reticulum stress in lipotoxic β-cell dysfunction.	Diabetes, obesity & metabolism	2010	43
21297467	Fatty Acids, Nonesterified	Boden G	Obesity, insulin resistance and free fatty acids.	Current opinion in endocrinology, diabetes, and obesity	2011	141
21659500	Fatty Acids, Nonesterified	Koutsari C	Storage of circulating free fatty acid in adipose tissue of postabsorptive humans: quantitative measures and implications for body fat distribution.	Diabetes	2011	38
21663979	Fatty Acids, Nonesterified	Talukdar S	Targeting GPR120 and other fatty acid-sensing GPCRs ameliorates insulin resistance and inflammatory diseases.	Trends in pharmacological sciences	2011	57
21841783	Fatty Acids, Nonesterified	Ohtsubo K	Pathway to diabetes through attenuation of pancreatic beta cell glycosylation and glucose transport.	Nature medicine	2011	39
22360800	Fatty Acids, Nonesterified	Martins AR	Mechanisms underlying skeletal muscle insulin resistance induced by fatty acids: importance of the mitochondrial function.	Lipids in health and disease	2012	46
22609131	Fatty Acids, Nonesterified	Capurso C	From excess adiposity to insulin resistance: the role of free fatty acids.	Vascular pharmacology	2012	41
23577240	Fatty Acids, Nonesterified	Patel PS	The role of the immune system in obesity and insulin resistance.	Journal of obesity	2013	29
23791483	Fatty Acids, Nonesterified	Prentki M	Metabolic signaling in fuel-induced insulin secretion.	Cell metabolism	2013	96
23855299	Fatty Acids, Nonesterified	Schuppan D	Non-alcoholic steatohepatitis: pathogenesis and novel therapeutic approaches.	Journal of gastroenterology and hepatology	2013	56
24529130	Fatty Acids, Nonesterified	Alexopoulos N	Visceral adipose tissue as a source of inflammation and promoter of atherosclerosis.	Atherosclerosis	2014	36
24577718	Fatty Acids, Nonesterified	Nielsen TS	Dissecting adipose tissue lipolysis: molecular regulation and implications for metabolic disease.	Journal of molecular endocrinology	2014	34
25175736	Fatty Acids, Nonesterified	Legrand-Poels S	Free fatty acids as modulators of the NLRP3 inflammasome in obesity/type 2 diabetes.	Biochemical pharmacology	2014	25
25702040	Fatty Acids, Nonesterified	Broussard JL	Sleep restriction increases free fatty acids in healthy men.	Diabetologia	2015	18
26223240	Fatty Acids, Nonesterified	Hernandez TL	Women With Gestational Diabetes Mellitus Randomized to a Higher-Complex Carbohydrate/Low-Fat Diet Manifest Lower Adipose Tissue Insulin Resistance, Inflammation, Glucose, and Free Fatty Acids: A Pilot Study.	Diabetes care	2016	12
26622051	Fatty Acids, Nonesterified	Dhindsa S	Insulin Resistance and Inflammation in Hypogonadotropic Hypogonadism and Their Reduction After Testosterone Replacement in Men With Type 2 Diabetes.	Diabetes care	2016	16
26628415	Fatty Acids, Nonesterified	Henson J	Breaking Up Prolonged Sitting With Standing or Walking Attenuates the Postprandial Metabolic Response in Postmenopausal Women: A Randomized Acute Study.	Diabetes care	2016	21
26780287	Fatty Acids, Nonesterified	Luukkonen PK	Hepatic ceramides dissociate steatosis and insulin resistance in patients with non-alcoholic fatty liver disease.	Journal of hepatology	2016	20
27002183	Fatty Acids, Nonesterified	Alvarez-Curto E	Metabolism meets immunity: The role of free fatty acid receptors in the immune system.	Biochemical pharmacology	2016	17
28323973	Fatty Acids, Nonesterified	Søndergaard E	How to Measure Adipose Tissue Insulin Sensitivity.	The Journal of clinical endocrinology and metabolism	2017	5
18281716	Steroids	Hotchkiss AK	Fifteen years after "Wingspread"--environmental endocrine disrupters and human and wildlife health: where we are today and where we need to go.	Toxicological sciences 	2008	57
18534913	Steroids	Okolo S	Incidence, aetiology and epidemiology of uterine fibroids.	Best practice & research. Clinical obstetrics & gynaecology	2008	83
19027922	Steroids	Bao P	The role of vascular endothelial growth factor in wound healing.	The Journal of surgical research	2009	121
19584865	Steroids	Weaver TA	Alefacept promotes co-stimulation blockade based allograft survival in nonhuman primates.	Nature medicine	2009	77
19755644	Steroids	van Kruijsdijk RC	Obesity and cancer: the role of dysfunctional adipose tissue.	Cancer epidemiology, biomarkers & prevention 	2009	161
21145432	Steroids	Singh T	Inflammatory markers in population studies of aging.	Ageing research reviews	2011	143
21997394	Steroids	Kopp JB	APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy.	Journal of the American Society of Nephrology 	2011	194
22701472	Steroids	Arcidiacono B	Insulin resistance and cancer risk: an overview of the pathogenetic mechanisms.	Experimental diabetes research	2012	74
23031671	Steroids	Miller JW	Vascular endothelial growth factor a in intraocular vascular disease.	Ophthalmology	2013	68
12454321	Folic Acid	Timms PM	Circulating MMP9, vitamin D and variation in the TIMP-1 response with VDR genotype: mechanisms for inflammatory damage in chronic disorders?	QJM 	2002	86
17851649	Folic Acid	Yajnik CS	Vitamin B12 and folate concentrations during pregnancy and insulin resistance in the offspring: the Pune Maternal Nutrition Study.	Diabetologia	2008	98
20223594	Folic Acid	Eden T	Aetiology of childhood leukaemia.	Cancer treatment reviews	2010	48
20492708	Folic Acid	Galanello R	Beta-thalassemia.	Orphanet journal of rare diseases	2010	107
25449138	Folic Acid	Liew SC	Methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism: epidemiology, metabolism and the associated diseases.	European journal of medical genetics	2015	20
26418287	Folic Acid	Nilsson E	Epigenetic Alterations in Human Liver From Subjects With Type 2 Diabetes in Parallel With Reduced Folate Levels.	The Journal of clinical endocrinology and metabolism	2015	19
3056758	Fructose	Reaven GM	Banting lecture 1988. Role of insulin resistance in human disease.	Diabetes	1988	1244
15723702	Fructose	Basciano H	Fructose, insulin resistance, and metabolic dyslipidemia.	Nutrition & metabolism	2005	138
15971409	Fructose	Havel PJ	Dietary fructose: implications for dysregulation of energy homeostasis and lipid/carbohydrate metabolism.	Nutrition reviews	2005	139
18224243	Fructose	Lorenzi M	The polyol pathway as a mechanism for diabetic retinopathy: attractive, elusive, and resilient.	Experimental diabetes research	2007	59
18395287	Fructose	Ouyang X	Fructose consumption as a risk factor for non-alcoholic fatty liver disease.	Journal of hepatology	2008	150
18398011	Fructose	Douard V	Regulation of the fructose transporter GLUT5 in health and disease.	American journal of physiology. Endocrinology and metabolism	2008	76
20086073	Fructose	Tappy L	Metabolic effects of fructose and the worldwide increase in obesity.	Physiological reviews	2010	200
22315413	Fructose	Kyriazis GA	Sweet taste receptor signaling in beta cells mediates fructose-induced potentiation of glucose-stimulated insulin secretion.	Proceedings of the National Academy of Sciences of the United States of America	2012	52
23112875	Fructose	Lanaspa MA	Uric acid stimulates fructokinase and accelerates fructose metabolism in the development of fatty liver.	PloS one	2012	43
23482247	Fructose	Basaranoglu M	Fructose as a key player in the development of fatty liver disease.	World journal of gastroenterology	2013	47
24652725	Fructose	Bray GA	Dietary sugar and body weight: have we reached a crisis in the epidemic of obesity and diabetes?: health be damned! Pour on the sugar.	Diabetes care	2014	62
26416735	Fructose	Nomura N	Structure and mechanism of the mammalian fructose transporter GLUT5.	Nature	2015	34
16912128	Gastric Inhibitory Polypeptide	Herman GA	Effect of single oral doses of sitagliptin, a dipeptidyl peptidase-4 inhibitor, on incretin and plasma glucose levels after an oral glucose tolerance test in patients with type 2 diabetes.	The Journal of clinical endocrinology and metabolism	2006	86
18080106	Gastric Inhibitory Polypeptide	Laakso M	Insulin sensitivity, insulin release and glucagon-like peptide-1 levels in persons with impaired fasting glucose and/or impaired glucose tolerance in the EUGENE2 study.	Diabetologia	2008	51
23083681	Gastric Inhibitory Polypeptide	Zhong J	An emerging role of dipeptidyl peptidase 4 (DPP4) beyond glucose control: potential implications in cardiovascular disease.	Atherosclerosis	2013	45
23478327	Gastric Inhibitory Polypeptide	Sadry SA	Emerging combinatorial hormone therapies for the treatment of obesity and T2DM.	Nature reviews. Endocrinology	2013	28
1551497	C-Peptide	Van Cauter E	Estimation of insulin secretion rates from C-peptide levels. Comparison of individual and standard kinetic parameters for C-peptide clearance.	Diabetes	1992	162
8423228	C-Peptide	Nauck MA	Preserved incretin activity of glucagon-like peptide 1 7-36 amide but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus.	The Journal of clinical investigation	1993	216
10857936	C-Peptide	Boyko EJ	Visceral adiposity and risk of type 2 diabetes: a prospective study among Japanese Americans.	Diabetes care	2000	122
11246881	C-Peptide	Vilsbøll T	Reduced postprandial concentrations of intact biologically active glucagon-like peptide 1 in type 2 diabetic patients.	Diabetes	2001	145
11289033	C-Peptide	Ryan EA	Clinical outcomes and insulin secretion after islet transplantation with the Edmonton protocol.	Diabetes	2001	95
11502801	C-Peptide	Toft-Nielsen MB	Determinants of the impaired secretion of glucagon-like peptide-1 in type 2 diabetic patients.	The Journal of clinical endocrinology and metabolism	2001	143
11734230	C-Peptide	Raz I	Beta-cell function in new-onset type 1 diabetes and immunomodulation with a heat-shock protein peptide (DiaPep277): a randomised, double-blind, phase II trial.	Lancet	2001	106
11893791	C-Peptide	Sinha R	Prevalence of impaired glucose tolerance among children and adolescents with marked obesity.	The New England journal of medicine	2002	218
11897280	C-Peptide	Zander M	Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and beta-cell function in type 2 diabetes: a parallel-group study.	Lancet	2002	197
12610045	C-Peptide	Steffes MW	Beta-cell function and the development of diabetes-related complications in the diabetes control and complications trial.	Diabetes care	2003	145
12788877	C-Peptide	Vilsbøll T	Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus.	The Journal of clinical endocrinology and metabolism	2003	95
14693724	C-Peptide	Palmer JP	C-peptide is the appropriate outcome measure for type 1 diabetes clinical trials to preserve beta-cell function: report of an ADA workshop, 21-22 October 2001.	Diabetes	2004	122
15069117	C-Peptide	Ma J	A prospective study of plasma C-peptide and colorectal cancer risk in men.	Journal of the National Cancer Institute	2004	79
15919798	C-Peptide	Herold KC	A single course of anti-CD3 monoclonal antibody hOKT3gamma1(Ala-Ala) results in improvement in C-peptide responses and clinical parameters for at least 2 years after onset of type 1 diabetes.	Diabetes	2005	172
15983207	C-Peptide	Ryan EA	Five-year follow-up after clinical islet transplantation.	Diabetes	2005	359
17426276	C-Peptide	Voltarelli JC	Autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus.	JAMA	2007	111
17595248	C-Peptide	Kotronen A	Liver fat in the metabolic syndrome.	The Journal of clinical endocrinology and metabolism	2007	80
17895322	C-Peptide	Goldfine AB	Patients with neuroglycopenia after gastric bypass surgery have exaggerated incretin and insulin secretory responses to a mixed meal.	The Journal of clinical endocrinology and metabolism	2007	71
17977954	C-Peptide	Taksali SE	High visceral and low abdominal subcutaneous fat stores in the obese adolescent: a determinant of an adverse metabolic phenotype.	Diabetes	2008	76
18264689	C-Peptide	Kirchhoff K	Polymorphisms in the TCF7L2, CDKAL1 and SLC30A8 genes are associated with impaired proinsulin conversion.	Diabetologia	2008	83
18843118	C-Peptide	Ludvigsson J	GAD treatment and insulin secretion in recent-onset type 1 diabetes.	The New England journal of medicine	2008	128
19074989	C-Peptide	Staiger H	Muscle-derived angiopoietin-like protein 4 is induced by fatty acids via peroxisome proliferator-activated receptor (PPAR)-delta and is of metabolic relevance in humans.	Diabetes	2009	50
19255591	C-Peptide	Zhang D	Highly efficient differentiation of human ES cells and iPS cells into mature pancreatic insulin-producing cells.	Cell research	2009	145
19940299	C-Peptide	Pescovitz MD	Rituximab, B-lymphocyte depletion, and preservation of beta-cell function.	The New England journal of medicine	2009	249
20699420	C-Peptide	Keenan HA	Residual insulin production and pancreatic ß-cell turnover after 50 years of diabetes: Joslin Medalist Study.	Diabetes	2010	101
21128002	C-Peptide	Nguyen NT	Relationship between obesity and diabetes in a US adult population: findings from the National Health and Nutrition Examination Survey, 1999-2006.	Obesity surgery	2011	59
21358855	C-Peptide	Schmid SM	Disturbed glucoregulatory response to food intake after moderate sleep restriction.	Sleep	2011	43
21430088	C-Peptide	Nauck MA	Rapid tachyphylaxis of the glucagon-like peptide 1-induced deceleration of gastric emptying in humans.	Diabetes	2011	55
21719095	C-Peptide	Sherry N	Teplizumab for treatment of type 1 diabetes (Protégé study): 1-year results from a randomised, placebo-controlled trial.	Lancet	2011	117
22233865	C-Peptide	Zhao Y	Reversal of type 1 diabetes via islet β cell regeneration following immune modulation by cord blood-derived multipotent stem cells.	BMC medicine	2012	38
22296077	C-Peptide	Ludvigsson J	GAD65 antigen therapy in recently diagnosed type 1 diabetes mellitus.	The New England journal of medicine	2012	69
22355018	C-Peptide	Wang L	Persistence of prolonged C-peptide production in type 1 diabetes as measured with an ultrasensitive C-peptide assay.	Diabetes care	2012	35
22535748	C-Peptide	Jørgensen NB	Acute and long-term effects of Roux-en-Y gastric bypass on glucose metabolism in subjects with Type 2 diabetes and normal glucose tolerance.	American journal of physiology. Endocrinology and metabolism	2012	55
23086558	C-Peptide	Herold KC	Teplizumab treatment may improve C-peptide responses in participants with type 1 diabetes after the new-onset period: a randomised controlled trial.	Diabetologia	2013	31
23413806	C-Peptide	Jones AG	The clinical utility of C-peptide measurement in the care of patients with diabetes.	Diabetic medicine 	2013	52
23562090	C-Peptide	Moran A	Interleukin-1 antagonism in type 1 diabetes of recent onset: two multicentre, randomised, double-blind, placebo-controlled trials.	Lancet	2013	73
23786881	C-Peptide	Xia W	Altered baseline brain activity in type 2 diabetes: a resting-state fMRI study.	Psychoneuroendocrinology	2013	29
23801579	C-Peptide	Hagopian W	Teplizumab preserves C-peptide in recent-onset type 1 diabetes: two-year results from the randomized, placebo-controlled Protégé trial.	Diabetes	2013	34
23803704	C-Peptide	Roep BO	Plasmid-encoded proinsulin preserves C-peptide while specifically reducing proinsulin-specific CD8⁺ T cells in type 1 diabetes.	Science translational medicine	2013	32
24704576	C-Peptide	Marek-Trzonkowska N	Therapy of type 1 diabetes with CD4(+)CD25(high)CD127-regulatory T cells prolongs survival of pancreatic islets - results of one year follow-up.	Clinical immunology	2014	47
25519448	C-Peptide	Davis AK	Prevalence of detectable C-Peptide according to age at diagnosis and duration of type 1 diabetes.	Diabetes care	2015	20
26193635	C-Peptide	Rigby MR	Alefacept provides sustained clinical and immunological effects in new-onset type 1 diabetes patients.	The Journal of clinical investigation	2015	29
26242184	C-Peptide	Jones AG	Markers of β-Cell Failure Predict Poor Glycemic Response to GLP-1 Receptor Agonist Therapy in Type 2 Diabetes.	Diabetes care	2016	11
26628416	C-Peptide	Cai J	Umbilical Cord Mesenchymal Stromal Cell With Autologous Bone Marrow Cell Transplantation in Established Type 1 Diabetes: A Pilot Randomized Controlled Open-Label Clinical Study to Assess Safety and Impact on Insulin Secretion.	Diabetes care	2016	11
27217482	C-Peptide	Gomez-Arango LF	Connections Between the Gut Microbiome and Metabolic Hormones in Early Pregnancy in Overweight and Obese Women.	Diabetes	2016	13
11073878	Nitric Oxide	Cai H	Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress.	Circulation research	2000	616
14990351	Nitric Oxide	Gladwin MT	The biochemistry of nitric oxide, nitrite, and hemoglobin: role in blood flow regulation.	Free radical biology & medicine	2004	76
15173060	Nitric Oxide	Landmesser U	Endothelial function: a critical determinant in atherosclerosis?	Circulation	2004	119
15284284	Nitric Oxide	Endemann DH	Endothelial dysfunction.	Journal of the American Society of Nephrology 	2004	161
15722114	Nitric Oxide	Naseem KM	The role of nitric oxide in cardiovascular diseases.	Molecular aspects of medicine	2005	80
15723618	Nitric Oxide	Pacher P	Role of nitrosative stress and peroxynitrite in the pathogenesis of diabetic complications. Emerging new therapeutical strategies.	Current medicinal chemistry	2005	73
15728243	Nitric Oxide	Barshes NR	Inflammation-mediated dysfunction and apoptosis in pancreatic islet transplantation: implications for intrahepatic grafts.	Journal of leukocyte biology	2005	91
16380482	Nitric Oxide	Segal MS	Nitric oxide cytoskeletal-induced alterations reverse the endothelial progenitor cell migratory defect associated with diabetes.	Diabetes	2006	69
16585403	Nitric Oxide	Förstermann U	Endothelial nitric oxide synthase in vascular disease: from marvel to menace.	Circulation	2006	344
16894049	Nitric Oxide	Goldin A	Advanced glycation end products: sparking the development of diabetic vascular injury.	Circulation	2006	336
17273169	Nitric Oxide	Leiper J	Disruption of methylarginine metabolism impairs vascular homeostasis.	Nature medicine	2007	97
17287464	Nitric Oxide	Cheng KK	Adiponectin-induced endothelial nitric oxide synthase activation and nitric oxide production are mediated by APPL1 in endothelial cells.	Diabetes	2007	78
17645639	Nitric Oxide	Durante W	Arginase: a critical regulator of nitric oxide synthesis and vascular function.	Clinical and experimental pharmacology & physiology	2007	107
17654441	Nitric Oxide	Hartge MM	The endothelium and vascular inflammation in diabetes.	Diabetes & vascular disease research	2007	56
17893272	Nitric Oxide	Dejam A	Nitrite infusion in humans and nonhuman primates: endocrine effects, pharmacokinetics, and tolerance formation.	Circulation	2007	107
17933965	Nitric Oxide	Palm F	Dimethylarginine dimethylaminohydrolase (DDAH): expression, regulation, and function in the cardiovascular and renal systems.	American journal of physiology. Heart and circulatory physiology	2007	75
18692595	Nitric Oxide	Chatterjee A	Endothelial nitric oxide (NO) and its pathophysiologic regulation.	Vascular pharmacology	2008	52
18801863	Nitric Oxide	Cade WT	Diabetes-related microvascular and macrovascular diseases in the physical therapy setting.	Physical therapy	2008	80
19302590	Nitric Oxide	Grgic I	Endothelial Ca+-activated K+ channels in normal and impaired EDHF-dilator responses--relevance to cardiovascular pathologies and drug discovery.	British journal of pharmacology	2009	55
20082095	Nitric Oxide	Michel T	Cellular signaling and NO production.	Pflugers Archiv 	2010	53
20678595	Nitric Oxide	Sitia S	From endothelial dysfunction to atherosclerosis.	Autoimmunity reviews	2010	52
21196259	Nitric Oxide	Chrissobolis S	Oxidative stress and endothelial dysfunction in cerebrovascular disease.	Frontiers in bioscience	2011	41
21300066	Nitric Oxide	Grover M	Cellular changes in diabetic and idiopathic gastroparesis.	Gastroenterology	2011	78
22112350	Nitric Oxide	Tousoulis D	The role of nitric oxide on endothelial function.	Current vascular pharmacology	2012	78
22167522	Nitric Oxide	Kietadisorn R	Tackling endothelial dysfunction by modulating NOS uncoupling: new insights into its pathogenesis and therapeutic possibilities.	American journal of physiology. Endocrinology and metabolism	2012	55
22653084	Nitric Oxide	Yi W	C1q/tumor necrosis factor-related protein-3, a newly identified adipokine, is a novel antiapoptotic, proangiogenic, and cardioprotective molecule in the ischemic mouse heart.	Circulation	2012	32
22871241	Nitric Oxide	Carnicer R	Nitric oxide synthases in heart failure.	Antioxidants & redox signaling	2013	36
23306778	Nitric Oxide	Muniyappa R	Role of insulin resistance in endothelial dysfunction.	Reviews in endocrine & metabolic disorders	2013	44
23473037	Nitric Oxide	Biason-Lauber A	Identification of a SIRT1 mutation in a family with type 1 diabetes.	Cell metabolism	2013	28
23684677	Nitric Oxide	Paulus WJ	A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation.	Journal of the American College of Cardiology	2013	257
23859953	Nitric Oxide	Rochette L	Nitric oxide synthase inhibition and oxidative stress in cardiovascular diseases: possible therapeutic targets?	Pharmacology & therapeutics	2013	46
24284821	Nitric Oxide	Andrukhova O	Vitamin D is a regulator of endothelial nitric oxide synthase and arterial stiffness in mice.	Molecular endocrinology	2014	31
24353182	Nitric Oxide	Cassuto J	Peroxynitrite disrupts endothelial caveolae leading to eNOS uncoupling and diminished flow-mediated dilation in coronary arterioles of diabetic patients.	Diabetes	2014	23
24918289	Nitric Oxide	Zhang Y	Erythropoietin action in stress response, tissue maintenance and metabolism.	International journal of molecular sciences	2014	26
25391251	Nitric Oxide	Lee RJ	Bitter and sweet taste receptors in the respiratory epithelium in health and disease.	Journal of molecular medicine	2014	22
25834230	Nitric Oxide	Carlström M	Renal autoregulation in health and disease.	Physiological reviews	2015	44
26800561	Nitric Oxide	Bretón-Romero R	Endothelial Dysfunction in Human Diabetes Is Mediated by Wnt5a-JNK Signaling.	Arteriosclerosis, thrombosis, and vascular biology	2016	13
27390338	Nitric Oxide	Vanhoutte PM	Thirty Years of Saying NO: Sources, Fate, Actions, and Misfortunes of the Endothelium-Derived Vasodilator Mediator.	Circulation research	2016	29
28209797	Nitric Oxide	Förstermann U	Roles of Vascular Oxidative Stress and Nitric Oxide in the Pathogenesis of Atherosclerosis.	Circulation research	2017	25
15504954	Sirolimus	Kim JE	regulation of peroxisome proliferator-activated receptor-gamma activity by mammalian target of rapamycin and amino acids in adipogenesis.	Diabetes	2004	106
15533996	Sirolimus	Manning BD	Balancing Akt with S6K: implications for both metabolic diseases and tumorigenesis.	The Journal of cell biology	2004	174
15718470	Sirolimus	Sarbassov DD	Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex.	Science	2005	2058
16354680	Sirolimus	Tzatsos A	Nutrients suppress phosphatidylinositol 3-kinase/Akt signaling via raptor-dependent mTOR-mediated insulin receptor substrate 1 phosphorylation.	Molecular and cellular biology	2006	125
17142730	Sirolimus	Battaglia M	Rapamycin promotes expansion of functional CD4+CD25+FOXP3+ regulatory T cells of both healthy subjects and type 1 diabetic patients.	Journal of immunology	2006	204
17273556	Sirolimus	Le Bacquer O	Elevated sensitivity to diet-induced obesity and insulin resistance in mice lacking 4E-BP1 and 4E-BP2.	The Journal of clinical investigation	2007	97
17275731	Sirolimus	Tsang CK	Targeting mammalian target of rapamycin (mTOR) for health and diseases.	Drug discovery today	2007	109
17419990	Sirolimus	Bhaskar PT	The two TORCs and Akt.	Developmental cell	2007	302
17452018	Sirolimus	Dann SG	mTOR Complex1-S6K1 signaling: at the crossroads of obesity, diabetes and cancer.	Trends in molecular medicine	2007	170
17463046	Sirolimus	Roos S	Mammalian target of rapamycin in the human placenta regulates leucine transport and is down-regulated in restricted fetal growth.	The Journal of physiology	2007	72
18367868	Sirolimus	Mammucari C	Downstream of Akt: FoxO3 and mTOR in the regulation of autophagy in skeletal muscle.	Autophagy	2008	76
18614546	Sirolimus	Rosner M	Cytoplasmic and nuclear distribution of the protein complexes mTORC1 and mTORC2: rapamycin triggers dephosphorylation and delocalization of the mTORC2 components rictor and sin1.	Human molecular genetics	2008	75
19074986	Sirolimus	Putnam AL	Expansion of human regulatory T-cells from patients with type 1 diabetes.	Diabetes	2009	112
19875810	Sirolimus	Lieberthal W	The role of the mammalian target of rapamycin (mTOR) in renal disease.	Journal of the American Society of Nephrology 	2009	81
20491627	Sirolimus	Zhou H	The complexes of mammalian target of rapamycin.	Current protein & peptide science	2010	42
20498714	Sirolimus	Squarize CH	Accelerated wound healing by mTOR activation in genetically defined mouse models.	PloS one	2010	40
21099108	Sirolimus	Badell IR	LFA-1-specific therapy prolongs allograft survival in rhesus macaques.	The Journal of clinical investigation	2010	53
21157483	Sirolimus	Zoncu R	mTOR: from growth signal integration to cancer, diabetes and ageing.	Nature reviews. Molecular cell biology	2011	1286
21269838	Sirolimus	Howell JJ	mTOR couples cellular nutrient sensing to organismal metabolic homeostasis.	Trends in endocrinology and metabolism	2011	113
21521467	Sirolimus	Thompson P	CD40-specific costimulation blockade enhances neonatal porcine islet survival in nonhuman primates.	American journal of transplantation 	2011	45
21576258	Sirolimus	Dai N	mTOR phosphorylates IMP2 to promote IGF2 mRNA translation by internal ribosomal entry.	Genes & development	2011	41
21576368	Sirolimus	Ekim B	mTOR kinase domain phosphorylation promotes mTORC1 signaling, cell growth, and cell cycle progression.	Molecular and cellular biology	2011	37
22065737	Sirolimus	Shin S	Glycogen synthase kinase (GSK)-3 promotes p70 ribosomal protein S6 kinase (p70S6K) activity and cell proliferation.	Proceedings of the National Academy of Sciences of the United States of America	2011	40
22354785	Sirolimus	Wiza C	Role of PRAS40 in Akt and mTOR signaling in health and disease.	American journal of physiology. Endocrinology and metabolism	2012	39
22500797	Sirolimus	Laplante M	mTOR signaling in growth control and disease.	Cell	2012	2019
22545721	Sirolimus	Chong ZZ	Mammalian target of rapamycin signaling in diabetic cardiovascular disease.	Cardiovascular diabetology	2012	39
22711699	Sirolimus	Winbanks CE	Follistatin-mediated skeletal muscle hypertrophy is regulated by Smad3 and mTOR independently of myostatin.	The Journal of cell biology	2012	32
22721971	Sirolimus	Long SA	Rapamycin/IL-2 combination therapy in patients with type 1 diabetes augments Tregs yet transiently impairs β-cell function.	Diabetes	2012	89
23124837	Sirolimus	Hung CM	mTOR-dependent cell survival mechanisms.	Cold Spring Harbor perspectives in biology	2012	34
23203037	Sirolimus	Maiese K	Oxidant stress and signal transduction in the nervous system with the PI 3-K, Akt, and mTOR cascade.	International journal of molecular sciences	2012	32
23223022	Sirolimus	Wang Y	MicroRNA-7 regulates the mTOR pathway and proliferation in adult pancreatic β-cells.	Diabetes	2013	38
23317514	Sirolimus	Cornu M	mTOR in aging, metabolism, and cancer.	Current opinion in genetics & development	2013	151
23460185	Sirolimus	Alayev A	mTOR signaling for biological control and cancer.	Journal of cellular physiology	2013	36
23641065	Sirolimus	Laplante M	Regulation of mTORC1 and its impact on gene expression at a glance.	Journal of cell science	2013	147
23710834	Sirolimus	Mercalli A	Rapamycin unbalances the polarization of human macrophages to M1.	Immunology	2013	36
23881200	Sirolimus	Barlow AD	Evidence for rapamycin toxicity in pancreatic β-cells and a review of the underlying molecular mechanisms.	Diabetes	2013	38
24336084	Sirolimus	Blagosklonny MV	TOR-centric view on insulin resistance and diabetic complications: perspective for endocrinologists and gerontologists.	Cell death & disease	2013	35
24508508	Sirolimus	Li J	Rapamycin: one drug, many effects.	Cell metabolism	2014	87
24698685	Sirolimus	Bar-Peled L	Regulation of mTORC1 by amino acids.	Trends in cell biology	2014	170
24899720	Sirolimus	Caccamo A	Genetic reduction of mammalian target of rapamycin ameliorates Alzheimer's disease-like cognitive and pathological deficits by restoring hippocampal gene expression signature.	The Journal of neuroscience 	2014	34
25224527	Sirolimus	Kumari D	Identification of fragile X syndrome specific molecular markers in human fibroblasts: a useful model to test the efficacy of therapeutic drugs.	Human mutation	2014	21
25468195	Sirolimus	Charbonnier LM	Regulatory T-cell deficiency and immune dysregulation, polyendocrinopathy, enteropathy, X-linked-like disorder caused by loss-of-function mutations in LRBA.	The Journal of allergy and clinical immunology	2015	28
25688110	Sirolimus	Cargnello M	The expanding role of mTOR in cancer cell growth and proliferation.	Mutagenesis	2015	23
27472076	Sirolimus	Al-Sheikh M	Swept-Source OCT Angiography Imaging of the Foveal Avascular Zone and Macular Capillary Network Density in Diabetic Retinopathy.	Investigative ophthalmology & visual science	2016	13
27748764	Sirolimus	Kim LC	mTORC1 and mTORC2 in cancer and the tumor microenvironment.	Oncogene	2017	23
28283069	Sirolimus	Saxton RA	mTOR Signaling in Growth, Metabolism, and Disease.	Cell	2017	128
7649494	Antioxidants	Packer L	alpha-Lipoic acid as a biological antioxidant.	Free radical biology & medicine	1995	171
11923038	Antioxidants	Nappo F	Postprandial endothelial activation in healthy subjects and in type 2 diabetic patients: role of fat and carbohydrate meals.	Journal of the American College of Cardiology	2002	93
12186805	Antioxidants	Lin KY	Impaired nitric oxide synthase pathway in diabetes mellitus: role of asymmetric dimethylarginine and dimethylarginine dimethylaminohydrolase.	Circulation	2002	106
12361782	Antioxidants	Fang YZ	Free radicals, antioxidants, and nutrition.	Nutrition	2002	181
12372842	Antioxidants	Evans JL	Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes.	Endocrine reviews	2002	325
12379575	Antioxidants	Esposito K	Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress.	Circulation	2002	278
12606496	Antioxidants	Robertson RP	Glucose toxicity in beta-cells: type 2 diabetes, good radicals gone bad, and the glutathione connection.	Diabetes	2003	133
12716823	Antioxidants	Ceriello A	New insights on oxidative stress and diabetic complications may lead to a "causal" antioxidant therapy.	Diabetes care	2003	121
14976002	Antioxidants	Ceriello A	Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited.	Arteriosclerosis, thrombosis, and vascular biology	2004	198
15448084	Antioxidants	Bottino R	Response of human islets to isolation stress and the effect of antioxidant treatment.	Diabetes	2004	84
15892631	Antioxidants	Valko M	Metals, toxicity and oxidative stress.	Current medicinal chemistry	2005	464
17569205	Antioxidants	Aggarwal BB	Curcumin: the Indian solid gold.	Advances in experimental medicine and biology	2007	188
18032779	Antioxidants	Milman U	Vitamin E supplementation reduces cardiovascular events in a subgroup of middle-aged individuals with both type 2 diabetes mellitus and the haptoglobin 2-2 genotype: a prospective double-blinded clinical trial.	Arteriosclerosis, thrombosis, and vascular biology	2008	78
18227481	Antioxidants	Paravicini TM	NADPH oxidases, reactive oxygen species, and hypertension: clinical implications and therapeutic possibilities.	Diabetes care	2008	159
19179352	Antioxidants	Gao L	Vascular NAD(P)H oxidase activation in diabetes: a double-edged sword in redox signalling.	Cardiovascular research	2009	91
19407051	Antioxidants	Barnes PJ	Systemic manifestations and comorbidities of COPD.	The European respiratory journal	2009	272
19433800	Antioxidants	Ristow M	Antioxidants prevent health-promoting effects of physical exercise in humans.	Proceedings of the National Academy of Sciences of the United States of America	2009	320
19442239	Antioxidants	Colombo SL	AMPKalpha1 regulates the antioxidant status of vascular endothelial cells.	The Biochemical journal	2009	61
19501608	Antioxidants	Pi J	ROS signaling, oxidative stress and Nrf2 in pancreatic beta-cell function.	Toxicology and applied pharmacology	2010	65
19659435	Antioxidants	Levy AP	Haptoglobin: basic and clinical aspects.	Antioxidants & redox signaling	2010	70
20524845	Antioxidants	Cheng X	Impaired redox signaling and antioxidant gene expression in endothelial cells in diabetes: a role for mitochondria and the nuclear factor-E2-related factor 2-Kelch-like ECH-associated protein 1 defense pathway.	Antioxidants & redox signaling	2011	43
20939814	Antioxidants	Kashihara N	Oxidative stress in diabetic nephropathy.	Current medicinal chemistry	2010	68
20939847	Antioxidants	Chandrasekharan B	Colonic motor dysfunction in human diabetes is associated with enteric neuronal loss and increased oxidative stress.	Neurogastroenterology and motility 	2011	38
21163347	Antioxidants	Henriksen EJ	Oxidative stress and the etiology of insulin resistance and type 2 diabetes.	Free radical biology & medicine	2011	88
21167901	Antioxidants	Rondeau P	The glycation of albumin: structural and functional impacts.	Biochimie	2011	49
21616142	Antioxidants	Batinic-Haberle I	Diverse functions of cationic Mn(III) N-substituted pyridylporphyrins, recognized as SOD mimics.	Free radical biology & medicine	2011	50
21629295	Antioxidants	Drummond GR	Combating oxidative stress in vascular disease: NADPH oxidases as therapeutic targets.	Nature reviews. Drug discovery	2011	207
21838680	Antioxidants	Folli F	The role of oxidative stress in the pathogenesis of type 2 diabetes mellitus micro- and macrovascular complications: avenues for a mechanistic-based therapeutic approach.	Current diabetes reviews	2011	44
22226887	Antioxidants	Galli F	Oxidative stress and antioxidant therapy in cystic fibrosis.	Biochimica et biophysica acta	2012	33
22843705	Antioxidants	Kröller-Schön S	Glucose-independent improvement of vascular dysfunction in experimental sepsis by dipeptidyl-peptidase 4 inhibition.	Cardiovascular research	2012	42
22995213	Antioxidants	Lu SC	Glutathione synthesis.	Biochimica et biophysica acta	2013	154
23436032	Antioxidants	Xu YJ	Prevention of diabetes-induced cardiovascular complications upon treatment with antioxidants.	Heart failure reviews	2014	20
23633659	Antioxidants	Zhong Q	Transcription factor Nrf2-mediated antioxidant defense system in the development of diabetic retinopathy.	Investigative ophthalmology & visual science	2013	27
23702245	Antioxidants	Dodson M	Cellular metabolic and autophagic pathways: traffic control by redox signaling.	Free radical biology & medicine	2013	81
24462787	Antioxidants	Huynh K	Diabetic cardiomyopathy: mechanisms and new treatment strategies targeting antioxidant signaling pathways.	Pharmacology & therapeutics	2014	72
24681256	Antioxidants	Levonen AL	Redox regulation of antioxidants, autophagy, and the response to stress: implications for electrophile therapeutics.	Free radical biology & medicine	2014	49
25134454	Antioxidants	Kaulmann A	Carotenoids, inflammation, and oxidative stress--implications of cellular signaling pathways and relation to chronic disease prevention.	Nutrition research	2014	31
25140450	Antioxidants	Choi BH	Effect of redox modulating NRF2 activators on chronic kidney disease.	Molecules	2014	21
25244505	Antioxidants	Li H	Vascular oxidative stress, nitric oxide and atherosclerosis.	Atherosclerosis	2014	76
25667085	Antioxidants	Picone P	Metformin increases APP expression and processing via oxidative stress, mitochondrial dysfunction and NF-κB activation: Use of insulin to attenuate metformin's effect.	Biochimica et biophysica acta	2015	16
26335400	Antioxidants	Richter K	Redox-fibrosis: Impact of TGFβ1 on ROS generators, mediators and functional consequences.	Redox biology	2015	25
27225690	Antioxidants	Gerber PA	The Role of Oxidative Stress and Hypoxia in Pancreatic Beta-Cell Dysfunction in Diabetes Mellitus.	Antioxidants & redox signaling	2017	7
17200940	Homocysteine	Greenwald SE	Ageing of the conduit arteries.	The Journal of pathology	2007	113
20100888	Homocysteine	Roy B	Association of optimism and pessimism with inflammation and hemostasis in the Multi-Ethnic Study of Atherosclerosis (MESA).	Psychosomatic medicine	2010	51
21680719	Homocysteine	Tan ZS	Association of metabolic dysregulation with volumetric brain magnetic resonance imaging and cognitive markers of subclinical brain aging in middle-aged adults: the Framingham Offspring Study.	Diabetes care	2011	46
24706014	Homocysteine	Westwood AJ	Insulin-like growth factor-1 and risk of Alzheimer dementia and brain atrophy.	Neurology	2014	22
18039814	Streptozocin	Toth C	Receptor for advanced glycation end products (RAGEs) and experimental diabetic neuropathy.	Diabetes	2008	50
18285558	Streptozocin	Ali TK	Peroxynitrite mediates retinal neurodegeneration by inhibiting nerve growth factor survival signaling in experimental and human diabetes.	Diabetes	2008	63
19017763	Streptozocin	Berthier CC	Enhanced expression of Janus kinase-signal transducer and activator of transcription pathway members in human diabetic nephropathy.	Diabetes	2009	77
19587243	Streptozocin	Samuel VT	Fasting hyperglycemia is not associated with increased expression of PEPCK or G6Pc in patients with Type 2 Diabetes.	Proceedings of the National Academy of Sciences of the United States of America	2009	54
19845582	Streptozocin	van der Windt DJ	Long-term controlled normoglycemia in diabetic non-human primates after transplantation with hCD46 transgenic porcine islets.	American journal of transplantation 	2009	60
21149549	Streptozocin	Choi D	Erythropoietin protects against diabetes through direct effects on pancreatic beta cells.	The Journal of experimental medicine	2010	49
22217880	Streptozocin	Asai O	Decreased renal α-Klotho expression in early diabetic nephropathy in humans and mice and its possible role in urinary calcium excretion.	Kidney international	2012	33
23139354	Streptozocin	Hodgin JB	Identification of cross-species shared transcriptional networks of diabetic nephropathy in human and mouse glomeruli.	Diabetes	2013	44
23649518	Streptozocin	Deshpande SD	Transforming growth factor-β-induced cross talk between p53 and a microRNA in the pathogenesis of diabetic nephropathy.	Diabetes	2013	36
24270983	Streptozocin	Albiero M	Diabetes causes bone marrow autonomic neuropathy and impairs stem cell mobilization via dysregulated p66Shc and Sirt1.	Diabetes	2014	27
24436191	Streptozocin	Yan B	Aberrant expression of long noncoding RNAs in early diabetic retinopathy.	Investigative ophthalmology & visual science	2014	23
26063197	Streptozocin	Koga K	MicroRNA-26a inhibits TGF-β-induced extracellular matrix protein expression in podocytes by targeting CTGF and is downregulated in diabetic nephropathy.	Diabetologia	2015	19
26523620	Streptozocin	Xie Z	Human umbilical cord-derived mesenchymal stem cells elicit macrophages into an anti-inflammatory phenotype to alleviate insulin resistance in type 2 diabetic rats.	Stem cells	2016	11
11424232	Reactive Oxygen Species	Rösen P	The role of oxidative stress in the onset and progression of diabetes and its complications: a summary of a Congress Series sponsored by UNESCO-MCBN, the American Diabetes Association and the German Diabetes Society.	Diabetes/metabolism research and reviews	2001	115
12874436	Reactive Oxygen Species	Inoguchi T	Protein kinase C-dependent increase in reactive oxygen species (ROS) production in vascular tissues of diabetes: role of vascular NAD(P)H oxidase.	Journal of the American Society of Nephrology 	2003	80
15128745	Reactive Oxygen Species	Schulze PC	Hyperglycemia promotes oxidative stress through inhibition of thioredoxin function by thioredoxin-interacting protein.	The Journal of biological chemistry	2004	95
15738989	Reactive Oxygen Species	Krauss S	The mitochondrial uncoupling-protein homologues.	Nature reviews. Molecular cell biology	2005	145
16765337	Reactive Oxygen Species	Paravicini TM	Redox signaling in hypertension.	Cardiovascular research	2006	120
16771662	Reactive Oxygen Species	Cave AC	NADPH oxidases in cardiovascular health and disease.	Antioxidants & redox signaling	2006	164
17184177	Reactive Oxygen Species	Nishikawa T	Impact of mitochondrial ROS production in the pathogenesis of diabetes mellitus and its complications.	Antioxidants & redox signaling	2007	83
17567459	Reactive Oxygen Species	Pessayre D	Role of mitochondria in non-alcoholic fatty liver disease.	Journal of gastroenterology and hepatology	2007	65
17584843	Reactive Oxygen Species	Newsholme P	Diabetes associated cell stress and dysfunction: role of mitochondrial and non-mitochondrial ROS production and activity.	The Journal of physiology	2007	114
18309108	Reactive Oxygen Species	Kim JA	Role of mitochondrial dysfunction in insulin resistance.	Circulation research	2008	193
18382884	Reactive Oxygen Species	Münzel T	Pathophysiology, diagnosis and prognostic implications of endothelial dysfunction.	Annals of medicine	2008	78
18783313	Reactive Oxygen Species	Frey RS	NADPH oxidase-dependent signaling in endothelial cells: role in physiology and pathophysiology.	Antioxidants & redox signaling	2009	128
19029992	Reactive Oxygen Species	Goldstein BJ	Protective vascular and myocardial effects of adiponectin.	Nature clinical practice. Cardiovascular medicine	2009	75
19118493	Reactive Oxygen Species	Zhang H	Role of TNF-alpha in vascular dysfunction.	Clinical science	2009	108
19135149	Reactive Oxygen Species	S Roriz-Filho J	(Pre)diabetes, brain aging, and cognition.	Biochimica et biophysica acta	2009	68
19706525	Reactive Oxygen Species	Block K	Subcellular localization of Nox4 and regulation in diabetes.	Proceedings of the National Academy of Sciences of the United States of America	2009	144
19889414	Reactive Oxygen Species	Salpea KD	Association of telomere length with type 2 diabetes, oxidative stress and UCP2 gene variation.	Atherosclerosis	2010	75
19893025	Reactive Oxygen Species	Chen Y	Activation of the Wnt pathway plays a pathogenic role in diabetic retinopathy in humans and animal models.	The American journal of pathology	2009	57
19910640	Reactive Oxygen Species	Lassègue B	NADPH oxidases: functions and pathologies in the vasculature.	Arteriosclerosis, thrombosis, and vascular biology	2010	180
20075245	Reactive Oxygen Species	Schroder K	The NLRP3 inflammasome: a sensor for metabolic danger?	Science	2010	238
20110125	Reactive Oxygen Species	Myatt L	Review: Reactive oxygen and nitrogen species and functional adaptation of the placenta.	Placenta	2010	65
20819950	Reactive Oxygen Species	de Cavanagh EM	Angiotensin II blockade: a strategy to slow ageing by protecting mitochondria?	Cardiovascular research	2011	37
21159388	Reactive Oxygen Species	Tiganis T	Reactive oxygen species and insulin resistance: the good, the bad and the ugly.	Trends in pharmacological sciences	2011	49
21350183	Reactive Oxygen Species	Chiang DJ	Obesity, diabetes mellitus, and liver fibrosis.	American journal of physiology. Gastrointestinal and liver physiology	2011	42
21916837	Reactive Oxygen Species	Arden GB	Hypoxia and oxidative stress in the causation of diabetic retinopathy.	Current diabetes reviews	2011	38
22286106	Reactive Oxygen Species	Ray PD	Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling.	Cellular signalling	2012	451
22350585	Reactive Oxygen Species	Hulsmans M	Mitochondrial reactive oxygen species and risk of atherosclerosis.	Current atherosclerosis reports	2012	30
22411934	Reactive Oxygen Species	Salminen A	Inflammaging: disturbed interplay between autophagy and inflammasomes.	Aging	2012	79
22454632	Reactive Oxygen Species	Ponugoti B	Role of forkhead transcription factors in diabetes-induced oxidative stress.	Experimental diabetes research	2012	51
22607099	Reactive Oxygen Species	Lee S	Thioredoxin and thioredoxin target proteins: from molecular mechanisms to functional significance.	Antioxidants & redox signaling	2013	51
22645602	Reactive Oxygen Species	Li B	Prevention of diabetic complications by activation of Nrf2: diabetic cardiomyopathy and nephropathy.	Experimental diabetes research	2012	33
22940046	Reactive Oxygen Species	Leung TM	CYP2E1 and oxidant stress in alcoholic and non-alcoholic fatty liver disease.	Journal of hepatology	2013	65
23085514	Reactive Oxygen Species	Urao N	Redox regulation of stem/progenitor cells and bone marrow niche.	Free radical biology & medicine	2013	44
23276949	Reactive Oxygen Species	Yin Y	Inflammasomes: sensors of metabolic stresses for vascular inflammation.	Frontiers in bioscience	2013	37
23323860	Reactive Oxygen Species	Padgett LE	The role of reactive oxygen species and proinflammatory cytokines in type 1 diabetes pathogenesis.	Annals of the New York Academy of Sciences	2013	61
23341580	Reactive Oxygen Species	Jansen F	High glucose condition increases NADPH oxidase activity in endothelial microparticles that promote vascular inflammation.	Cardiovascular research	2013	35
23379642	Reactive Oxygen Species	Wilkinson-Berka JL	Reactive oxygen species, Nox and angiotensin II in angiogenesis: implications for retinopathy.	Clinical science	2013	32
23472786	Reactive Oxygen Species	Santos CX	Endoplasmic reticulum stress and Nox-mediated reactive oxygen species signaling in the peripheral vasculature: potential role in hypertension.	Antioxidants & redox signaling	2014	25
23564668	Reactive Oxygen Species	Gray SP	NADPH oxidase 1 plays a key role in diabetes mellitus-accelerated atherosclerosis.	Circulation	2013	86
23767990	Reactive Oxygen Species	Gorin Y	Nox as a target for diabetic complications.	Clinical science	2013	30
23975169	Reactive Oxygen Species	Magenta A	Oxidative stress and microRNAs in vascular diseases.	International journal of molecular sciences	2013	40
23984879	Reactive Oxygen Species	Ishibashi Y	Advanced glycation end products evoke endothelial cell damage by stimulating soluble dipeptidyl peptidase-4 production and its interaction with mannose 6-phosphate/insulin-like growth factor II receptor.	Cardiovascular diabetology	2013	35
23994495	Reactive Oxygen Species	Lawlor KE	Ambiguities in NLRP3 inflammasome regulation: is there a role for mitochondria?	Biochimica et biophysica acta	2014	29
24180474	Reactive Oxygen Species	Konior A	NADPH oxidases in vascular pathology.	Antioxidants & redox signaling	2014	52
24186494	Reactive Oxygen Species	Xu Z	NRF2 plays a protective role in diabetic retinopathy in mice.	Diabetologia	2014	31
24511132	Reactive Oxygen Species	Jha JC	Genetic targeting or pharmacologic inhibition of NADPH oxidase nox4 provides renoprotection in long-term diabetic nephropathy.	Journal of the American Society of Nephrology 	2014	51
25617478	Reactive Oxygen Species	Cashman CR	Mechanisms of distal axonal degeneration in peripheral neuropathies.	Neuroscience letters	2015	28
25782072	Reactive Oxygen Species	Zeng H	High-fat diet induces cardiac remodelling and dysfunction: assessment of the role played by SIRT3 loss.	Journal of cellular and molecular medicine	2015	17
26184557	Reactive Oxygen Species	Klotz LO	Redox regulation of FoxO transcription factors.	Redox biology	2015	45
26210446	Reactive Oxygen Species	O'Neill S	Genetic disorders coupled to ROS deficiency.	Redox biology	2015	19
26612684	Reactive Oxygen Species	Kim H	Janus-faced Sestrin2 controls ROS and mTOR signalling through two separate functional domains.	Nature communications	2015	21
26998193	Reactive Oxygen Species	Zhang J	ROS and ROS-Mediated Cellular Signaling.	Oxidative medicine and cellular longevity	2016	40
14715836	Cholesterol, HDL	Cruz ML	The metabolic syndrome in overweight Hispanic youth and the role of insulin sensitivity.	The Journal of clinical endocrinology and metabolism	2004	100
15466496	Cholesterol, HDL	Nicklas BJ	Association of visceral adipose tissue with incident myocardial infarction in older men and women: the Health, Aging and Body Composition Study.	American journal of epidemiology	2004	73
16894037	Cholesterol, HDL	Sattar N	Adiponectin and coronary heart disease: a prospective study and meta-analysis.	Circulation	2006	86
18258416	Cholesterol, HDL	Meyer JM	Change in metabolic syndrome parameters with antipsychotic treatment in the CATIE Schizophrenia Trial: prospective data from phase 1.	Schizophrenia research	2008	56
18305138	Cholesterol, HDL	Love-Gregory L	Variants in the CD36 gene associate with the metabolic syndrome and high-density lipoprotein cholesterol.	Human molecular genetics	2008	62
21730284	Cholesterol, HDL	Giannini C	The triglyceride-to-HDL cholesterol ratio: association with insulin resistance in obese youths of different ethnic backgrounds.	Diabetes care	2011	48
23479408	Cholesterol, HDL	Chehade JM	Dyslipidemia in type 2 diabetes: prevalence, pathophysiology, and management.	Drugs	2013	29
23965489	Cholesterol, HDL	Boekholdt SM	Levels and changes of HDL cholesterol and apolipoprotein A-I in relation to risk of cardiovascular events among statin-treated patients: a meta-analysis.	Circulation	2013	32
24347174	Cholesterol, HDL	Jayashree B	Increased circulatory levels of lipopolysaccharide (LPS) and zonulin signify novel biomarkers of proinflammation in patients with type 2 diabetes.	Molecular and cellular biochemistry	2014	31
25948681	Cholesterol, HDL	Fall T	Using Genetic Variants to Assess the Relationship Between Circulating Lipids and Type 2 Diabetes.	Diabetes	2015	19
26025389	Cholesterol, HDL	Saleheen D	Association of HDL cholesterol efflux capacity with incident coronary heart disease events: a prospective case-control study.	The lancet. Diabetes & endocrinology	2015	65
15273546	Adrenocorticotropic Hormone	Rubino F	The early effect of the Roux-en-Y gastric bypass on hormones involved in body weight regulation and glucose metabolism.	Annals of surgery	2004	98
21257974	Adrenocorticotropic Hormone	Stetler C	Depression and hypothalamic-pituitary-adrenal activation: a quantitative summary of four decades of research.	Psychosomatic medicine	2011	131
22844441	Adrenocorticotropic Hormone	Reynolds AC	Impact of five nights of sleep restriction on glucose metabolism, leptin and testosterone in young adult men.	PloS one	2012	42
19781131	Cholecalciferol	von Hurst PR	Vitamin D supplementation reduces insulin resistance in South Asian women living in New Zealand who are insulin resistant and vitamin D deficient - a randomised, placebo-controlled trial.	The British journal of nutrition	2010	127
22486948	Cholecalciferol	Harris SS	A randomized, placebo-controlled trial of vitamin D supplementation to improve glycaemia in overweight and obese African Americans.	Diabetes, obesity & metabolism	2012	33
23407306	Cholecalciferol	Belenchia AM	Correcting vitamin D insufficiency improves insulin sensitivity in obese adolescents: a randomized controlled trial.	The American journal of clinical nutrition	2013	52
23527013	Cholecalciferol	Hossein-nezhad A	Influence of vitamin D status and vitamin D3 supplementation on genome wide expression of white blood cells: a randomized double-blind clinical trial.	PloS one	2013	40
24477043	Cholecalciferol	Daly RM	Protein-enriched diet, with the use of lean red meat, combined with progressive resistance training enhances lean tissue mass and muscle strength and reduces circulating IL-6 concentrations in elderly women: a cluster randomized controlled trial.	The American journal of clinical nutrition	2014	29
26944421	Cholecalciferol	Cooper C	Maternal gestational vitamin D supplementation and offspring bone health (MAVIDOS): a multicentre, double-blind, randomised placebo-controlled trial.	The lancet. Diabetes & endocrinology	2016	26
27353492	Cholecalciferol	Barchetta I	No effects of oral vitamin D supplementation on non-alcoholic fatty liver disease in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial.	BMC medicine	2016	13
1944469	Cyclic AMP	Weinstein LS	Activating mutations of the stimulatory G protein in the McCune-Albright syndrome.	The New England journal of medicine	1991	221
11342529	Cyclic AMP	Yamagishi SI	Leptin induces mitochondrial superoxide production and monocyte chemoattractant protein-1 expression in aortic endothelial cells by increasing fatty acid oxidation via protein kinase A.	The Journal of biological chemistry	2001	104
16177793	Cyclic AMP	Zhang J	Insulin disrupts beta-adrenergic signalling to protein kinase A in adipocytes.	Nature	2005	101
16966319	Cyclic AMP	Wang J	Medium-chain fatty acids as ligands for orphan G protein-coupled receptor GPR84.	The Journal of biological chemistry	2006	72
17003332	Cyclic AMP	Carey AL	Interleukin-6 increases insulin-stimulated glucose disposal in humans and glucose uptake and fatty acid oxidation in vitro via AMP-activated protein kinase.	Diabetes	2006	143
17327455	Cyclic AMP	Sriwijitkamol A	Effect of acute exercise on AMPK signaling in skeletal muscle of subjects with type 2 diabetes: a time-course and dose-response study.	Diabetes	2007	85
17565987	Cyclic AMP	Zhang F	Proteasome function is regulated by cyclic AMP-dependent protein kinase through phosphorylation of Rpt6.	The Journal of biological chemistry	2007	67
18604457	Cyclic AMP	Cheng X	Epac and PKA: a tale of two intracellular cAMP receptors.	Acta biochimica et biophysica Sinica	2008	97
19136996	Cyclic AMP	Villanueva EC	Leptin receptor signaling and the regulation of mammalian physiology.	International journal of obesity	2008	55
19196246	Cyclic AMP	Richter EA	AMPK and the biochemistry of exercise: implications for human health and disease.	The Biochemical journal	2009	85
20181668	Cyclic AMP	Hallows KR	Role of the energy sensor AMP-activated protein kinase in renal physiology and disease.	American journal of physiology. Renal physiology	2010	43
21130749	Cyclic AMP	Gauthier MS	Decreased AMP-activated protein kinase activity is associated with increased inflammation in visceral adipose tissue and with whole-body insulin resistance in morbidly obese humans.	Biochemical and biophysical research communications	2011	48
21209017	Cyclic AMP	Tolhurst G	Glutamine triggers and potentiates glucagon-like peptide-1 secretion by raising cytosolic Ca2+ and cAMP.	Endocrinology	2011	44
22702974	Cyclic AMP	Carling D	AMP-activated protein kinase: new regulation, new roles?	The Biochemical journal	2012	94
24606903	Cyclic AMP	Lee S	Adenylyl cyclase-associated protein 1 is a receptor for human resistin and mediates inflammatory actions of human monocytes.	Cell metabolism	2014	29
24768298	Cyclic AMP	Luan B	Leptin-mediated increases in catecholamine signaling reduce adipose tissue inflammation via activation of macrophage HDAC4.	Cell metabolism	2014	30
26644581	Cyclic AMP	Luan B	CREB pathway links PGE2 signaling with macrophage polarization.	Proceedings of the National Academy of Sciences of the United States of America	2015	21
10788730	Dietary Fats	Block G	A rapid food screener to assess fat and fruit and vegetable intake.	American journal of preventive medicine	2000	109
11508264	Dietary Fats	Hu FB	Diet and risk of Type II diabetes: the role of types of fat and carbohydrate.	Diabetologia	2001	105
11874924	Dietary Fats	van Dam RM	Dietary fat and meat intake in relation to risk of type 2 diabetes in men.	Diabetes care	2002	116
17090532	Dietary Fats	Qiao L	SIRT1 regulates adiponectin gene expression through Foxo1-C/enhancer-binding protein alpha transcriptional complex.	The Journal of biological chemistry	2006	94
17344486	Dietary Fats	Corcoran MP	Skeletal muscle lipid deposition and insulin resistance: effect of dietary fatty acids and exercise.	The American journal of clinical nutrition	2007	62
18697794	Dietary Fats	Qi L	The common obesity variant near MC4R gene is associated with higher intakes of total energy and dietary fat, weight change and diabetes risk in women.	Human molecular genetics	2008	56
19032965	Dietary Fats	Risérus U	Dietary fats and prevention of type 2 diabetes.	Progress in lipid research	2009	103
21835098	Dietary Fats	Harford KA	Fats, inflammation and insulin resistance: insights to the role of macrophage and T-cell accumulation in adipose tissue.	The Proceedings of the Nutrition Society	2011	49
25998293	Dietary Fats	Bell KJ	Impact of fat, protein, and glycemic index on postprandial glucose control in type 1 diabetes: implications for intensive diabetes management in the continuous glucose monitoring era.	Diabetes care	2015	24
27379574	Dietary Fats	Wang DD	Association of Specific Dietary Fats With Total and Cause-Specific Mortality.	JAMA internal medicine	2016	20
28275132	Dietary Fats	Perfilyev A	Impact of polyunsaturated and saturated fat overfeeding on the DNA-methylation pattern in human adipose tissue: a randomized controlled trial.	The American journal of clinical nutrition	2017	6
16338283	Glucagon-Like Peptide 1	Herman GA	Pharmacokinetics and pharmacodynamics of sitagliptin, an inhibitor of dipeptidyl peptidase IV, in healthy subjects: results from two randomized, double-blind, placebo-controlled studies with single oral doses.	Clinical pharmacology and therapeutics	2005	78
16517403	Glucagon-Like Peptide 1	Drucker DJ	The biology of incretin hormones.	Cell metabolism	2006	428
17174230	Glucagon-Like Peptide 1	Sokos GG	Glucagon-like peptide-1 infusion improves left ventricular ejection fraction and functional status in patients with chronic heart failure.	Journal of cardiac failure	2006	133
17498508	Glucagon-Like Peptide 1	Baggio LL	Biology of incretins: GLP-1 and GIP.	Gastroenterology	2007	589
17928588	Glucagon-Like Peptide 1	Holst JJ	The physiology of glucagon-like peptide 1.	Physiological reviews	2007	487
18786605	Glucagon-Like Peptide 1	Holst JJ	The incretin system and its role in type 2 diabetes mellitus.	Molecular and cellular endocrinology	2009	79
19151200	Glucagon-Like Peptide 1	Noyan-Ashraf MH	GLP-1R agonist liraglutide activates cytoprotective pathways and improves outcomes after experimental myocardial infarction in mice.	Diabetes	2009	116
20075143	Glucagon-Like Peptide 1	Read PA	DPP-4 inhibition by sitagliptin improves the myocardial response to dobutamine stress and mitigates stunning in a pilot study of patients with coronary artery disease.	Circulation. Cardiovascular imaging	2010	46
20226203	Glucagon-Like Peptide 1	Hayes MR	Role of the glucagon-like-peptide-1 receptor in the control of energy balance.	Physiology & behavior	2010	53
20368410	Glucagon-Like Peptide 1	Isbell JM	The importance of caloric restriction in the early improvements in insulin sensitivity after Roux-en-Y gastric bypass surgery.	Diabetes care	2010	61
20871975	Glucagon-Like Peptide 1	Nauck MA	Secretion of glucagon-like peptide-1 (GLP-1) in type 2 diabetes: what is up, what is down?	Diabetologia	2011	84
21340625	Glucagon-Like Peptide 1	Shimoda M	The human glucagon-like peptide-1 analogue liraglutide preserves pancreatic beta cells via regulation of cell kinetics and suppression of oxidative and endoplasmic reticulum stress in a mouse model of diabetes.	Diabetologia	2011	37
21454562	Glucagon-Like Peptide 1	Miller LJ	Refinement of glucagon-like peptide 1 docking to its intact receptor using mid-region photolabile probes and molecular modeling.	The Journal of biological chemistry	2011	35
21664294	Glucagon-Like Peptide 1	Fadini GP	Cardiovascular effects of DPP-4 inhibition: beyond GLP-1.	Vascular pharmacology	2011	43
21844879	Glucagon-Like Peptide 1	Astrup A	Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analog, liraglutide.	International journal of obesity	2012	100
21975753	Glucagon-Like Peptide 1	Shyangdan DS	Glucagon-like peptide analogues for type 2 diabetes mellitus.	The Cochrane database of systematic reviews	2011	38
22323472	Glucagon-Like Peptide 1	Ussher JR	Cardiovascular biology of the incretin system.	Endocrine reviews	2012	109
22338093	Glucagon-Like Peptide 1	Nyborg NC	The human GLP-1 analog liraglutide and the pancreas: evidence for the absence of structural pancreatic changes in three species.	Diabetes	2012	32
22519295	Glucagon-Like Peptide 1	Salcedo I	Neuroprotective and neurotrophic actions of glucagon-like peptide-1: an emerging opportunity to treat neurodegenerative and cerebrovascular disorders.	British journal of pharmacology	2012	39
22519963	Glucagon-Like Peptide 1	Shimpukade B	Discovery of a potent and selective GPR120 agonist.	Journal of medicinal chemistry	2012	32
22538359	Glucagon-Like Peptide 1	Dirksen C	Mechanisms of improved glycaemic control after Roux-en-Y gastric bypass.	Diabetologia	2012	35
22745245	Glucagon-Like Peptide 1	Makdissi A	Sitagliptin exerts an antinflammatory action.	The Journal of clinical endocrinology and metabolism	2012	45
22938097	Glucagon-Like Peptide 1	Hölscher C	Potential role of glucagon-like peptide-1 (GLP-1) in neuroprotection.	CNS drugs	2012	34
23010561	Glucagon-Like Peptide 1	Alves C	A meta-analysis of serious adverse events reported with exenatide and liraglutide: acute pancreatitis and cancer.	Diabetes research and clinical practice	2012	35
23062489	Glucagon-Like Peptide 1	Satoh-Asahara N	A dipeptidyl peptidase-4 inhibitor, sitagliptin, exerts anti-inflammatory effects in type 2 diabetic patients.	Metabolism	2013	29
23377698	Glucagon-Like Peptide 1	Calanna S	Secretion of glucagon-like peptide-1 in patients with type 2 diabetes mellitus: systematic review and meta-analyses of clinical studies.	Diabetologia	2013	37
23684623	Glucagon-Like Peptide 1	Campbell JE	Pharmacology, physiology, and mechanisms of incretin hormone action.	Cell metabolism	2013	152
23812094	Glucagon-Like Peptide 1	Wadden TA	Weight maintenance and additional weight loss with liraglutide after low-calorie-diet-induced weight loss: the SCALE Maintenance randomized study.	International journal of obesity	2013	50
23818527	Glucagon-Like Peptide 1	Drucker DJ	Incretin action in the pancreas: potential promise, possible perils, and pathological pitfalls.	Diabetes	2013	62
24323912	Glucagon-Like Peptide 1	van Bloemendaal L	Effects of glucagon-like peptide 1 on appetite and body weight: focus on the CNS.	The Journal of endocrinology	2014	29
24325907	Glucagon-Like Peptide 1	Remely M	Effects of short chain fatty acid producing bacteria on epigenetic regulation of FFAR3 in type 2 diabetes and obesity.	Gene	2014	29
24917578	Glucagon-Like Peptide 1	Beiroa D	GLP-1 agonism stimulates brown adipose tissue thermogenesis and browning through hypothalamic AMPK.	Diabetes	2014	66
25249673	Glucagon-Like Peptide 1	Avogaro A	The effects of dipeptidyl peptidase-4 inhibition on microvascular diabetes complications.	Diabetes care	2014	25
26132939	Glucagon-Like Peptide 1	Pi-Sunyer X	A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management.	The New England journal of medicine	2015	79
26394161	Glucagon-Like Peptide 1	Armstrong MJ	Glucagon-like peptide 1 decreases lipotoxicity in non-alcoholic steatohepatitis.	Journal of hepatology	2016	18
26700562	Glucagon-Like Peptide 1	Wootten D	A Hydrogen-Bonded Polar Network in the Core of the Glucagon-Like Peptide-1 Receptor Is a Fulcrum for Biased Agonism: Lessons from Class B Crystal Structures.	Molecular pharmacology	2016	12
26831302	Glucagon-Like Peptide 1	Farr OM	GLP-1 receptors exist in the parietal cortex, hypothalamus and medulla of human brains and the GLP-1 analogue liraglutide alters brain activity related to highly desirable food cues in individuals with diabetes: a crossover, randomised, placebo-controlled trial.	Diabetologia	2016	11
27345422	Glucagon-Like Peptide 1	Drucker DJ	The Cardiovascular Biology of Glucagon-like Peptide-1.	Cell metabolism	2016	25
27514514	Glucagon-Like Peptide 1	Avogaro A	Continued efforts to translate diabetes cardiovascular outcome trials into clinical practice.	Cardiovascular diabetology	2016	11
12225726	Natriuretic Peptide, Brain	Redfield MM	Plasma brain natriuretic peptide concentration: impact of age and gender.	Journal of the American College of Cardiology	2002	111
14769680	Natriuretic Peptide, Brain	Wang TJ	Impact of obesity on plasma natriuretic peptide levels.	Circulation	2004	137
18480203	Natriuretic Peptide, Brain	Zethelius B	Use of multiple biomarkers to improve the prediction of death from cardiovascular causes.	The New England journal of medicine	2008	186
19245965	Natriuretic Peptide, Brain	Frankel DS	Resistin, adiponectin, and risk of heart failure the Framingham offspring study.	Journal of the American College of Cardiology	2009	60
22026577	Natriuretic Peptide, Brain	de Boer RA	The fibrosis marker galectin-3 and outcome in the general population.	Journal of internal medicine	2012	49
22431676	Natriuretic Peptide, Brain	Kavousi M	Evaluation of newer risk markers for coronary heart disease risk classification: a cohort study.	Annals of internal medicine	2012	65
22806632	Natriuretic Peptide, Brain	van Heerebeek L	Low myocardial protein kinase G activity in heart failure with preserved ejection fraction.	Circulation	2012	63
23797610	Natriuretic Peptide, Brain	Chavali V	Differential expression of dicer, miRNAs, and inflammatory markers in diabetic Ins2+/- Akita hearts.	Cell biochemistry and biophysics	2014	25
19082520	Glyburide	Monami M	Sulphonylureas and cancer: a case-control study.	Acta diabetologica	2009	46
20835230	Glyburide	Masters SL	Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1β in type 2 diabetes.	Nature immunology	2010	307
22751341	Glyburide	Buchanan TA	Gestational diabetes mellitus: risks and management during and after pregnancy.	Nature reviews. Endocrinology	2012	35
9385294	Antihypertensive Agents	-	The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure.	Archives of internal medicine	1997	457
11937178	Antihypertensive Agents	Dahlöf B	Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol.	Lancet	2002	460
16832001	Antihypertensive Agents	Folsom AR	An assessment of incremental coronary risk prediction using C-reactive protein and other novel risk markers: the atherosclerosis risk in communities study.	Archives of internal medicine	2006	84
17240286	Antihypertensive Agents	Elliott WJ	Incident diabetes in clinical trials of antihypertensive drugs: a network meta-analysis.	Lancet	2007	152
17707755	Antihypertensive Agents	Messerli FH	Essential hypertension.	Lancet	2007	81
17878749	Antihypertensive Agents	Chiamvimonvat N	The soluble epoxide hydrolase as a pharmaceutical target for hypertension.	Journal of cardiovascular pharmacology	2007	74
20576628	Antihypertensive Agents	Wijndaele K	Television viewing time independently predicts all-cause and cardiovascular mortality: the EPIC Norfolk study.	International journal of epidemiology	2011	78
21093036	Antihypertensive Agents	Symplicity HTN-2 Investigators.	Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial.	Lancet	2010	272
24210779	Antihypertensive Agents	Krum H	Percutaneous renal denervation in patients with treatment-resistant hypertension: final 3-year report of the Symplicity HTN-1 study.	Lancet	2014	80
24898552	Antihypertensive Agents	Esler MD	Catheter-based renal denervation for treatment of patients with treatment-resistant hypertension: 36 month results from the SYMPLICITY HTN-2 randomized clinical trial.	European heart journal	2014	33
25236375	Antihypertensive Agents	Hamnvik OP	Clinical risk factors for the development of hypertension in patients treated with inhibitors of the VEGF signaling pathway.	Cancer	2015	21
2195544	Islet Amyloid Polypeptide	Westermark P	Islet amyloid polypeptide: pinpointing amino acid residues linked to amyloid fibril formation.	Proceedings of the National Academy of Sciences of the United States of America	1990	160
10078548	Islet Amyloid Polypeptide	Janson J	The mechanism of islet amyloid polypeptide toxicity is membrane disruption by intermediate-sized toxic amyloid particles.	Diabetes	1999	156
11926832	Islet Amyloid Polypeptide	Padrick SB	Islet amyloid: phase partitioning and secondary nucleation are central to the mechanism of fibrillogenesis.	Biochemistry	2002	87
12234175	Islet Amyloid Polypeptide	Anguiano M	Protofibrillar islet amyloid polypeptide permeabilizes synthetic vesicles by a pore-like mechanism that may be relevant to type II diabetes.	Biochemistry	2002	84
15292279	Islet Amyloid Polypeptide	Hull RL	Islet amyloid: a critical entity in the pathogenesis of type 2 diabetes.	The Journal of clinical endocrinology and metabolism	2004	128
16142909	Islet Amyloid Polypeptide	Jayasinghe SA	Lipid membranes modulate the structure of islet amyloid polypeptide.	Biochemistry	2005	88
16878984	Islet Amyloid Polypeptide	Knight JD	Conserved and cooperative assembly of membrane-bound alpha-helical states of islet amyloid polypeptide.	Biochemistry	2006	104
17123962	Islet Amyloid Polypeptide	Williamson JA	Direct detection of transient alpha-helical states in islet amyloid polypeptide.	Protein science 	2007	71
17475933	Islet Amyloid Polypeptide	Huang CJ	High expression rates of human islet amyloid polypeptide induce endoplasmic reticulum stress mediated beta-cell apoptosis, a characteristic of humans with type 2 but not type 1 diabetes.	Diabetes	2007	133
18556473	Islet Amyloid Polypeptide	Wiltzius JJ	Atomic structure of the cross-beta spine of islet amyloid polypeptide (amylin).	Protein science 	2008	82
18710262	Islet Amyloid Polypeptide	Yonemoto IT	Amylin proprotein processing generates progressively more amyloidogenic peptides that initially sample the helical state.	Biochemistry	2008	50
18989932	Islet Amyloid Polypeptide	Nanga RP	Structures of rat and human islet amyloid polypeptide IAPP(1-19) in micelles by NMR spectroscopy.	Biochemistry	2008	56
19244249	Islet Amyloid Polypeptide	Patil SM	Dynamic alpha-helix structure of micelle-bound human amylin.	The Journal of biological chemistry	2009	53
19346479	Islet Amyloid Polypeptide	Shim SH	Two-dimensional IR spectroscopy and isotope labeling defines the pathway of amyloid formation with residue-specific resolution.	Proceedings of the National Academy of Sciences of the United States of America	2009	93
19647750	Islet Amyloid Polypeptide	Williamson JA	Helix stabilization precedes aqueous and bilayer-catalyzed fiber formation in islet amyloid polypeptide.	Journal of molecular biology	2009	59
20042670	Islet Amyloid Polypeptide	Gurlo T	Evidence for proteotoxicity in beta cells in type 2 diabetes: toxic islet amyloid polypeptide oligomers form intracellularly in the secretory pathway.	The American journal of pathology	2010	65
20160085	Islet Amyloid Polypeptide	Potter KJ	Islet amyloid deposition limits the viability of human islet grafts but not porcine islet grafts.	Proceedings of the National Academy of Sciences of the United States of America	2010	57
21742788	Islet Amyloid Polypeptide	Westermark P	Islet amyloid polypeptide, islet amyloid, and diabetes mellitus.	Physiological reviews	2011	174
21813778	Islet Amyloid Polypeptide	Westwell-Roper C	IL-1 blockade attenuates islet amyloid polypeptide-induced proinflammatory cytokine release and pancreatic islet graft dysfunction.	Journal of immunology	2011	42
21818468	Islet Amyloid Polypeptide	DeToma AS	Misfolded proteins in Alzheimer's disease and type II diabetes.	Chemical Society reviews	2012	55
21916515	Islet Amyloid Polypeptide	Wang L	2DIR spectroscopy of human amylin fibrils reflects stable β-sheet structure.	Journal of the American Chemical Society	2011	37
21942864	Islet Amyloid Polypeptide	Brender JR	Membrane disruption and early events in the aggregation of the diabetes related peptide IAPP from a molecular perspective.	Accounts of chemical research	2012	71
22187437	Islet Amyloid Polypeptide	Bedrood S	Fibril structure of human islet amyloid polypeptide.	The Journal of biological chemistry	2012	38
22522254	Islet Amyloid Polypeptide	Middleton CT	Two-dimensional infrared spectroscopy reveals the complex behaviour of an amyloid fibril inhibitor.	Nature chemistry	2012	48
23337872	Islet Amyloid Polypeptide	Abedini A	Mechanisms of islet amyloidosis toxicity in type 2 diabetes.	FEBS letters	2013	32
23380070	Islet Amyloid Polypeptide	Cao P	Islet amyloid: from fundamental biophysics to mechanisms of cytotoxicity.	FEBS letters	2013	38
23794448	Islet Amyloid Polypeptide	Jackson K	Amylin deposition in the brain: A second amyloid in Alzheimer disease?	Annals of neurology	2013	60
24218609	Islet Amyloid Polypeptide	Buchanan LE	Mechanism of IAPP amyloid fibril formation involves an intermediate with a transient β-sheet.	Proceedings of the National Academy of Sciences of the United States of America	2013	41
24222351	Islet Amyloid Polypeptide	Westwell-Roper CY	Resident macrophages mediate islet amyloid polypeptide-induced islet IL-1β production and β-cell dysfunction.	Diabetes	2014	28
24589570	Islet Amyloid Polypeptide	Bram Y	Apoptosis induced by islet amyloid polypeptide soluble oligomers is neutralized by diabetes-associated specific antibodies.	Scientific reports	2014	24
25036705	Islet Amyloid Polypeptide	Kim J	Amyloidogenic peptide oligomer accumulation in autophagy-deficient β cells induces diabetes.	The Journal of clinical investigation	2014	32
25036706	Islet Amyloid Polypeptide	Shigihara N	Human IAPP-induced pancreatic β cell toxicity and its regulation by autophagy.	The Journal of clinical investigation	2014	30
25149184	Islet Amyloid Polypeptide	Srodulski S	Neuroinflammation and neurologic deficits in diabetes linked to brain accumulation of amylin.	Molecular neurodegeneration	2014	25
25700985	Islet Amyloid Polypeptide	Oskarsson ME	In vivo seeding and cross-seeding of localized amyloidosis: a molecular link between type 2 diabetes and Alzheimer disease.	The American journal of pathology	2015	31
25998900	Islet Amyloid Polypeptide	Mukherjee A	Type 2 diabetes as a protein misfolding disease.	Trends in molecular medicine	2015	25
26649319	Islet Amyloid Polypeptide	Akter R	Islet Amyloid Polypeptide: Structure, Function, and Pathophysiology.	Journal of diabetes research	2016	11
10675071	Angiotensin-Converting Enzyme Inhibitors	-	Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators.	Lancet	2000	337
11453706	Angiotensin-Converting Enzyme Inhibitors	Jafar TH	Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease. A meta-analysis of patient-level data.	Annals of internal medicine	2001	106
16338452	Angiotensin-Converting Enzyme Inhibitors	Casas JP	Effect of inhibitors of the renin-angiotensin system and other antihypertensive drugs on renal outcomes: systematic review and meta-analysis.	Lancet	2005	82
16760444	Angiotensin-Converting Enzyme Inhibitors	Cooper WO	Major congenital malformations after first-trimester exposure to ACE inhibitors.	The New England journal of medicine	2006	122
17984482	Angiotensin-Converting Enzyme Inhibitors	Kunz R	Meta-analysis: effect of monotherapy and combination therapy with inhibitors of the renin angiotensin system on proteinuria in renal disease.	Annals of internal medicine	2008	98
17984484	Angiotensin-Converting Enzyme Inhibitors	Matchar DB	Systematic review: comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers for treating essential hypertension.	Annals of internal medicine	2008	64
21872920	Angiotensin-Converting Enzyme Inhibitors	Yusuf S	Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): a prospective epidemiological survey.	Lancet	2011	141
22135311	Angiotensin-Converting Enzyme Inhibitors	Vegter S	Sodium intake, ACE inhibition, and progression to ESRD.	Journal of the American Society of Nephrology 	2012	43
22189484	Angiotensin-Converting Enzyme Inhibitors	Vejakama P	Reno-protective effects of renin-angiotensin system blockade in type 2 diabetic patients: a systematic review and network meta-analysis.	Diabetologia	2012	32
23100218	Angiotensin-Converting Enzyme Inhibitors	Ruggenenti P	Mechanisms and treatment of CKD.	Journal of the American Society of Nephrology 	2012	41
24157497	Angiotensin-Converting Enzyme Inhibitors	Wu HY	Comparative effectiveness of renin-angiotensin system blockers and other antihypertensive drugs in patients with diabetes: systematic review and bayesian network meta-analysis.	BMJ	2013	32
24206457	Angiotensin-Converting Enzyme Inhibitors	Fried LF	Combined angiotensin inhibition for the treatment of diabetic nephropathy.	The New England journal of medicine	2013	121
26009228	Angiotensin-Converting Enzyme Inhibitors	Palmer SC	Comparative efficacy and safety of blood pressure-lowering agents in adults with diabetes and kidney disease: a network meta-analysis.	Lancet	2015	37
12672737	Simvastatin	Thompson PD	Statin-associated myopathy.	JAMA	2003	185
18650507	Simvastatin	SEARCH Collaborative Group.	SLCO1B1 variants and statin-induced myopathy--a genomewide study.	The New England journal of medicine	2008	370
24657242	Simvastatin	Sirtori CR	The pharmacology of statins.	Pharmacological research	2014	25
25066560	Simvastatin	Blazing MA	Evaluating cardiovascular event reduction with ezetimibe as an adjunct to simvastatin in 18,144 patients after acute coronary syndromes: final baseline characteristics of the IMPROVE-IT study population.	American heart journal	2014	22
25082583	Simvastatin	Boekholdt SM	Very low levels of atherogenic lipoproteins and the risk for cardiovascular events: a meta-analysis of statin trials.	Journal of the American College of Cardiology	2014	42
25471221	Simvastatin	Tenenbaum A	Hypertriglyceridemia: a too long unfairly neglected major cardiovascular risk factor.	Cardiovascular diabetology	2014	23
25980762	Simvastatin	Dongiovanni P	Statin use and non-alcoholic steatohepatitis in at risk individuals.	Journal of hepatology	2015	25
27908689	Simvastatin	Schmidt AF	PCSK9 genetic variants and risk of type 2 diabetes: a mendelian randomisation study.	The lancet. Diabetes & endocrinology	2017	23
10454950	Hypoglycemic Agents	DeFronzo RA	Pharmacologic therapy for type 2 diabetes mellitus.	Annals of internal medicine	1999	114
12093242	Hypoglycemic Agents	Kirpichnikov D	Metformin: an update.	Annals of internal medicine	2002	188
12829629	Hypoglycemic Agents	Iwaki M	Induction of adiponectin, a fat-derived antidiabetic and antiatherogenic factor, by nuclear receptors.	Diabetes	2003	137
14749265	Hypoglycemic Agents	Ferré P	The biology of peroxisome proliferator-activated receptors: relationship with lipid metabolism and insulin sensitivity.	Diabetes	2004	122
15111553	Hypoglycemic Agents	Cramer JA	A systematic review of adherence with medications for diabetes.	Diabetes care	2004	242
15669880	Hypoglycemic Agents	Krentz AJ	Oral antidiabetic agents: current role in type 2 diabetes mellitus.	Drugs	2005	137
16443869	Hypoglycemic Agents	Bowker SL	Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin.	Diabetes care	2006	244
16860976	Hypoglycemic Agents	Vuksan V	Korean red ginseng (Panax ginseng) improves glucose and insulin regulation in well-controlled, type 2 diabetes: results of a randomized, double-blind, placebo-controlled study of efficacy and safety.	Nutrition, metabolism, and cardiovascular diseases 	2008	52
17157112	Hypoglycemic Agents	Rosenstock J	Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin added to ongoing pioglitazone therapy in patients with type 2 diabetes: a 24-week, multicenter, randomized, double-blind, placebo-controlled, parallel-group study.	Clinical therapeutics	2006	92
17622601	Hypoglycemic Agents	Amori RE	Efficacy and safety of incretin therapy in type 2 diabetes: systematic review and meta-analysis.	JAMA	2007	209
17638885	Hypoglycemic Agents	Buzzai M	Systemic treatment with the antidiabetic drug metformin selectively impairs p53-deficient tumor cell growth.	Cancer research	2007	307
18056893	Hypoglycemic Agents	Schwartz AV	Diabetes-related complications, glycemic control, and falls in older adults.	Diabetes care	2008	75
18158075	Hypoglycemic Agents	Barnett AH	Tolerability and efficacy of exenatide and titrated insulin glargine in adult patients with type 2 diabetes previously uncontrolled with metformin or a sulfonylurea: a multinational, randomized, open-label, two-period, crossover noninferiority trial.	Clinical therapeutics	2007	62
18782641	Hypoglycemic Agents	Drucker DJ	Exenatide once weekly versus twice daily for the treatment of type 2 diabetes: a randomised, open-label, non-inferiority study.	Lancet	2008	212
19375425	Hypoglycemic Agents	Li D	Antidiabetic therapies affect risk of pancreatic cancer.	Gastroenterology	2009	169
19515413	Hypoglycemic Agents	Buse JB	Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6).	Lancet	2009	310
20331505	Hypoglycemic Agents	Donadon V	Metformin and reduced risk of hepatocellular carcinoma in diabetic patients with chronic liver disease.	Liver international 	2010	63
20388847	Hypoglycemic Agents	Rozengurt E	Crosstalk between insulin/insulin-like growth factor-1 receptors and G protein-coupled receptor signaling systems: a novel target for the antidiabetic drug metformin in pancreatic cancer.	Clinical cancer research 	2010	80
20388897	Hypoglycemic Agents	Phung OJ	Effect of noninsulin antidiabetic drugs added to metformin therapy on glycemic control, weight gain, and hypoglycemia in type 2 diabetes.	JAMA	2010	81
20442309	Hypoglycemic Agents	Ben Sahra I	Metformin in cancer therapy: a new perspective for an old antidiabetic drug?	Molecular cancer therapeutics	2010	145
20444419	Hypoglycemic Agents	Kalender A	Metformin, independent of AMPK, inhibits mTORC1 in a rag GTPase-dependent manner.	Cell metabolism	2010	214
20448207	Hypoglycemic Agents	Oeseburg H	Glucagon-like peptide 1 prevents reactive oxygen species-induced endothelial cell senescence through the activation of protein kinase A.	Arteriosclerosis, thrombosis, and vascular biology	2010	61
20587723	Hypoglycemic Agents	Gogitidze Joy N	Effects of acute hypoglycemia on inflammatory and pro-atherothrombotic biomarkers in individuals with type 1 diabetes and healthy individuals.	Diabetes care	2010	44
21114598	Hypoglycemic Agents	Deacon CF	Dipeptidyl peptidase-4 inhibitors in the treatment of type 2 diabetes: a comparative review.	Diabetes, obesity & metabolism	2011	81
21301998	Hypoglycemic Agents	Kourelis TV	Metformin and cancer: new applications for an old drug.	Medical oncology	2012	73
21307137	Hypoglycemic Agents	Blevins T	DURATION-5: exenatide once weekly resulted in greater improvements in glycemic control compared with exenatide twice daily in patients with type 2 diabetes.	The Journal of clinical endocrinology and metabolism	2011	75
21734003	Hypoglycemic Agents	Drucker DJ	The safety of incretin-based therapies--review of the scientific evidence.	The Journal of clinical endocrinology and metabolism	2011	41
21955459	Hypoglycemic Agents	DeFronzo RA	The role of the kidneys in glucose homeostasis: a new path towards normalizing glycaemia.	Diabetes, obesity & metabolism	2012	83
21959118	Hypoglycemic Agents	Elsadek B	Impact of albumin on drug delivery--new applications on the horizon.	Journal of controlled release 	2012	71
22046219	Hypoglycemic Agents	McIntosh B	Second-line therapy in patients with type 2 diabetes inadequately controlled with metformin monotherapy: a systematic review and mixed-treatment comparison meta-analysis.	Open medicine 	2011	40
22112968	Hypoglycemic Agents	He X	Metformin and thiazolidinediones are associated with improved breast cancer-specific survival of diabetic women with HER2+ breast cancer.	Annals of oncology 	2012	54
22162232	Hypoglycemic Agents	Li D	Diabetes and pancreatic cancer.	Molecular carcinogenesis	2012	55
22194737	Hypoglycemic Agents	Mazza A	The role of metformin in the management of NAFLD.	Experimental diabetes research	2012	37
22236411	Hypoglycemic Agents	Vilsbøll T	Effects of glucagon-like peptide-1 receptor agonists on weight loss: systematic review and meta-analyses of randomised controlled trials.	BMJ	2012	128
22310849	Hypoglycemic Agents	Ferrannini E	SGLT2 inhibition in diabetes mellitus: rationale and clinical prospects.	Nature reviews. Endocrinology	2012	49
22340932	Hypoglycemic Agents	Desai NR	Patterns of medication initiation in newly diagnosed diabetes mellitus: quality and cost implications.	The American journal of medicine	2012	36
22699287	Hypoglycemic Agents	Cavelti-Weder C	Effects of gevokizumab on glycemia and inflammatory markers in type 2 diabetes.	Diabetes care	2012	53
22703861	Hypoglycemic Agents	Patil HR	Meta-analysis of effect of dipeptidyl peptidase-4 inhibitors on cardiovascular risk in type 2 diabetes mellitus.	The American journal of cardiology	2012	40
23292119	Hypoglycemic Agents	Hou G	Clinical pathological characteristics and prognostic analysis of 1,013 breast cancer patients with diabetes.	Breast cancer research and treatment	2013	26
23514733	Hypoglycemic Agents	Sloan-Lancaster J	Double-blind, randomized study evaluating the glycemic and anti-inflammatory effects of subcutaneous LY2189102, a neutralizing IL-1β antibody, in patients with type 2 diabetes.	Diabetes care	2013	33
23704520	Hypoglycemic Agents	Castellano JM	Biochemical basis of the antidiabetic activity of oleanolic acid and related pentacyclic triterpenes.	Diabetes	2013	27
24026259	Hypoglycemic Agents	Vasilakou D	Sodium-glucose cotransporter 2 inhibitors for type 2 diabetes: a systematic review and meta-analysis.	Annals of internal medicine	2013	98
24189526	Hypoglycemic Agents	Anisimov VN	Metformin: do we finally have an anti-aging drug?	Cell cycle	2013	26
24322626	Hypoglycemic Agents	Tseng CL	Assessing potential glycemic overtreatment in persons at hypoglycemic risk.	JAMA internal medicine	2014	29
24602971	Hypoglycemic Agents	Baker WL	Effects of sodium-glucose co-transporter 2 inhibitors on blood pressure: a systematic review and meta-analysis.	Journal of the American Society of Hypertension 	2014	52
24842985	Hypoglycemic Agents	Umpierrez G	Efficacy and safety of dulaglutide monotherapy versus metformin in type 2 diabetes in a randomized controlled trial (AWARD-3).	Diabetes care	2014	39
24857538	Hypoglycemic Agents	Preston MA	Metformin use and prostate cancer risk.	European urology	2014	24
24899464	Hypoglycemic Agents	Halperin F	Roux-en-Y gastric bypass surgery or lifestyle with intensive medical management in patients with type 2 diabetes: feasibility and 1-year results of a randomized clinical trial.	JAMA surgery	2014	40
24917306	Hypoglycemic Agents	Mitsuhashi A	Effects of metformin on endometrial cancer cell growth in vivo: a preoperative prospective trial.	Cancer	2014	24
24937531	Hypoglycemic Agents	Santovito D	Plasma exosome microRNA profiling unravels a new potential modulator of adiponectin pathway in diabetes: effect of glycemic control.	The Journal of clinical endocrinology and metabolism	2014	23
24957699	Hypoglycemic Agents	Fisman EZ	Adiponectin: a manifold therapeutic target for metabolic syndrome, diabetes, and coronary disease?	Cardiovascular diabetology	2014	38
24961373	Hypoglycemic Agents	Chen L	OCT1 is a high-capacity thiamine transporter that regulates hepatic steatosis and is a target of metformin.	Proceedings of the National Academy of Sciences of the United States of America	2014	33
25011946	Hypoglycemic Agents	Diamant M	Glucagon-like peptide 1 receptor agonist or bolus insulin with optimized basal insulin in type 2 diabetes.	Diabetes care	2014	24
25193531	Hypoglycemic Agents	Yki-Järvinen H	New insulin glargine 300 units/mL versus glargine 100 units/mL in people with type 2 diabetes using oral agents and basal insulin: glucose control and hypoglycemia in a 6-month randomized controlled trial (EDITION 2).	Diabetes care	2014	38
25242225	Hypoglycemic Agents	Soccio RE	Thiazolidinediones and the promise of insulin sensitization in type 2 diabetes.	Cell metabolism	2014	52
25792818	Hypoglycemic Agents	Li X	Link between type 2 diabetes and Alzheimer's disease: from epidemiology to mechanism and treatment.	Clinical interventions in aging	2015	17
25913633	Hypoglycemic Agents	Meier C	Effects of diabetes drugs on the skeleton.	Bone	2016	17
26052984	Hypoglycemic Agents	Green JB	Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes.	The New England journal of medicine	2015	242
26078479	Hypoglycemic Agents	Peters AL	Euglycemic Diabetic Ketoacidosis: A Potential Complication of Treatment With Sodium-Glucose Cotransporter 2 Inhibition.	Diabetes care	2015	62
26086329	Hypoglycemic Agents	Taylor SI	SGLT2 Inhibitors May Predispose to Ketoacidosis.	The Journal of clinical endocrinology and metabolism	2015	51
26577417	Hypoglycemic Agents	Buse JB	Randomized Clinical Trial Comparing Basal Insulin Peglispro and Insulin Glargine in Patients With Type 2 Diabetes Previously Treated With Basal Insulin: IMAGINE 5.	Diabetes care	2016	12
26580234	Hypoglycemic Agents	Bilezikian JP	Evaluation of Bone Mineral Density and Bone Biomarkers in Patients With Type 2 Diabetes Treated With Canagliflozin.	The Journal of clinical endocrinology and metabolism	2016	14
26597596	Hypoglycemic Agents	Deacon CF	Comparative review of dipeptidyl peptidase-4 inhibitors and sulphonylureas.	Diabetes, obesity & metabolism	2016	13
26769791	Hypoglycemic Agents	Sharma M	Trends in incidence, prevalence and prescribing in type 2 diabetes mellitus between 2000 and 2013 in primary care: a retrospective cohort study.	BMJ open	2016	22
26822324	Hypoglycemic Agents	Mita T	Sitagliptin Attenuates the Progression of Carotid Intima-Media Thickening in Insulin-Treated Patients With Type 2 Diabetes: The Sitagliptin Preventive Study of Intima-Media Thickness Evaluation (SPIKE): A Randomized Controlled Trial.	Diabetes care	2016	24
26888822	Hypoglycemic Agents	Li L	Dipeptidyl peptidase-4 inhibitors and risk of heart failure in type 2 diabetes: systematic review and meta-analysis of randomised and observational studies.	BMJ	2016	22
26932742	Hypoglycemic Agents	Ou HT	Risks of cardiovascular diseases associated with dipeptidyl peptidase-4 inhibitors and other antidiabetic drugs in patients with type 2 diabetes: a nation-wide longitudinal study.	Cardiovascular diabetology	2016	14
27007958	Hypoglycemic Agents	Filion KB	A Multicenter Observational Study of Incretin-based Drugs and Heart Failure.	The New England journal of medicine	2016	26
27062145	Hypoglycemic Agents	Ou HT	Recent trends in the use of antidiabetic medications from 2008 to 2013: A nation-wide population-based study from Taiwan.	Journal of diabetes	2017	5
27362768	Hypoglycemic Agents	Sośnicki S	Molecular targets of metformin antitumor action.	Pharmacological reports 	2016	12
27399082	Hypoglycemic Agents	Ko SH	Trends of antidiabetic drug use in adult type 2 diabetes in Korea in 2002-2013: Nationwide population-based cohort study.	Medicine	2016	11
27418629	Hypoglycemic Agents	Cameron AR	Anti-Inflammatory Effects of Metformin Irrespective of Diabetes Status.	Circulation research	2016	20
27470878	Hypoglycemic Agents	Heerspink HJ	Sodium Glucose Cotransporter 2 Inhibitors in the Treatment of Diabetes Mellitus: Cardiovascular and Kidney Effects, Potential Mechanisms, and Clinical Applications.	Circulation	2016	35
27483064	Hypoglycemic Agents	Margulies KB	Effects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.	JAMA	2016	20
27502359	Hypoglycemic Agents	Klil-Drori AJ	Cancer, obesity, diabetes, and antidiabetic drugs: is the fog clearing?	Nature reviews. Clinical oncology	2017	17
27636731	Hypoglycemic Agents	Martel J	Anti-obesogenic and antidiabetic effects of plants and mushrooms.	Nature reviews. Endocrinology	2017	9
23040568	irbesartan	Akiyama E	Incremental prognostic significance of peripheral endothelial dysfunction in patients with heart failure with normal left ventricular ejection fraction.	Journal of the American College of Cardiology	2012	38
17268245	NAD	Revollo JR	The regulation of nicotinamide adenine dinucleotide biosynthesis by Nampt/PBEF/visfatin in mammals.	Current opinion in gastroenterology	2007	56
17694090	NAD	Vaquero A	NAD+-dependent deacetylation of H4 lysine 16 by class III HDACs.	Oncogene	2007	93
19109034	NAD	Garten A	Nampt: linking NAD biology, metabolism and cancer.	Trends in endocrinology and metabolism	2009	117
19887598	NAD	Ritov VB	Deficiency of electron transport chain in human skeletal muscle mitochondria in type 2 diabetes mellitus and obesity.	American journal of physiology. Endocrinology and metabolism	2010	66
20226541	NAD	Imai S	Ten years of NAD-dependent SIR2 family deacetylases: implications for metabolic diseases.	Trends in pharmacological sciences	2010	137
20409078	NAD	Donmez G	Aging and disease: connections to sirtuins.	Aging cell	2010	119
21709297	NAD	Uribarri J	Restriction of advanced glycation end products improves insulin resistance in human type 2 diabetes: potential role of AGER1 and SIRT1.	Diabetes care	2011	58
22249520	NAD	Chalkiadaki A	Sirtuins mediate mammalian metabolic responses to nutrient availability.	Nature reviews. Endocrinology	2012	95
22479251	NAD	Yamakuchi M	MicroRNA Regulation of SIRT1.	Frontiers in physiology	2012	42
22553202	NAD	Nin V	Role of deleted in breast cancer 1 (DBC1) protein in SIRT1 deacetylase activation induced by protein kinase A and AMP-activated protein kinase.	The Journal of biological chemistry	2012	40
22811431	NAD	Nogueiras R	Sirtuin 1 and sirtuin 3: physiological modulators of metabolism.	Physiological reviews	2012	83
22863012	NAD	Qiang L	Brown remodeling of white adipose tissue by SirT1-dependent deacetylation of Pparγ.	Cell	2012	148
23075334	NAD	Kitada M	Sirtuins and renal diseases: relationship with aging and diabetic nephropathy.	Clinical science	2013	40
23374890	NAD	Wickman C	Obesity and kidney disease: potential mechanisms.	Seminars in nephrology	2013	36
23417962	NAD	Donmez G	SIRT1 and SIRT2: emerging targets in neurodegeneration.	EMBO molecular medicine	2013	58
26215259	NAD	Garten A	Physiological and pathophysiological roles of NAMPT and NAD metabolism.	Nature reviews. Endocrinology	2015	36
26303641	NAD	Poulose N	Sirtuin regulation in aging and injury.	Biochimica et biophysica acta	2015	38
26574954	NAD	Jukarainen S	Obesity Is Associated With Low NAD(+)/SIRT Pathway Expression in Adipose Tissue of BMI-Discordant Monozygotic Twins.	The Journal of clinical endocrinology and metabolism	2016	12
11756336	Diglycerides	Ido Y	Hyperglycemia-induced apoptosis in human umbilical vein endothelial cells: inhibition by the AMP-activated protein kinase activation.	Diabetes	2002	87
12086926	Diglycerides	Itani SI	Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and IkappaB-alpha.	Diabetes	2002	295
16563942	Diglycerides	Petersen KF	Etiology of insulin resistance.	The American journal of medicine	2006	174
18267070	Diglycerides	Chibalin AV	Downregulation of diacylglycerol kinase delta contributes to hyperglycemia-induced insulin resistance.	Cell	2008	69
19833891	Diglycerides	Coen PM	Insulin resistance is associated with higher intramyocellular triglycerides in type I but not type II myocytes concomitant with higher ceramide content.	Diabetes	2010	58
20609972	Diglycerides	Samuel VT	Lipid-induced insulin resistance: unravelling the mechanism.	Lancet	2010	263
21498783	Diglycerides	Badin PM	Altered skeletal muscle lipase expression and activity contribute to insulin resistance in humans.	Diabetes	2011	39
21873552	Diglycerides	Amati F	Skeletal muscle triglycerides, diacylglycerols, and ceramides in insulin resistance: another paradox in endurance-trained athletes?	Diabetes	2011	107
21930939	Diglycerides	Kumashiro N	Cellular mechanism of insulin resistance in nonalcoholic fatty liver disease.	Proceedings of the National Academy of Sciences of the United States of America	2011	118
22560210	Diglycerides	Jornayvaz FR	Diacylglycerol activation of protein kinase Cε and hepatic insulin resistance.	Cell metabolism	2012	69
22807032	Diglycerides	Bosma M	Perilipin 2 improves insulin sensitivity in skeletal muscle despite elevated intramuscular lipid levels.	Diabetes	2012	33
23833274	Diglycerides	Asrih M	Inflammation as a potential link between nonalcoholic fatty liver disease and insulin resistance.	The Journal of endocrinology	2013	35
23929732	Diglycerides	Birkenfeld AL	Nonalcoholic fatty liver disease, hepatic insulin resistance, and type 2 diabetes.	Hepatology	2014	87
24899308	Diglycerides	Perry RJ	The role of hepatic lipids in hepatic insulin resistance and type 2 diabetes.	Nature	2014	130
24979806	Diglycerides	Szendroedi J	Role of diacylglycerol activation of PKCθ in lipid-induced muscle insulin resistance in humans.	Proceedings of the National Academy of Sciences of the United States of America	2014	44
10818001	Adenosine Monophosphate	Milan D	A mutation in PRKAG3 associated with excess glycogen content in pig skeletal muscle.	Science	2000	104
12847291	Adenosine Monophosphate	Hong SP	Activation of yeast Snf1 and mammalian AMP-activated protein kinase by upstream kinases.	Proceedings of the National Academy of Sciences of the United States of America	2003	180
12878598	Adenosine Monophosphate	Waki H	Impaired multimerization of human adiponectin mutants associated with diabetes. Molecular structure and multimer formation of adiponectin.	The Journal of biological chemistry	2003	180
12960011	Adenosine Monophosphate	Unger RH	Minireview: weapons of lean body mass destruction: the role of ectopic lipids in the metabolic syndrome.	Endocrinology	2003	141
14614828	Adenosine Monophosphate	Woods A	LKB1 is the upstream kinase in the AMP-activated protein kinase cascade.	Current biology 	2003	431
14729328	Adenosine Monophosphate	Carling D	The AMP-activated protein kinase cascade--a unifying system for energy control.	Trends in biochemical sciences	2004	232
16644800	Adenosine Monophosphate	Hardie DG	AMP-activated protein kinase--development of the energy sensor concept.	The Journal of physiology	2006	210
17021375	Adenosine Monophosphate	Ahima RS	Adipose tissue as an endocrine organ.	Obesity	2006	127
17192291	Adenosine Monophosphate	Körner A	Total and high-molecular-weight adiponectin in breast cancer: in vitro and in vivo studies.	The Journal of clinical endocrinology and metabolism	2007	60
17307971	Adenosine Monophosphate	Towler MC	AMP-activated protein kinase in metabolic control and insulin signaling.	Circulation research	2007	317
18022388	Adenosine Monophosphate	Hardie DG	Role of AMP-activated protein kinase in the metabolic syndrome and in heart disease.	FEBS letters	2008	64
18054335	Adenosine Monophosphate	Kadowaki T	The physiological and pathophysiological role of adiponectin and adiponectin receptors in the peripheral tissues and CNS.	FEBS letters	2008	63
18184930	Adenosine Monophosphate	McGee SL	AMP-activated protein kinase regulates GLUT4 transcription by phosphorylating histone deacetylase 5.	Diabetes	2008	96
18202144	Adenosine Monophosphate	Ahima RS	Adipokines and the peripheral and neural control of energy balance.	Molecular endocrinology	2008	56
19243571	Adenosine Monophosphate	Wang W	AMP-activated protein kinase and cancer.	Acta physiologica	2009	47
19276890	Adenosine Monophosphate	Gong J	CIDE proteins and metabolic disorders.	Current opinion in lipidology	2009	60
19416711	Adenosine Monophosphate	Zhang BB	AMPK: an emerging drug target for diabetes and the metabolic syndrome.	Cell metabolism	2009	206
19468337	Adenosine Monophosphate	Dzeja P	Adenylate kinase and AMP signaling networks: metabolic monitoring, signal communication and body energy sensing.	International journal of molecular sciences	2009	59
20103737	Adenosine Monophosphate	Ruderman NB	AMPK and SIRT1: a long-standing partnership?	American journal of physiology. Endocrinology and metabolism	2010	145
20371735	Adenosine Monophosphate	Lira VA	PGC-1alpha regulation by exercise training and its influences on muscle function and insulin sensitivity.	American journal of physiology. Endocrinology and metabolism	2010	67
22446165	Adenosine Monophosphate	Chowdhury SK	The role of aberrant mitochondrial bioenergetics in diabetic neuropathy.	Neurobiology of disease	2013	37
22798688	Adenosine Monophosphate	Srivastava RA	AMP-activated protein kinase: an emerging drug target to regulate imbalances in lipid and carbohydrate metabolism to treat cardio-metabolic diseases.	Journal of lipid research	2012	33
23028138	Adenosine Monophosphate	Nitert MD	Impact of an exercise intervention on DNA methylation in skeletal muscle from first-degree relatives of patients with type 2 diabetes.	Diabetes	2012	69
24026768	Adenosine Monophosphate	Matsuda M	Roles of adiponectin and oxidative stress in obesity-associated metabolic and cardiovascular diseases.	Reviews in endocrine & metabolic disorders	2014	20
24359125	Adenosine Monophosphate	Lang F	Oxidative stress and suicidal erythrocyte death.	Antioxidants & redox signaling	2014	24
25018645	Adenosine Monophosphate	Coughlan KA	AMPK activation: a therapeutic target for type 2 diabetes?	Diabetes, metabolic syndrome and obesity 	2014	43
26077742	Arginine Vasopressin	Bockenhauer D	Pathophysiology, diagnosis and management of nephrogenic diabetes insipidus.	Nature reviews. Nephrology	2015	17
15238246	Acetylglucosamine	Zachara NE	O-GlcNAc a sensor of cellular state: the role of nucleocytoplasmic glycosylation in modulating cellular function in response to nutrition and stress.	Biochimica et biophysica acta	2004	114
16317114	Acetylglucosamine	Love DC	The hexosamine signaling pathway: deciphering the "O-GlcNAc code".	Science's STKE 	2005	176
16970929	Acetylglucosamine	Fülöp N	Role of protein O-linked N-acetyl-glucosamine in mediating cell function and survival in the cardiovascular system.	Cardiovascular research	2007	56
17460662	Acetylglucosamine	Hart GW	Cycling of O-linked beta-N-acetylglucosamine on nucleocytoplasmic proteins.	Nature	2007	371
18420577	Acetylglucosamine	Housley MP	O-GlcNAc regulates FoxO activation in response to glucose.	The Journal of biological chemistry	2008	101
18445751	Acetylglucosamine	Copeland RJ	Cross-talk between GlcNAcylation and phosphorylation: roles in insulin resistance and glucose toxicity.	American journal of physiology. Endocrinology and metabolism	2008	95
19028792	Acetylglucosamine	Laczy B	Protein O-GlcNAcylation: a new signaling paradigm for the cardiovascular system.	American journal of physiology. Heart and circulatory physiology	2009	55
19647786	Acetylglucosamine	Butkinaree C	O-linked beta-N-acetylglucosamine (O-GlcNAc): Extensive crosstalk with phosphorylation to regulate signaling and transcription in response to nutrients and stress.	Biochimica et biophysica acta	2010	114
20202486	Acetylglucosamine	Ozcan S	Modulation of transcription factor function by O-GlcNAc modification.	Biochimica et biophysica acta	2010	70
20466550	Acetylglucosamine	Slawson C	O-GlcNAc signaling: a metabolic link between diabetes and cancer?	Trends in biochemical sciences	2010	97
20488252	Acetylglucosamine	Love DC	O-GlcNAc cycling: emerging roles in development and epigenetics.	Seminars in cell & developmental biology	2010	43
20651294	Acetylglucosamine	Ngoh GA	O-GlcNAc signaling in the cardiovascular system.	Circulation research	2010	50
21391816	Acetylglucosamine	Hart GW	Cross talk between O-GlcNAcylation and phosphorylation: roles in signaling, transcription, and chronic disease.	Annual review of biochemistry	2011	314
21878340	Acetylglucosamine	Darley-Usmar VM	Protein O-linked β-N-acetylglucosamine: a novel effector of cardiomyocyte metabolism and function.	Journal of molecular and cellular cardiology	2012	31
22371497	Acetylglucosamine	Fong JJ	β-N-Acetylglucosamine (O-GlcNAc) is a novel regulator of mitosis-specific phosphorylations on histone H3.	The Journal of biological chemistry	2012	40
22522719	Acetylglucosamine	Hanover JA	Bittersweet memories: linking metabolism to epigenetics through O-GlcNAcylation.	Nature reviews. Molecular cell biology	2012	111
22745122	Acetylglucosamine	Gawlowski T	Modulation of dynamin-related protein 1 (DRP1) function by increased O-linked-β-N-acetylglucosamine modification (O-GlcNAc) in cardiac myocytes.	The Journal of biological chemistry	2012	47
23642195	Acetylglucosamine	Bond MR	O-GlcNAc cycling: a link between metabolism and chronic disease.	Annual review of nutrition	2013	73
23647930	Acetylglucosamine	Ruan HB	Cracking the O-GlcNAc code in metabolism.	Trends in endocrinology and metabolism	2013	51
23982206	Acetylglucosamine	Ramakrishnan P	Activation of the transcriptional function of the NF-κB protein c-Rel by O-GlcNAc glycosylation.	Science signaling	2013	30
23992419	Acetylglucosamine	Ma J	Protein O-GlcNAcylation in diabetes and diabetic complications.	Expert review of proteomics	2013	36
24287310	Acetylglucosamine	Dassanayaka S	O-GlcNAc and the cardiovascular system.	Pharmacology & therapeutics	2014	24
24713701	Acetylglucosamine	Tan EP	Altering O-linked β-N-acetylglucosamine cycling disrupts mitochondrial function.	The Journal of biological chemistry	2014	22
24759912	Acetylglucosamine	Yuzwa SA	O-GlcNAc and neurodegeneration: biochemical mechanisms and potential roles in Alzheimer's disease and beyond.	Chemical Society reviews	2014	25
25100062	Acetylglucosamine	Hardivillé S	Nutrient regulation of signaling, transcription, and cell physiology by O-GlcNAcylation.	Cell metabolism	2014	57
17476361	Metformin	Shu Y	Effect of genetic variation in the organic cation transporter 1 (OCT1) on metformin action.	The Journal of clinical investigation	2007	182
17485570	Metformin	Goldstein BJ	Effect of initial combination therapy with sitagliptin, a dipeptidyl peptidase-4 inhibitor, and metformin on glycemic control in patients with type 2 diabetes.	Diabetes care	2007	109
17519421	Metformin	Pearson ER	Variation in TCF7L2 influences therapeutic response to sulfonylureas: a GoDARTs study.	Diabetes	2007	68
18006825	Metformin	Dowling RJ	Metformin inhibits mammalian target of rapamycin-dependent translation initiation in breast cancer cells.	Cancer research	2007	269
18250273	Metformin	Xie Z	Phosphorylation of LKB1 at serine 428 by protein kinase C-zeta is required for metformin-enhanced activation of the AMP-activated protein kinase in endothelial cells.	Circulation	2008	87
18256928	Metformin	Phoenix KN	Therapeutic metformin/AMPK activation promotes the angiogenic phenotype in the ERalpha negative MDA-MB-435 breast cancer model.	Breast cancer research and treatment	2009	47
18469241	Metformin	Bray GA	Relation of central adiposity and body mass index to the development of diabetes in the Diabetes Prevention Program.	The American journal of clinical nutrition	2008	55
18945255	Metformin	Loomba R	Clinical trial: pilot study of metformin for the treatment of non-alcoholic steatohepatitis.	Alimentary pharmacology & therapeutics	2009	54
19228809	Metformin	Becker ML	Genetic variation in the multidrug and toxin extrusion 1 transporter protein influences the glucose-lowering effect of metformin in patients with diabetes: a preliminary study.	Diabetes	2009	57
19289857	Metformin	Zinman B	Efficacy and safety of the human glucagon-like peptide-1 analog liraglutide in combination with metformin and thiazolidinedione in patients with type 2 diabetes (LEAD-4 Met+TZD).	Diabetes care	2009	188
19367387	Metformin	Masini M	Autophagy in human type 2 diabetes pancreatic beta cells.	Diabetologia	2009	70
19381165	Metformin	Becker ML	Genetic variation in the organic cation transporter 1 is associated with metformin response in patients with diabetes mellitus.	The pharmacogenomics journal	2009	49
19440038	Metformin	Liu B	Metformin induces unique biological and molecular responses in triple negative breast cancer cells.	Cell cycle	2009	123
19679549	Metformin	Kisfalvi K	Metformin disrupts crosstalk between G protein-coupled receptor and insulin receptor signaling systems and inhibits pancreatic cancer growth.	Cancer research	2009	109
19822355	Metformin	Cantrell LA	Metformin is a potent inhibitor of endometrial cancer cell proliferation--implications for a novel treatment strategy.	Gynecologic oncology	2010	77
20222801	Metformin	Luo Z	AMPK as a metabolic tumor suppressor: control of metabolism and cell growth.	Future oncology	2010	106
20357375	Metformin	Fadini GP	The oral dipeptidyl peptidase-4 inhibitor sitagliptin increases circulating endothelial progenitor cells in patients with type 2 diabetes: possible role of stromal-derived factor-1alpha.	Diabetes care	2010	70
20417856	Metformin	Pratley RE	Liraglutide versus sitagliptin for patients with type 2 diabetes who did not have adequate glycaemic control with metformin: a 26-week, randomised, parallel-group, open-label trial.	Lancet	2010	127
20656475	Metformin	Jalving M	Metformin: taking away the candy for cancer?	European journal of cancer	2010	99
20682687	Metformin	Jablonski KA	Common variants in 40 genes assessed for diabetes incidence and response to metformin and lifestyle intervention in the diabetes prevention program.	Diabetes	2010	70
20923485	Metformin	Durán A	Benefits of self-monitoring blood glucose in the management of new-onset Type 2 diabetes mellitus: the St Carlos Study, a prospective randomized clinic-based interventional study with parallel groups.	Journal of diabetes	2010	42
21088486	Metformin	Cufí S	Metformin against TGFβ-induced epithelial-to-mesenchymal transition (EMT): from cancer stem cells to aging-associated fibrosis.	Cell cycle	2010	75
21114605	Metformin	Taskinen MR	Safety and efficacy of linagliptin as add-on therapy to metformin in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled study.	Diabetes, obesity & metabolism	2011	65
21355967	Metformin	Pratley R	One year of liraglutide treatment offers sustained and more effective glycaemic control and weight reduction compared with sitagliptin, both in combination with metformin, in patients with type 2 diabetes: a randomised, parallel-group, open-label trial.	International journal of clinical practice	2011	51
21540236	Metformin	Ben Sahra I	Metformin, independent of AMPK, induces mTOR inhibition and cell-cycle arrest through REDD1.	Cancer research	2011	162
21781152	Metformin	Owens DR	Efficacy and safety of linagliptin in persons with type 2 diabetes inadequately controlled by a combination of metformin and sulphonylurea: a 24-week randomized study.	Diabetic medicine 	2011	55
21989078	Metformin	Christensen MM	The pharmacogenetics of metformin and its impact on plasma metformin steady-state levels and glycosylated hemoglobin A1c.	Pharmacogenetics and genomics	2011	44
22129971	Metformin	Lai SW	Antidiabetes drugs correlate with decreased risk of lung cancer: a population-based observation in Taiwan.	Clinical lung cancer	2012	40
22203527	Metformin	Del Barco S	Metformin: multi-faceted protection against cancer.	Oncotarget	2011	100
22266668	Metformin	Gier B	Chronic GLP-1 receptor activation by exendin-4 induces expansion of pancreatic duct glands in rats and accelerates formation of dysplastic lesions and chronic pancreatitis in the Kras(G12D) mouse model.	Diabetes	2012	49
22326465	Metformin	Baffy G	Hepatocellular carcinoma in non-alcoholic fatty liver disease: an emerging menace.	Journal of hepatology	2012	152
22355097	Metformin	Dowling RJ	Metformin in cancer: translational challenges.	Journal of molecular endocrinology	2012	77
22356132	Metformin	Haak T	Initial combination of linagliptin and metformin improves glycaemic control in type 2 diabetes: a randomized, double-blind, placebo-controlled study.	Diabetes, obesity & metabolism	2012	33
22465831	Metformin	Sadeghi N	Metformin use is associated with better survival of diabetic patients with pancreatic cancer.	Clinical cancer research 	2012	87
22467080	Metformin	Bhalla K	Metformin prevents liver tumorigenesis by inhibiting pathways driving hepatic lipogenesis.	Cancer prevention research	2012	41
22500211	Metformin	Song CW	Metformin kills and radiosensitizes cancer cells and preferentially kills cancer stem cells.	Scientific reports	2012	70
22564993	Metformin	Bonanni B	Dual effect of metformin on breast cancer proliferation in a randomized presurgical trial.	Journal of clinical oncology 	2012	66
22689798	Metformin	Chlebowski RT	Diabetes, metformin, and breast cancer in postmenopausal women.	Journal of clinical oncology 	2012	49
23086037	Metformin	Lee HM	Upregulated NLRP3 inflammasome activation in patients with type 2 diabetes.	Diabetes	2013	96
23102217	Metformin	Hardie DG	AMP-activated protein kinase: a target for drugs both ancient and modern.	Chemistry & biology	2012	99
23255107	Metformin	Würth R	Metformin selectively affects human glioblastoma tumor-initiating cell viability: A role for metformin-induced inhibition of Akt.	Cell cycle	2013	57
23267855	Metformin	Stocker SL	The effect of novel promoter variants in MATE1 and MATE2 on the pharmacokinetics and pharmacodynamics of metformin.	Clinical pharmacology and therapeutics	2013	28
23564919	Metformin	Schernthaner G	Canagliflozin compared with sitagliptin for patients with type 2 diabetes who do not have adequate glycemic control with metformin plus sulfonylurea: a 52-week randomized trial.	Diabetes care	2013	97
23667692	Metformin	Gou S	Low concentrations of metformin selectively inhibit CD133⁺ cell proliferation in pancreatic cancer and have anticancer action.	PloS one	2013	33
23801715	Metformin	Hardie DG	AMPK: a target for drugs and natural products with effects on both diabetes and cancer.	Diabetes	2013	77
23835523	Metformin	Rena G	Molecular mechanism of action of metformin: old or new insights?	Diabetologia	2013	80
24026211	Metformin	Lavalle-González FJ	Efficacy and safety of canagliflozin compared with placebo and sitagliptin in patients with type 2 diabetes on background metformin monotherapy: a randomised trial.	Diabetologia	2013	89
24118688	Metformin	Wilding JP	Efficacy and safety of canagliflozin in patients with type 2 diabetes mellitus inadequately controlled with metformin and sulphonylurea: a randomised trial.	International journal of clinical practice	2013	65
24269517	Metformin	Ko EM	Metformin is associated with improved survival in endometrial cancer.	Gynecologic oncology	2014	36
24322659	Metformin	Zhu P	Metformin selectively targets tumor-initiating cells in ErbB2-overexpressing breast cancer models.	Cancer prevention research	2014	24
24419232	Metformin	Dallaglio K	Paradoxic effects of metformin on endothelial cells and angiogenesis.	Carcinogenesis	2014	26
24577463	Metformin	Ng TP	Long-term metformin usage and cognitive function among older adults with diabetes.	Journal of Alzheimer's disease 	2014	22
24622668	Metformin	Yang W	Acarbose compared with metformin as initial therapy in patients with newly diagnosed type 2 diabetes: an open-label, non-inferiority randomised trial.	The lancet. Diabetes & endocrinology	2014	24
24998080	Metformin	Weir DL	Sitagliptin use in patients with diabetes and heart failure: a population-based retrospective cohort study.	JACC. Heart failure	2014	28
25002509	Metformin	Janzer A	Metformin and phenformin deplete tricarboxylic acid cycle and glycolytic intermediates during cell transformation and NTPs in cancer stem cells.	Proceedings of the National Academy of Sciences of the United States of America	2014	57
25051360	Metformin	Davis NM	Deregulation of the EGFR/PI3K/PTEN/Akt/mTORC1 pathway in breast cancer: possibilities for therapeutic intervention.	Oncotarget	2014	61
25336746	Metformin	Diabetes Prevention Program Research Group.	HbA1c as a predictor of diabetes and as an outcome in the diabetes prevention program: a randomized clinical trial.	Diabetes care	2015	19
25361004	Metformin	Gritti M	Metformin repositioning as antitumoral agent: selective antiproliferative effects in human glioblastoma stem cells, via inhibition of CLIC1-mediated ion current.	Oncotarget	2014	33
25456737	Metformin	Foretz M	Metformin: from mechanisms of action to therapies.	Cell metabolism	2014	110
25510240	Metformin	Dujic T	Association of Organic Cation Transporter 1 With Intolerance to Metformin in Type 2 Diabetes: A GoDARTS Study.	Diabetes	2015	23
25563903	Metformin	Han TK	Four cation-selective transporters contribute to apical uptake and accumulation of metformin in Caco-2 cell monolayers.	The Journal of pharmacology and experimental therapeutics	2015	18
25576058	Metformin	Cifarelli V	Metformin and Rapamycin Reduce Pancreatic Cancer Growth in Obese Prediabetic Mice by Distinct MicroRNA-Regulated Mechanisms.	Diabetes	2015	21
25849721	Metformin	Dowling RJ	Changes in insulin receptor signaling underlie neoadjuvant metformin administration in breast cancer: a prospective window of opportunity neoadjuvant study.	Breast cancer research 	2015	17
25862373	Metformin	Kato H	Metformin inhibits the proliferation of human prostate cancer PC-3 cells via the downregulation of insulin-like growth factor 1 receptor.	Biochemical and biophysical research communications	2015	17
25940306	Metformin	O'Brien AJ	Salicylate activates AMPK and synergizes with metformin to reduce the survival of prostate and lung cancer cells ex vivo through inhibition of de novo lipogenesis.	The Biochemical journal	2015	17
26065921	Metformin	Takahashi RU	Loss of microRNA-27b contributes to breast cancer stem cell generation by activating ENPP1.	Nature communications	2015	19
26360050	Metformin	Lee SY	Metformin Ameliorates Inflammatory Bowel Disease by Suppression of the STAT3 Signaling Pathway and Regulation of the between Th17/Treg Balance.	PloS one	2015	22
26377054	Metformin	Diabetes Prevention Program Research Group.	Long-term effects of lifestyle intervention or metformin on diabetes development and microvascular complications over 15-year follow-up: the Diabetes Prevention Program Outcomes Study.	The lancet. Diabetes & endocrinology	2015	47
26457538	Metformin	Ou SM	Effects on Clinical Outcomes of Adding Dipeptidyl Peptidase-4 Inhibitors Versus Sulfonylureas to Metformin Therapy in Patients With Type 2 Diabetes Mellitus.	Annals of internal medicine	2015	19
26780750	Metformin	McCreight LJ	Metformin and the gastrointestinal tract.	Diabetologia	2016	28
26813102	Metformin	Lai YC	SIRT3-AMP-Activated Protein Kinase Activation by Nitrite and Metformin Improves Hyperglycemia and Normalizes Pulmonary Hypertension Associated With Heart Failure With Preserved Ejection Fraction.	Circulation	2016	23
27088241	Metformin	Maruthur NM	Diabetes Medications as Monotherapy or Metformin-Based Combination Therapy for Type 2 Diabetes: A Systematic Review and Meta-analysis.	Annals of internal medicine	2016	27
27378194	Metformin	Gadducci A	Metformin use and gynecological cancers: A novel treatment option emerging from drug repositioning.	Critical reviews in oncology/hematology	2016	11
27500523	Metformin	Zhou K	Variation in the glucose transporter gene SLC2A2 is associated with glycemic response to metformin.	Nature genetics	2016	13
27549367	Metformin	Feng Y	Metformin - a potentially effective drug for gestational diabetes mellitus: a systematic review and meta-analysis.	The journal of maternal-fetal & neonatal medicine 	2017	5
27589252	Metformin	Rodbard HW	Safety and efficacy of insulin degludec/liraglutide (IDegLira) added to sulphonylurea alone or to sulphonylurea and metformin in insulin-naïve people with Type 2 diabetes: the DUAL IV trial.	Diabetic medicine 	2017	11
27984722	Metformin	Wu L	An Ancient, Unified Mechanism for Metformin Growth Inhibition in C. elegans and Cancer.	Cell	2016	19
28052845	Metformin	Barry E	Efficacy and effectiveness of screen and treat policies in prevention of type 2 diabetes: systematic review and meta-analysis of screening tests and interventions.	BMJ	2017	14
28055075	Metformin	Qaseem A	Oral Pharmacologic Treatment of Type 2 Diabetes Mellitus: A Clinical Practice Guideline Update From the American College of Physicians.	Annals of internal medicine	2017	8
28089566	Metformin	Howell JJ	Metformin Inhibits Hepatic mTORC1 Signaling via Dose-Dependent Mechanisms Involving AMPK and the TSC Complex.	Cell metabolism	2017	14
7935656	troglitazone	Nolan JJ	Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone.	The New England journal of medicine	1994	127
10189543	troglitazone	-	The Diabetes Prevention Program. Design and methods for a clinical trial in the prevention of type 2 diabetes.	Diabetes care	1999	189
10984506	troglitazone	Mueller E	Effects of ligand activation of peroxisome proliferator-activated receptor gamma in human prostate cancer.	Proceedings of the National Academy of Sciences of the United States of America	2000	98
12196473	troglitazone	Buchanan TA	Preservation of pancreatic beta-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk hispanic women.	Diabetes	2002	191
20938440	troglitazone	Famulla S	Pigment epithelium-derived factor (PEDF) is one of the most abundant proteins secreted by human adipocytes and induces insulin resistance and inflammatory signaling in muscle and fat cells.	International journal of obesity	2011	37
10839530	Thiazolidinediones	Kersten S	Roles of PPARs in health and disease.	Nature	2000	301
15925327	Thiazolidinediones	Feinstein DL	Receptor-independent actions of PPAR thiazolidinedione agonists: is mitochondrial function the key?	Biochemical pharmacology	2005	82
16046315	Thiazolidinediones	Staels B	Therapeutic roles of peroxisome proliferator-activated receptor agonists.	Diabetes	2005	101
16447287	Thiazolidinediones	Farrell GC	Nonalcoholic fatty liver disease: from steatosis to cirrhosis.	Hepatology	2006	502
16634986	Thiazolidinediones	Whitehead JP	Adiponectin--a key adipokine in the metabolic syndrome.	Diabetes, obesity & metabolism	2006	100
16823476	Thiazolidinediones	Kadowaki T	Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome.	The Journal of clinical investigation	2006	537
16879084	Thiazolidinediones	Hardie DG	AMP-activated protein kinase as a drug target.	Annual review of pharmacology and toxicology	2007	135
17391153	Thiazolidinediones	Oh DK	Adiponectin in health and disease.	Diabetes, obesity & metabolism	2007	56
17442990	Thiazolidinediones	Govindarajan R	Thiazolidinediones and the risk of lung, prostate, and colon cancer in patients with diabetes.	Journal of clinical oncology 	2007	104
18177270	Thiazolidinediones	Wang Y	Post-translational modifications of adiponectin: mechanisms and functional implications.	The Biochemical journal	2008	94
19567523	Thiazolidinediones	Sacks HS	Uncoupling protein-1 and related messenger ribonucleic acids in human epicardial and other adipose tissues: epicardial fat functioning as brown fat.	The Journal of clinical endocrinology and metabolism	2009	49
19906796	Thiazolidinediones	Higgins LS	Selective peroxisome proliferator-activated receptor gamma (PPARgamma) modulation as a strategy for safer therapeutic PPARgamma activation.	The American journal of clinical nutrition	2010	45
20361178	Thiazolidinediones	DeFronzo RA	Insulin resistance, lipotoxicity, type 2 diabetes and atherosclerosis: the missing links. The Claude Bernard Lecture 2009.	Diabetologia	2010	140
21457225	Thiazolidinediones	Hui X	Adiponectin and cardiovascular health: an update.	British journal of pharmacology	2012	47
22513163	Thiazolidinediones	Cariou B	Thiazolidinediones and PPARγ agonists: time for a reassessment.	Trends in endocrinology and metabolism	2012	79
22616948	Thiazolidinediones	Kung J	Thiazolidinedione safety.	Expert opinion on drug safety	2012	44
23363012	Thiazolidinediones	Masuoka HC	Nonalcoholic fatty liver disease: an emerging threat to obese and diabetic individuals.	Annals of the New York Academy of Sciences	2013	50
25148456	Thiazolidinediones	Wright MB	Minireview: Challenges and opportunities in development of PPAR agonists.	Molecular endocrinology	2014	26
27729660	Thiazolidinediones	Tilg H	NAFLD and diabetes mellitus.	Nature reviews. Gastroenterology & hepatology	2017	11
12520530	1,25-dihydroxyvitamin D	Holick MF	Vitamin D: A millenium perspective.	Journal of cellular biochemistry	2003	207
16563471	1,25-dihydroxyvitamin D	Lips P	Vitamin D physiology.	Progress in biophysics and molecular biology	2006	173
17205962	1,25-dihydroxyvitamin D	Craver L	Mineral metabolism parameters throughout chronic kidney disease stages 1-5--achievement of K/DOQI target ranges.	Nephrology, dialysis, transplantation 	2007	55
18694980	1,25-dihydroxyvitamin D	Bouillon R	Vitamin D and human health: lessons from vitamin D receptor null mice.	Endocrine reviews	2008	262
18801384	1,25-dihydroxyvitamin D	Holick MF	The vitamin D deficiency pandemic and consequences for nonskeletal health: mechanisms of action.	Molecular aspects of medicine	2008	61
19443637	1,25-dihydroxyvitamin D	de Boer IH	25-hydroxyvitamin D levels inversely associate with risk for developing coronary artery calcification.	Journal of the American Society of Nephrology 	2009	69
19667238	1,25-dihydroxyvitamin D	Oh J	1,25(OH)2 vitamin d inhibits foam cell formation and suppresses macrophage cholesterol uptake in patients with type 2 diabetes mellitus.	Circulation	2009	82
20511061	1,25-dihydroxyvitamin D	Takiishi T	Vitamin D and diabetes.	Endocrinology and metabolism clinics of North America	2010	49
21640757	1,25-dihydroxyvitamin D	Jorde R	Vitamin D and metabolic health with special reference to the effect of vitamin D on serum lipids.	Progress in lipid research	2011	57
21947295	1,25-dihydroxyvitamin D	Chen S	Cardiomyocyte-specific deletion of the vitamin D receptor gene results in cardiac hypertrophy.	Circulation	2011	63
24949660	1,25-dihydroxyvitamin D	Girgis CM	The vitamin D receptor (VDR) is expressed in skeletal muscle of male mice and modulates 25-hydroxyvitamin D (25OHD) uptake in myofibers.	Endocrinology	2014	28
25308530	1,25-dihydroxyvitamin D	D'Aurizio F	Is vitamin D a player or not in the pathophysiology of autoimmune thyroid diseases?	Autoimmunity reviews	2015	18
28409320	1,25-dihydroxyvitamin D	Garbossa SG	Vitamin D, sub-inflammation and insulin resistance. A window on a potential role for the interaction between bone and glucose metabolism.	Reviews in endocrine & metabolic disorders	2017	6
17452738	Pyruvaldehyde	Uribarri J	Circulating glycotoxins and dietary advanced glycation endproducts: two links to inflammatory response, oxidative stress, and aging.	The journals of gerontology. Series A, Biological sciences and medical sciences	2007	87
21593200	Pyruvaldehyde	Zhao Y	Klotho depletion contributes to increased inflammation in kidney of the db/db mouse model of diabetes via RelA (serine)536 phosphorylation.	Diabetes	2011	44
25818485	Pyruvaldehyde	Maessen DE	The role of methylglyoxal and the glyoxalase system in diabetes and other age-related diseases.	Clinical science	2015	29
18393104	resveratrol	Elliott PJ	Sirtuins: novel targets for metabolic disease.	Current opinion in investigational drugs	2008	54
18482975	resveratrol	Hou X	SIRT1 regulates hepatocyte lipid metabolism through activating AMP-activated protein kinase.	The Journal of biological chemistry	2008	218
18835033	resveratrol	Wang RH	Impaired DNA damage response, genome instability, and tumorigenesis in SIRT1 mutant mice.	Cancer cell	2008	260
18851829	resveratrol	Wang RH	Interplay among BRCA1, SIRT1, and Survivin during BRCA1-associated tumorigenesis.	Molecular cell	2008	116
19749157	resveratrol	Ungvari Z	Resveratrol attenuates mitochondrial oxidative stress in coronary arterial endothelial cells.	American journal of physiology. Heart and circulatory physiology	2009	95
19897059	resveratrol	Baur JA	Biochemical effects of SIRT1 activators.	Biochimica et biophysica acta	2010	40
20061378	resveratrol	Pacholec M	SRT1720, SRT2183, SRT1460, and resveratrol are not direct activators of SIRT1.	The Journal of biological chemistry	2010	286
20068143	resveratrol	de Kreutzenberg SV	Downregulation of the longevity-associated protein sirtuin 1 in insulin resistance and metabolic syndrome: potential biochemical mechanisms.	Diabetes	2010	64
20534755	resveratrol	Ghanim H	An antiinflammatory and reactive oxygen species suppressive effects of an extract of Polygonum cuspidatum containing resveratrol.	The Journal of clinical endocrinology and metabolism	2010	47
21241768	resveratrol	Fröjdö S	Phosphoinositide 3-kinase as a novel functional target for the regulation of the insulin signaling pathway by SIRT1.	Molecular and cellular endocrinology	2011	38
21261639	resveratrol	Szkudelski T	Anti-diabetic effects of resveratrol.	Annals of the New York Academy of Sciences	2011	38
21321189	resveratrol	Li Y	Hepatic overexpression of SIRT1 in mice attenuates endoplasmic reticulum stress and insulin resistance in the liver.	FASEB journal 	2011	83
21385509	resveratrol	Brasnyó P	Resveratrol improves insulin sensitivity, reduces oxidative stress and activates the Akt pathway in type 2 diabetic patients.	The British journal of nutrition	2011	111
22653216	resveratrol	Baur JA	Are sirtuins viable targets for improving healthspan and lifespan?	Nature reviews. Drug discovery	2012	107
22885100	resveratrol	Chung JH	Resveratrol as a calorie restriction mimetic: therapeutic implications.	Trends in cell biology	2012	44
23104101	resveratrol	Morris BJ	Seven sirtuins for seven deadly diseases of aging.	Free radical biology & medicine	2013	72
23193181	resveratrol	Poulsen MM	High-dose resveratrol supplementation in obese men: an investigator-initiated, randomized, placebo-controlled clinical trial of substrate metabolism, insulin sensitivity, and body composition.	Diabetes	2013	92
23498665	resveratrol	Siriwardhana N	Modulation of adipose tissue inflammation by bioactive food compounds.	The Journal of nutritional biochemistry	2013	35
23557933	resveratrol	Tomé-Carneiro J	One-year supplementation with a grape extract containing resveratrol modulates inflammatory-related microRNAs and cytokines expression in peripheral blood mononuclear cells of type 2 diabetes and hypertensive patients with coronary artery disease.	Pharmacological research	2013	43
23884882	resveratrol	Fiori JL	Resveratrol prevents β-cell dedifferentiation in nonhuman primates given a high-fat/high-sugar diet.	Diabetes	2013	31
24160699	resveratrol	Sinclair DA	Small-molecule allosteric activators of sirtuins.	Annual review of pharmacology and toxicology	2014	54
24184811	resveratrol	Li Y	Hepatic SIRT1 attenuates hepatic steatosis and controls energy balance in mice by inducing fibroblast growth factor 21.	Gastroenterology	2014	44
24439680	resveratrol	Hubbard BP	Small molecule SIRT1 activators for the treatment of aging and age-related diseases.	Trends in pharmacological sciences	2014	89
24606795	resveratrol	Valero T	Mitochondrial biogenesis: pharmacological approaches.	Current pharmaceutical design	2014	29
24695890	resveratrol	Liu K	Effect of resveratrol on glucose control and insulin sensitivity: a meta-analysis of 11 randomized controlled trials.	The American journal of clinical nutrition	2014	22
25445538	resveratrol	Szkudelski T	Resveratrol and diabetes: from animal to human studies.	Biochimica et biophysica acta	2015	24
25647160	resveratrol	Ido Y	Resveratrol prevents oxidative stress-induced senescence and proliferative dysfunction by activating the AMPK-FOXO3 cascade in cultured primary human keratinocytes.	PloS one	2015	25
26234526	resveratrol	Faghihzadeh F	The effects of resveratrol supplementation on cardiovascular risk factors in patients with non-alcoholic fatty liver disease: a randomised, double-blind, placebo-controlled study.	The British journal of nutrition	2015	19
27144581	resveratrol	Bonnefont-Rousselot D	Resveratrol and Cardiovascular Diseases.	Nutrients	2016	18
28611316	resveratrol	McCubrey JA	Effects of resveratrol, curcumin, berberine and other nutraceuticals on aging, cancer development, cancer stem cells and microRNAs.	Aging	2017	6
12432042	Cholesterol, LDL	Ridker PM	Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events.	The New England journal of medicine	2002	516
14559957	Cholesterol, LDL	Barzilai N	Unique lipoprotein phenotype and genotype associated with exceptional longevity.	JAMA	2003	163
18458145	Cholesterol, LDL	Fonseca VA	Colesevelam HCl improves glycemic control and reduces LDL cholesterol in patients with inadequately controlled type 2 diabetes on sulfonylurea-based therapy.	Diabetes care	2008	51
18997196	Cholesterol, LDL	Ridker PM	Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein.	The New England journal of medicine	2008	998
23415864	Cholesterol, LDL	Zhang R	Emerging roles of Lipasin as a critical lipid regulator.	Biochemical and biophysical research communications	2013	30
23704675	Cholesterol, LDL	TODAY Study Group.	Lipid and inflammatory cardiovascular risk worsens over 3 years in youth with type 2 diabetes: the TODAY clinical trial.	Diabetes care	2013	28
24507775	Cholesterol, LDL	Lange LA	Whole-exome sequencing identifies rare and low-frequency coding variants associated with LDL cholesterol.	American journal of human genetics	2014	67
25262344	Cholesterol, LDL	Swerdlow DI	HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials.	Lancet	2015	82
25282519	Cholesterol, LDL	Raal FJ	PCSK9 inhibition with evolocumab (AMG 145) in heterozygous familial hypercholesterolaemia (RUTHERFORD-2): a randomised, double-blind, placebo-controlled trial.	Lancet	2015	78
25350695	Cholesterol, LDL	Postmus I	Pharmacogenetic meta-analysis of genome-wide association studies of LDL cholesterol response to statins.	Nature communications	2014	38
26131930	Cholesterol, LDL	Joshi PK	Directional dominance on stature and cognition in diverse human populations.	Nature	2015	29
26578202	Cholesterol, LDL	Lipinski MJ	The impact of proprotein convertase subtilisin-kexin type 9 serine protease inhibitors on lipid levels and outcomes in patients with primary hypercholesterolaemia: a network meta-analysis.	European heart journal	2016	33
27959767	Cholesterol, LDL	Ference BA	Variation in PCSK9 and HMGCR and Risk of Cardiovascular Disease and Diabetes.	The New England journal of medicine	2016	41
28304224	Cholesterol, LDL	Sabatine MS	Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease.	The New England journal of medicine	2017	105
18779465	Dextromethorphan	Grant RW	Practice-linked online personal health records for type 2 diabetes mellitus: a randomized controlled trial.	Archives of internal medicine	2008	74
20651284	Dextromethorphan	Zampetaki A	Plasma microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes.	Circulation research	2010	289
23250986	Dextromethorphan	Spinetti G	Global remodeling of the vascular stem cell niche in bone marrow of diabetic patients: implication of the microRNA-155/FOXO3a signaling pathway.	Circulation research	2013	25
23395779	Dextromethorphan	Gilchrist M	Effect of dietary nitrate on blood pressure, endothelial function, and insulin sensitivity in type 2 diabetes.	Free radical biology & medicine	2013	30
14752837	pioglitazone	Promrat K	A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis.	Hepatology	2004	114
15855325	pioglitazone	Bogacka I	Pioglitazone induces mitochondrial biogenesis in human subcutaneous adipose tissue in vivo.	Diabetes	2005	111
16030142	pioglitazone	Hida K	Visceral adipose tissue-derived serine protease inhibitor: a unique insulin-sensitizing adipocytokine in obesity.	Proceedings of the National Academy of Sciences of the United States of America	2005	95
16046295	pioglitazone	Di Gregorio GB	Expression of CD68 and macrophage chemoattractant protein-1 genes in human adipose and muscle tissues: association with cytokine expression, insulin resistance, and reduction by pioglitazone.	Diabetes	2005	116
16214598	pioglitazone	Dormandy JA	Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial.	Lancet	2005	537
18057090	pioglitazone	Varma V	Thrombospondin-1 is an adipokine associated with obesity, adipose inflammation, and insulin resistance.	Diabetes	2008	64
19515415	pioglitazone	Henry RR	Effect of the dual peroxisome proliferator-activated receptor-alpha/gamma agonist aleglitazar on risk of cardiovascular disease in patients with type 2 diabetes (SYNCHRONY): a phase II, randomised, dose-ranging study.	Lancet	2009	49
19837927	pioglitazone	Pasarica M	Adipose tissue collagen VI in obesity.	The Journal of clinical endocrinology and metabolism	2009	59
19923038	pioglitazone	Sato T	Efficacy of PPAR-γ agonist pioglitazone in mild Alzheimer disease.	Neurobiology of aging	2011	80
20580422	pioglitazone	Bergenstal RM	Efficacy and safety of exenatide once weekly versus sitagliptin or pioglitazone as an adjunct to metformin for treatment of type 2 diabetes (DURATION-2): a randomised trial.	Lancet	2010	131
21138825	pioglitazone	Buse JB	Use of twice-daily exenatide in Basal insulin-treated patients with type 2 diabetes: a randomized, controlled trial.	Annals of internal medicine	2011	97
21403054	pioglitazone	Bennett WL	Comparative effectiveness and safety of medications for type 2 diabetes: an update including new drugs and 2-drug combinations.	Annals of internal medicine	2011	96
21410628	pioglitazone	Gomis R	Efficacy and safety of initial combination therapy with linagliptin and pioglitazone in patients with inadequately controlled type 2 diabetes: a randomized, double-blind, placebo-controlled study.	Diabetes, obesity & metabolism	2011	38
21788481	pioglitazone	Zuris JA	Facile transfer of 2Fe-2S clusters from the diabetes drug target mitoNEET to an apo-acceptor protein.	Proceedings of the National Academy of Sciences of the United States of America	2011	37
21875310	pioglitazone	Smith BW	Non-alcoholic fatty liver disease.	Critical reviews in clinical laboratory sciences	2011	65
22240811	pioglitazone	Kono T	PPAR-γ activation restores pancreatic islet SERCA2 levels and prevents β-cell dysfunction under conditions of hyperglycemic and cytokine stress.	Molecular endocrinology	2012	35
22446170	pioglitazone	Rosenstock J	Effects of dapagliflozin, an SGLT2 inhibitor, on HbA(1c), body weight, and hypoglycemia risk in patients with type 2 diabetes inadequately controlled on pioglitazone monotherapy.	Diabetes care	2012	64
23718573	pioglitazone	Hoofnagle JH	Vitamin E and changes in serum alanine aminotransferase levels in patients with non-alcoholic steatohepatitis.	Alimentary pharmacology & therapeutics	2013	29
23906415	pioglitazone	Kovacs CS	Empagliflozin improves glycaemic and weight control as add-on therapy to pioglitazone or pioglitazone plus metformin in patients with type 2 diabetes: a 24-week, randomized, placebo-controlled trial.	Diabetes, obesity & metabolism	2014	57
24062327	pioglitazone	Yki-Järvinen H	Effects of adding linagliptin to basal insulin regimen for inadequately controlled type 2 diabetes: a ≥52-week randomized, double-blind study.	Diabetes care	2013	35
24424032	pioglitazone	Hara T	Calcium efflux from the endoplasmic reticulum leads to β-cell death.	Endocrinology	2014	22
24722248	pioglitazone	Kurtz CL	MicroRNA-29 fine-tunes the expression of key FOXA2-activated lipid metabolism genes and is dysregulated in animal models of insulin resistance and diabetes.	Diabetes	2014	29
24879836	pioglitazone	Wysham C	Efficacy and safety of dulaglutide added onto pioglitazone and metformin versus exenatide in type 2 diabetes in a randomized controlled trial (AWARD-1).	Diabetes care	2014	49
24898300	pioglitazone	Rosenstock J	Advancing basal insulin replacement in type 2 diabetes inadequately controlled with insulin glargine plus oral agents: a comparison of adding albiglutide, a weekly GLP-1 receptor agonist, versus thrice-daily prandial insulin lispro.	Diabetes care	2014	35
25481707	pioglitazone	Levin D	Pioglitazone and bladder cancer risk: a multipopulation pooled, cumulative exposure analysis.	Diabetologia	2015	30
26643070	pioglitazone	Osman I	Pioglitazone, a PPARγ agonist, attenuates PDGF-induced vascular smooth muscle cell proliferation through AMPK-dependent and AMPK-independent inhibition of mTOR/p70S6K and ERK signaling.	Biochemical pharmacology	2016	13
26886418	pioglitazone	Kernan WN	Pioglitazone after Ischemic Stroke or Transient Ischemic Attack.	The New England journal of medicine	2016	72
27530399	pioglitazone	Korhonen P	Pioglitazone use and risk of bladder cancer in patients with type 2 diabetes: retrospective cohort study using datasets from four European countries.	BMJ	2016	11
27978584	pioglitazone	Colle R	PPAR-γ Agonists for the Treatment of Major Depression: A Review.	Pharmacopsychiatry	2017	5
28098353	pioglitazone	Derosa G	The role of various peroxisome proliferator-activated receptors and their ligands in clinical practice.	Journal of cellular physiology	2018	10
8405741	Glucagon-Like Peptides	Nauck MA	Normalization of fasting hyperglycaemia by exogenous glucagon-like peptide 1 (7-36 amide) in type 2 (non-insulin-dependent) diabetic patients.	Diabetologia	1993	140
14981009	Glucagon-Like Peptides	Nikolaidis LA	Effects of glucagon-like peptide-1 in patients with acute myocardial infarction and left ventricular dysfunction after successful reperfusion.	Circulation	2004	184
16219666	Glucagon-Like Peptides	Theodorakis MJ	Human duodenal enteroendocrine cells: source of both incretin peptides, GLP-1 and GIP.	American journal of physiology. Endocrinology and metabolism	2006	76
17213325	Glucagon-Like Peptides	Knudsen LB	Small-molecule agonists for the glucagon-like peptide 1 receptor.	Proceedings of the National Academy of Sciences of the United States of America	2007	56
24742660	Glucagon-Like Peptides	Nauck M	Efficacy and safety of dulaglutide versus sitagliptin after 52 weeks in type 2 diabetes in a randomized controlled trial (AWARD-5).	Diabetes care	2014	41
25018121	Glucagon-Like Peptides	Dungan KM	Once-weekly dulaglutide versus once-daily liraglutide in metformin-treated patients with type 2 diabetes (AWARD-6): a randomised, open-label, phase 3, non-inferiority trial.	Lancet	2014	55
25614665	Glucagon-Like Peptides	Drucker DJ	Deciphering metabolic messages from the gut drives therapeutic innovation: the 2014 Banting Lecture.	Diabetes	2015	16
26358288	Glucagon-Like Peptides	Nauck MA	A Phase 2, Randomized, Dose-Finding Study of the Novel Once-Weekly Human GLP-1 Analog, Semaglutide, Compared With Placebo and Open-Label Liraglutide in Patients With Type 2 Diabetes.	Diabetes care	2016	14
27633186	Glucagon-Like Peptides	Marso SP	Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.	The New England journal of medicine	2016	136
10882139	rosiglitazone	Gampe RT Jr	Asymmetry in the PPARgamma/RXRalpha crystal structure reveals the molecular basis of heterodimerization among nuclear receptors.	Molecular cell	2000	109
10953027	rosiglitazone	Li AC	Peroxisome proliferator-activated receptor gamma ligands inhibit development of atherosclerosis in LDL receptor-deficient mice.	The Journal of clinical investigation	2000	163
11861525	rosiglitazone	Combs TP	Induction of adipocyte complement-related protein of 30 kilodaltons by PPARgamma agonists: a potential mechanism of insulin sensitization.	Endocrinology	2002	96
11872682	rosiglitazone	Mayerson AB	The effects of rosiglitazone on insulin sensitivity, lipolysis, and hepatic and skeletal muscle triglyceride content in patients with type 2 diabetes.	Diabetes	2002	106
12163427	rosiglitazone	Haffner SM	Effect of rosiglitazone treatment on nontraditional markers of cardiovascular disease in patients with type 2 diabetes mellitus.	Circulation	2002	91
12504108	rosiglitazone	Patel L	Resistin is expressed in human macrophages and directly regulated by PPAR gamma activators.	Biochemical and biophysical research communications	2003	151
12747837	rosiglitazone	Polekhina G	AMPK beta subunit targets metabolic stress sensing to glycogen.	Current biology 	2003	95
12807871	rosiglitazone	Tiraby C	Acquirement of brown fat cell features by human white adipocytes.	The Journal of biological chemistry	2003	108
14512888	rosiglitazone	Neuschwander-Tetri BA	Improved nonalcoholic steatohepatitis after 48 weeks of treatment with the PPAR-gamma ligand rosiglitazone.	Hepatology	2003	101
15181049	rosiglitazone	Mohanty P	Evidence for a potent antiinflammatory effect of rosiglitazone.	The Journal of clinical endocrinology and metabolism	2004	74
15277403	rosiglitazone	Tiikkainen M	Effects of rosiglitazone and metformin on liver fat content, hepatic insulin resistance, insulin clearance, and gene expression in adipose tissue in patients with type 2 diabetes.	Diabetes	2004	78
16034410	rosiglitazone	Yang Q	Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes.	Nature	2005	450
16737350	rosiglitazone	Yang RZ	Acute-phase serum amyloid A: an inflammatory adipokine and potential link between obesity and its metabolic complications.	PLoS medicine	2006	72
16873691	rosiglitazone	Bandyopadhyay GK	Increased malonyl-CoA levels in muscle from obese and type 2 diabetic subjects lead to decreased fatty acid oxidation and increased lipogenesis; thiazolidinedione treatment reverses these defects.	Diabetes	2006	75
17040956	rosiglitazone	Wang Y	Lipocalin-2 is an inflammatory marker closely associated with obesity, insulin resistance, and hyperglycemia in humans.	Clinical chemistry	2007	103
17090751	rosiglitazone	Creely SJ	Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes.	American journal of physiology. Endocrinology and metabolism	2007	175
17145742	rosiglitazone	Kahn SE	Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy.	The New England journal of medicine	2006	549
17592079	rosiglitazone	Sorrentino SA	Oxidant stress impairs in vivo reendothelialization capacity of endothelial progenitor cells from patients with type 2 diabetes mellitus: restoration by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone.	Circulation	2007	88
18325386	rosiglitazone	Lewis JD	Rosiglitazone for active ulcerative colitis: a randomized placebo-controlled trial.	Gastroenterology	2008	65
18503774	rosiglitazone	Ratziu V	Rosiglitazone for nonalcoholic steatohepatitis: one-year results of the randomized placebo-controlled Fatty Liver Improvement with Rosiglitazone Therapy (FLIRT) Trial.	Gastroenterology	2008	103
18719601	rosiglitazone	Hardie DG	AMPK: a key regulator of energy balance in the single cell and the whole organism.	International journal of obesity	2008	153
19115254	rosiglitazone	Shockley KR	PPARgamma2 nuclear receptor controls multiple regulatory pathways of osteoblast differentiation from marrow mesenchymal stem cells.	Journal of cellular biochemistry	2009	54
19188609	rosiglitazone	De Felice FG	Protection of synapses against Alzheimer's-linked toxins: insulin signaling prevents the pathogenic binding of Abeta oligomers.	Proceedings of the National Academy of Sciences of the United States of America	2009	144
19317822	rosiglitazone	Marre M	Liraglutide, a once-daily human GLP-1 analogue, added to a sulphonylurea over 26 weeks produces greater improvements in glycaemic and weight control compared with adding rosiglitazone or placebo in subjects with Type 2 diabetes (LEAD-1 SU).	Diabetic medicine 	2009	183
19800084	rosiglitazone	Zhang H	Berberine lowers blood glucose in type 2 diabetes mellitus patients through increasing insulin receptor expression.	Metabolism	2010	56
20651683	rosiglitazone	Choi JH	Anti-diabetic drugs inhibit obesity-linked phosphorylation of PPARgamma by Cdk5.	Nature	2010	247
22315431	rosiglitazone	Wei W	Fibroblast growth factor 21 promotes bone loss by potentiating the effects of peroxisome proliferator-activated receptor γ.	Proceedings of the National Academy of Sciences of the United States of America	2012	88
23166672	rosiglitazone	Sharp LZ	Human BAT possesses molecular signatures that resemble beige/brite cells.	PloS one	2012	158
24623020	rosiglitazone	Hampp C	Use of antidiabetic drugs in the U.S., 2003-2012.	Diabetes care	2014	39
24788520	rosiglitazone	Step SE	Anti-diabetic rosiglitazone remodels the adipocyte transcriptome by redistributing transcription to PPARγ-driven enhancers.	Genes & development	2014	28
15007034	telmisartan	Benson SC	Identification of telmisartan as a unique angiotensin II receptor antagonist with selective PPARgamma-modulating activity.	Hypertension	2004	162
15516696	telmisartan	Barnett AH	Angiotensin-receptor blockade versus converting-enzyme inhibition in type 2 diabetes and nephropathy.	The New England journal of medicine	2004	112
18378520	telmisartan	ONTARGET Investigators.	Telmisartan, ramipril, or both in patients at high risk for vascular events.	The New England journal of medicine	2008	443
18707986	telmisartan	Mann JF	Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial.	Lancet	2008	252
18757085	telmisartan	Telmisartan Randomised AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease (TRANSCEND) Investigators.	Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial.	Lancet	2008	143
25399731	telmisartan	Torres VE	Angiotensin blockade in late autosomal dominant polycystic kidney disease.	The New England journal of medicine	2014	40
11522676	2,4-thiazolidinedione	Maeda N	PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein.	Diabetes	2001	238
11818477	2,4-thiazolidinedione	Unger RH	Lipotoxic diseases.	Annual review of medicine	2002	179
14699128	2,4-thiazolidinedione	Pajvani UB	Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity.	The Journal of biological chemistry	2004	234
18348689	2,4-thiazolidinedione	Melton LJ 3rd	Fracture risk in type 2 diabetes: update of a population-based study.	Journal of bone and mineral research 	2008	58
19670459	2,4-thiazolidinedione	Gastaldelli A	Importance of changes in adipose tissue insulin resistance to histological response during thiazolidinedione treatment of patients with nonalcoholic steatohepatitis.	Hepatology	2009	49
21129444	2,4-thiazolidinedione	Bao B	The complexities of obesity and diabetes with the development and progression of pancreatic cancer.	Biochimica et biophysica acta	2011	36
23539735	2,4-thiazolidinedione	Lee SA	CD26/DPP4 levels in peripheral blood and T cells in patients with type 2 diabetes mellitus.	The Journal of clinical endocrinology and metabolism	2013	28
23815104	2,4-thiazolidinedione	Curkendall SM	Predictors of medication adherence in patients with type 2 diabetes mellitus.	Current medical research and opinion	2013	27
25157153	2,4-thiazolidinedione	Majithia AR	Rare variants in PPARG with decreased activity in adipocyte differentiation are associated with increased risk of type 2 diabetes.	Proceedings of the National Academy of Sciences of the United States of America	2014	37
24703046	Fructosamine	Selvin E	Fructosamine and glycated albumin for risk stratification and prediction of incident diabetes and microvascular complications: a prospective cohort analysis of the Atherosclerosis Risk in Communities (ARIC) study.	The lancet. Diabetes & endocrinology	2014	38
9655393	Fenofibrate	Staels B	Activation of human aortic smooth-muscle cells is inhibited by PPARalpha but not by PPARgamma activators.	Nature	1998	149
17599422	Fenofibrate	ACCORD Study Group.	Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial: design and methods.	The American journal of cardiology	2007	113
19702724	Fenofibrate	Mraz M	Serum concentrations and tissue expression of a novel endocrine regulator fibroblast growth factor-21 in patients with type 2 diabetes and obesity.	Clinical endocrinology	2009	61
19706858	clopidogrel	Shuldiner AR	Association of cytochrome P450 2C19 genotype with the antiplatelet effect and clinical efficacy of clopidogrel therapy.	JAMA	2009	261
20435227	clopidogrel	Ashley EA	Clinical assessment incorporating a personal genome.	Lancet	2010	234
23111421	clopidogrel	Lewis JP	The functional G143E variant of carboxylesterase 1 is associated with increased clopidogrel active metabolite levels and greater clopidogrel response.	Pharmacogenetics and genomics	2013	33
23583249	clopidogrel	Reddy VY	Left atrial appendage closure with the Watchman device in patients with a contraindication for oral anticoagulation: the ASAP study (ASA Plavix Feasibility Study With Watchman Left Atrial Appendage Closure Technology).	Journal of the American College of Cardiology	2013	64
18802479	preproinsulin	Skowera A	CTLs are targeted to kill beta cells in patients with type 1 diabetes through recognition of a glucose-regulated preproinsulin epitope.	The Journal of clinical investigation	2008	125
22102287	preproinsulin	Wooldridge L	A single autoimmune T cell receptor recognizes more than a million different peptides.	The Journal of biological chemistry	2012	96
22245737	preproinsulin	Bulek AM	Structural basis for the killing of human beta cells by CD8(+) T cells in type 1 diabetes.	Nature immunology	2012	54
22974359	preproinsulin	Fu Z	Regulation of insulin synthesis and secretion and pancreatic Beta-cell dysfunction in diabetes.	Current diabetes reviews	2013	46
26216854	preproinsulin	Fisher MM	Elevations in Circulating Methylated and Unmethylated Preproinsulin DNA in New-Onset Type 1 Diabetes.	Diabetes	2015	21
27920090	preproinsulin	Michels AW	Islet-Derived CD4 T Cells Targeting Proinsulin in Human Autoimmune Diabetes.	Diabetes	2017	15
15716560	pro-brain natriuretic peptide (1-76)	Kragelund C	N-terminal pro-B-type natriuretic peptide and long-term mortality in stable coronary heart disease.	The New England journal of medicine	2005	81
15811980	pro-brain natriuretic peptide (1-76)	Kistorp C	N-terminal pro-brain natriuretic peptide, C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults.	JAMA	2005	110
23733199	pro-brain natriuretic peptide (1-76)	Lazo M	NH2-terminal pro-brain natriuretic peptide and risk of diabetes.	Diabetes	2013	27
25414155	pro-brain natriuretic peptide (1-76)	Lovshin JA	Liraglutide promotes natriuresis but does not increase circulating levels of atrial natriuretic peptide in hypertensive subjects with type 2 diabetes.	Diabetes care	2015	18
25765696	pro-brain natriuretic peptide (1-76)	Zannad F	Heart failure and mortality outcomes in patients with type 2 diabetes taking alogliptin versus placebo in EXAMINE: a multicentre, randomised, double-blind trial.	Lancet	2015	82
26390057	pro-brain natriuretic peptide (1-76)	Kato N	Trans-ancestry genome-wide association study identifies 12 genetic loci influencing blood pressure and implicates a role for DNA methylation.	Nature genetics	2015	58
26497848	pro-brain natriuretic peptide (1-76)	Chan MM	Growth differentiation factor 15 in heart failure with preserved vs. reduced ejection fraction.	European journal of heart failure	2016	10
9742976	Chlorpropamide	-	Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.	Lancet	1998	2807
17101640	glimepiride	Mazzone T	Effect of pioglitazone compared with glimepiride on carotid intima-media thickness in type 2 diabetes: a randomized trial.	JAMA	2006	113
17593236	glimepiride	Hermansen K	Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, in patients with type 2 diabetes mellitus inadequately controlled on glimepiride alone or on glimepiride and metformin.	Diabetes, obesity & metabolism	2007	107
17711996	glimepiride	Basu A	Beneficial effects of GLP-1 on endothelial function in humans: dampening by glyburide but not by glimepiride.	American journal of physiology. Endocrinology and metabolism	2007	63
19930006	glimepiride	Jendle J	Weight loss with liraglutide, a once-daily human glucagon-like peptide-1 analogue for type 2 diabetes treatment as monotherapy or added to metformin, is primarily as a result of a reduction in fat tissue.	Diabetes, obesity & metabolism	2009	48
21205128	glimepiride	Garber A	Liraglutide, a once-daily human glucagon-like peptide 1 analogue, provides sustained improvements in glycaemic control and weight for 2 years as monotherapy compared with glimepiride in patients with type 2 diabetes.	Diabetes, obesity & metabolism	2011	42
21672123	glimepiride	Strojek K	Effect of dapagliflozin in patients with type 2 diabetes who have inadequate glycaemic control with glimepiride: a randomized, 24-week, double-blind, placebo-controlled trial.	Diabetes, obesity & metabolism	2011	77
22234149	glimepiride	Johansen OE	Cardiovascular safety with linagliptin in patients with type 2 diabetes mellitus: a pre-specified, prospective, and adjudicated meta-analysis of a phase 3 programme.	Cardiovascular diabetology	2012	53
22374408	glimepiride	Burant CF	TAK-875 versus placebo or glimepiride in type 2 diabetes mellitus: a phase 2, randomised, double-blind, placebo-controlled trial.	Lancet	2012	59
22683137	glimepiride	Gallwitz B	Exenatide twice daily versus glimepiride for prevention of glycaemic deterioration in patients with type 2 diabetes with metformin failure (EUREXA): an open-label, randomised controlled trial.	Lancet	2012	37
22748821	glimepiride	Gallwitz B	2-year efficacy and safety of linagliptin compared with glimepiride in patients with type 2 diabetes inadequately controlled on metformin: a randomised, double-blind, non-inferiority trial.	Lancet	2012	78
22985213	glimepiride	Nauck M	Long-term efficacy and safety comparison of liraglutide, glimepiride and placebo, all in combination with metformin in type 2 diabetes: 2-year results from the LEAD-2 study.	Diabetes, obesity & metabolism	2013	26
23433305	glimepiride	Wang B	Blood pressure-lowering effects of GLP-1 receptor agonists exenatide and liraglutide: a meta-analysis of clinical trials.	Diabetes, obesity & metabolism	2013	31
23449634	glimepiride	Rosenstock J	Cardiovascular outcome trials in type 2 diabetes and the sulphonylurea controversy: rationale for the active-comparator CAROLINA trial.	Diabetes & vascular disease research	2013	30
23850055	glimepiride	Cefalu WT	Efficacy and safety of canagliflozin versus glimepiride in patients with type 2 diabetes inadequately controlled with metformin (CANTATA-SU): 52 week results from a randomised, double-blind, phase 3 non-inferiority trial.	Lancet	2013	142
24898304	glimepiride	Ahrén B	HARMONY 3: 104-week randomized, double-blind, placebo- and active-controlled trial assessing the efficacy and safety of albiglutide compared with placebo, sitagliptin, and glimepiride in patients with type 2 diabetes taking metformin.	Diabetes care	2014	46
24948511	glimepiride	Ridderstråle M	Comparison of empagliflozin and glimepiride as add-on to metformin in patients with type 2 diabetes: a 104-week randomised, active-controlled, double-blind, phase 3 trial.	The lancet. Diabetes & endocrinology	2014	53
25205142	glimepiride	Leiter LA	Canagliflozin provides durable glycemic improvements and body weight reduction over 104 weeks versus glimepiride in patients with type 2 diabetes on metformin: a randomized, double-blind, phase 3 study.	Diabetes care	2015	43
26089386	glimepiride	Giorgino F	Efficacy and Safety of Once-Weekly Dulaglutide Versus Insulin Glargine in Patients With Type 2 Diabetes on Metformin and Glimepiride (AWARD-2).	Diabetes care	2015	18
27186364	glimepiride	Seino Y	Incretin-based drugs for type 2 diabetes: Focus on East Asian perspectives.	Journal of diabetes investigation	2016	20
27539604	glimepiride	Heerspink HJ	Canagliflozin Slows Progression of Renal Function Decline Independently of Glycemic Effects.	Journal of the American Society of Nephrology 	2017	20
21049026	Sulfonylurea Compounds	Bonnefond A	Molecular diagnosis of neonatal diabetes mellitus using next-generation sequencing of the whole exome.	PloS one	2010	42
21544514	Sulfonylurea Compounds	Tseng CH	Diabetes and risk of bladder cancer: a study using the National Health Insurance database in Taiwan.	Diabetologia	2011	38
28095040	Sulfonylurea Compounds	Garber AJ	CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM - 2017 EXECUTIVE SUMMARY.	Endocrine practice 	2017	42
22815298	pramlintide	Weinzimer SA	Effect of pramlintide on prandial glycemic excursions during closed-loop control in adolescents and young adults with type 1 diabetes.	Diabetes care	2012	31
24239383	pramlintide	Adler BL	Neuroprotective effects of the amylin analogue pramlintide on Alzheimer's disease pathogenesis and cognition.	Neurobiology of aging	2014	26
25409149	pramlintide	Venkatanarayan A	IAPP-driven metabolic reprogramming induces regression of p53-deficient tumours in vivo.	Nature	2015	29
26071095	pramlintide	Hay DL	Amylin: Pharmacology, Physiology, and Clinical Potential.	Pharmacological reviews	2015	22
15265818	Ghrelin	Meier U	Endocrine regulation of energy metabolism: review of pathobiochemical and clinical chemical aspects of leptin, ghrelin, adiponectin, and resistin.	Clinical chemistry	2004	118
19896496	Ghrelin	Castañeda TR	Ghrelin in the regulation of body weight and metabolism.	Frontiers in neuroendocrinology	2010	78
24760977	Ghrelin	Goldstone AP	Ghrelin mimics fasting to enhance human hedonic, orbitofrontal cortex, and hippocampal responses to food.	The American journal of clinical nutrition	2014	23
28232667	Ghrelin	Cui H	The cellular and molecular bases of leptin and ghrelin resistance in obesity.	Nature reviews. Endocrinology	2017	11
28398233	Ghrelin	Colldén G	Therapeutic Potential of Targeting the Ghrelin Pathway.	International journal of molecular sciences	2017	5
18525041	aliskiren	Parving HH	Aliskiren combined with losartan in type 2 diabetes and nephropathy.	The New England journal of medicine	2008	183
19145003	aliskiren	Parving HH	Aliskiren Trial in Type 2 Diabetes Using Cardio-Renal Endpoints (ALTITUDE): rationale and study design.	Nephrology, dialysis, transplantation 	2009	51
23121378	aliskiren	Parving HH	Cardiorenal end points in a trial of aliskiren for type 2 diabetes.	The New England journal of medicine	2012	152
23478743	aliskiren	Gheorghiade M	Effect of aliskiren on postdischarge mortality and heart failure readmissions among patients hospitalized for heart failure: the ASTRONAUT randomized trial.	JAMA	2013	38
27043774	aliskiren	McMurray JJ	Aliskiren, Enalapril, or Aliskiren and Enalapril in Heart Failure.	The New England journal of medicine	2016	19
19010326	Alanine	Goessling W	Aminotransferase levels and 20-year risk of metabolic syndrome, diabetes, and cardiovascular disease.	Gastroenterology	2008	66
19131466	Alanine	Fraser A	Alanine aminotransferase, gamma-glutamyltransferase, and incident diabetes: the British Women's Heart and Health Study and meta-analysis.	Diabetes care	2009	77
19523535	Alanine	Shah AG	Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease.	Clinical gastroenterology and hepatology 	2009	95
21540183	Alanine	Gao Z	Sirtuin 1 (SIRT1) protein degradation in response to persistent c-Jun N-terminal kinase 1 (JNK1) activation contributes to hepatic steatosis in obesity.	The Journal of biological chemistry	2011	51
23824655	Alanine	Fall T	The role of adiposity in cardiometabolic traits: a Mendelian randomization analysis.	PLoS medicine	2013	53
23991091	Alanine	Miller AM	MiR-155 has a protective role in the development of non-alcoholic hepatosteatosis in mice.	PloS one	2013	35
24436062	Alanine	Konerman MA	Fibrosis progression in human immunodeficiency virus/hepatitis C virus coinfected adults: prospective analysis of 435 liver biopsy pairs.	Hepatology	2014	23
24681128	Alanine	Fontana RJ	Idiosyncratic drug-induced liver injury is associated with substantial morbidity and mortality within 6 months from onset.	Gastroenterology	2014	26
25019921	Alanine	Weiß J	Non-alcoholic fatty liver disease: epidemiology, clinical course, investigation, and treatment.	Deutsches Arzteblatt international	2014	22
25873639	Alanine	Kwok R	Screening diabetic patients for non-alcoholic fatty liver disease with controlled attenuation parameter and liver stiffness measurements: a prospective cohort study.	Gut	2016	18
26171685	Alanine	Koehler EM	Presence of diabetes mellitus and steatosis is associated with liver stiffness in a general population: The Rotterdam study.	Hepatology	2016	15
26667191	Alanine	Ballestri S	Nonalcoholic fatty liver disease is associated with an almost twofold increased risk of incident type 2 diabetes and metabolic syndrome. Evidence from a systematic review and meta-analysis.	Journal of gastroenterology and hepatology	2016	33
27002799	Alanine	Nelson JE	Vitamin D Deficiency Is Associated With Increased Risk of Non-alcoholic Steatohepatitis in Adults With Non-alcoholic Fatty Liver Disease: Possible Role for MAPK and NF-κB?	The American journal of gastroenterology	2016	15
27151177	Alanine	Cui J	Sitagliptin vs. placebo for non-alcoholic fatty liver disease: A randomized controlled trial.	Journal of hepatology	2016	15
28119464	Alanine	Nystoriak MA	Ser1928 phosphorylation by PKA stimulates the L-type Ca2+ channel CaV1.2 and vasoconstriction during acute hyperglycemia and diabetes.	Science signaling	2017	9
9054939	Amino Acids	Fleury C	Uncoupling protein-2: a novel gene linked to obesity and hyperinsulinemia.	Nature genetics	1997	199
12077142	Amino Acids	Miura S	Functional conservation for lipid storage droplet association among Perilipin, ADRP, and TIP47 (PAT)-related proteins in mammals, Drosophila, and Dictyostelium.	The Journal of biological chemistry	2002	98
15878852	Amino Acids	Long X	Rheb binding to mammalian target of rapamycin (mTOR) is regulated by amino acid sufficiency.	The Journal of biological chemistry	2005	112
17310145	Amino Acids	Li W	A ubiquitin ligase transfers preformed polyubiquitin chains from a conjugating enzyme to a substrate.	Nature	2007	102
18460336	Amino Acids	Gulati P	Amino acids activate mTOR complex 1 via Ca2+/CaM signaling to hVps34.	Cell metabolism	2008	131
18765678	Amino Acids	Avruch J	Amino acid regulation of TOR complex 1.	American journal of physiology. Endocrinology and metabolism	2009	146
19966268	Amino Acids	Nelson SM	Maternal metabolism and obesity: modifiable determinants of pregnancy outcome.	Human reproduction update	2010	67
20483768	Amino Acids	Lodolce JP	African-derived genetic polymorphisms in TNFAIP3 mediate risk for autoimmunity.	Journal of immunology	2010	43
21284988	Amino Acids	Kim S	Amino acid signaling to mTOR mediated by inositol polyphosphate multikinase.	Cell metabolism	2011	47
22496159	Amino Acids	Cheng S	Metabolite profiling identifies pathways associated with metabolic risk in humans.	Circulation	2012	116
22749019	Amino Acids	Efeyan A	Amino acids and mTORC1: from lysosomes to disease.	Trends in molecular medicine	2012	126
23150676	Amino Acids	Jansson N	Activation of placental mTOR signaling and amino acid transporters in obese women giving birth to large babies.	The Journal of clinical endocrinology and metabolism	2013	50
23165769	Amino Acids	Rosario FJ	Mammalian target of rapamycin signalling modulates amino acid uptake by regulating transporter cell surface abundance in primary human trophoblast cells.	The Journal of physiology	2013	39
23694989	Amino Acids	Kim SG	Nutrient regulation of the mTOR complex 1 signaling pathway.	Molecules and cells	2013	58
23762245	Amino Acids	Jia X	Imputing amino acid polymorphisms in human leukocyte antigens.	PloS one	2013	132
23884885	Amino Acids	Menni C	Biomarkers for type 2 diabetes and impaired fasting glucose using a nontargeted metabolomics approach.	Diabetes	2013	58
23933118	Amino Acids	Thakker RV	Multiple endocrine neoplasia type 1 (MEN1) and type 4 (MEN4).	Molecular and cellular endocrinology	2014	46
24337580	Amino Acids	Oshiro N	Amino acids activate mammalian target of rapamycin (mTOR) complex 1 without changing Rag GTPase guanyl nucleotide charging.	The Journal of biological chemistry	2014	24
24622670	Amino Acids	Roberts LD	Towards metabolic biomarkers of insulin resistance and type 2 diabetes: progress from the metabolome.	The lancet. Diabetes & endocrinology	2014	28
25242279	Amino Acids	Huang K	Growing knowledge of the mTOR signaling network.	Seminars in cell & developmental biology	2014	66
25651891	Amino Acids	Bowes J	Dense genotyping of immune-related susceptibility loci reveals new insights into the genetics of psoriatic arthritis.	Nature communications	2015	29
25691689	Amino Acids	Soininen P	Quantitative serum nuclear magnetic resonance metabolomics in cardiovascular epidemiology and genetics.	Circulation. Cardiovascular genetics	2015	58
25956028	Amino Acids	Hiramatsu N	Multiple Mechanisms of Unfolded Protein Response-Induced Cell Death.	The American journal of pathology	2015	40
25994336	Amino Acids	Cortes A	Major histocompatibility complex associations of ankylosing spondylitis are complex and involve further epistasis with ERAP1.	Nature communications	2015	22
26168013	Amino Acids	Hu X	Additive and interaction effects at three amino acid positions in HLA-DQ and HLA-DR molecules drive type 1 diabetes risk.	Nature genetics	2015	31
26311460	Amino Acids	Stinghen AE	Uremic Toxicity of Advanced Glycation End Products in CKD.	Journal of the American Society of Nephrology 	2016	23
26733412	Amino Acids	Aguirre GA	Insulin-like growth factor-1 deficiency and metabolic syndrome.	Journal of translational medicine	2016	23
26895884	Amino Acids	Lee CC	Branched-Chain Amino Acids and Insulin Metabolism: The Insulin Resistance Atherosclerosis Study (IRAS).	Diabetes care	2016	11
27304512	Amino Acids	Schafer MJ	Quantification of GDF11 and Myostatin in Human Aging and Cardiovascular Disease.	Cell metabolism	2016	22
27409811	Amino Acids	Pedersen HK	Human gut microbes impact host serum metabolome and insulin sensitivity.	Nature	2016	63
27597529	Amino Acids	Wolk A	Potential health hazards of eating red meat.	Journal of internal medicine	2017	7
27617932	Amino Acids	Pan M	Regional glutamine deficiency in tumours promotes dedifferentiation through inhibition of histone demethylation.	Nature cell biology	2016	19
27749844	Amino Acids	Majithia AR	Prospective functional classification of all possible missense variants in PPARG.	Nature genetics	2016	15
27898682	Amino Acids	Lotta LA	Genetic Predisposition to an Impaired Metabolism of the Branched-Chain Amino Acids and Risk of Type 2 Diabetes: A Mendelian Randomisation Analysis.	PLoS medicine	2016	13
28089725	Amino Acids	Zhenyukh O	High concentration of branched-chain amino acids promotes oxidative stress, inflammation and migration of human peripheral blood mononuclear cells via mTORC1 activation.	Free radical biology & medicine	2017	7
28380384	Amino Acids	Krishnaiah SY	Clock Regulation of Metabolites Reveals Coupling between Transcription and Metabolism.	Cell metabolism	2017	9
22432104	lixisenatide	Fonseca VA	Efficacy and safety of the once-daily GLP-1 receptor agonist lixisenatide in monotherapy: a randomized, double-blind, placebo-controlled trial in patients with type 2 diabetes (GetGoal-Mono).	Diabetes care	2012	53
22564709	lixisenatide	Seino Y	Randomized, double-blind, placebo-controlled trial of the once-daily GLP-1 receptor agonist lixisenatide in Asian patients with type 2 diabetes insufficiently controlled on basal insulin with or without a sulfonylurea (GetGoal-L-Asia).	Diabetes, obesity & metabolism	2012	69
23368510	lixisenatide	Kapitza C	Pharmacodynamic characteristics of lixisenatide once daily versus liraglutide once daily in patients with type 2 diabetes insufficiently controlled on metformin.	Diabetes, obesity & metabolism	2013	36
23564915	lixisenatide	Riddle MC	Adding once-daily lixisenatide for type 2 diabetes inadequately controlled with newly initiated and continuously titrated basal insulin glargine: a 24-week, randomized, placebo-controlled study (GetGoal-Duo 1).	Diabetes care	2013	57
23628617	lixisenatide	Riddle MC	Adding once-daily lixisenatide for type 2 diabetes inadequately controlled by established basal insulin: a 24-week, randomized, placebo-controlled comparison (GetGoal-L).	Diabetes care	2013	61
23698396	lixisenatide	Rosenstock J	Efficacy and safety of lixisenatide once daily versus exenatide twice daily in type 2 diabetes inadequately controlled on metformin: a 24-week, randomized, open-label, active-controlled study (GetGoal-X).	Diabetes care	2013	43
24650952	lixisenatide	Rosenstock J	Beneficial effects of once-daily lixisenatide on overall and postprandial glycemic levels without significant excess of hypoglycemia in type 2 diabetes inadequately controlled on a sulfonylurea with or without metformin (GetGoal-S).	Journal of diabetes and its complications	2014	31
26384381	lixisenatide	Hernández C	Topical Administration of GLP-1 Receptor Agonists Prevents Retinal Neurodegeneration in Experimental Diabetes.	Diabetes	2016	10
26630143	lixisenatide	Pfeffer MA	Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome.	The New England journal of medicine	2015	126
22614056	copeptins	Enhörning S	Copeptin, a marker of vasopressin, in abdominal obesity, diabetes and microalbuminuria: the prospective Malmö Diet and Cancer Study cardiovascular cohort.	International journal of obesity	2013	26
26794439	copeptins	Christ-Crain M	Copeptin in the diagnosis of vasopressin-dependent disorders of fluid homeostasis.	Nature reviews. Endocrinology	2016	12
19444259	Incretins	Lovshin JA	Incretin-based therapies for type 2 diabetes mellitus.	Nature reviews. Endocrinology	2009	153
21194578	Incretins	Nauck MA	Incretin-based therapies for type 2 diabetes mellitus: properties, functions, and clinical implications.	The American journal of medicine	2011	67
23524641	Incretins	Butler AE	Marked expansion of exocrine and endocrine pancreas with incretin therapy in humans with increased exocrine pancreas dysplasia and the potential for glucagon-producing neuroendocrine tumors.	Diabetes	2013	97
23645884	Incretins	Nauck MA	A critical analysis of the clinical use of incretin-based therapies: The benefits by far outweigh the potential risks.	Diabetes care	2013	51
23645885	Incretins	Butler PC	A critical analysis of the clinical use of incretin-based therapies: Are the GLP-1 therapies safe?	Diabetes care	2013	62
24375052	Incretins	Muskiet MH	The gut-renal axis: do incretin-based agents confer renoprotection in diabetes?	Nature reviews. Nephrology	2014	27
24736555	Incretins	Li L	Incretin treatment and risk of pancreatitis in patients with type 2 diabetes mellitus: systematic review and meta-analysis of randomised and non-randomised studies.	BMJ	2014	41
25325735	Incretins	Balestrieri ML	Sirtuin 6 expression and inflammatory activity in diabetic atherosclerotic plaques: effects of incretin treatment.	Diabetes	2015	22
26450639	Incretins	Fulcher G	Efficacy and safety of canagliflozin when used in conjunction with incretin-mimetic therapy in patients with type 2 diabetes.	Diabetes, obesity & metabolism	2016	11
16154196	pegaptanib	Cunningham ET Jr	A phase II randomized double-masked trial of pegaptanib, an anti-vascular endothelial growth factor aptamer, for diabetic macular edema.	Ophthalmology	2005	109
16518379	pegaptanib	Ng EW	Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular disease.	Nature reviews. Drug discovery	2006	228
18163003	pegaptanib	Andreoli CM	Anti-vascular endothelial growth factor therapy for ocular neovascular disease.	Current opinion in ophthalmology	2007	60
21529957	pegaptanib	Sultan MB	A phase 2/3, multicenter, randomized, double-masked, 2-year trial of pegaptanib sodium for the treatment of diabetic macular edema.	Ophthalmology	2011	39
23385630	pegaptanib	Zehetner C	Plasma levels of vascular endothelial growth factor before and after intravitreal injection of bevacizumab, ranibizumab and pegaptanib in patients with age-related macular degeneration, and in patients with diabetic macular oedema.	The British journal of ophthalmology	2013	31
16816950	vildagliptin	Matikainen N	Vildagliptin therapy reduces postprandial intestinal triglyceride-rich lipoprotein particles in patients with type 2 diabetes.	Diabetologia	2006	61
17098089	vildagliptin	Drucker DJ	The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes.	Lancet	2006	626
17277036	vildagliptin	Bosi E	Effects of vildagliptin on glucose control over 24 weeks in patients with type 2 diabetes inadequately controlled with metformin.	Diabetes care	2007	79
17353295	vildagliptin	Wajchenberg BL	beta-cell failure in diabetes and preservation by clinical treatment.	Endocrine reviews	2007	147
17387446	vildagliptin	Fonseca V	Addition of vildagliptin to insulin improves glycaemic control in type 2 diabetes.	Diabetologia	2007	69
18425967	vildagliptin	Richter B	Dipeptidyl peptidase-4 (DPP-4) inhibitors for type 2 diabetes mellitus.	The Cochrane database of systematic reviews	2008	55
21812507	vildagliptin	Baetta R	Pharmacology of dipeptidyl peptidase-4 inhibitors: similarities and differences.	Drugs	2011	42
22106978	vildagliptin	Monami M	Safety of dipeptidyl peptidase-4 inhibitors: a meta-analysis of randomized clinical trials.	Current medical research and opinion	2011	42
22608780	vildagliptin	Aroda VR	Efficacy of GLP-1 receptor agonists and DPP-4 inhibitors: meta-analysis and systematic review.	Clinical therapeutics	2012	48
22688551	vildagliptin	Rizzo MR	Reduction of oxidative stress and inflammation by blunting daily acute glucose fluctuations in patients with type 2 diabetes: role of dipeptidyl peptidase-IV inhibition.	Diabetes care	2012	55
23375680	vildagliptin	Barbieri M	Decreased carotid atherosclerotic process by control of daily acute glucose fluctuations in diabetic patients treated by DPP-IV inhibitors.	Atherosclerosis	2013	29
23837679	vildagliptin	Monami M	Dipeptidyl peptidase-4 inhibitors and pancreatitis risk: a meta-analysis of randomized clinical trials.	Diabetes, obesity & metabolism	2014	22
28231835	vildagliptin	Dei Cas A	Vildagliptin, but not glibenclamide, increases circulating endothelial progenitor cell number: a 12-month randomized controlled trial in patients with type 2 diabetes.	Cardiovascular diabetology	2017	6
23992601	saxagliptin	Scirica BM	Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus.	The New England journal of medicine	2013	448
24793580	saxagliptin	Monami M	Dipeptidyl peptidase-4 inhibitors and heart failure: a meta-analysis of randomized clinical trials.	Nutrition, metabolism, and cardiovascular diseases 	2014	31
25352655	saxagliptin	Rosenstock J	Dual add-on therapy in type 2 diabetes poorly controlled with metformin monotherapy: a randomized double-blind trial of saxagliptin plus dapagliflozin addition versus single addition of saxagliptin or dapagliflozin to metformin.	Diabetes care	2015	26
25552421	saxagliptin	Udell JA	Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes and moderate or severe renal impairment: observations from the SAVOR-TIMI 53 Trial.	Diabetes care	2015	22
27075625	saxagliptin	Wang H	NRF2 activation by antioxidant antidiabetic agents accelerates tumor metastasis.	Science translational medicine	2016	21
27797925	saxagliptin	Mosenzon O	Effect of Saxagliptin on Renal Outcomes in the SAVOR-TIMI 53 Trial.	Diabetes care	2017	12
22007077	alogliptin	Shah Z	Long-term dipeptidyl-peptidase 4 inhibition reduces atherosclerosis and inflammation via effects on monocyte recruitment and chemotaxis.	Circulation	2011	81
26628419	alogliptin	Mita T	Alogliptin, a Dipeptidyl Peptidase 4 Inhibitor, Prevents the Progression of Carotid Atherosclerosis in Patients With Type 2 Diabetes: The Study of Preventive Effects of Alogliptin on Diabetic Atherosclerosis (SPEAD-A).	Diabetes care	2016	21
18356408	2-(3-(4-ethoxybenzyl)-4-chlorophenyl)-6-hydroxymethyltetrahydro-2H-pyran-3,4,5-triol	Han S	Dapagliflozin, a selective SGLT2 inhibitor, improves glucose homeostasis in normal and diabetic rats.	Diabetes	2008	56
19129748	2-(3-(4-ethoxybenzyl)-4-chlorophenyl)-6-hydroxymethyltetrahydro-2H-pyran-3,4,5-triol	Komoroski B	Dapagliflozin, a novel SGLT2 inhibitor, induces dose-dependent glucosuria in healthy subjects.	Clinical pharmacology and therapeutics	2009	58
19129749	2-(3-(4-ethoxybenzyl)-4-chlorophenyl)-6-hydroxymethyltetrahydro-2H-pyran-3,4,5-triol	Komoroski B	Dapagliflozin, a novel, selective SGLT2 inhibitor, improved glycemic control over 2 weeks in patients with type 2 diabetes mellitus.	Clinical pharmacology and therapeutics	2009	69
19528367	2-(3-(4-ethoxybenzyl)-4-chlorophenyl)-6-hydroxymethyltetrahydro-2H-pyran-3,4,5-triol	Wilding JP	A study of dapagliflozin in patients with type 2 diabetes receiving high doses of insulin plus insulin sensitizers: applicability of a novel insulin-independent treatment.	Diabetes care	2009	87
20609968	2-(3-(4-ethoxybenzyl)-4-chlorophenyl)-6-hydroxymethyltetrahydro-2H-pyran-3,4,5-triol	Bailey CJ	Effect of dapagliflozin in patients with type 2 diabetes who have inadequate glycaemic control with metformin: a randomised, double-blind, placebo-controlled trial.	Lancet	2010	141
21495788	2-(3-(4-ethoxybenzyl)-4-chlorophenyl)-6-hydroxymethyltetrahydro-2H-pyran-3,4,5-triol	Musso G	A novel approach to control hyperglycemia in type 2 diabetes: sodium glucose co-transport (SGLT) inhibitors: systematic review and meta-analysis of randomized trials.	Annals of medicine	2012	45
21816980	2-(3-(4-ethoxybenzyl)-4-chlorophenyl)-6-hydroxymethyltetrahydro-2H-pyran-3,4,5-triol	Nauck MA	Dapagliflozin versus glipizide as add-on therapy in patients with type 2 diabetes who have inadequate glycemic control with metformin: a randomized, 52-week, double-blind, active-controlled noninferiority trial.	Diabetes care	2011	95
22238392	2-(3-(4-ethoxybenzyl)-4-chlorophenyl)-6-hydroxymethyltetrahydro-2H-pyran-3,4,5-triol	Bolinder J	Effects of dapagliflozin on body weight, total fat mass, and regional adipose tissue distribution in patients with type 2 diabetes mellitus with inadequate glycemic control on metformin.	The Journal of clinical endocrinology and metabolism	2012	109
22413962	2-(3-(4-ethoxybenzyl)-4-chlorophenyl)-6-hydroxymethyltetrahydro-2H-pyran-3,4,5-triol	Henry RR	Dapagliflozin, metformin XR, or both: initial pharmacotherapy for type 2 diabetes, a randomised controlled trial.	International journal of clinical practice	2012	51
22431673	2-(3-(4-ethoxybenzyl)-4-chlorophenyl)-6-hydroxymethyltetrahydro-2H-pyran-3,4,5-triol	Wilding JP	Long-term efficacy of dapagliflozin in patients with type 2 diabetes mellitus receiving high doses of insulin: a randomized trial.	Annals of internal medicine	2012	91
23194084	2-(3-(4-ethoxybenzyl)-4-chlorophenyl)-6-hydroxymethyltetrahydro-2H-pyran-3,4,5-triol	Kaku K	Efficacy and safety of dapagliflozin as a monotherapy for type 2 diabetes mellitus in Japanese patients with inadequate glycaemic control: a phase II multicentre, randomized, double-blind, placebo-controlled trial.	Diabetes, obesity & metabolism	2013	25
23668478	2-(3-(4-ethoxybenzyl)-4-chlorophenyl)-6-hydroxymethyltetrahydro-2H-pyran-3,4,5-triol	Lambers Heerspink HJ	Dapagliflozin a glucose-regulating drug with diuretic properties in subjects with type 2 diabetes.	Diabetes, obesity & metabolism	2013	62
23735727	2-(3-(4-ethoxybenzyl)-4-chlorophenyl)-6-hydroxymethyltetrahydro-2H-pyran-3,4,5-triol	DeFronzo RA	Characterization of renal glucose reabsorption in response to dapagliflozin in healthy subjects and subjects with type 2 diabetes.	Diabetes care	2013	34
23806570	2-(3-(4-ethoxybenzyl)-4-chlorophenyl)-6-hydroxymethyltetrahydro-2H-pyran-3,4,5-triol	Johnsson KM	Vulvovaginitis and balanitis in patients with diabetes treated with dapagliflozin.	Journal of diabetes and its complications	2013	31
23849632	2-(3-(4-ethoxybenzyl)-4-chlorophenyl)-6-hydroxymethyltetrahydro-2H-pyran-3,4,5-triol	Johnsson KM	Urinary tract infections in patients with diabetes treated with dapagliflozin.	Journal of diabetes and its complications	2013	31
23906445	2-(3-(4-ethoxybenzyl)-4-chlorophenyl)-6-hydroxymethyltetrahydro-2H-pyran-3,4,5-triol	Bolinder J	Dapagliflozin maintains glycaemic control while reducing weight and body fat mass over 2 years in patients with type 2 diabetes mellitus inadequately controlled on metformin.	Diabetes, obesity & metabolism	2014	58
23911013	2-(3-(4-ethoxybenzyl)-4-chlorophenyl)-6-hydroxymethyltetrahydro-2H-pyran-3,4,5-triol	Wilding JP	Dapagliflozin in patients with type 2 diabetes receiving high doses of insulin: efficacy and safety over 2 years.	Diabetes, obesity & metabolism	2014	47
24067431	2-(3-(4-ethoxybenzyl)-4-chlorophenyl)-6-hydroxymethyltetrahydro-2H-pyran-3,4,5-triol	Kohan DE	Long-term study of patients with type 2 diabetes and moderate renal impairment shows that dapagliflozin reduces weight and blood pressure but does not improve glycemic control.	Kidney international	2014	79
24144654	2-(3-(4-ethoxybenzyl)-4-chlorophenyl)-6-hydroxymethyltetrahydro-2H-pyran-3,4,5-triol	Jabbour SA	Dapagliflozin is effective as add-on therapy to sitagliptin with or without metformin: a 24-week, multicenter, randomized, double-blind, placebo-controlled study.	Diabetes care	2014	48
24257692	2-(3-(4-ethoxybenzyl)-4-chlorophenyl)-6-hydroxymethyltetrahydro-2H-pyran-3,4,5-triol	Gilbert RE	Sodium-glucose linked transporter-2 inhibitors: potential for renoprotection beyond blood glucose lowering?	Kidney international	2014	23
24378206	2-(3-(4-ethoxybenzyl)-4-chlorophenyl)-6-hydroxymethyltetrahydro-2H-pyran-3,4,5-triol	Ji L	Dapagliflozin as monotherapy in drug-naive Asian patients with type 2 diabetes mellitus: a randomized, blinded, prospective phase III study.	Clinical therapeutics	2014	28
24463448	2-(3-(4-ethoxybenzyl)-4-chlorophenyl)-6-hydroxymethyltetrahydro-2H-pyran-3,4,5-triol	Merovci A	Dapagliflozin improves muscle insulin sensitivity but enhances endogenous glucose production.	The Journal of clinical investigation	2014	110
24631482	2-(3-(4-ethoxybenzyl)-4-chlorophenyl)-6-hydroxymethyltetrahydro-2H-pyran-3,4,5-triol	Oliva RV	Blood pressure effects of sodium-glucose co-transport 2 (SGLT2) inhibitors.	Journal of the American Society of Hypertension 	2014	38
24890683	2-(3-(4-ethoxybenzyl)-4-chlorophenyl)-6-hydroxymethyltetrahydro-2H-pyran-3,4,5-triol	Leiter LA	Dapagliflozin added to usual care in individuals with type 2 diabetes mellitus with preexisting cardiovascular disease: a 24-week, multicenter, randomized, double-blind, placebo-controlled study with a 28-week extension.	Journal of the American Geriatrics Society	2014	21
25246775	2-(3-(4-ethoxybenzyl)-4-chlorophenyl)-6-hydroxymethyltetrahydro-2H-pyran-3,4,5-triol	Nauck MA	Update on developments with SGLT2 inhibitors in the management of type 2 diabetes.	Drug design, development and therapy	2014	40
25271207	2-(3-(4-ethoxybenzyl)-4-chlorophenyl)-6-hydroxymethyltetrahydro-2H-pyran-3,4,5-triol	Henry RR	Exploring the potential of the SGLT2 inhibitor dapagliflozin in type 1 diabetes: a randomized, double-blind, placebo-controlled pilot study.	Diabetes care	2015	36
25488697	2-(3-(4-ethoxybenzyl)-4-chlorophenyl)-6-hydroxymethyltetrahydro-2H-pyran-3,4,5-triol	Scheen AJ	Pharmacodynamics, efficacy and safety of sodium-glucose co-transporter type 2 (SGLT2) inhibitors for the treatment of type 2 diabetes mellitus.	Drugs	2015	31
25592197	2-(3-(4-ethoxybenzyl)-4-chlorophenyl)-6-hydroxymethyltetrahydro-2H-pyran-3,4,5-triol	Matthaei S	Dapagliflozin improves glycemic control and reduces body weight as add-on therapy to metformin plus sulfonylurea: a 24-week randomized, double-blind clinical trial.	Diabetes care	2015	19
25735400	2-(3-(4-ethoxybenzyl)-4-chlorophenyl)-6-hydroxymethyltetrahydro-2H-pyran-3,4,5-triol	Del Prato S	Long-term glycaemic response and tolerability of dapagliflozin versus a sulphonylurea as add-on therapy to metformin in patients with type 2 diabetes: 4-year data.	Diabetes, obesity & metabolism	2015	23
25894829	2-(3-(4-ethoxybenzyl)-4-chlorophenyl)-6-hydroxymethyltetrahydro-2H-pyran-3,4,5-triol	Bonner C	Inhibition of the glucose transporter SGLT2 with dapagliflozin in pancreatic alpha cells triggers glucagon secretion.	Nature medicine	2015	58
26620248	2-(3-(4-ethoxybenzyl)-4-chlorophenyl)-6-hydroxymethyltetrahydro-2H-pyran-3,4,5-triol	Weber MA	Blood pressure and glycaemic effects of dapagliflozin versus placebo in patients with type 2 diabetes on combination antihypertensive therapy: a randomised, double-blind, placebo-controlled, phase 3 study.	The lancet. Diabetes & endocrinology	2016	17
26895767	2-(3-(4-ethoxybenzyl)-4-chlorophenyl)-6-hydroxymethyltetrahydro-2H-pyran-3,4,5-triol	Sonesson C	Cardiovascular effects of dapagliflozin in patients with type 2 diabetes and different risk categories: a meta-analysis.	Cardiovascular diabetology	2016	26
27059700	2-(3-(4-ethoxybenzyl)-4-chlorophenyl)-6-hydroxymethyltetrahydro-2H-pyran-3,4,5-triol	Zaccardi F	Efficacy and safety of sodium-glucose co-transporter-2 inhibitors in type 2 diabetes mellitus: systematic review and network meta-analysis.	Diabetes, obesity & metabolism	2016	21
27651331	2-(3-(4-ethoxybenzyl)-4-chlorophenyl)-6-hydroxymethyltetrahydro-2H-pyran-3,4,5-triol	Frías JP	Exenatide once weekly plus dapagliflozin once daily versus exenatide or dapagliflozin alone in patients with type 2 diabetes inadequately controlled with metformin monotherapy (DURATION-8): a 28 week, multicentre, double-blind, phase 3, randomised controlled trial.	The lancet. Diabetes & endocrinology	2016	13
28504650	2-(3-(4-ethoxybenzyl)-4-chlorophenyl)-6-hydroxymethyltetrahydro-2H-pyran-3,4,5-triol	Kraakman MJ	Neutrophil-derived S100 calcium-binding proteins A8/A9 promote reticulated thrombocytosis and atherogenesis in diabetes.	The Journal of clinical investigation	2017	10
28522450	2-(3-(4-ethoxybenzyl)-4-chlorophenyl)-6-hydroxymethyltetrahydro-2H-pyran-3,4,5-triol	Kosiborod M	Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study (Comparative Effectiveness of Cardiovascular Outcomes in New Users of Sodium-Glucose Cotransporter-2 Inhibitors).	Circulation	2017	27
21208359	rGLP-1 protein	Madsbad S	An overview of once-weekly glucagon-like peptide-1 receptor agonists--available efficacy and safety data and perspectives for the future.	Diabetes, obesity & metabolism	2011	42
24703047	rGLP-1 protein	Pratley RE	Once-weekly albiglutide versus once-daily liraglutide in patients with type 2 diabetes inadequately controlled on oral drugs (HARMONY 7): a randomised, open-label, multicentre, non-inferiority phase 3 study.	The lancet. Diabetes & endocrinology	2014	51
27981757	rGLP-1 protein	Htike ZZ	Efficacy and safety of glucagon-like peptide-1 receptor agonists in type 2 diabetes: A systematic review and mixed-treatment comparison analysis.	Diabetes, obesity & metabolism	2017	6
21270174	insulin degludec	Birkeland KI	Insulin degludec in type 1 diabetes: a randomized controlled trial of a new-generation ultra-long-acting insulin compared with insulin glargine.	Diabetes care	2011	43
22521071	insulin degludec	Heller S	Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 1 diabetes (BEGIN Basal-Bolus Type 1): a phase 3, randomised, open-label, treat-to-target non-inferiority trial.	Lancet	2012	76
22521072	insulin degludec	Garber AJ	Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 2 diabetes (BEGIN Basal-Bolus Type 2): a phase 3, randomised, open-label, treat-to-target non-inferiority trial.	Lancet	2012	74
22594461	insulin degludec	Heise T	Insulin degludec: four times lower pharmacodynamic variability than insulin glargine under steady-state conditions in type 1 diabetes.	Diabetes, obesity & metabolism	2012	88
23043166	insulin degludec	Zinman B	Insulin degludec versus insulin glargine in insulin-naive patients with type 2 diabetes: a 1-year, randomized, treat-to-target trial (BEGIN Once Long).	Diabetes care	2012	69
23393185	insulin degludec	Mathieu C	Efficacy and safety of insulin degludec in a flexible dosing regimen vs insulin glargine in patients with type 1 diabetes (BEGIN: Flex T1): a 26-week randomized, treat-to-target trial with a 26-week extension.	The Journal of clinical endocrinology and metabolism	2013	41
23715753	insulin degludec	Gough SC	Low-volume insulin degludec 200 units/ml once daily improves glycemic control similarly to insulin glargine with a low risk of hypoglycemia in insulin-naive patients with type 2 diabetes: a 26-week, randomized, controlled, multinational, treat-to-target trial: the BEGIN LOW VOLUME trial.	Diabetes care	2013	31
25114296	insulin degludec	Buse JB	Contribution of liraglutide in the fixed-ratio combination of insulin degludec and liraglutide (IDegLira).	Diabetes care	2014	43
25179915	insulin degludec	Haahr H	A review of the pharmacological properties of insulin degludec and their clinical relevance.	Clinical pharmacokinetics	2014	23
25190523	insulin degludec	Gough SC	Efficacy and safety of a fixed-ratio combination of insulin degludec and liraglutide (IDegLira) compared with its components given alone: results of a phase 3, open-label, randomised, 26-week, treat-to-target trial in insulin-naive patients with type 2 diabetes.	The lancet. Diabetes & endocrinology	2014	45
26934259	insulin degludec	Lingvay I	Effect of Insulin Glargine Up-titration vs Insulin Degludec/Liraglutide on Glycated Hemoglobin Levels in Patients With Uncontrolled Type 2 Diabetes: The DUAL V Randomized Clinical Trial.	JAMA	2016	24
21985634	empagliflozin	Grempler R	Empagliflozin, a novel selective sodium glucose cotransporter-2 (SGLT-2) inhibitor: characterisation and comparison with other SGLT-2 inhibitors.	Diabetes, obesity & metabolism	2012	60
23390498	empagliflozin	Panchapakesan U	Effects of SGLT2 inhibition in human kidney proximal tubular cells--renoprotection in diabetic nephropathy?	PloS one	2013	38
23398530	empagliflozin	Ferrannini E	A Phase IIb, randomized, placebo-controlled study of the SGLT2 inhibitor empagliflozin in patients with type 2 diabetes.	Diabetes, obesity & metabolism	2013	32
23906374	empagliflozin	Rosenstock J	Efficacy and safety of empagliflozin, a sodium glucose cotransporter 2 (SGLT2) inhibitor, as add-on to metformin in type 2 diabetes with mild hyperglycaemia.	Diabetes, obesity & metabolism	2013	33
23963895	empagliflozin	Häring HU	Empagliflozin as add-on to metformin plus sulfonylurea in patients with type 2 diabetes: a 24-week, randomized, double-blind, placebo-controlled trial.	Diabetes care	2013	59
24186878	empagliflozin	Ferrannini E	Long-term safety and efficacy of empagliflozin, sitagliptin, and metformin: an active-controlled, parallel-group, randomized, 78-week open-label extension study in patients with type 2 diabetes.	Diabetes care	2013	34
24334175	empagliflozin	Cherney DZ	Renal hemodynamic effect of sodium-glucose cotransporter 2 inhibition in patients with type 1 diabetes mellitus.	Circulation	2014	136
24463454	empagliflozin	Ferrannini E	Metabolic response to sodium-glucose cotransporter 2 inhibition in type 2 diabetic patients.	The Journal of clinical investigation	2014	109
24475922	empagliflozin	Cherney DZ	The effect of empagliflozin on arterial stiffness and heart rate variability in subjects with uncomplicated type 1 diabetes mellitus.	Cardiovascular diabetology	2014	58
24595630	empagliflozin	Perkins BA	Sodium-glucose cotransporter 2 inhibition and glycemic control in type 1 diabetes: results of an 8-week open-label proof-of-concept trial.	Diabetes care	2014	42
24722494	empagliflozin	Häring HU	Empagliflozin as add-on to metformin in patients with type 2 diabetes: a 24-week, randomized, double-blind, placebo-controlled trial.	Diabetes care	2014	47
24766495	empagliflozin	Liakos A	Efficacy and safety of empagliflozin for type 2 diabetes: a systematic review and meta-analysis.	Diabetes, obesity & metabolism	2014	36
24795251	empagliflozin	Barnett AH	Efficacy and safety of empagliflozin added to existing antidiabetes treatment in patients with type 2 diabetes and chronic kidney disease: a randomised, double-blind, placebo-controlled trial.	The lancet. Diabetes & endocrinology	2014	70
24929430	empagliflozin	Rosenstock J	Improved glucose control with weight loss, lower insulin doses, and no increased hypoglycemia with empagliflozin added to titrated multiple daily injections of insulin in obese inadequately controlled type 2 diabetes.	Diabetes care	2014	50
24943000	empagliflozin	Zinman B	Rationale, design, and baseline characteristics of a randomized, placebo-controlled cardiovascular outcome trial of empagliflozin (EMPA-REG OUTCOME™).	Cardiovascular diabetology	2014	23
25583754	empagliflozin	DeFronzo RA	Combination of empagliflozin and linagliptin as second-line therapy in subjects with type 2 diabetes inadequately controlled on metformin.	Diabetes care	2015	34
25633662	empagliflozin	Lewin A	Initial combination of empagliflozin and linagliptin in subjects with type 2 diabetes.	Diabetes care	2015	25
26040302	empagliflozin	Rosenstock J	Impact of empagliflozin added on to basal insulin in type 2 diabetes inadequately controlled on basal insulin: a 78-week randomized, double-blind, placebo-controlled trial.	Diabetes, obesity & metabolism	2015	25
26180105	empagliflozin	Ferrannini G	Energy Balance After Sodium-Glucose Cotransporter 2 Inhibition.	Diabetes care	2015	24
26861783	empagliflozin	Ferrannini E	Shift to Fatty Substrate Utilization in Response to Sodium-Glucose Cotransporter 2 Inhibition in Subjects Without Diabetes and Patients With Type 2 Diabetes.	Diabetes	2016	20
26880444	empagliflozin	Rajasekeran H	Sodium-glucose cotransporter 2 inhibition and cardiovascular risk reduction in patients with type 2 diabetes: the emerging role of natriuresis.	Kidney international	2016	13
27112340	empagliflozin	Sattar N	SGLT2 Inhibition and cardiovascular events: why did EMPA-REG Outcomes surprise and what were the likely mechanisms?	Diabetologia	2016	16
27208375	empagliflozin	Abdul-Ghani M	SGLT2 Inhibitors and Cardiovascular Risk: Lessons Learned From the EMPA-REG OUTCOME Study.	Diabetes care	2016	30
27289124	empagliflozin	Mudaliar S	Can a Shift in Fuel Energetics Explain the Beneficial Cardiorenal Outcomes in the EMPA-REG OUTCOME Study? A Unifying Hypothesis.	Diabetes care	2016	43
27299675	empagliflozin	Wanner C	Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes.	The New England journal of medicine	2016	143
27488726	empagliflozin	Monami M	Effects of SGLT-2 inhibitors on mortality and cardiovascular events: a comprehensive meta-analysis of randomized controlled trials.	Acta diabetologica	2017	11
27878313	empagliflozin	Vallon V	Targeting renal glucose reabsorption to treat hyperglycaemia: the pleiotropic effects of SGLT2 inhibition.	Diabetologia	2017	15
15504986	22-hydroxyvitamin D4	Smyth D	Replication of an association between the lymphoid tyrosine phosphatase locus (LYP/PTPN22) with type 1 diabetes, and evidence for its role as a general autoimmunity locus.	Diabetes	2004	105
15934099	22-hydroxyvitamin D4	Hinks A	Association between the PTPN22 gene and rheumatoid arthritis and juvenile idiopathic arthritis in a UK population: further support that PTPN22 is an autoimmunity gene.	Arthritis and rheumatism	2005	72
16697661	22-hydroxyvitamin D4	Bottini N	Role of PTPN22 in type 1 diabetes and other autoimmune diseases.	Seminars in immunology	2006	65
19073967	22-hydroxyvitamin D4	Smyth DJ	Shared and distinct genetic variants in type 1 diabetes and celiac disease.	The New England journal of medicine	2008	216
21983784	22-hydroxyvitamin D4	Rivas MA	Deep resequencing of GWAS loci identifies independent rare variants associated with inflammatory bowel disease.	Nature genetics	2011	243
